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1. Abusing: Verbal or physical behavior intended to harm PLHIV, such as ridicule, insult and 
blame.1 
2. Actionable drivers: Factors that negatively influence the stigmatization process.2These 
include: lack of awareness of stigma and its negative impacts, fear of casual contact with 
PLHIV, fear of social breakdown due to HIV-positive family, and prejudice and stereotypes 
towards PLHIV and populations at highest risk of HIV infection.2 
3. Anticipated stigma: Real or imagined fears of societal attitudes and behaviors (e.g., from 
family, community, health care professionals) if HIV or other stigmatized behavior (e.g., drug 
use) is disclosed.3 
4. Appropriateness: ‘The extent to which an intervention or activity fits with a particular context 
or situation.’4(pp.5) 
5. Cognitive behavioral therapy:Structured, problem-orientated, approach that uses cognitive 
and behavioural methods to challenge dysfunctional beliefs and promote adaptive way of 
thinking and bring about behavioural and emotional changes.5 
6. Code of conduct: An agreed-upon set of principles and behaviors in areas such as patient 
confidentiality, patient rights and respect, and quality of care.6 
7. Discrimination: The experience of prejudice and discrimination that falls inside the purview 
of the law.7Discrimination focuses on behavior. It refers to actions or omissions as the 
enactment of stigma. It occurs when a distinction is made against a person that results in them 
being treated unfairly or unjustly on the basis of their belonging, or perceived to be belonging, 
to a particular group.8 
8. Dissemination: Getting guidelines to the intended users.9 
9. Effectiveness: ‘The extent to which an intervention achieves the intended result or 
outcome.’4(pp.5) 
10. Experienced (enacted) stigma: Forms of stigmatizing behaviors or discrimination that are not 
typically actionable under law and are experienced by PLHIV or key populations.7 
11. Expert patients: ‘HIVpositive lay health workers who function as adherence counsellors, 





12. External stigma: Received and enacted behaviors and attitudes towards PLHIV. This may 
include verbal abuse (blaming, moral judgment, singing offensive songs, scolding and 
insulting PLHIV).11 
13. Facilitators of guideline use: Factors that promote shared decision-making in clinical 
practice.12 
14. Fear-based stigma: Stigma and discrimination that results from irrational fear of acquiring 
infection based on knowledge of the modes of transmission.13 
15. Fear of contagion: Behavior showing a fear of close or direct contact with a PLHIV or things 
s/he has used, and offering/giving less care than is expected in a situation.1 
16. Feasibility: ‘The extent to which an activity or intervention is practical or viable in a particular 
context or situation.’4(pp.5) 
17. Gossiping: Spreading rumors and talking inappropriately to others about another person and 
their illness (such as without permission, in an uncaring manner, in public, or 'behind their 
back').1 
18. Guideline: ‘Statements that include recommendations intended to optimize patient care that 
are informed by a systematic review of evidence and an assessment of the benefits and harms 
of alternative care options.’14(pp.4) 
19. Guideline adaptation:‘A systematic approach for considering the endorsement or 
modification of guidelines produced in one setting for application and implementation in 
another as an alternative to de novo guideline development or as a first step in the process of 
implementation, while preserving evidence-based principles.’15(pp.2) 
20. Healthcare setting: Any type of healthcare facility, which may include, but not limited to 
hospitals, health centers, clinics and health posts.  
21. Healthcare workers:Any health personnel,regardless of their year of training or whether they 
have had specialty training or not, whoare involved in the provision of professional healthcare 
for patients in health facilities. These may include, but not limited to health professionals from 
different disciplines including, Nurses, Medical Doctors, Laboratory Technicians, Medical 
Anthropologists, Medical Sociologists, Psychologists and Psychiatrists, Health Promotion 
experts, Midwives, Pharmacists, Health Extension Workers and community volunteers.  
22. HIV-related stigma: is defined as ‘prejudice, discounting, discrediting and discrimination 
directed at people perceived to have HIV or AIDS and individuals, groups and communities 




23. Internalized (self) stigma: Acceptance by the self that the external stigma—society’s 
judgment of oneself as being of a ‘lesser status’—is true and justified. Can manifest in low 
self-esteem and low sense of worth, self-blame, and self-isolation/withdrawal, fear of 
disclosure.7 
24. Intersecting/compound/layered stigma: Experience of multiple stigmas (e.g., stigma toward 
transgender, migrants, poor women plus HIV stigma).7HIV stigma that is layered on top of 
pre-existing stigmas (frequently toward most-at-risk groups). 
25. Key population groups: Population groups who are more likely to be exposed to HIV or who 
are more likely to transmit HIV and whose engagement is critical for the success of HIV 
response.17 
26. Labeling: Attaching an identifying, often negative, term or sign to a PLHIV.1 
27. Meaningfulness: ‘The extent to which an intervention or activity is positively experienced by 
an individual or a group.’4(pp.5) 
28. Mentorship: An onsite training where experienced health professionals teach other junior and 
less experienced professionals. 
29. Negating: Disallowing access to services and opportunities based on someone's HIV status.1 
30. Neglecting: Offering/giving less care than is expected in a situation.1 
31. Observed stigma: Forms of stigma witnessed by an individual (e.g., gossiping about a client’s 
HIV status as seen by a lab technician).3 
32. One-to-five network: Anetwork of five to six people working in a unit.  
33. People associated with HIV: Population groups who are vulnerable to HIV and who are 
stigmatized in association with HIV 
34. People living close to HIV (PLC): Population groups who are family members or care 
providers for HIV positive clients. 
35. Pestering: Persistent questioning of a PLHIV about his/her behavior or illnesses.1 
36. Perceived stigma: The perception of how people believe and react to PLHIV.18 
37. Practice guidelines: ‘Systematically developed statements to assist practitioner and patient 
decisions about appropriate health care for specific clinical circumstances.9(pp.8) 
38. Psycho education: ‘Systematic, didactic psychotherapeutic interventions that are adequate for 
informing PLHIV and their relatives about the illness and its treatment, facilitating both an 
understanding and personally responsible handling of the illness and supporting those afflicted 




39. Psychological support: ‘Any form of support which is aimed at helping people living with 
HIV to enhance their mental health and their cognitive, emotional and behavioral 
wellbeing.’20(pp.9) 
40. Quality of evidence: The extent to which one can be confident that an estimate of effect is 
correct.21 
41. Quality of life: Overall subjective feelings of wellbeing.19 
42. Received stigma: All types of stigmatizing behavior (e.g. neglecting, fearing contagion, 
avoiding, rejecting, labeling, pestering, negating, abusing and gossiping) directed towards a 
person living with HIV, as experienced or described by themselves or others.7 
43. Rejecting: Behavior that humiliates or breaks off relationships, or that actively separates a 
PLHIV from groups or meetings.11 
44. Resilience: The ability of an individual experiencing stigma and discrimination to overcome 
threats to health and development.22 
45. Revenge and anger: Statements of behaviors indicating a wish for harm to others — usually 
the people who discriminate against PLHIV.11 
46. Secondary (courtesy) stigma: Stigma experienced by individuals who are associated with 
people living with HIV (e.g., family, partners, friends, healthcare professionals).3, 18 
47. Self-exclusion: A process by which a person decides not to use certain services due to his/her 
HIV status and fear of discrimination, and behavior that shows higher levels of achievement 
or exaggerated behavior, to compensate for illness or to lessen stigma.3 
48. Sero-status: The presence or absence of HIV antibodies in blood.17 
49. Social stigma: Stigma stemming from judgment of a person for having HIV, and for engaging 
in a behavior such as drug use or sexual activity or sexual orientation.13 
50. Social withdrawal: When a PLHIV withdraws from a sexual or loving relationship to protect 
him/herself from discrimination.7 
51. Standards: The performance expectations and/or structure and processes that must be in place 
for an organization to provide safe and highquality services.23 
52. Standard precaution: The basic level of infection control precautions for all patients that 
protects both healthcare worker and the patient from exposure to body fluids.6, 24 
53. Stigma: A social process of devaluing persons, beginning with marking or labeling of 
differences, attributing negative connotations or values to those differences, leading to 




54. Strength of evidence: The extent to which one can be confident that the desirable effects of 
the recommended actions outweigh the undesirable effects.21, 25 
55. Structural interventions: ‘Those interventions that seek to alter legal, physical and social 
environment in which a behavior takes place.’17(pp.44) 
56. Thematic analysis:  A method of qualitative data analysis that involves identifying, analyzing 
and reporting patterns within data.26 
57. Value-based stigma: The negative judgments of people living with HIV resulting from 
cultural views and norms about marginalized groups and negative assessments of behaviors 
associated with them.13 
58. Vulnerable groups:  Groups that are subject to societal pressures or social circumstances that 








The stigma and discrimination related to human immunodeficiency virus (HIV) have been 
obstacles against the achievement of the global health priority targets by negatively impacting 
adherence to, and uptake of services. As an effort to improve the practice and service in HIV and 
related areas, this project sought to develop an evidence-informed guideline to reduce HIV-related 
stigma and discrimination.  
Aims: The overall aim of this project was to develop an evidence-informed guideline to reduce 
HIV-related stigma and discrimination among healthcare workers in the Ethiopian context.  
Method 
First, I conducted a systematic literature search for guidelines and systematic reviews, followed 
by systematic review of primary studies. After appraising the evidence found through the literature 
search, a content analysis of the included units of evidences was carried out to generate a list of 
working recommendations. Summaries of Findings tables were produced using software package 
developed by the Grading of Recommendations, Assessment, Development and Evaluation 
(GRADE) working group. The feasibility and appropriateness of the recommendations were then 
assessed using the Guideline Implementability Appraisal (GLIA v.2) checklist. Consensus was 
established through two rounds of a Delphi panel survey and two consensus meetings. The 
recommendations were also evaluated by external reviewers. In the final phase of this project, 
barriers and facilitators to the implementation of the guideline were assessed through key 
informant interviews with health professionals and health managers. 
Results 
Through the systematic literature search for guidelines, best practices, tools and systematic reviews 
I included 12 records (six guideline-related tools, and six systematic reviews). Since adequate 
conclusive evidence could not be drawn from these resources,a systematic review of quantitative 
evidence was undertaken. Initially, 31 recommendations and good practice points were extracted 
and drafted from the content analysis of the documents included. The recommendations were 
evaluated using a Delphi panel and external experts. Based on these evaluations, 12 
recommendations and three good practice points were retained in the final draft. To contextualize 
the recommendations, barriers and facilitators were further explored using key informant 
interviews. The key informants suggested that the guideline should be introduced through training, 
workshops, hard copies, multidisciplinary team (MDT) meeting of experts working on care and 




networks in healthcare facilities. It was also suggested that the indicators should be integrated into 
local hospital key performance indicators (KPI). The importance of identifying and establishing 
the implementation structure, implementation team and a focal person responsible for overseeing 
the implementation of the guideline was stressed. Key informants specifically reported that the 
guideline would help to achieve not only HIV-related goals, but also other health facility initiatives 
such as ‘compassionate,respectful, and caring’ (CRC) services and clean and safe health facility 
(CASH)initiatives.   
Conclusion 
The project sought to develop trustworthy and rigorous guideline that is applicable and can be 
integrated into current initiatives and practices in the Ethiopian context. The current guideline can 
be implemented into new and existing health facility initiatives (such as CRC and CASH) and 
included in platforms like mentorship, multidisciplinary team (MDT) meetings and one-to-five 
networks. To ensure uptake of this guideline, health managers need to identify the implementation 














1.1. Structure of the thesis 
The overall aim of this project was to develop an evidence-informed guideline to reduce 
stigma and discrimination related to human immunodeficiency syndrome (HIV) and 
Acquired Immunodeficiency Syndrome (AIDS) in healthcare settings. The thesis has been 
organized in nine chapters. Chapter one provides an overall introduction to the thesis, the 
general and specific objectives of the research, the significance of the research, the structure 
of the thesis and a background of HIV, HIV-related stigma and discrimination and gaps in 
practice and research. 
Chapter two describesthe methodological background for the project and the methodology 
used for the systematic review, guideline development, evaluation and contextualization. It 
summarizes the significance of putting research into practice, and of developing and 
evaluating guidelines. Chapter three presents the results of systematic reviews of guidelines, 
tools, best practices and systematic reviews on interventions addressing HIV-related stigma 
and discrimination. Chapter four reportson systematic reviews of primary studies of 
interventions on HIV-related stigma and discrimination in healthcare settings. Chapter five 
describesthe guideline development process employed in this project. Chapter six presents 
the internal and external evaluation of the guideline. Chapter seven is a detailed exploration 
of the barriers and facilitators to the implementation of the developed guideline, here after 
referred as ‘the guideline’. Chapter eight contains the guideline. Chapter nine presents the 
discussion, conclusion and recommendations related to the entire project.  
1.2. HIV/AIDS as a public health concern 
The human immunodeficiency virus infection affects all dimensions of the infected person’s 
life: physical, psychological, social and spiritual.27, 28Although the improved access to 
antiretroviral therapy (ART) has improved the survival of people living with HIV (PLHIV), 
there have been increased non-communicable disease co-morbidities in PLHIV.29The co-
morbidities include common mental disorders such as depression, anxiety, somatoform and 
neurological disorders,30 and substance misuse.31-35 
In the last three decades, the HIV and AIDS epidemics have been one of the most challenging 
public health problems in the world. In 2010, HIV was the fifth cause of global disability 
adjusted life years (DALYs).36In 2014, nearly two million were infected by HIV and 1.2 




million PLHIV worldwide. Out of the 36.9 million PLHIV, 17.1 million did not know their 
HIV positive status and 22 million PLHIV did not have access to HIV treatments. Only 15.8 
million had accessed HIV treatment by June 2015.37 
Currently, there is a global commitment to end the HIV/AIDS epidemics by 2030.38As a 
roadmap to end the HIV/AIDS epidemic as a public health threat by the year 2030, the 
United Nations Joint Program of HIV/AIDS (UNAIDS) has set an ambitious goal to be 
achieved by 2020. These goals include making sure 90% of PLHIV know their sero-status 
and 90% of those who know their sero-status are receiving treatment, with 90% of PLHIV 
on treatment having suppressed viral loads.39 If these goals are to be achieved, the stumbling 
blocks of stigma and discrimination need to be addressed.39, 40 
1.3. HIV-related stigma and discrimination 
Stigma and discrimination and their impacts 
Stigma and discrimination have contributed to the continued transmission of HIV and its 
negative impacts from the very beginning of the epidemics of HIV/AIDS.38, 41HIV/AIDS 
stigma is defined as ‘Prejudice, discounting, discrediting and discrimination directed at 
people perceived to have HIV or AIDS and individuals, groups and communities with which 
they are associated.’16(pp.1107) 
Stigma and discrimination were also among the major obstacles against the success of 
prevention, treatment and support programs related to HIV42-50and tuberculosis, because 
tuberculosis is associated with HIV infection.49, 50For example, stigma related to HIV 
compromises access to and adherence to treatment and support programs among people 
living with HIV (PLHIV).51-54HIV/AIDS-related stigma is also associated with poor 
physical health and mental health outcomes47, 53, 55 and low social support and poor income 
for those affected by the virus.55 
Domains of stigma and discrimination 
Stigma and discrimination related to human immune-deficiency virus (HIV) can be 
categorized into four domains: drivers, facilitators, manifestations and intersecting stigma.2 
Drivers are individual level factors that influence the occurrence of stigma. These include 
lack of adequate knowledge, fear of infection or prejudicial attitude towards people living 
with HIV (PLHIV) or key population groups.2 Facilitators are organizational or societal level 
factors that influence stigma. These may include the presence or absence of protective or 
punitive laws, redress systems or support systems.2 Manifestations are the immediate 




perceived stigma.56 Layered or intersecting stigma is stigma faced as a result of HIV status, 
gender, profession, poverty or sexual orientation.2 
Although they are expected to be a source of comfort, support and encouragement, it has 
been documented that healthcare providers stigmatize PLHIV.57, 58 This stigma is often 
manifested in the form of negligence, breaches of confidentiality, gossip, excessive or 
differential precautions, poor support, delayed or denial of treatment, or differential 
treatment and unnecessary referrals based on their sero-status.57, 59 Therefore, PLHIV are not 
getting enough support because of their low healthcare seeking behavior related to fear of 
stigma or because of negligence by healthcare workers (HCWs).  
Globally, all governments have committed to protect the human rights of PLHIV.60 Studies 
have indicated that the involvement of PLHIV,61 and the  improvement of communication 
and HIV-related knowledge,62 help in reducing HIV-related stigma and discrimination.To 
improve the coping skills of PLHIV and people living close to HIV (PLC), there is a need 
for evidence-based interventions for promoting the psychological wellbeing of PLHIV and 
PLC, and addressing stigma and discrimination.54, 63While the nature of stigma and 
discrimination is similar across countries,64 no standard guideline has been developed for 
averting HIV-related stigma and discrimination. Researchers recommend that theory and 
evidence-based interventions are important for reducing HIV-related stigma and 
discrimination in developing countries.65 
1.4. Researcher’s history and experience 
Garumma Tolu Feyissa has a bachelor-level training as a Medical Officer. With this training, 
Garumma has been engaged in teaching and mentoring health science students on clinical 
and public health subjects. He has also been supervising them during their clinical 
attachments. He has receivedhis master’s degree in Public Health (Masters of Public Health) 
with both research and course components, after which his engagement in research 
commenced. Garumma has conducted qualitative, quantitative and mixed methods research 
on areas such as HIV, alcohol use disorders, substance use disorders, nutrition, depression, 
psychosis, primary healthcareand community-based health services. Garumma also has 
experience in conducting systematic reviews, best practice implementation and in guideline 
development. In addition, Garumma has been supervising medical and health sciences 
students in Jimma University on different topics for their master’s thesis and senior research 
projects. In addition, Garumma has undergone community-based education (CBE) programs 




a faculty member. Garumma has also undertaken various short-term trainings such as clinical 
fellowship program and a train the trainer program in comprehensive systematic reviews 
with the Joanna Brigg’s Institute (JBI) and other training programs on health systems 
research, policy brief and health technology assessment (HTA). These opportunities have 
contributed to Garumma’s understanding of the social and medical approaches for solving 
health problems. Particularly, Garumma’s previous experience on HIV-related stigma and 
HIV care givers research projects has laid the foundation for the current PhD project which 
aimed to put research into practice to reduce HIV-related stigma and discrimination. 
1.5. Aims/objectives of the PhD project 
The overall aim of this project was to develop an evidence-informed guideline to reduce 
HIV-related stigma and discrimination inEthiopian healthcare settings. Specifically, the 
main aims of this project were: 
1. To conduct a systematic review to establish a global evidence base on approaches to 
reducing HIV-related stigma and discrimination in healthcare settings. 
2. To appraise and select existing evidence on reducing HIV-related stigma and 
discrimination. 
3. To develop a guideline to reduce HIV-related stigma and discrimination for the 
Ethiopian context. 
4. To conduct internal and external evaluation of the guideline. 
5. To contextualize the guideline to local policy and practice. 
The stated objectives, were addressed through activities conducted using a series of phases. 
In phase 1, asystematic search was conducted to locate guidelines, tools, best practices, 
consensus statements and systematic reviews on this topic. Following this, a systematic 
review of primary studies was conducted.In phase 2, recommendations were extracted from 
the best available evidence on the strategies/interventions to reduce HIV-related stigma and 
discrimination. Based on the CAN Implement Guideline methodology,66 and drawing upon 
the Knowledge to Action model published by Graham et al,67 all available 
guidelines/systematic reviews were identified, reviewed and evaluated to confirm whether a 
de-novo development was required, or whether adaption was appropriate.In this phase, the 
units of evidence (systematic reviews, guidelines and primary studies) were identified and 
critically appraised. Following that, content analyses of the units of evidence were carried 
out to generate the list of working recommendations and draft a guideline. The draft 




recommendations drafted were tested for feasibility and appropriateness to the Ethiopian 
context. In this phase, the clarity, acceptability and relevance of the guideline were assessed 
using a multi-round Delphi survey and external panel review.In phase 4, barriers and 
facilitators to guideline implementation were identified through key informant interviews. 





Figure 1. Phases of the PhD project 
 
1.6. Significance/Contribution of the project 
It has been indicated that HIV-related stigma and discrimination are obstaclesto the 
achievement of the global health priority targets, such as prevention of maternal to child 
transmission of HIV (PMTCT) by negatively impacting adherence to, and uptake of 
services.45, 68 Researchers recommend the integration of stigma reduction into maternal, 
neonatal, and child health services.45 
However, there are no rigorous evidence-informed guidelines to guide interventions to 
reduce HIV-related stigma. Without an evidence-informed guideline, it is difficult to judge 
whether a program is being implemented effectively or not and whether or not it is having a 
positive impact. In addition, whether the activities being undertaken are averting stigma or 
enhancing stigma is not clear. Systematic methods of making judgements based on evidence 
can reduce such errors.69 
As an effort to fill this knowledge and practice gap, this project searched the evidence and 
developed an evidence-informed guideline to tackle HIV-related stigma and discrimination, 
and to form a basis for regular auditing for adherence to this guideline and other guidelines. 
To customize the guideline to Ethiopian healthcare settings, the project identified potential 
barriers and facilitators of the implementation of the guideline. Such tailoring of the 
guideline based on the local context will potentially increase the uptake of the guideline. 




a. Healthcare providers, including health extension workers/community health workers 
b. Health managers at different levels 
c. Social support groups/home-based care volunteers; in Ethiopia, community 
volunteers provide free care and support services for PLHIV.70 
In addition, faith-based organizations and non-governmental organizations (NGO’s) 
involved in providing services for PLHIV may use the guideline to advocate for the 
improvement of services provided to PLHIV. 
The guideline provides evidence-informed recommendations for policy makers and health 
professionals to accomplish the following objectives: 
1. To reduce stigmatizing attitudes and actions towards people living with, or affected 
by HIV. 
2. To reduce perceived or felt stigma faced by people living with, or affected by HIV. 
3. To promote healthcare seeking and utilization behavior among people affected by or 
living with HIV. 
The fulfillment of the above objectives will, in the long run, help to ensure that all people 








2.1. Chapter overview 
This chapter describes evidence-based healthcare and theunderpinning theoretical basis for 
the methods employed in the different phases of this PhD work. The first phase was 
searching global evidence for existing guidelines, tools, best practices, and systematic 
reviews, and a separate search for intervention studies addressing HIV-related stigma and 
discrimination in healthcare settings. The second phase included formulation of 
recommendations and development of the guideline. The third phase was internal and 
external evaluation of the guideline and the fourth phase was contextualizing the guideline 
to local policy and practice. Therefore, this chapter describes an overview of the methods 
related to activities conducted in these phases of the PhD project. 
2.2. Evidence-Based Medicine and its evolution 
The philosophy of Evidence-Based Medicine (EBM) dates back to the mid-19th century. It 
was defined by Sackettet al.71(pp.71)as: ‘The conscientious, explicit, and judicious use of 
current best evidence in making decisions about the care of individual patients. The practice 
of evidence-based medicine means integrating individual clinical expertise with the best 
available external clinical evidence from systematic research. 
Evidence-Based Medicine has evolved as a result of the recognition by professionals from 
various disciplines that evidence is critical to informing healthcare decisions. Apart from the 
discipline of medicine, other health disciplines such as Nursing, Social Care and Public 
Health have adopted the principle of EBMin their disciplines.72-74 Jenicek argued that the 
same procedure and principle of basing decisions on evidence should be considered in public 
health. Hence, he defined Evidence-Based Public Health (EBPH) as ‘…the conscientious, 
explicit, and judicious use of current best evidence in making decisions about the care of 
communities and populations in the domain of health protection, disease prevention, health 
maintenance and improvement (health promotion)’.73(pp.190) 
Kohatsu defined EBPH as ‘the process of integrating science-based interventions with 
community preferences to improve the health of populations’.(pp.419)75Similarly, recognizing 
the importance of evidence in social care, evidence-based social care was defined as ‘…the 
conscientious, and judicious use of current best evidence in making decisions regarding the 




Moreover, there has been an evolution in the paradigm of EBM. French et al.72 criticized the 
concept of EBM for its tendency to medicalise the healthcare system and for neglecting other 
perspectives of evidence related to healthcare systems such as preventive healthcare. They 
also criticized EBM for defining evidence in quantitative terms. In addition, they criticized 
EBM for failing to incorporate the links between practitioner’s understanding of the situation 
and the evidence that already exists.72 Based on this analysis French et al.72 clarified the 
definition put by Sachett et al. and they put definition of evidence based practice (EBP) as 
‘The systematic interconnecting of scientifically generated evidence with the tacit 
knowledge of the expert practitioners to achieve change in a particular practice for the 
benefit of a well-defined client or patient group’.72(pp.74) 
French et al.72 emphasized that there should be a link between external global evidence and 
the expert’s experience. In line with the clarification made by French et al.,72 the current 
project considered both global evidence found through systematic literature searchesas well 
as tacit knowledge of experts through Delphi surveys, consultative meetings (reported in 
chapter six), key informant interviews (reported in chapter seven) and formal and informal 
engagement with the experts to develop a guideline to reduce HIV-related stigma and 
discrimination (reported in chapter eight).  
Evidence-based practice (EBP) involves the identification, evaluation and application of the 
best available evidence related to a client’s problems to make decisions.76Nevertheless, EBP 
has been criticized in that it tries to utilize scientific rationality in an area in which scientific 
rationality traditionally competes with more practical forms of wisdom. Some of the early 
criticisms of EBP have been reduced by incorporating both interpretive and positivist 
approaches to evidence and decision-making.However, some scholars still argue that such 
modification cannot solve problems in EBP, claiming that it does not address the appropriate 
relationship between evidence and practice. These scholars argued that practice should be 
informed by evidence and that it should not be wholly ‘based’ on evidence alone. Hence, 
they adopted the term evidence-informed practice (EIP). Evidence-informed practice takes 
into consideration ethics and application issues.The proponents of EIP also incorporate 
factors such as values, goals, perspectives and alliances.77 
In line with this claim, this project aimed to develop an evidence-informed guideline to 
reduce HIV-related stigma and discrimination in healthcare settings. This is because, apart 
from the consideration of the available evidence on the effectiveness of interventions that 




barriers to the implementation of the evidence were considered. Hence, the guideline 
developed through this process is named as an evidence-informed guideline.  
2.3. The Joanna Briggs Institute approach to evidence-based healthcare 
The Joanna Briggs Institute (JBI) model of evidence informed healthcare (updated in 2016) 
defines evidence-based healthcare as follows: 
Clinical decision-making that considers the feasibility, appropriateness, 
meaningfulness and effectiveness of healthcare practices. The feasibility, 
appropriateness, meaningfulness and effectiveness of healthcare practices may be 
informed by the best available evidence, the context in which the care is delivered, 
the individual patient, and the professional judgment and expertise of the health 
professional.4(pp.5) 
The JBI model has four major components: a) healthcare evidence generation; b) evidence 
synthesis; c) evidence (knowledge) transfer; and d) evidence utilisation.78 The model uses 
high quality systematic reviews as a basis for the translation of evidence into practice.79 The 






Figure 2. The JBI Model of Evidence based healthcare (source Jordan et al).4(pp.4) 
Evidence synthesized in the form of systematic reviews is translated into guidelines to 
facilitate the dissemination and utilization of evidence generated through research, and the 
evaluation of the impact of utilizing the evidence in practice.79 The current PhD project was 
informed by the JBI model of evidence-based healthcare. Therefore, it considered global 
evidence on the effectiveness of interventions (reported in chapters three and four)located 
through systematic literature searches.The meaningfulness data taken from previous 
systematic reviews of qualitative research (reported in chapter three) was included to 
describe what the problem means and to emphasize the significance of addressing the 
problem in the light of the voices of PLHIV.In addition, the appropriateness and feasibilityof 
adapting these global evidence to the local Ethiopian context were assessed through the 
involvement of local experts and collecting contextual information. The experts were 
involved in evaluating (chapter six) and contextualizing the guideline (chapter seven). 
2.2.1. Evidence generation 
According to the modified JBI model of evidence-based healthcare, evidence generation 
comprises both secondary research and primary research. Evidence takes different forms and 




personal experience).4The model4emphasizes the consideration of the best available 
evidence, client preference, professional judgment and contextual factors when making 
evidence-based decisions in healthcare. Hence, the model encourages decision-making 
based on evidence of feasibility, applicability, meaningfulness and effectiveness.4In line 
with this, in the current project, I developed a guideline to reduce HIV-related stigma and 
discrimination with the consideration of evidence generated both through systematic search, 
and expert consultation. The evidence of feasibility and applicability was generated through 
key informant interviews as described in chapter seven. Therefore, the expertise and 
experiences of the local experts and contextual factors influenced the decision on what 
should be included in the guideline and how the guideline should be implemented.  
2.2.2. Evidence synthesis 
According to Jordan etal.,4evidence synthesis is defined as ‘…the evaluation or analysis of 
research evidence and opinion on a specific topic to aid in decision-making in 
healthcare’.4(pp.8)Systematic reviews constitute core part of evidence synthesis.4  Systematic 
reviews differ from traditional literature reviews in that they are systematic and involve 
transparent methods to search, appraise and synthesize the evidence.80The JBI has tools and 
manuals on different types of systematic reviews.81A systematic review needs careful 
planning and guidance. Based on guidance from JBI and other organizations, the conduct of 
a systematic review includes the following steps. 
1. Defining a review question82 
2. Defining inclusion and exclusion criteria82 
3. Searching for evidence 
4. Critical appraisal of retrieved evidence 
5. Data extraction from included studies83 
6. Data analysis/synthesis83 
7. Presentation of findings.84 
The JBI guidelines for systematic reviews recommend that steps be based on an a-priori 
protocol.81The authors of systematic reviews are advised to follow the Preferred Reporting 
Items for Systematic Reviews and Meta-analyses (PRISMA) statement for the conduct and 
reporting of systematic reviews.85Systematic searching and collation of evidence are key 
features of this thesis. Chapter three presents a systematic review of guideline documents, 
tools, best practices, consensus statements and systematic reviews. In this chapter, I critically 




tool developed by the Grading of Recommendations, Assessment, Development and 
Evaluation (GRADE) working group86 and critical appraisal tools for systematic reviews 
from JBI. In this chapter, I analyzed the quality of existing documents and described the 
strengths and limitations of the documents. Chapter four describes a systematic review of 
primary studies of interventions to reduce stigma and discrimination in healthcare settings. 
The qualities of the primary studies were assessed using critical appraisal tools from JBI. In 
presenting the findings of systematic reviews and in developing guidelines, it is imperative 
to indicate both quality and strength of evidence. Quality of evidence shows the degree to 
which one can be confident that an estimate of effect is correct.69 The strength of a 
recommendation indicates the extent to which one can be confident that adherence to the 
recommendation will do more good than harm.69In order to reduce the differences and 
shortcomings in the various grading systems that exist internationally, the GRADE working 
group has created a systematic and transparent method of making judgments about the 
quality and strength of evidence.69 
The GRADE approach considers study design, study quality, consistency, precision, 
publication bias and directness in determining the quality of evidence for each outcome. The 
approach considers the balance between benefits and harms, quality of evidence, 
appropriateness, and the certainty of the baseline risk in making judgments about the strength 
of recommendations.69The GRADE approach has been utilized to assess the quality and 
strength of evidence in the systematic review reported in chapter four and in the guideline 
reported in chapter eight. Details of how the grading system has been applied to develop the 
guideline recommendations are described in chapter five. 
2.2.3. Evidence transfer 
Jordanet al.4argue that evidence transfer should include active dissemination, education and 
clinical integration. They define evidence transfer as “a coactive, participatory process to 
advance access to and uptake of evidence in local contexts.”4(pp8-9)The new JBI model 
emphasizes that evidence transfer should include active dissemination, education and 
clinical integration.4In the model, evidence transfer incorporates development of 
transferrable and actionable messages, accommodation of the context, and the delivery of 
messages in cost effective ways. In accordance with this guidance, in the current project, 
through systematic literature searches, I identified effective interventions to reduce HIV-
related stigma and discrimination. Based on this evidence, along with the guideline panel, I 




Chapter six reports the feasibility, clarity and applicability of these messages assessed 
through a Delphi survey. To accommodate local and contextual factors, as described in 
chapter seven, I assessed contextual factors through key informant interviews and suggested 
dissemination strategies based on thecurrent local policy and practice environment. 
2.2.4. Knowledge translation 
Knowledge translation has been defined differently by different organizations based on the 
roles assumed by different actors in the process.87Pearson et al.88identified three gaps in 
knowledge translation: gaps between knowledge need and knowledge discovery, gaps 
between knowledge discovery and its practical application, and gaps between practical 
application and policy and practice.88 The JBI has integrated these translational gaps into its 
model of evidence-based healthcare.4There are various barriers to translation of research into 
practice. Some of these barriers are related to social, political, historical, economic, cultural 
and organizational factors, and may be beyond the scope of researchers.89 Nevertheless, 
some barriers may be partially or wholly tackled by contextualizing the research findings.89, 
90 
Practice guidelines are among the tools used to translate evidence into practice.91Practice 
guidelines can contribute to health care as an educational tool and a source of guidance in 
clinical decision-making.They improve patient outcomes, minimize ineffective practice, and 
increase consistency in practice. Guidelines help practitioners to make better decisions and 
improve quality of care and prioritize research areas.91They also improve the reputation of 
health professionals in their profession.92Theycan empower clients by enabling them to 
make informed decisions, especially if they are accompanied by consumer versions of the 
guideline. Guidelines may also influence public policy.93 
On the other hand, if not systematically developed, and informed by evidence, they may 
result in wrong, harmful, ineffective, or suboptimal practice.93 Such guidelines may have 
detrimental effects both on patients and practitioners. Therefore, it is essential to employ a 
transparent and rigorous methodology to develop practice guidelines.91The Institute of 
Medicine (IOM) has listed the attributes of practice guidelines as valid (leading to health 
and cost outcomes), reliable, clinicallyappropriate and flexible, clear and being developed 
by a multidisciplinary team, having ascheduled review, and documenting the process 




2.4. Approaches to guideline development, evaluation and implementation 
Guideline development and implementation may employ an adaptation of an already 
existing guideline, be generated de novo (developing a new guideline) or  a mixture of 
both.23Shekelle et al.94 list the following five essential steps to be used in guideline 
development. 
1. Identifying and refining the subject area. 
2. Organizing and running guideline development groups. 
3. Assessing evidence identified through systematic reviews. 
4. Translating evidence into recommendations. 
5. Subjecting the guideline to external review. 
The Guideline International Network (GIN) has proposed a set of recommendations for 
guideline developers that lie under the following domains:95 
a. The guideline development group should include diverse stakeholders composed of 
health professionals, methodologists and consumers. 
b. The decision-making process should be set up before the commencement of 
guideline development and should be transparent. 
c. The guideline panel should declare conflicts of interest. 
d. The guideline objective and scope should be specified. 
e. The methods of the guideline development should be clearly described. 
f. Guideline developers should use systematic methods of evidence reviews. 
g. Guideline recommendations should be based on scientific evidence of benefits, 
harms and if possible, costs. 
h. A guideline should use a rating system to communicate the quality and reliability of 
both the evidence and the strength of its recommendations. 
i. Guidelines should be peer-reviewed by external stakeholders before publication. 
j. An expiration date and/or the process used to update recommendations should be 
indicated. 
k. Financial support obtained for the development of the guideline should be described. 
Guideline development generally involves establishing the guideline panel, determination of 
the  scope of the guideline, searching for evidence, selecting the evidence, extracting and 
synthesizing the results, assessing quality, interpreting results, developing evidence 
statements and internal and external evaluation of the guideline.96 Based on this guidance, 




Chapter five describes the establishment of the guideline panel, determining the scope of the 
guideline and development of evidence statements. Chapter six presents internal and external 
evaluation of the guideline.  
2.4.1. Content analyses 
Evidence is often analyzed using content analysis to develop recommendations that 
constitute practice guidelines. A content analysis is a data analysis method for analyzing 
written and verbal communication messages to attain a condensed and broad description of 
a phenomenon.97, 98 It has long been used in the nursing and allied health disciplines to 
analyze qualitative data.97, 98 There are two broad approaches to content analysis: the 
deductive approach and the inductive approach.98 Deductive content analysis is used to test 
theories in different settings or to compare categories. This approach starts with an a-priori 
matrix developed from previous researche or knowledge to test theories. The inductive 
approach is a conventional method used when there are no previous studies on the 
phenomenon or when the existing knowledge is fragmented.98 Hsieh and Shannon further 
categorize the deductive approach into directive and comparative approaches and hence 
describe three approaches to qualitative content analysis: conventional (inductive) approach, 
directive approach and a summative (comparative) approach.99 
In the current project, the inductive method was used to develop guideline recommendations 
from emerging data from systematic reviews, best practice documents and guidelines. 
Chapter five describes how content analysis has been utilized to analyze evidence and 
develop guideline recommendations.  
2.4.2. Consensus development methods 
Guidelines are ideally based on the best available evidence, preferably randomized 
controlled trials (RCTs). This evidence is summarized through the systematic search, 
appraisal and synthesis.93However, the evidence may be limited, of lowquality or non-
existent. Some researchers recommend that very low or lowquality evidence should not be 
used to develop recommendations to guide practice since this may result in wrong 
conclusions.100 
On the other hand, topics on which there are only limited or lowquality evidence are usually 
areas where uncertainty exists.101 In addition, since research evidence exists only for some 
problems, policy makers and practitioners use consensus-based methods to develop 
recommendations. Therefore, it is still important to make recommendations even in the 




procedure should be transparently documented.94Even in the presence of high quality 
evidence, the consensus of experts is required.In line with this, guidelines are developed 
using multidisciplinary team members. Consensus of these team members is achieved 
through either formal or informal consensus methods. In the health field, since the 1950s, 
formal research methods have been in use to establish consensus.102 Formal methods are 
used because of the following reasons:103 
a. To reduce the risk of wrong decisions being made by individuals, by involving 
several people. 
b. To improve decisions by reasoned arguments. 
c. To control the decision-making process through providing structured process and 
thereby reducing the negative aspects of group decision-making. 
d. To meet the requirements of scientific methods. 
Formal methods of establishing consensus have been found to result in less risk of bias and 
a more evidence-based process compared to an informal process of establishing 
consensus.95The three most commonly used formal methods of establishing consensus 
during guideline development include: consensus development conference, nominal group 
techniques (NGT) and the Delphi technique.102 
In a consensus development conference, a group of decision makers are presented with 
evidence from experts in the field to produce consensus statements based on their own 
judgments. This method provides an opportunity for clarification. Nevertheless, because of 
the limited time available, the topic experts may be unable to present all the available 
evidence. In addition, some of the meanings of the data may be lost.104 
The second method (NGT) is conducted in several iterative stages over one session. In this 
technique, a small group of members who are affected by the guideline will be involved. 
The final consensus is established as an aggregation of the members’ views rather than a 
communal viewpoint.103 The advantage of this technique is that each member of the group 
is given equal opportunity to generate and present suggestions.104 However, because a small 
number of participants is involved, generalization will be difficult. In addition, since there 
is limited time available, all evidence from the literature review may not be integrated into 
the discussion. Furthermore, certain members of the panel may dominate the discussion and 
drive results. Hence, the technique lacks rigor.102,104 
In the Delphi technique, the third method, a series of questionnaires are used to gather 




Corporation.106It is used to test opinion consensus amongst a group of experts.102,105Delphi 
technique can be conducted by email, online surveys or by post.102 The Delphi technique is 
the research method of choice when there is little evidence regarding the topic, when 
participant anonymity is required, and when the cost and practicalities of bringing the 
participants together are prohibitive.104 By assuring anonymity, it reduces the effect of 
dominant individuals, and the unwillingness to abandon publicly expressed opinions.107 It 
reduces the reluctance to, mention opinions that are unpopular, disagree with one's 
associates, or modify previously stated positions.108Taking these factors into consideration, 
a modified Delphi techniquewas chosento establish consensus in developing the current 
guideline. The entire process of establishing consensus is described in chapter six.  
The potential limitation of the Delphi technique is that some people who participate in early 
rounds may drop out in subsequent rounds. However, in the Delphi technique, it is possible 
to involve large numbers of participants from different geographical areas.105 In addition, 
anonymity can help to increase the response rates in the Delphi surveys.107 Moreover, experts 
participate in the consensus process at a stage when convenient to them and only contribute 
to those aspects that they feel best able to contribute.109 
2.5. Guideline adaptation 
It is not always practical to develop a new guideline. An alternative to developing new 
guidelines is to adapt guidelines from other groups for local purposes. Guideline adaptation 
is defined as ‘a systematic approach to considering the use and/or modification of (a) 
guidelines(s) produced in one cultural and organizational setting for application in a different 
context’.23(pp.1) 
The ADAPTE guideline adaptation methodology110 is commonly used by many 
organizations to adapt practice guidelines.111The CAN implement approach uses the 
ADAPTE methodology and provides detailed guidance on adaptation of practice guidelines. 
According to CAN implement, adaptation has three phases: the set-up phase, the adaptation 
phase and the finalization phase. The set-up phase involves establishing the committee, 
identifying the topic and resources, determining whether adaptation is feasible and the write-
up of the protocol. The adaptation phase involves determining research questions and search, 
retrieval, assessment and customization of existing guidelines. The finalization phase 
comprises external review, after care planning and final production.23Although guideline 




uptake of guidelines,23 sometimes it may consume substantial resources and time as 
guideline de novo does.111 
2.6. Dissemination and implementation of guidelines 
The mere production of a guideline is not enough to impact practice. Hence, active 
dissemination of the guidelines is mandatory.4According to the JBI model of evidence-based 
healthcare, evidence implementation is defined as ‘a purposeful and enabling set of activities 
designed to engage key stakeholders with research evidence to inform decision-making and 
generate sustained improvement in the quality of healthcare delivery’.4(pp.10)Effective 
implementation of research evidence depends on the interaction between evidence, context, 
and facilitation.112 
Gagliardi et al.113 identified 22 elements organized into eight implementation domains that 
guideline developers might use to increase implementability of guidelines. These domains 
are: usability, adaptability,validity,appropriateness,communicability, accommodation, 
implementation, and evaluation.113Most guideline developing organizations have integrated 
these implementation domains into their hand-books and manuals for guideline 
developmentalthough the details of each component varies.114 
Currently, there are tools that are used to assess the methodological quality of guidelines, 
among which the Appraisal of Guideline Research and Evaluation (AGREE) checklist115is 
the most commonly used one.The quality and strength of evidence supporting 
recommendations are rated using a software tool developed by the GRADE working group.86 
In addition, the Guideline Implementability Appraisal (GLIA) checklist116is used to identify 
potential barriers to implement guidelines.In the current project, as described in chapter six, 
I used GLIA v.2.0 checklist to assess the implementability of the guideline. Detailed 
contextual information is also needed to customize a guideline to the local policy 
environment. Hence, in chapter seven, indepth contextual factors were explored based on 
the framework suggested by the Registered Nurses Association of Ontario (RNAO).117 
Conclusion:Evidence-based healthcare involves the creation, synthesis, transfer and 
implementation of evidence. Systematic reviews constitute a core part of evidence synthesis. 
Practice guidelines are among tools that are used to translate evidence into practice. If 
systematically developed, they can contribute to health care as an educational tool and a 
source of guidance for decision-making in clinical and public policy. There are systematic 
methods and tools that assist in developing and adapting practice guidelines and improving 




feasibility, applicability, meaningfulness and effectiveness to aid decision-making for policy 
and practice. Informed by the JBI model of evidence-based healthcare, the current project 
attempted to link external global evidence to contextual factors in developing a guideline 








REDUCING HIV-RELATED STIGMA AND DISCRIMINATION IN 
HEALTHCARE SETTINGS: A SYSTEMATIC REVIEW OF GUIDELINES, 
TOOLS, STANDARDS OF PRACTICE, BEST PRACTICES, CONSENSUS 
STATEMENTS AND SYSTEMATIC REVIEWS 
3.1. Abstract 
Concise introduction 
Policy makers and health professionals prefer to use a pre-appraised and summarized 
evidence. Stigma and discrimination (SAD) reduction activities and programs are needed to 
improve the quality of care delivered to people living with the human immunodeficiency 
virus (HIV) and improve the success of HIV-related prevention, care, and treatment 
programs. 
Review questions/objectives 
The objective of this review was to identify and describe systematic reviews, best practices, 
consensus statements, standards of practice and guidelines that addressed stigma and 
discrimination among healthcare workers (HCWs) and people living withHIV (PLHIV). 
Inclusion criteria 
Types of participants 
This review considered HCWs, health managers and healthcare institutions. 
Type of intervention 
I considered interventions addressing SAD includinginterventions targeting health 
professionals or people living with HIV (PLHIV) such as training and interventions related 
to healthcare institution policies for inclusion. 
Comparators 
Comparators that I considered for this review were: no intervention or baseline intervention 
or one intervention compared to the other  
Types of outcomes 
 The primary outcomes I considered for inclusion were HIV-related SAD reported in the 
form of fear-based stigma, value-based stigma, discrimination and internalized stigma. The 
secondary outcome I considered was PLHIV-specific extra-precaution. 
Types of studies/documents 
This review considered all documents in the form of systematic reviews, best practices, 





The search strategy aimed to find both published and unpublished studies reported in English 
with unlimited date range in Excerpta Medica database from Elsevier (EMBASE), 
Cumulative Index to Nursing and Allied Health (CINAHL), Psychological Information 
(PsycINFO) database and Medical Literature Analysis and Retrieval System Online 
(MEDLINE).Websites of organizations and guideline databases were also searched. 
Methodological quality 
Two individuals independently appraised the quality of the guideline-related documents 
using the Appraisal of Guidelines for Research and Evaluation (AGREE II) checklist. The 
reviews were independently assessed by two individuals using the Joanna Briggs Institute 
(JBI) critical appraisal checklist for systematic reviews. 
Data extraction 
Data extraction was done using a customized tool that was developed to record the key 
information of the source that is relevant to the review question.  
Results 
Twelve records (six guidelinerelated documents and six systematic reviews) were included 
in the review.Interventions and recommendations developed to reduce HIV-related SAD 
were categorized into: information-based; structural, biomedical, counseling and support, 
skillsbuilding and contact interventions.  
Conclusion 
Implications for practice:Interventions that reduce HIV-related SAD are broadly 
categorized into information-based, structural, biomedical, counseling and support, 
skillsbuilding and contact interventions. Because of limited methodological description of 
the included documents, it was difficult to draw recommendations for policy and practice.  
Implications for research: Future studies need to use up-to-date instruments to measure 
stigma and discrimination. Further studies of greater methodological quality are needed. 
Guidelines, tools and best practice documents that aim to reduce HIV-related SAD should 
be developed with the considerations of research evidence on thespecific setting and specific 
targeted populations. 
3.2. Concise introduction 
Policy makers and health professionals need high quality research evidence to make 




an overwhelmingly increasing volume of research published everday.118 Taking the 
increasing volume of published research evidence into account, systematic reviews are being 
prioritized to make policy and practice decisions.118Nevertheless, because of the limited 
time, health managers and health professionals prefer evidence in a summarized form such 
as guidelines and evidence summaries.119Particularly,they prefer to use a pre-processed and 
summarized evidence.119, 120 
Cognizant of this, scholars and organizations, such as the Joanna Briggs Institute (JBI) have 
developed a system to avail evidence at the point of care through presenting evidence in a 
summarized and usable format.119 Some scholars have developed a hierarchical model to 
search for and utilize pre-appraised bodies of evidence.120 The list from top down in the 
hierarchy includes a) systems (computerized decision support systems), b) summaries such 
as evidence-based practice guidelines, c) synopsis of syntheses, d) syntheses of primary 
studies, e) synopsis of single studies and f) single studies.121, 122According to this model, 
while making a decision in healthcare practice, one always should start from the top and 
proceed down until one gets the best available evidence saving time and resources.122 
Currently, only few systemslevel evidences are available. Hence, the highest universally 
available evidence for most health topics is summaries.122As one example of summary level 
evidence, guidelines are accessible globally through different organizational web pages and 
publications. Guidelines offer options for practitioners, policy makers and patients to make 
informed decisions to improve the outcomes of patients. Guidelines are believed to improve 
the quality of healthcare practices by making explicit recommendations on specific 
healthcare practice.93 Guidelines also reduce variations in practices.23 
The lack of uniformity in handling People Living with human immunodeficiency Virus 
(PLHIV)such as differential treatment, denial of treatment, or differential or excessive use 
of barriers are considered as discrimination.57, 58The fear of being stigmatized discourages 
PLHIV from disclosing their sero-status to families, friends and healthcare workers (HCWs) 
and getting healthcare services and the support they need.53To this end, globally, there has 
been effort to reduce stigma and discrimination (SAD) related to HIV.2, 123It has been 
indicated that the absence of guidelines and protocols that protect PLHIV from SAD was 
associated with higher levels of SAD among HCWs.124, 125Researchers recommend theory 





Evidence-based SAD reduction activities and programs are urgently needed to improve the 
quality of care delivered to PLHIV and improve the success of HIV-related prevention, care, 
and treatment programs.3, 125 There should be healthcare facilitylevel policies and practices 
that support SAD reduction activities.3In line with this, it is imperative to identify and 
summarize the best available evidence to inform policy and practice on HIV-related SAD.To 
this end, this review aimed to identify and describe systematic reviews, best practices, 
consensus statements, standards of practice and guidelines that have addressed HIV-related 
stigma and discrimination among healthcare workers and/or in healthcare settings. 
3.3. Review questions/objectives 
This review sought to locate and describe international literature in the form of guidelines, 
tools, best practice documents, consensus statements and systematic reviews that contained 
recommendations and/or interventions for reducing HIV-related stigma and discrimination. 
Specifically, the review aimed to:  
• Identify and describe guidelines, tools, consensus statements and best practices 
containing recommendations or interventions to reduce HIV-related stigma and 
discrimination. 
• Identify systematic reviews containing findings, conclusions and recommendations 
to reduce stigma and discrimination related to HIV.  
3.4. Inclusion criteria 
For this review, I considered the following inclusion criteria. 
Population 
This review considered HCWs, health managers, PLHIVor healthcare institutions. 
Interventions 
I considered records for inclusion if they contained research results or recommendations to 
reduce HIV-related SAD. This review considered interventions on: 
• Interventions targeting health professionals such as training,  
• Interventions related to health institution policies such as institutional protocols and 
standards. 
Comparators 
Comparisons I considered for inclusion were: no intervention or baseline intervention or one 





The primary outcomes I considered for inclusion were HIV-related stigma and 
discrimination among HCWs or healthcare institutions. Stigma reported in the form of fear-
based stigma, value-based stigma, discrimination and internalized stigmawere included. The 
secondary outcome considered was PLHIV-specific extra-precaution. 
Context 
This review considered all documents and studies conducted worldwide that addressed HIV-
related SADamong HCWs and in healthcare settings. 
Types of studies/documents 
This review considered all documents in the form of systematic reviews, consensus 
statements, best practices, standards of practice, tools and guidelines that report on the 
interventions or recommendations to reduce stigma and discrimination related to HIV.Both 
published and unpublished (gray literature) studies reported in the English language were 
considered.Reviews that did not indicate inclusion and exclusion criteria, and an appraisal 
process, were not considered as systematic reviews. Guideline documents that did not 
indicate recommendations specific to the reduction of HIV-related stigma and discrimination 
in healthcare settings were not included in the current review. Scoping reviews, critical 
reviews or systematic reviews with the lack of specific focus and inclusion criteria for the 
inclusion of interventions or trials were excluded. Interventions such as specific treatments 
for PLHIV diagnosed with mental disorders were nor considered. In addition, interventions 
beyond the scope healthcare facilities such as financial interventions were not the focus of 
current review.  
3.5. Search strategy 
The search strategy aimed to find both published and unpublished studies. A three-step 
search strategy was utilized in this review. An initial limited search of Cumulative Index to 
Nursing and Allied Health (CINAHL) and Medical Literature Analysis and Retrieval System 
Online (MEDLINE) was undertaken followed by an analysis of the text words contained in 
the title and abstract, and of the index terms used to describe the article. A second search 
using all identified keywords and index terms was then undertaken across all included 
databases. Thirdly, the reference list of all identified reports and articles was searched for 
additional studies.Both published and unpublished papers reported in English language were 
searched with no restriction to age, country and date of publication.The databases searched 
included: Excerpta Medica Database from Elsevier (EMBASE), CINAHL,MEDLINE and 




included: HIVinSite, AIDSinfo, HIV and AIDS clearinghouse, Communicable Diseases 
Control (CDC) HIV publications, British HIV Association (BHIVA)websites,Health Policy 
Project (HPP) website, United States Aid for International Development (USAID) 
experience clearinghouse, World Health Organization (WHO) guidelines and Joint United 
Nations Program on HIV/AIDS (UNAIDS) publications.An additional search was 
conducted for existing guidelines and systematic reviews in the following websites: Turning 
Research into Practice (TRIP) database, Guideline International (GIN) library, National 
Guideline Clearinghouse (NGC), National Institute for Health and Clinical Excellence 
(NICE), and Task Force on Community Preventive Services. A detailed search strategy for 
each database was appended (Appendix 1). The result of the search for each website and 
database isshown in Appendix 2. 
3.5. Assessment of methodological quality 
Two individuals independently appraised the quality of the guideline documents using the 
Appraisal of Guidelines for Research and Evaluation (AGREE II) checklist.115The AGREE 
II checklist has six domains, namely scope and purpose (three items), stakeholder 
involvement (three items), rigor of development (eight items), clarity of presentation (three 
items), appropriateness (four items) and editorial independence (two items).115The reviews 
were independently assessed by two individuals using the JBI critical appraisal checklist for 
systematic reviews (Appendix 3). 
3.6. Data extraction 
Data extraction was done using a format developed to record the key information of the 
source relevant to the review question. The data extraction instrument was developed both 
for systematic reviews and guideline-related documents. Relevant information such as 
population characteristics, publication year, authors and summary of the findings and 
recommendations were extracted. 
3.5. Results 
The search yielded a total of 1670 records. After removing duplicates, 1605 documents were 
retained for further analysis. Based on the analysis of the titles and abstracts, 118 records 
were retained for further full text analysis. Based on pre-defined inclusion criteria, we 
retained 12 records (Figure 3). Six of the records were guidelinerelated documents (best 







Figure 3. Study selection process for systematic review of guidelines, best practices and 
systematic reviews 
(From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items 
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3.5.1. Description of the characteristics of the documents 
Guidelines, best practice documents, standards of practice and tools 
Among the six guideline-related documents, two were published by the USAID6, 7 and one 
was published by the Department for International Development (DFID),127 one by 
Physicians for Human Rights (PHR),128 one guideline document was developed by the 
UNAIDS129and one national guide130was published by Tanzania Commission of AIDS 
(TCA) (Table 1). The guidelines were assessed against AGREE II reporting criteria.131 
a. USAID 20127 
The first guide (USAID 20127) which was published by the USAID health policy initiative 
in 2012, provided an overview of HIV epidemics and the impact of HIV-related SAD. The 
guide developed the recommendations under six guiding principles. This guide addressed 
four criteria out of the 23 criteria on AGREE II reporting checklist. It provides advice on 
how to implement the recommendations into practice. The guide had resources for 
implementation such as tool kits. Although it indicates and cites existing research evidence 
in the recommendations, it does not explicitly indicate the link between recommendations 
and research evidence. It does not provide details on how the recommendations were 
developed. Even though the guideline provides recommendations to be applied in healthcare 
settings, the target of most of the recommendations were not specifically described. The 
specific health questions considered, the potential resource implications of the 
recommendations and whether a systematic search was used to develop the 
recommendations were not described. Recommendations found in the guide addressed 
biomedical, information-based, structural, contact, skillsbuilding and counseling and 
support interventions.  
b. Carr et al 20156 
The second guide (Carr et al 20156) was published by the USAID health policy initiative. 
The guide addressed seven of the AGREE II criteria for reporting guidelines. The guide was 
specifically developed to reduce HIV-related SAD in healthcare settings. It was developed 
by the synthesis of existing programs, tools and research evidence. However, details of how 
the developers located these sources werenot described. The guide had added resources for 
implementation, including tool kits, health facility and provider assessment checklists. The 
recommendations included in the guideline were under the categories of information-based 
and structural interventions. 




The third guide (PHR 2011132) was developed by Physicians for PHR. This guideline 
addressed ten of the criteria for AGREE II reporting standards. The recommendations in the 
guideline were easily identifiable. The guide indicated tools and references that supported 
the recommendations. The guide addressed the roles of different actors to reduce SAD in 
healthcare settings. The guide was based on examples and experiences of previous research 
and programs. Nevertheless, it did not indicate the details of the development process. 
Moreover, the link between the recommendations and the research evidence was not 
explicitly reported. While most of the citations were from the field of HIV-related stigma, it 
also included citations from other diseases, such as leprosy. Recommendations found in the 
guideline generally fell under information-based, structural, counseling and support 
approaches to stigma and discrimination-reduction. 
d. UNAIDS2007129 
The fourth guideline (UNAIDS 2007129) was published by UNAIDS. This guide addressed 
five of the 23 AGREE II criteria for reporting guidelines. It provided programmatic 
examples, research findings and resources for the reduction of stigma and discrimination. 
However, the details of the retrieval of this body of evidence and the process of the 
development of the recommendations were not described. The guideline recommendations 
were under the categories of information-based, structural, skillsbuilding, contact and 
counseling and support approaches. 
e. Carr et al 2007127 
The fifth guideline (Carr  et al 2007127) was developed by the DFID. This document 
addressed six of the 23 AGREE II criteria for reporting guidelines. The guideline presented 
best practices and lessons learnt to tackle SAD. It provided resources for implementation. 
However, it did not detail the process for the development of recommendations. It was 
mainly developed for DFID and their partners. Moreover, the settings where 
recommendations were to be implemented were not clearly described. The guideline 
addressed recommendations that comprised information-based, structural, skillsbuilding, 
contact, and counseling and support domains of stigma and discriminationreduction 
interventions. 
f. TCA 2009130 
The sixth guide (TCA 2009130) was developed by the Tanzania Commission for AIDS 
(TCA). This guideline addressed six of the 23 AGREE II reporting criteria for guidelines. 




research findings and tool kits. The guide mentioned that it was developed from the research 
and intervention programs. Nevertheless, the process of developing that guide was not 
detailed. The guideline addressed SAD reduction interventions falling under information-
based, structural, skillsbuilding, contact and counseling and support interventions. 
In all the documents, the expected update timeline and process were not mentioned. The 
results of assessment based on AGREE II reporting criteria for each guideline is found in 
Appendix 4. As none of the guidelines and tools mentioned any information on the quality 







Table 1. Summary of guideline topics and citation details 
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NB: AGREE: Appraisal of Guidelines for Research and Evaluation USAID: United States Aid for International Development,HIV: Human 
immunodeficiency virus, PLHIV: People Living with HIV, HCWs: Healthcare workers, PHR: Physicans for Human Rights, UNAIDS: 
United Nations program on HIV/AIDS, DFID: Department for International Development, TCA: Tanzanian Commision of AIDS.. 
Systematic reviews  
Of the six systematic reviews, four of them (Stangl et al.2013;2 Senguptaet al.2011;133 
Loutfyet al 2015;134 and Paudel et al.2015135) scored 9/11 using the JBI critical appraisal 
checklist for systematic reviews. One qualitative review (Chamber et al. 2015) scored 7/11. 
One quantitative review (Brownet al.2003136) scored 4/11. All reviews did not assess the 
likelihood of publication bias. None of the systematic reviews combined the findings of the 




and comprehensive search strategies. All of the included reviews except one (Brownet 
al.2003136), included both published and unpublished studies. However, formal assessment 
of risk of publication bias was not indicated in all the systematic reviews. All reviews except 
two (Brown et al.2003136and Chamberset al.2015137), reported the appraisal criteria, process 
and results explicitly (Table 2).The appraisal results for the systematic reviews are found in 
Appendix 5.  
Stangl et al.20132 
This systematic review (Stangl et al.2013)2 aimed to obtain a complete picture of 
intervention efforts in interrupting stigma and discrimination. The review included 48 
studies. The included studies were randomized controlled trials (RCTs), quasi-experimental 
designs with and without control groups, repeated cross-sectional surveys, qualitative studies 
and mixed method studies.2 The review conceptualized domains of stigma and 
discrimination, and stigma reduction approaches as follows  
a) Domains of HIV-related stigma and discrimination: The authors categorized HIV-
related stigma domains into drivers, facilitators and manifestation domains. Drivers are 
individual-level factors that negatively influence the stigmatization process.2  
Manifestations of stigma include how stigma is executed or experienced.2 
b) HIV-related stigma and discriminationreduction approaches: The authors 
categorized the interventions into information-based, skillsbuilding, counseling and 
support, contact, structural and biomedical interventions.2 
As indicated in the review, most programs used information-based approaches, but some 
used a combination of two or more of these approaches.The information-based approaches 
were both written and verbal information to increase the understanding of HIV, and of stigma 
and discrimination. These were provided in the form of leaflets, brochures and other 
methods.2 The structural approaches to SAD reduction employed in healthcare settings were 
availing supplies for standard precautions, revision and development of standard operating 
procedures (SOPs), policies and regulations, and putting a grievance addressing system in 
place.2Biomedical approaches are interventions such as universal access to care and 
treatment.2 Contact strategies are activities such as testimonials of PLHIV and activities that 
encourage interaction between HCWs and PLHIV. Counseling and support approaches are 
activities that aid in minimizing the negative  psychosocial impact of HIV-related SAD on 




The review conceptualized levels and targets of stigma and discrimination reduction 
interventions as follows: 
a) Levels of HIV-related stigma and discriminationreduction interventions: The 
review considered a range of interventions at the individual, interpersonal, 
organizational and community and public policy levels. At the individual level, 
interventions were targeted to influence how individuals feel about HIV and how 
they respond to it. At the interpersonal level, interventions addressed stigma between 
individuals, including family and friends. At the organizational level, interventions 
addressed stigma within institutions, such as schools and hospitals. At public policy 
level, interventions addressed stigma that was reflected in public laws or policies.2 
b) Targets of stigma and discriminationreduction interventions: The review 
comprised interventions that targeted various population groups, including HCWs, 
people living with HIV, female sex workers and men who have sex with men.2 
Out of the included studies, 38 (79%) of them reported statistically significant reductions in 
all stigma measures. Five studies reported reductions in some stigma measures. The review, 
however, did not pool the findings from the primary studies because of heterogeneity of the 
interventions and measures used in the primary studies. The authors called for more rigor 
and improved quality studies and future interventions to address intersectional stigma 
(multiple prejudices experienced by clients both because of their disease status and their 
other attributes such as sexual activity or orientation).2 
Sengupta et al. 2011133 
This review assessed the effectiveness of HIV-related interventions to reduce HIV-related 
stigma and discrimination. The review included 19 studies. The designs of the included 
studies were RCTs and pre-post study designs with and without control groups. This review 
identified interventions that targeted a range of population groups such as students, 
healthcare workers, working women and the general community.The included studies 
addressed information-based approaches, PLHIV testimonials, skillsbuilding, support 
groups and a combination of these approaches.133Outcomes reported were perceived, 
enacted, internalized and compounded stigma. Fourteen of the included studies 
demonstrated a reduction in HIV-related stigma and discrimination. Only two of these 
studies were considered good quality by the reviewers. The reviewers called for further 




Loutfy et al. 2015134 
This review identified studies addressing interventions to reduce HIV-related stigma and 
discrimination among African diasporic women living with HIV (WLHIV). The review 
included three RCTs and two prospective cohort studies. The included studies measured 
internalized stigma (holding negative attitude against oneself); and perceived stigma 
(awareness of social devaluation, social rejection, diminished social identity and limited 
social opportunity attributed to stigma). Four of the studies demonstrated a positive effect in 
the reduction of HIV-related stigma and discrimination among WLHIV. The reviewer 
concluded that the included studies addressed interpersonal and intrapersonal stigma. The 
authors recommended further research to address stigma and discrimination at community, 
institutional or structural levels. They also concluded that there was alack of research 
evidence addressing intersectional stigma and discrimination experienced by African 
diasporic women living with HIV.134 
 Paudel et al. 2015135 
This review examined the feelings, experiences and perceptions of women living with HIV 
(WLHIV) and assessed the role of support groups as a coping strategy from seven qualitative 
studies. The review identified five themes: a) disclosure is a sensitive issue for WLHIV b) 
WLHIV have physical, social, emotional and spiritual difficulties in dealing with stigma and 
discrimination from family, friends, community and health professionals, c) internalized or 
self-stigma affects WLHIV more than the actual experience of stigma, d) WLHIV are 
rejected, shunned and treated differently by physicians, family and close friends: e) support 
groups are among the best interventions for HIV-related stigma and discrimination. Based 
on the findings, the authors recommended that support group interventions should constitute 
the main approach for HIV programs. They also recommended additional RCTs to 
demonstrate the effectiveness of support group interventions.135 
Chambers et al. 2015137 
This review synthesized and presented the findings of 55 qualitative studies into three 
categories. These included; the conceptualization of HIV-related stigma and discrimination, 
which included dimensions of stigma, experiences of stigma and managing stigma. The 
review also showed that healthcare practices were negatively affected by personal 
stigmatizing perceptions of practitioners. The reviewers also found that feeling stigmatised 
negatively influenced health services utilization, adherence to treatment, and overall health 




discrimination in healthcare settings was interlinked with other forms of marginalization due 
to sexual behaviour or orientation, race, gender and other factors. This is called intersectional 
or double stigma. The review identified social support, education, self-efficacy, resilience 
activities, and advocacy as major strategies to address HIV-related stigma and 
discrimination.137 
Brown et al.2003136 
This review included 22 studies that reported on interventions to reduce stigma and 
discrimination related to HIV. Among the included studies, 14 reported on interventions 
aimed to reduce stigma and discrimination towards PLHIV among the general population 
and five studies included interventions aimed at increasing the willingness of healthcare 
workers to treat PLHIV. Three studies aimed to improve coping strategies to deal with HIV-
related stigma using counseling and information-based approaches. Most studies included in 
this review found that information combined with a skillsbuilding approach was more 
effective than the information-only approach to reduce HIV-related stigma and 
discrimination in the general population. The studies also found that contact with PLHIV 
was more effective in reducing HIV-related stigma and discrimination when combined with 
information provision than a contact-only approach. Taking the limitations of the studies 
included into account, the authors recommended the utilization of validated scales of 
measurement to aid appropriatequantification of HIV-related stigma and discrimination and 
assessment of the long-term impact of the interventions. The settings, population 







Table 2. Description of systematic reviews 
Authors/year  Stanglet al. 
20132 
Sengupta et al. 
2011133 




Brown et al. 
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Number of studies 
included 
48 19  5 7 22 55 
Types of studies Qualitative and 
quantitative  
RCT, pre-post 
studies with or 
without a 
control group  
3 RCTs and 2 
prospective 
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NB: HIV: Human immunodeficiency virus, PLHIV: People Living with HIV, HCWs: Healthcare workers, WLHIV: Women Living with 
HIV, AHRQ: Agnecy for Healthcare Research and Quality, QOL: Quality of life, NA: Not applicable, RCT: Randomized controlled trial, 
SAD: Stigma and discrimination. 
 
None of the systematic reviews reported a meta-analysis nor a Summary of Findings table.  
3.6. Discussions 
In this review, I attempted to locate documents in the form of guidelines, consensus 
statements, best practices, standards of practice and systematic reviews indicating directions 
on how to tackle stigma and discrimination. In this project, I searched both published and 
gray literature to locate the evidence on stigma and discrimination related to HIV. 
Acknowledging stigma and discrimination as a significant barrier to HIV prevention and 
control programs45 and its negative impact on clients,53 for more than three decades, 
organizations have been working to reduce stigma and discrimination related to HIV,138and 
through time, implementers and researchers are improving practice, based on the lessons 
they learn from their experiences.138 
In addition to the interventions and primary studies conducted so far, researchers have tried 
to synthesize the global evidence to reduce stigma and discrimination related to HIV and 
present the evidence in the form of guidelines, best practices and systematic 
reviews.2Through these efforts, they have understood and conceptualized the interventions 
falling under the following general categories: information-based interventions; structural 
interventions, biomedical interventions, counseling and support, skillsbuilding and contact 
strategies.2 
The quality of thefive systematic reviews included in the current review weregenerally good. 
Nevertheless, in the current review, we could not obtain evidence in a usable form. 
Systematic reviews are supposed to facilitate the guideline development and knowledge 
translation process.94The following were missing from the reviews included in the current 
project: indication of the quality of the findings and pooling of the results of the primary 
studies or presenting Summary of Findings tables to inform policy and practice. There were 
no meta-analyses conducted on interventions to reduce HIV-related stigma and 























Quality of evidence  Most studies 
were rated as 
high quality 








systematic reviews. One of the reasons that contributed to these gaps was due to the fact that 
stigma measures were not always uniform across different studies.2, 133, 136 The other reason 
was that the interventions, most of which were behavioral in nature, were not always similar 
across different studies in mode of delivery, duration of delivery and type of population they 
addressed.2, 133 Public health interventions are often complex and this makes the systematic 
review challenging.139 In circumstances where the interventions were found to be similar, 
the study designs or the populations varied.2, 133In addition, programs and policy 
implementers also need to consider others factors such as, the degree to which the 
interventionsdescribed in the protocols were implemented (intervention fidelity).139 
As was recommended in most of the systematic reviews, it is vital to focus on the design of 
the studies which includes, paying attention to internal validities and using validated 
instruments to measure stigma and discrimination.2, 133, 134, 136 Future studies may fill these 
gaps as stigma instruments have been evolving over time. This, however, will be possible 
only if the researchers are aware of the recent developments in measurements and scales. 
The other limitation that the reviews had was that some did not report the findings 
specifically within different population sub-groups and settings.2, 133 
Different guidelines and best practice documents were developed globally based on the 
lessons learnt from primary studies and implementation programs.7, 127, 130, 132 Efforts were 
made to develop standard tools and instruments to reduce HIV-related stigma and 
discrimination and to monitor these efforts.6Nonetheless, most of these guideline-related 
documents did not indicate the details of how they developed the recommendations and the 
scientific rigor of their methods. The guidelines and best practice documents for addressing 
HIV-related stigma and discrimination were developed based on the experiences of 
implementers and best practices in tackling stigma and discrimination. In most of these 
documents, however, detailed information on how these best practices were located, 
selected, appraised and synthesized was missing.  
The systematic reviews included in the current review, did not give conclusion on direction 
regarding the specific nature, content and duration of an ideal healthcare setting or with 
specific population shouldto help HCWs living with HIV cope with stigma or secondary 
stigma.140One of the strengths of the guideline documents on the reduction of HIV-related 
stigma and discrimination included in this review was that implementers of stigmareduction 




implementers developed the guidelines based on their work worldwide.129, 138 This might 
have been because the funding organizations were working worldwide.  
Because of the limitations in the transparency of how the reviews and the guideline-related 
documents were developed, putting them into practice and setting priorities for specific 
intervention is challenging. While drawing conclusions from the reviews and guideline 
documents available to date, it is very important to consider the details of the primary studies 
linked to these documents. The context in which the primary studies linked to these 
documents were conducted (healthcare settings, community, media, faith-based 
organizations) and the target beneficiaries involved in the original primary studies must be 
examined. The intervention might have been effective or not effective, simply because of 
pre-existing contextual factors.139, 141 In addition, details of the intervention characteristics 
such as the providers of the intervention and the fidelity of the intervention are worthy of 
consideration.141, 142 
In healthcare settings, additional factors exist that fuel stigma and discrimination related to 
HIV. Some of these factors are specific to the practice of HCWs such as fear of casual 
transmission, and limited knowledge of what stigma is and its negative consequences. 
Hence, these factors should be addressed through skillsbuilding and infrastructural 
interventions such as availing universal precaution supplies.58 This makes the stigma related 
to HIV in healthcare settings different from HIV-related stigma and discrimination in other 
settings. However, some of the guidelinerelated documents included in this review have 
extrapolated community-based findings to healthcare settings.132It is therefore essential to 
develop context and populationspecific recommendations and guidelines that help to 
improve accountability for monitoring and evaluation, as well as those that support efficient 
delivery of audiencespecific recommendations. 
It is critical to consider the specific nature of stigma and discrimination related to HIV. 
Stigma related to HIV results from associating HIV with immoral or unacceptable 
behaviors.58 However, only two of the guideline-related documents identified in this review 
were specific with respect to the setting or population or the disease condition they 
addressed.7, 129 In some of the guideline-related documents, although most of the evidence 
was drawn from HIV-related stigma and discrimination, the guidelines also drew 
recommendations based on interventions that were found effective in addressing stigma 




working on stigma and discrimination reduction should consider the settings and specific 
population for which each of these interventions should be applied. 
On the other hand, it is encouraging to see some of the guidelines mentioning the roles of 
different stakeholders in reducing stigma and discrimination in healthcare settings.7 As 
clearly indicated in the guidelines, it is imperative to consider that stigma in healthcare 
settings is affected by the factors and actors beyond healthcare settings.7, 132 
3.7. Conclusion 
Implications for practice: Stigma and discriminationreduction interventions are framed as 
information-based, skillsbuilding, structural, biomedical, counseling and support and 
contact-based approaches. Currently existing systematic reviews and guideline-related 
documents are not transparent enough to provide details of the quality of evidence supporting 
the recommendations. 
Implications for research:Although good quality systematic reviews exist, they were not 
presented in a usable form. Future systematic reviews should address this by including 
Summary of Findings tables. Future studies need to use up-to-date stigma instruments to 
measure HIV-related stigma and discrimination. Studies with rigorous designs, such as 





REDUCING HIV-RELATED STIGMA AND DISCRIMINATION IN 




In healthcare settings, both structural and individual-level factors fuel stigma and 
discrimination (SAD) related to human immunodeficiency virus (HIV).  
Review questions/objectives 
The objective of this review was to locate, appraise and describe international literature 
reporting on interventions that addressed SAD related to HIV in healthcare settings. 
Inclusion criteria 
Population 
This review considered healthcare workers (HCWs), health managers and healthcare 
institutions for inclusion.  
Interventions 
I considered interventions that addressed HIV-related SAD. These comprised information-
based, skillsbuilding, structural, contact-based, biomedical and counseling and support 
interventions. 
Comparators 
Comparators considered for inclusion were baseline (before intervention), no intervention, 
usual care or one or more of the above components compared to one another. 
Outcomes 
The primary outcomes considered for inclusion were HIV-related SAD among HCWs or in 
healthcare institutions.  
Context 
This review considered all studies conducted worldwide that addressed HIV-related SAD in 
healthcare settings. 
Types of studies 
Both published and unpublished studies with comparative designs, such as randomized 






The databases searched were: Cumulative Index to Nursing and Allied Health (CINAHL), 
Excerpta Medica Database from Elsevier (EMBASE), Medical Literature Analysis and 
Retrieval System Online (MEDLINE) and Psychological Information (PsycINFO) database  
Assessment of methodological quality 
Two individuals independently appraised the quality of the papers prior to inclusion in the 
review using appraisal instruments from the Joanna Briggs Institute (JBI). 
Data extraction and analysis 
Quantitative data were extracted from papers included in the review using the standardized 
data extraction tool from JBI. Since the studies were methodologically or clinically 
heterogeneous, statistical pooling was not possible; hence, the findings are presented in 
narrative form. Quality of evidence for major outcomes was assessed using Grading of 
Recommendations, Assessment, Development and Evaluation (GRADE). 
Results 
We retained 14 records reporting on eight studies. Five categories of SADreduction 
(information-based, skillsbuilding, structural, contact-based and biomedical interventions) 
were identified. Training popular opinion leaders (POL’s) resulted in significantly lower 
mean avoidance intent scores (MD=-1.87 [95% CI -2.05 to -1.69]), mean prejudicial attitude 
scores (MD=-3.77 [95% CI -5.4 to -2.09]) and significantly higher scores in mean 
compliance to universal precaution (MD=1.65 [95% CI 1.41 to 1.89]) when compared to 
usual care (moderatequality evidence). In addition, professionallyassisted peergroup 
interventions, modular interactive training, participatory self-guided assessment and 
intervention, contact strategy combined with information giving and empowerment were 
effective in reducing HIV-related stigma (very lowquality evidence). The Summary of 
Findings table (SOF) is shown in Table 3. 
Conclusion 
Implications for practice: Moderatequality evidence indicates that training popular opinion 
leaders is effective in reducing avoidance intent and prejudicial attitude and improving 
compliance to universal precaution. Very lowquality evidence indicates that 
professionallyassisted peergroup interventions, modular interactive training, participatory 
self-guided assessment and intervention, contact strategy combined with information giving 
and empowerment are effective in reducing HIV-related stigma. 
Implications for research: Further RCTs are needed to provide information that guide 










Table 3. Summary of Findings table 
1. Training popular opinion leaders 











Assumed risk Corresponding risk 
 Control Training popular opinion 
leaders 
    
Avoidance intent 
Scale from: 8 to 40. 
Follow-up: mean 12 
months 
The mean avoidance intent 
in the control groups was 
18.65  
The mean avoidance intent in the 
intervention groups was 1.87 








Scale from 8 to 40 
Follow-up: mean 12 
months 
The mean prejudicial 
attitude in the control 
groups was not given 
The mean prejudicial attitude in 
the intervention groups was 









Scale from: 0 to 52. 
Follow-up: mean 12 
months 
The mean compliance to 
UP in the control groups 
was32.88  
The mean compliance to UP in the 
intervention groups was 1.65 







2. Peer education of HCWs for HIV-related stigma 











Assumed risk Corresponding risk 
 Control Peer education of HCWs     
Public contact 
stigma 
Scale from: 1 to 3. 
Follow-up: mean 12 
months 
The mean blame in the 
control groups was 1.11 
The mean blame in the 
intervention groups was 0.07 









 Scale from: 1 to 4 
Follow-up: mean 12 
months 
The mean contact stigma in 
the control groups was 
1.81 
The mean contact stigma in the 
intervention groups was 








3. Interactive training and discussion focusing on HIV-related stigma, infection control and medical ethics and contact 
with PLHIV for value-based stigma and fear-based stigma 











Assumed risk Corresponding risk 
 
Control Interactive training and 
discussion focusing on HIV-
related stigma, infection control 
and medical ethics and contact 
with PLHIV 
    
Fear-based stigma 
Scale from: 1 to 10 
Follow-up: mean 3 
months 
The mean fear-based 
stigma in the control 
groups was3.2  
The mean fear-based stigma in the 
intervention groups was 2.1 lower 








Scale from: 1 to 10 
Follow-up: mean 3 
months 
The mean value-based 
stigma in the control 
groups was 3.8  
The mean value-based stigma in 
the intervention groups was 1.7 







4. Participatory self-guided assessment and intervention for Stigma 















 Control Participatory self-guided 
assessment and intervention 






Scale from 21 to 63 
Follow-up: mean 6 
months 
The mean stigma index 
(attitude towards PLHIV 
and healthcare-related 
practices) in the control 
groups was 42.79  
The mean stigma index (attitude 
towards PLHIV and healthcare 
related practices) in the 
intervention groups was 4.72 







Use of glove when 
drawing blood if 
sero-status is 
unknown 
Follow-up: mean 6 
months 








642 per 1000 1000 per 1000 
(1000 to 1000) 
Sought informed 
consent before HIV 
test 
Follow-up: mean 6 
months 








403 per 1000 862 per 1000 
(471 to 1000) 
5. Addressing both fear-based and social stigma (stemming from moral judgments) compared to addressing only ‘fear-
based’ stigma (stemming from lack of knowledge) for Hospital staff 











Assumed risk Corresponding risk 
 
Addressing both fear-
based and social stigma 
(stemming from moral 
judgments). 
Addressing ‘fear-based’ stigma 
(stemming from lack of 
knowledge) 
    
Fear-based stigma 
Scale from: 4to 12. 
Follow-up: mean 6 
months 
The mean fear-based 
stigma in the control 
groups was5.1  
The rate of change in mean fear-
based stigma in the intervention 









 Scale from 5 to 15 
Follow-up: mean 6 
months 
The mean social stigma in 
the control groups was7.4  
Therate of change in mean social 
stigma in the intervention groups 








Overusing any form 
of barrier protection 
Follow-up: mean 6 
months 








168 per 1000 98 per 1000 
(59 to 155) 
Signs on bed 
indicating HIV 
status 
Follow-up: mean 6 
months 








851 per 1000 587 per 1000 




Follow-up: mean 6 
months 








98 per 1000 55 per 1000 
(30 to 98) 
6. Contact strategy combined with information giving and empowerment for HIV-related stigma 











Assumed risk Corresponding risk 
 
Control Contact strategy with 
information giving and 
empowerment  
    
PLHIV self-esteem 
Scale: from 10 to 40 
Follow-up: mean 1 
months 
The mean PLHIV self-
esteem in the control 
groups was 19.46  
The mean PLHIV self-esteem in 
the intervention groups was 










The mean PLHIV 
workplace stigma in the 
control groups was 0.46  
The mean PLHIV workplace 
















randomized into intervention and control groups. A matched-pair design was applied to optimize the randomization. However, method 
of the selection of the pairs was not clear. Downgraded one level for risk of bias 
2 No explanation was given about blinding of allocators 
Scale: Not described 
Follow-up: mean 1 
months 
was 0.31 lower (0.61 to 0.01 
lower) 
Total stigma score 
Scale: Not described 
Follow-up: mean 1 
months 
The mean total stigma 
score in the control groups 
was 0.42  
The mean total stigma score in the 
intervention groups was 











Scale: Not described 
Follow-up: mean 1 
months 
The mean self-perception 
in the control groups was 
0.82  
The mean self-perception in the 
intervention groups was 0.46 










Scale: Not described 
Follow-up: mean 1 
months 
The mean nurses' 
stigmatizing behaviour in 
the control groups was 
0.46  
The mean nurses' stigmatizing 
behaviour in the intervention 
groups was 0.07 higher (0.04 
lower to 0.18 higher) 
 




7. A 5-day workshop comprising didactic lecture for Stigma 











Assumed risk Corresponding risk 
 Control A 5-day workshop comprising 
didactic lecture 
    
Empathy 
Scale: from 1 to 6 
Follow-up: mean 5 
days 
The mean empathy in the 
control groups was 4.1  
The mean empathy in the 
intervention groups was 0.2 








 Scale: from 1 to 6 
Follow-up: mean 5 
days 
The mean avoidance 
attitude in the control 
groups was 3.5  
The mean avoidance attitude in 
the intervention groups was 0.4 









Scale: from -5 to 15 
Follow-up: mean 5 
days 
The mean general attitude 
towards PLHIV in the 
control groups was 3.5  
The mean general attitude towards 
PLHIV in the intervention groups 









to care for PLHIV 
Scale: from 0 to 130 
Follow-up: mean 5 
days 
The mean nurses’ 
willingness to care for 
PLHIV in the control 
groups was 97  
The mean nurses’ willingness to 
care for PLHIV in the intervention 








8. A one-hour group education (homophobia and fear of death) for AIDS phobia 











Assumed risk Corresponding risk 
 
Control A one-hour group education 
(homophobia and fear of death 
program) 
    
AIDS phobia 
Scale from: 15 to 75. 
Follow up: NA 
The mean AIDS phobia in 
the control groups was 
39.49 
The mean AIDS phobia in the 
intervention groups was 0.03 







*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk 
(and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and 
its 95% CI). CI: Confidence interval;  
GRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of effect.  
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change 
the estimate. 
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to 
change the estimate. 




3 No control group and the sample sizes at the baseline and post intervention survey are different, hence downgraded two levels for risk 
of bias 
4 Wide and statistically non-significant confidence interval 
5 One control hospital and one experimental hospital was used (conveniently selected), so downgraded one level for risk of bias 
6 Groups had different scores in fear-based stigma at baseline 
7 No control group 
8 The hospitals were conveniently selected. A cross-sectional sample of providers was taken from the selected hospitals. (downgraded 
one level for risk of bias) 
9 Cross-sectional nature of data collection, facility characteristics were not considered 
10 No control group. The intervention sites were conveniently chosen by researchers based on accessibility and willingness to participate. 
(downgraded one level for risk of bias) 
11 Five unique case studies were combined, which might have masked differences among the settings 
12 case series 
13 Wider confidence interval 
14 No explanationwas given on how lost participants were handled. Around 9% did not provide responses to all questions 
15 No control group 
16 No adequate follow up, poor intervention focus. 
17 Wide confidence interval (additionally downgraded for risk of bias) 
NB: CI: Confidence Interval, HCWs: Healthcare workers, HIV: Human immunodeficiency virus, PLHIV: People Living with HIV, OR: 
Odds Ratio, UP: Universal precaution.AIDS: Acquired immunodeficiiency syndrome. 
4.2. Concise introduction 
Stigma and discrimination (SAD) related to human immunodeficiency virus (HIV) occur in 
healthcare settings because of a discriminatory policy environment, or limited awareness of 
what constitutes stigma among healthcare workers (HCWs).2Stigmatizing interactions are 
often not recognized by healthcare providers.59 For instance, marking the files of People 
Living with HIV (PLHIV) is taken as an appropriate practice by some HCWs.59Although 
there are reviews that addressed interventions targeting stigma and discrimination related to 
HIV,2, 133, 136 some of them did not report the findings specifically within different population 
sub-groups (healthcare workers, PLHIV, community members, etc.) and settings 
(community, healthcare settings, schools, etc.).2, 133 The effectiveness of these interventions 
might have been affected by pre-existing contextual factors.139, 141 In addition, details of the 
intervention characteristics such as the implementers of the target intervention and its fidelity 
should be considered.141, 142 
In healthcare settings,both structural and individual-level factors fuel stigma and 
discrimination related to HIV. These include factors specific to the practice of HCWs such 
as fear of casual transmission, and limited knowledge of what stigma is and its negative 
consequences,58 shortage of protective equipment, or the absence of a redressal system or a 
supportive policy in the healthcare facility.58 Hence, these factors should be addressed 
through skillsbuilding and structural interventions such as availing supplies for standard 
precautions.58 
As reported in chapter three, I found no systematic review addressing stigma and 
discriminationreduction interventions specific to healthcare settings or HCWs published 




thesis, were not context and populationspecific. Therefore, the aim of this review was to 
identify, appraise and analyze findings of studies reporting on interventions aimed to reduce 
HIV-related stigma and discrimination among HCWsin healthcare facilities. 
4.3. Review questions/objectives 
This review sought to locate, appraise and describe international literature reporting on 
interventions that addressed stigma and discrimination related to HIV in healthcare settings. 
Specifically, the review aimed to:  
• Identify, appraise and describe studies containing interventions to reduce HIV-
related stigma and discrimination by HCWs. 
• Identify, appraise and describe studies that report on institutional-level interventions 
to reduce SAD related to HIV.  
4.4. Inclusion criteria 
For this review, I considered the following inclusion criteria. 
Population 
This review considered interventions addressing HCWsand health managers in healthcare 
institutions. I included only in-service healthcare professionals (those professionals engaged 
in care provision after graduation) in this review. Hence, I did not include medical, allied 
health, nursing and other health and medical science students. 
Interventions 
I considered interventions that addressed stigma and discrimination related to HIV. These 
included, but were not limited to the following:  
• Information-based approaches including both written and verbal information to 
increase the understanding of HIV, and the associated stigma and discrimination that 
may be provided in the form of leaflets and brochures or through other methods. 
• Skillsbuilding approaches, such as demonstrations and role-play. 
• Structural approaches such as availing supplies for standard precautions, revision and 
development of standard operating procedures, polices and regulations, and putting 
a grievance addressing system in place. 
• Contact strategies, such as testimonials of PLHIV and activities that encourage 
interaction between HCWs and PLHIV.2, 133 
• Biomedical interventions such as universal access to care and treatment or expansion 




• Counseling and support interventions to help cope with stigma and discrimination.2 
Comparators 
The comparators I considered for inclusion were baseline (before intervention), no 
intervention, usual care and one or more of the above components compared to one another. 
Outcomes 
The primary outcomes I considered for inclusion were HIV-related stigma and 
discrimination among HCWsin healthcare institutions. Stigma reported in the form of fear-
based stigma, value-based stigma, enacted stigma, internalized stigma or in other forms were 
included. The secondary outcome I considered for inclusion was PLHIV-specific extra-
precaution. 
Context 
This review considered all studies conducted worldwide that addressed HIV-related SAD 
among healthcare workers in healthcare settings (hospitals, clinics or health centers). 
Types of studies 
This review considered all studies with comparative designs, such as randomized controlled 
trials (RCTs), quasi-experimental studies and before and after studies. 
4.5. Search strategy 
The search strategy aimed to find both published and unpublished studies reported in English 
language. A three-step search strategy was utilized in this review. An initial limited search 
of Cumulative Index to Nursing and Allied Health (CINAHL) and Medical Literature 
Analysis and Retrieval System Online (MEDLINE) was undertaken followed by an 
examination of the text words contained in the title and abstract, and of the index terms used 
to describe the article. A second search using all identified keywords and index terms was 
then undertaken across all included databases. Thirdly, the reference list of all identified 
reports and articles was searched for additional studies.  
Both published and unpublished papers reported in the English language were searched with 
no restriction to age, country and date of publication.The databases searched were: CINAHL, 
Excerpta Medica Database from Elsevier (EMBASE), MEDLINE and Psychological 
information (PsycINFO) database. The search for unpublished studies included: HIVinSite, 
AIDSinfo, HIV and AIDS clearinghouse, Communicable Diseases Control (CDC) HIV 
publications, Health Policy Project (HPP) website, United States Aid for International 
Development (USAID) experience clearinghouse, and United Nations Joint Program on 




appended (Appendix 6). The results of the search for each website and database areshown 
in Appendix 7. 
4.6. Assessment of methodological quality 
Two individuals independently appraised the quality of the papers prior to inclusion in the 
review using appraisal instruments from the Joanna Briggs Institute (JBI)143, 144(Appendices 
8-11). All disagreements that arose between the reviewers were resolved through discussion, 
and there was no requirement for a third reviewer. 
4.7. Data extraction and syntheses 
Quantitative data were extracted from papers included in the review using the standardized 
data extraction tool from the JBI (Appendix 12). Relevant information such as population 
characteristics, publication year, authors, intervention type and summary of the findings 
were extracted. Where necessary, I asked primary authors to provide additional information 
on the articles. Details of data from primary studies with limited data or with limited follow 
up were checked through making request to the authors and checking subsequent publication 
from the same project based on cross-checkingthe linked publications from the registries of 
trials (if trial registry number existed). For instance, Li et al. 2013145 published another article 
from the same project in 2015.146 
Since the studies were methodologically or clinically heterogeneous, statistical pooling was 
not possible; hence, the findings are presented in narrative form. The quality of evidence for 
major outcomes reported in each study was assessed using a software package developed by 
the Grading of Recommendations, Assessment, Development and Evaluation (GRADE)86 
working group. The Summary of Findings (SOF) for all outcomes extracted from all 
studiesare then presented in a single table (Table 3). 
4.8. Results 
The search yielded a total of 2,927 records. After removing, duplicates, 2,856 documents 
were retained for further examination. After screening the titles and abstracts, 167 records 
were retained for full text examination. Based on pre-defined inclusion criteria, 30 records 
were included in critical appraisal. Finally, 14 records reporting on eight studies were 
retained (Figure 4).  Sixteen studies were excluded based on reason. Almost all studies 








Figure 4. Study selection process 
(From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. 
doi:10.1371/journal.pmed1000097126 
 
4.8.1. Description of the characteristics of included studies 
Among the 14 records included in this review, six articles (Li et al. 2013a;147 Li et al. 
2013b;148 Li et al. 2013c;149 Li et al. 2014a;150 Li et al. 2014b;151 and Liet al. 2015.146) 
reported on the findings of a single randomized trial. The trial was conducted in 40 hospitals 
of China. Hereafter,Li et al. 2015146will be used to describe the findings extracted from the 
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through other sources 
(n =   0) 
Records after duplicates removed 
(n = 2,856) 
Full text articles assessed for 
eligibility 
(n = 167) 
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(n =137) 
Full-text articles critically 
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(n = 30) 
Full-text articles excluded, 
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Studies included in 
narrative synthesis 
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studyalthough data were extracted from all the six articles to get complete information. In 
addition, another before and after study (Williams et al. 2006152) was conducted in 
China.The other studies were conducted in Chile (Norret al. 2012153); India (Mahendra et 
al.2006154);Vietnam (Pulewitz et al. 201513and Oahnet al.2008155); Egypt (Lohiniva et al. 
2016156); USA (Zachary1998157) and one study was a  multi-country case study (Uyset 
al.2009158) (Table 4). Pulewitz et al.201513 and Oahn et al.2008155 both reported on a single 
study. For reporting purpose, hereafter, I will use Pulewitzet al.2015.13The characteristics of 
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NB: POL: Popular opinion leaders, HCWs: Healthcare workers, SAD: Stigma and discrimination,HIV: Human immunodeficiency virus, 
PLHIV: People Living with HIV, USA: United States of America, AIDS: Acquired immunodeficiency syndrome.  
  
4.8.2. Methodological quality of individual studies 
Six articles (Li et al. 2013a;147 Li et al. 2013b;148 Li et al. 2013c;149 Li et al 2014a;150 Li et 
al. 2014b;151 and Li et al. 2015146) reported on the findings of a single randomized trial. None 
of the included articles clearly described the method of randomization and allocation 
concealment. Three studies (Norr et al. 2012;153 Lohiniva et al. 2016156and Pulewitz et al. 
201513) were non-randomized trials with control groups. Two before and after trials without 
control groups (Williams et al. 2006152 and Zachary1998157) had post intervention data taken 
from the same cohort of participants as those of baseline participants. One study (Uys et al. 
2009158) was a multiple-case study design reporting on the same cohort of nurses and PLHIV 
before and after the intervention. One before and after study without a control group 
(Mahendra et al.2006154) reported on independent cross-sectional samples from the same 
institution. The study did not identify and control for confounding factors.  
Participant blinding is not practical for such behavioral interventions. Hence, none of the 
studies described blinding of participants or assessors, and outcome concealment. However, 
five of the studies (Li et al. 2015;146 Lohiniva et al.2015;156 Pulewitzet al.2015;13 Norret al. 
2012153 and Zachariah1998157) used self-administered questionnaires.Five studies (Lohiniva 
et al 2016;156 Williams et al.2006;152 Pulewitz et al. 2015;13 Mahendraet al. 2006154 and Uys 




because either there was significant loss to follow up or inadequate information (Lohinivaet 
al. 2016156 and Williams et al. 2006152), or they used repeated cross-sectional samples with 
different samples (Mahendra et al. 2006154) or there was a considerable proportion of 
participants within completedatawho were excluded from analyses (Pulewitz et al. 
201513).Overall, the included RCT (Li et al. 2015146)scored 8/13. One of the quasi-
experimental studies (Norr et al. 2012153)  scored 9/13. Four studies ((Lohiniva et al. 2016;156 
Williams et al. 2006152and Pulewitz et al. 201513) scored 8/9. One repeated cross-sectional 
study (Mahendra et al. 2006154) scored 6/8. The multiple case study (Uys et al. 2009158) was 
given a score of 8/10. Summaries of assessment scores are presented in Tables 5-8. 
Table 5. Methodological quality of randomized controlled trails 
S/n Study ID Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Total of ‘yes’ 
scores 
1.  Li et al. 
2015 
U U Y U U U Y Y Y Y Y Y Y 8 
NB: Y=Yes, U=unclear, NA=not applicable 
Q1. Was true randomization used for assignment of participants to treatment groups? 
Q2. Was allocation to treatment groups concealed? 
Q3. Were treatment groups similar at the baseline? 
Q4. Were participants blind to treatment assignment? 
Q5. Were those delivering treatment blind to treatment assignment? 
Q6. Were outcomes assessors blind to treatment assignment? 
Q7. Were treatments groups treated identically other than the intervention of interest? 
Q8. Was follow-up complete, and if not, were strategies to address incomplete follow-up utilized? 
Q9. Were participants analyzed in the groups to which they were randomized? 
Q10. Were outcomes measured in the same way for treatment groups? 
Q11. Were outcomes measured in a reliable way? 
Q12. Was appropriate statistical analysis used? 
Q13. Was the trial design appropriate, and any deviations from the standard RCT design (individual randomization, parallel 
groups) accounted for in the conduct and analysis of the trial? 
Table 6. Methodological quality of quasi-experimental studies 
S/n Study ID Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Total of ‘yes’ scores 
1.  Lohinva et al. 
2015 
Y Y Y Y Y N Y Y Y 8 
2.  Norr et al. 2012 Y Y Y Y Y Y Y Y Y 9 
3.  Pulewitz et  al. 
2015 
Y Y Y Y Y N Y Y Y 8 
4.  Williams et al. 
2006 
Y Y Y N Y U Y Y Y 8 
5.  Zachariah 1998 Y Y Y N Y Y Y Y Y 8 
NB: Y=Yes, U=unclear, NA=not applicable 
Q1. Is it clear in the study what is the ‘cause’ and what is the ‘effect’ (i.e. there is no confusion about which variable comes 
first)? 
Q2. Were the participants included in any comparisons similar? 
Q3. Were the participants included in any comparisons receiving similar treatment/care, other than the exposure or 
intervention of interest? 
Q4. Was there a control group? 
Q5. Were there multiple measurements of the outcome both pre-and post the intervention/exposure? 
Q6. Was follow up complete and if not, were differences between groups in terms of their follow up adequately described 
and analyzed? 




Q8. Were outcomes measured in a reliable way? 
Q9. Was appropriate statistical analysis used? 
Table 7. Summary score for methodological quality of repeated cross-sectional 
studies 
Study ID Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Total of ‘yes’ scores 
Mahendra et al. 2006 Y Y Y Y N N Y Y 6/8 
NB: Y=Yes, U=unclear, NA=not applicable 
Q1. Were the criteria for inclusion in the sample clearly defined? 
Q2. Were the study subjects and the setting described in detail? 
Q3. Was the exposure measured in a valid and reliable way? 
Q4. Were objective, standard criteria used for measurement of the condition? 
Q5. Were confounding factors identified? 
Q6. Were strategies to deal with confounding factors stated? 
Q7. Were the outcomes measured in a valid and reliable way? 
Q8. Was appropriate statistical analysis used? 
Table 8. Summary score for methodological quality of case series studies 
Study 
ID 
Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Total 
of ‘yes’ 
scores 
Uys et al 
2009 
Y Y Y NA Y Y NA Y Y Y 8 
 
NB: Y=Yes, U=unclear, NA=not applicable 
Q1. Were there clear criteria for inclusion in the case series? 
Q2. Was the condition measured in a standard, reliable way for all participants included in the case series? 
Q3. Were valid methods used for identification of the condition for all participants included in the case series? 
Q4. Did the case series have consecutive inclusion of participants?  
Q5. Did the case series have complete inclusion of participants? 
Q6. Was there clear reporting of the demographics of the participants in the study? 
Q7. Was there clear reporting of clinical information of the participants? 
Q8. Were the outcomes or follow up results of cases clearly reported? 
Q9. Was there clear reporting of the presenting site(s)/clinic(s) demographic information? 
Q10. Was statistical analysis appropriate? 
 
4.8.3. Findings of the studies 
Interventions used in studies included in this review fell under five general categories: 
information-based interventions; structural interventions, biomedical interventions, and 
skillsbuilding and contact strategies. Most studies utilized more than one of the above 
general categories of interventions. One study (Mahendra et al2006154) used all of the five 
categories of interventions in combination (information-based, skillsbuilding, structural, 
contact and biomedical approaches). One study (Pulewitz et al. 201513) utilized a 
combination of information-based, skillsbuilding, structural and contact approaches. Two 
studies (Uys et al. 2009158 and Lohiniva et al. 2016156) used a combination of information-
based, skillsbuilding, and contact approaches. One study (2015146) utilized a combination of 
information-based, skillsbuilding and structural approaches. One study (Williams et al. 
2006152) utilized a combination of information-based and skillsbuilding approaches. The 
remaining two studies (Norret al. 2012153and Zachary1998157) utilized only information-




Since the design, duration of follow up and instruments used to measure the effect of the 
interventions were not uniform, I could not compare one type of intervention with another 
nor multiple interventions with a single intervention. Ialso could not pool the findings of the 
studies using meta-analysis. Nevertheless, I present the findings of the studies along with 
their respective quality of evidence.The details of the intervention and their effects are 
described in detail below. 
a. Training popular opinion leaders 
The study by Li et al.146identified and trained popular opinion leaders (POLs)through group 
discussions, games, and role-play. The POLs attended a 1.5-hour weekly group training 
session run for four weeks and fortnightly re-union sessions. Materials for universal 
precaution were supplied in both control and intervention hospitals. The authors took data 
from 880 HCWs of 20 intervention hospitals (where POLs were trained) and from another 
880 HCWs from 20 control hospitals.  
An avoidance intent was measured using a five-point Likert-scale that asked HCWs about 
their willingness to treat PLHIV in eight scenarios. Higher scores indicated a higher intent 
to avoid service provision to PLHIV. The intervention effect on avoidance intent was 
sustained even at 12 months follow up. At 12 months, avoidance intent among HCWs in the 
intervention hospitals was significantly lower (mean difference (MD)=-1.87 [95% CI -2.05 
to -1.69]) when compared to that of healthcare workers in control hospitals (P<0.01). 
Prejudicial attitude was measured using eight items rated on the five-point Likert scale. 
However, only effect estimate was reported.At 12 months, the prejudicial attitude among 
healthcare workers in the intervention hospitals was significantly lower (MD=–3.77[95% CI 
-5.4 to -2.09]) when compared to that of HCWs in control hospitals (P<0.01). Universal 
precaution (UP) was measured using 13 items with responses ranging from 0 (never) to 4 
(always) on Likert scale. Higher scores indicate higher levels of adherence to 
UP.Compliance to Universal precautionwassignificantly higher among HCWs in the 
intervention group (MD=1.65 [95% CI 1.41 to 1.89]) when compared to HCWs assigned to 
usual care (P<0.01) [moderate quality of evidence]. 
b. Modular interactive training and discussion 
The study by Lohiniva et al.156conducted an interactive training and discussion intervention 
focusing on HIV-related stigma, infection control and medical ethics using five modules.The 
intervention was complemented by interaction with PLHIV. The authors assessed the effect 




participants. They used 12 items to measure fear-based stigma. Nine items were used to 
measure value-based stigma. Both scales were standardized to obtain scores ranging from 1 
to 10. For both scales higher scores indicated higher levels of stigma. At the post-
intervention survey, the participants from the experimental group reported significantly 
lower levels of value-based stigma (mean= 2.1) when compared to participants in the control 
group (mean=3.8)(MD=-1.7, P<0.01, CI was not given). Similarly, fear-based stigma was 
significantly lower among participants in the experimental group (mean=1.1) when 
compared to that of participants in the control group (mean=3.2) (MD=-2.1, P<0.01, CI was 
not given) [very lowquality evidence]. 
c. Professionallyassisted peergroup intervention 
The study by Norr et al.153conducted eight sessions of professionallyassisted peergroup 
interventions. The sessions covered (a) the importance of community HIV prevention; (b) 
standard precautions in the healthcare setting; (c) HIV testing and treatment; (d) offering 
care that respects human dignity and confidentiality; (e) human sexuality, sexual 
transmission of HIV and other sexually transmitted infections (STIs), and HIV transmission 
through drug use and blood; (f) partner communication and HIV prevention;(g) counselling 
about HIV infection; and (h) HIV prevention to clients and families using roleplays.  
To assess the effect of the intervention, pre-and post-intervention measurements were made 
for both control and intervention groups. Public contact stigma was measured using three 
items on the four-point Likert scale. Since mean item score (instead of the mean scale score) 
were reported possible scores ranged from 1 to 4. Client contact stigma was measured using 
three items on the three-point Likert scale. Since mean item scoreswere reported possible 
scores ranged from 1 to 3. For both scales, higher scores indicated a higher level of 
stigma.After the intervention, the level of client contact stigma among participants in the 
intervention group was significantly lower [MD=-0.28 (95% CI -0.37 to -0.19)] 
(P<0.01)[very lowquality of evidence]. Similarly, public contact stigma among the 
intervention group was significantly lower (MD=-0.07(95% CI -0.12 to -0.02) (P<0.01) 
[very lowquality of evidence]. 
d. Staff training, participatory hospital policy development, provision of materials 
and supplies, and expansion of HCT services 
1. Participatory self-guided assessment and intervention with training and the 




The study by Mahendra et al.154conducted a participatory self-guided assessment and 
intervention with interactive training facilitated by representatives of AIDS service 
organizations (including PLHIV),which involved the development and dissemination of 
policy guidelines and educational materials, such as posters on infection control and 
expansion and strengthening of HIV counseling and testing (HCT) in three hospitals. The 
effect of the intervention was measured using an index score of stigma that could range from 
a minimum of 21 to a maximum of 63, a higher score indicating greater stigma. They 
assessed the effect of the intervention using repeated cross-sectional surveys. After the 
intervention, there was a significant decrease in stigma score from 42.79 at baseline to 38.08 
after the intervention (MD=-4.72, CI not given, P<0.01) [very lowquality evidence]. 
In addition, the risk of seeking informed consent was 2.14 (95%CI1.17 to 3.91) times higher 
after the intervention when compared to the risk before the intervention (P<0.01) [very 
lowquality evidence].Therisk of using gloves after the intervention was 7.81  
(95% CI 3.64 to 16.76) times higher after the intervention when compared to the risk before 
the intervention (P<0.01) [very lowquality evidence]. 
2. Staff training, participatory hospital policy development and provision of 
material supplies 
The study by Pulewitz et al.13compared the effect of addressing fear-based stigma alone (arm 
1) to that of addressing both fear-based stigma and social stigma (stemming from moral 
judgments) (arm 2) through interventions that encompassed staff training, participatory 
hospital policy development and provision of materials and supplies. Healthcare workers in 
arm 1 received interventions that addressed only fear-based stigma. The interventions 
included a half-day training on basic knowledge of HIV/AIDS and a one-day training on 
universal precaution. Healthcare workers in arm 2 received interventions that addressed both 
fear-based stigma and social stigma. The training for arm 2 participants encompassed basic 
knowledge of HIV, universal precaution and stigma. The authors reported that both 
interventions had significantly reduced stigma.  
The authors measured fear-based stigma using four items with alternative responses ranging 
from 1 (no fear) to 3 (a lot of fear). Hence, the composite score ranged from 4 to 12. Social 
stigma was measured using five items, each having a score range of 1 to 3. The composite 
score ranged from 5 to 15. In both scales, higher scores indicated a higher level of stigma. 
After the intervention, HCWs exposed to interventions that addressed both fear-based stigma 




based stigma when compared to those HCWs exposed to interventions that addressed only 
fear-based stigma (P<0.01) [Very lowquality evidence]. On the other hand, there was no 
statistically significant difference in social stigma (MD=-0.14, 95% CI -0.43 to 0.15) 
between the two intervention groups[very lowquality evidence]. 
The odds of over-using barriers was 46% (OR 0.54 (95 % CI 0.31 to 0.91) lower among 
HCWs exposed to interventions addressing both fear-based and social stigma when 
compared tothose ofHCWs exposed to intervention that addressed fear-based stigma alone 
(P<0.01) [Very lowquality evidence]. The odds of marking files of HIV positive clients was 
46% (OR 0.54 (95 % CI 0.29 to 1) lower among HCWs exposed to interventions addressing 
both fear-based and social stigma when compared to those of HCWs exposed to 
interventions that addressed fear-based stigma alone(P<0.01) [very lowquality evidence]. 
The odds of marking files of HIV positive clients was 46% (OR 0.54 (95 % CI 0.29 to 1) 
lower among HCWs exposed to interventions addressing both fear-based and social stigma 
when compared to those of HCWs exposed to intervention that addressed fear-based stigma 
alone [very lowquality evidence].The odds of putting signs on bed indicating HIV status was 
75% (OR 0.25 (95 % CI 0.07 to 0.87)) lower among HCWs exposed to interventions 
addressing both fear-based and social stigma when compared to those of HCWs exposed to 
interventions that addressed fear-based stigma alone (P<0.01) [very lowquality evidence]. 
e. Multifaceted educational programs comprising didactic lectures and activities 
eliciting discussions 
The study by Williams et al.152investigated a five-day workshop comprising didactic lectures 
on HIV/AIDS epidemiology, natural history, transmission routes and clinical care combined 
with activities that provoked discussion of participants’ values and personal feelings about 
HIV/AIDS.To measure the effect of the intervention, both empathyand avoidance attitude 
scores ranged from 1 to 6. Higher scores in empathy and lower scores in avoidance attitude 
indicated a more desirable attitude.General attitude score was calculated by substracting the 
avoidance score from the empathy score. It ranged from -5 to 5. Positive and negative general 
attitude scores suggested a supportive attitude and a negative attitude respectively.The 
nurses’ willingness questionnaire (NWQ) was used to measure the willingness of nurses to 
perform activities on HIV positive patients. This questionnaire comprised 13 items measured 
on the 11-point Likert scaleranging from 0(not all willing) to 10 (extremely willing).Hence 




The intervention resulted in significant improvement in empathy (MD=0.2 (CI not given, 
P<0.01); reduction in avoidance attitude (MD=-0.4, CI not given, P<0.01) and improvement 
in general attitude towards PLHIV (MD=0.6, CI not given, P<0.01) and willingness to care 
for PLHIV (MD=13, CI not given, P<0.01). [Very low quality of evidence] 
f. Contact strategy: Workshops bringing PLHIV and Healthcare workers 
together  
The study by Uyset al.158conducted a two-day workshop that brought PLHIV and nurses 
together using a multi-country case study. The authors measured self-esteem using 
Rosenberg’s self-esteem scale, which consists of ten items rated on a four-point Likert scale. 
Scores could range from 10 to 40. Stigma among PLHIV was measured using 33 items. It 
had six domains: verbal abuse, negative self-perception, healthcare neglect, social isolation, 
fear of contagion and workplace stigma. The HIV/AIDS stigma instrument for nurses that 
contained 19 items was used to measure stigma among nurses. The authors reported stigma 
items in mean scores, but did not indicate the possible ranges for mean scores. 
After the intervention, there was a significant increase in self-esteem (MD=2.12 (95% CI 
0.18 to 4.06)) (P<0.05), decrease in workplace stigma [MD=-0.31 (95% CI -0.61 to -0.01)) 
(P<0.05), total stigma score (MD=-0.17 (95% CI -0.35 to -0.01))(P<0.01), and negative self-
perception (MD=-0.46 (95% CI -0.81 to -0.11)) (P<0.01) among PLHIV[Very lowquality 
evidence]. On the other hand, there was no significant effect observed on verbal abuse 
(P=0.38), healthcare neglect (P=0.24), social isolation (P=0.51) and fear of contagion 
(P=0.29).Similarly, there was no significant change in nurses’ stigmatizing attitudes 
(MD=0.07 (95% CI -0.04 to 0.18)) (P=0.37) [very lowquality evidence]. 
g. Group education on homophobia and fear of death  
The study by Zachary1998157used group education on homophobia and fear of death. The 
study measured AIDS phobia using 15 items rated on the five-point Likert scale. Hence, the 
score could range from 15 to 75. The intervention did not result in a significant reduction in 
AIDS phobia (MD=0.03 (-3.13 to 3.19) (P=0.94). [Very lowquality evidence] 
4.9. Discussions 
This systematic review attempted to locate, critically appraise and describe the best available 
evidence on interventions to reduce HIV-related stigma and discrimination in healthcare 
settings among HCWs. Studies included in this review employed different measures, 
intervention types and durations of interventions. Hence, I could not pool the results of the 




Previous reviews categorizedSADreduction interventions into the following 
categories:information-based; structural, biomedical, counseling and support, skillsbuilding 
and contact.2, 133, 136Most studies included in this review used a combination of two or more 
interventions to reduce stigma and discrimination in healthcare settings. Information-based 
approaches used in the studies included in the current review were: 
a. Training popular opinion leaders through group discussions, games, and role-play.146 
b. Professionallyassisted peergroup intervention.153 
c. Group education on fear of death and homophobia.157 
d. Interactive modular training and discussion focusing on HIV-related stigma, 
infection control, medical ethics and contact with PLHIV.156 
e. Workshops,152, 158 training and dissemination of policy guidelines and educational 
materials, such as posters on infection control.13, 154 
These information-based approaches were used alone153, 157or in combination with others. 
Among the combinations were: information-based approaches combined with skillsbuilding 
and structural approaches.146 
information-based approaches combined with skillsbuilding and contact-based 
approaches;156information-based approaches combined with skillsbuilding, structural, 
contact and biomedical approaches;13 information-based approaches combined with 
skillsbuilding, structural and contact-based approaches; 158 and information-based with 
skillsbuilding approaches.152 
Although some results reached statistical significance, because of the poor design of the 
studies, most of the interventions were assigned low or very lowquality evidence. Only 
outcomes reported in one intervention (identifying and training popular opinion leaders, in 
the presence of adequate supplies) was assigned a moderatequality evidence.This 
intervention was reported by Li et al.146The study used both an information-based and 
structural approach to reduce SAD. The intervention employed diffusion of innovation 
theory to disseminate information to correct misconceptions related to PLHIV2015.146 
The intervention was effective in reducing avoidance intent and prejudicial attitudes and in 
improving compliance to universal precaution. This indicates that structural interventions 
(availing materials for standard precaution) alone are not sufficient, whichhighlights the 
necessity of complementing structural interventions with behavioral interventions.  
As reported in one study, interventions addressing fear-based stigma reduction through 




both social stigma and fear-based stigma.13However, the study showed that the effect of the 
interventions that addressed both fear-based and social stigma was significantly higher in 
reducing fear-based stigma and extraprecaution when compared to interventions addressing 
fear-based stigma alone.13This implies that behavioral interventions targeting stigma and 
discrimination among healthcare providers should address prejudices and social stigma that 
may also be part of wider cultural beliefs.137Apart from equipping healthcare providers with 
knowledge and skills, it is paramount to address their emotions.159 
The outcomes reported by all other interventions were assigned very lowquality evidence. 
These interventions were modular interactive training and education on 
HIV/AIDS,156professionallyassisted peergroup interventions,160participatory self-guided 
assessment and interventions,154 workshops that included didactic lectures,152 and contact-
based  strategies combined with information provision.158All these interventions resulted in 
statistically significant reductions in stigma scores. As well, a study that used group 
education on homophobia reported no significant change on AIDS phobia after the 
intervention.157On the other hand, the poor design of the studies included in this review and 
the poor quality of evidence supporting most of the findings underscores that more rigorous 
studies such as RCTs are needed to make appropriate decisions for policy and practice. 
This review identified five categories of stigma and discriminationreduction interventions: 
information-based, skillsbuilding, structural, contact and biomedical interventions. Unlike 
other previous reviews,2, 133, 136 in this review we did not identify any study conducted among 
HCWs reporting on counseling and support approaches to SADreduction. This may be 
because, unlike other population groups,HCWswere not provided counseling and support 
interventions to cope with secondary stigma (stigma that they may face because of their 
association with PLHIV). 
On the other hand, previous studies indicated that HCWs themselves face secondary stigma 
as a result of their association with PLHIV.161, 162It wasalso shown that HCWs living with 
HIV faced perceived or actual SAD from colleagues or the community.161It was 
demonstrated that counseling and support interventions helped to minimize the negative 
psychosocial impact of HIV-related SAD on clients living with HIV and their families.134-
136, 140, 163, 164 
After I completed this review one meta-analysis and systematic review was published. The 
study indicated that stigma and discriminationreduction programs resulted in small effect 




indicated that effect sizes were moderated by the settings in which the intervention was 
conducted, population type and number of intervention sessions.165The review 
hadalimitation in that it was not focused enough with regard to settings, intervention type 
and population type. Other previous reviews on HIV-related SAD did not provide a focused 
summary of SAD reduction interventions for specific population groups and settings and an 
indication of the quality of the findings and the pooling the results of the primary studies to 
inform policy and practice.2, 133, 136Although, I could not pool the findings of the studies in 
the current review because of the heterogeneity of the interventions and outcome measures, 
I have indicated the quality of evidence for findings reported in this review.These 
summarized findings may guide policy makers, practitioners and researchers to make 
appropriate decisions. Nevertheless, the poor quality of evidence supporting most of the 
findings poses a challenge especially for practitioners and policy makers. 
Most studies were excluded from this review because of poor quality of evidence, mainly 
related to measurement bias. Therefore, future studies need to fill these gaps. As has been 
recommended in previous systematic reviews,2, 133 it is important to focus on the design of 
the studies, which includes working to improve the internal validityof the studies and 
usingvalidated instruments to measure SAD.2, 133, 134, 136In addition, there was variability 
among the measures used in the studies included in the review. This might have been 
attributed to the absence of standardized measurements. Future studies may fill these gaps 
as efforts are being made to develop standard tools and instruments to reduce SAD and to 
monitor these efforts.6This, however, will be possible only if the researchers are aware of 
the recent developments in measurements and scales. Moreover, further study is needed to 
identify working interventions to reduce internalized stigma and secondary stigma among 
HCWs. 
4.10. Conclusion 
Implications for practice: Moderatequality evidence indicates that training popular opinion 
leaders is effective in reducing avoidance intent and prejudicial attitude and improving 
compliance to universal precaution. Very lowquality evidence indicates that interventions 
addressing both fear-based stigma and social stigma are more effective in reducing fear-
based stigmaand extra-precautions when compared to interventions addressing only fear-
based stigma.Very low quality evidence indicates that the following are effective in reducing 
stigma-related outcomes: a) professionallyassisted peergroup interventions, b) modular 




interventions, d) contact strategy with information giving and empowerment, e) workshops 
comprising didactic lectures. When utilizing the evidence from the current review in policy 
making and in practice, it is vital to consider the quality of evidence supporting the findings 
and the limitations of the primary studies reported. 
Implications for research: Further RCTs are needed to provide evidence that guides 
interventions to reduce HIV-related stigma and discrimination in healthcare settings. Future 
trials need to use up-to-date stigma instruments to measure stigma and discrimination. 
Studies are needed to address internalized stigma and secondary stigma among healthcare 
providers. Further attempts should be made to standardize measures for stigma and 







THE DEVELOPMENT OF GUIDELINE RECOMMENDATIONS TO REDUCE 
HIV-RELATED STIGMA AND DISCRIMINATION IN HEALTHCARE 
SETTINGS 
5.1. Chapter overview 
This chapter describes the process involved in the development of a guideline to reduce 
stigma and discrimination (SAD) related to the human immunodeficiency virus (HIV). In 
addition to a systematic search for literature presented in previous chapters, the development 
of the guideline as part of this PhD project involved establishment of a guideline panel, 
determining the scope of the guideline, and assessment and analysis of evidence to develop 
a tentative list of recommendations. The details of the methodological procedures and the 
results of this process are described in this chapter. 
5.2. Abstract 
Concise introduction  
The lack of awareness among healthcare workers (HCWs) of what stigma looks like and 
why it is damaging; thefear of casual contact stemming from incomplete knowledge about 
HIV transmission; and the association of HIV with improper or immoral behavior have 
contributed to the continued presence of SAD inhealthcare settings. 
Objective 
The objective of this project was to develop guideline recommendations to reduce HIV-
related SAD.  
Methods 
Experts were invited through e-mails, telephone and personal contacts to establish the 
guideline panel. The established panel was then consulted through informal and formal 
meetings to determine the scope of the guideline. A content analysis of the included 
documents was conducted to develop initial tentative guideline recommendations. Strength 
and quality of evidence were assigned for each recommendation using a software package 
developed by Grading of Recommendations, Assessment, Development and Evaluation 
(GRADE)working group. 
Results 
A multidisciplinary panel consisting of 13 experts was established. The experts stressed the 
necessity of developing a guideline to reduce HIV-related SAD in healthcare institutions. 




programmatic performance criteria for their institution and that to date their institutions had 
not developed one. The panel then determined the scope of the guideline. They suggested 
that the guideline should target both HCW behaviors and attitudes and institutional practices 
and programs. Then an initial list of 31tentative recommendations was drafted through 
acontent analysis of included documents. The initial recommendations were framed under 
the following themes: structural, information-based and skillsbuilding, contact and 
empowerment, biomedical, measurement of SAD, and steps to integrate SAD reduction into 
healthcare settings. 
Conclusion 
Tentative recommendations were drafted based on the best available global evidence. The 
tentative recommendations were framed under the following themes: structural 
interventions, information-based andskillsbuilding interventions, contact and empowerment, 
biomedical interventions, measurement of stigma and discrimination, and steps to integrate 
SADreduction into healthcare settings. The appropriateness of these recommendations to the 
local context required further evaluation. 
5.3. Concise introduction 
People living with the human immunodeficiency virus (HIV) are confronted with the 
physical, psychological and social impacts of the disease.34, 166-169 Stigma and discrimination 
(SAD) also called the “third phase of HIV/AIDS”, have been one of the challenges facing 
stakeholders working on the prevention and control of HIV.170Stigma and discrmination 
related to HIV are manifested in various forms such as: differential care or refusal to treat, 
testing and disclosure of the sero-status of clients without consent, verbal abuses or gossip, 
marking the files of patients, isolating them and excessive use of precautions.57, 58 
Lack of awareness among healthcare workers (HCWs) of what stigma is and why it is 
damaging, fear of casual contact because of incomplete knowledge about HIV transmission 
and the association of HIV with improper or immoral behavior have contributed to the 
continued presence of stigma and discrimination in healthcare settings.2Institutional factors 
such as shortages of supplies and lack of training programs, lack of appropriate policies, 
guidelines, standards and regress systems to address SADalso contributed to the continuation 
ofSAD-related to HIV.2These problems underscore the necessity of guidelines and evidence-
informed interventions to tackle SAD and promote uniform practice among healthcare 




Cognizant of this, organizations have been working to reduce SAD related to HIV in the last 
few decades.171, 172 As part of the approach, countries have responded to HIV-related SAD 
through changing legislation related to HIV and PLHIV and supportingSADreduction 
interventions.173 Part of the global response has been developing resource materials that 
guide SADreduction interventions. However, some of these materials and toolsare too broad 
and not context and populationspecific.7, 129 Although guidelines and best practices 
developed to reduce SADreduction in healthcare settings contain resources for 
implementation and monitoring,6 most of them lack detailed description on their methods of 
development.132Hence, it is difficult to judge whether these guidelines have been 
systematically developed or not. This poses a challenge in making an informed choice in 
prioritizing the interventions. To this end, we have developed an evidence-informed 
guideline to reduce HIV-related SAD in healthcare settings. 
5.4. Objectives 
The objective of this project was to develop guideline recommendations to reduce HIV-
related SAD. Specifically, the project aimed  
• To establish a guideline panel comprising a multidisciplinary team of experts 
• To determine the scope of the guideline  
• To draft guideline recommendations  
5.5. Methods 
This section describes methods specific to this chapter, which comprises establishment of 
the guideline panel, determining the scope of the guideline, and assessment and analyses of 
evidence and developing a tentative list of recommendations.  
5.5.1. Establishing the guideline panel 
I established a guideline panel that comprised researchers, program managers 
andHCWsthrough the assistance of the Jimma University HIV Prevention and Control 
Office (JUHAPCO) coordinator. I requested JUHAPCO coordinator to identify local experts 
working on HIV and he also identified some experts with experience in systematic reviews 
and HIV-related research. I asked these experts for their willingness to be part of a guideline 
panel through e-mail, telephone and personal contacts using an invitation form shown in 
Appendix 14. 
I invited experts who were willing to be part of the panel to a half-day meeting held on 




necessity of declaring conflicts of interests before contributing towards the development of 
the guideline. I sent all of them a declaration of conflicts of interest form (Appendix 15)in 
which they declared potential conflicts related to the guideline.  
Roles of the panel members 
Some members of the panel helped me through the provision of information on existing 
guidelines. All panel members assisted me in determining the scope of the guideline and 
developing research questions.Since panel membership was based on voluntary 
contributions, I asked some of the panel members having experience or knowledge of 
systematic reviews to contribute to the appraisal of documents retrieved through the 
literature search. In phase 3, all the panel members evaluated the draft guideline using the 
Guideline Implementability Appraisal (GLIA) v.2.0 checklist.174 This is described in the 
following chapter (chapter six).  
5.5.2. Determining the scope of the guideline 
The scope of the guideline was informed through systematic reviews and informal and 
formal consultationswith experts. I asked the experts whether they knew any existing local 
guidelines on the reduction of stigma and discrimination.  
5.5.3. Development of guideline recommendations 
I mapped and extracted recommendations and interventions from the review of guidelines, 
best practice tools and systematic reviews reported in chapter three and a systematic review 
of primary studies reported in chapter four. The development of the guideline 
recommendations involved an iterative process of data extraction, appraisal of linked 
evidence and drafting of tentative recommendations. A content analysis of the body of 
evidence reported in chapter three and chapter four was undertaken to describe interventions 
effective in reducing HIV-related stigma and discrimination in a conceptual form.98 
5.5.3.1. Content analysis 
I used a content analysis to identify and describe effective interventions to reduce HIV-
related stigma and discrimination, and to produce recommendations. The project did not start 
with ana-priori matrix or framework to be tested. Rather, the project tried to develop a 
framework from the data extracted from the evidence (guidelines, systematic reviews and 
primary studies) retrieved through systematic reviews. In such circumstances, an inductive 
content analysis is preferred. Hence, I conducted an inductive approach content analysis.  
The advantage of inductive (conventional) content analysis is that knowledge generated is 




However, this approach may fail to identify key categories.99 This limitation was accepted 
in this project. This is because it was assumed that there were interventions yet to be formally 
investigated or that had been underreported or investigated with poor design and might not 
have been identified as effective interventions in the current project.Inductive content 
analysis includes open coding (generating codes while reading), creating categories and 
abstraction.98 
A content analysis of the included units of evidence reported in chapter three and chapter 
four was carried out. As indicated in chapter three, most of the guidelines, best practices and 
systematic reviews did not allow us to draw recommendations to develop a list of 
recommendations. Hence, the details of primary evidence linked to the guidelinerelated 
documents and systematic reviews were further examined.The primary studies of the 
reported guidelines, best practices and systematic reviews reported in chapter three were 
examined only if they are related to interventions targeting HCWs.  
In general, the process involved the following steps:  
1. Identifying content, unit of analysis and meaning of the content 
2. Listing a tentative list of documents  
3. Re-analysis of the content (the initial recommendations)which involved condensing 
and abstracting the contents and developing a content area, codes, categories and 
themes to assist conceptualization and describing working recommendations.98 
Identifying content, unit of analysis and meaning of a content 
I repeatedly read the selected units of evidence to achieve immersion and to obtain the sense 
of the whole data. I gave attention to the nature of the interventions, the settings in which 
they were conducted, populations involved and design of the studies.While extracting data 
from the documents, I considered the following parameters: 
a. Content of the intervention, 
b. Duration and intensity of the interventions, 
c. Mode of delivery (individual or group), 
d. Context (healthcare settings,home) and level (individual, interpersonal, 
organizational) in which the intervention was delivered, 
e. Recipients (HCWs, health managers, healthcare institutions, PLHIV and 
f. Acceptability of the interventions in the local context. 
Then, I described interventions effective in reducing HIV-related SADamong HCWs in a 




such as, stigma related to mental health, leprosy or other diseases or conditions. In addition, 
I did not extract interventions that were not relevant to healthcare settings or interventions 
not related to health professional’s professional responsibility to help the patient. For 
example, I did not consider SADreduction interventions in the general community and in 
faith-based organizations. Moreover, I did not extract recommendations from studies that 
utilized single separate items without creating a scale or composite score if invalidated 
instruments were used to measure stigma and other attitudinal outcomes. 
I further assessed data extracted from the primary studies for quality of evidence using the 
GRADEpro GDT software package. I then developed recommendations based on the nature 
of the interventions, participants and settings in which the interventions were conducted. 
However, I did not assign any quality of evidence for recommendations that were not 
supported by research evidence were not assigned any quality of evidence. Finally, I 
assigned grades of recommendations for each recommendation. For each recommendation, 
along with the panel members, I assigned strength and quality of evidence except for 
interventions not supported by research evidence.  
The strength of a recommendation reflects the extent to which one can be confident that the 
desirable effects of the recommended actions outweigh the undesirable effects.21, 175, 176The 
World Health Organization (WHO) handbook for guideline development provides four 
criteria to judge the strength of recommendations: a) quality of evidence. b) balance of 
benefits versus harms, c) values and preferences and d) resource use.177 In line with these 
four criteria,the GRADEpro GDT software package has four parameters. These parameters 
include: a) absence of high quality evidence, b) uncertainty of balance of benefits and 
harm/burdens, c) uncertainty or different values and preferences, and d) uncertainty that net 
benefits are worth the costs.21 Hence, each recommendation was assigned either a “yes” or 
a “no” score for each of these four parameters. The panel decided on each parameter based 
on evidence from literature, and clinical, research and programmatic experiences.In the 
current project, we used the following guide to assign a “yes” or a “no” score for each of the 
four parameters.  
a. Absence of high quality evidence: For any low or verylow-quality evidence, the 
panel assigned this parametera “yes’ score. For recommendations with moderate or 
high-quality evidence, this parameter was assigned a “no” score. 
b. Uncertainty of balance of benefits and harms/burdens related to the 




harms, if the harms associated with the interventions outweighed or equaled the 
benefits, the panel gave the evidence a score of “yes” for this parameter; otherwise, 
the panel would give it a score of “no”. 
c. Uncertainty or different values and preferences:The guideline panel considered 
the values and preferences of implementers (health professionals and health 
managers) related to the intervention were considered. This information was based 
on the discussion and comments made by the panel. For recommendations 
considered as a burden for health professionals and health managers, the guideline 
panelwould assign a “yes” score, otherwise, the recommendation it would assign a 
“no” score for this parameter. In some of the recommendations, the values and 
preferences might vary with context.21 In such cases, the panel made decisions based 
on the local Ethiopian context.21 
d. Uncertainty if net benefits are worth the costs: This involves balance of the costs 
for running the suggested interventions with the benefits resulting from the 
interventions. In this assessment, the guideline panel considered the ease with which 
the recommendation could be implemented as compared to their benefits. Factors 
such as existence of a program, and priority goal or plan related to the 
recommendation in the current system were considered. If the panel decided that the 
costs outweighed or equaled the net benefits, the panel would the evidence would be 
assigned a “yes” score for this parameter. Otherwise, the panel would assign the 
recommendation a “no” score. This criterion might vary from context to 
context;hence, we considered the local context at Jimma University Medical 
Centerwhen making decisions, in line with Eisenberg’s recommendation 
‘globalizing evidence, localizing recommendations’.21, 178 
Eventually, if the recommendation was assigned a “no” score for three or four of the 
parameters, the panel would assign “strong” evidence for the recommendation. That means 
the evidence strongly favored the intervention (for a beneficial intervention having a 
desirable effect) or was strongly against the intervention (for a harmful intervention having 
undesirable effect). If the evidence was assigned a “no” score for only one or two of the 
parameters, the panel would assign “weak” or “conditional” evidence for the 
intervention/recommendation. That means the evidence conditionally favored the 




against the intervention (for a harmful intervention having an undesirable effect).Therefore, 
there would be four options for the strength of a recommendation.176 
a) Strong evidence in favor of the recommendation means that the desirable consequences 
of implementing the recommendation clearly outweighed the undesirable consequences.177, 
179 
b) Weak or conditional evidence in favor of the intervention means that the desirable 
consequences of implementing the recommendation probably outweighed the undesirable 
consequences.177, 179 
c) Strong evidence against the intervention or the recommendation means that undesirable 
consequences of implementing the recommendation clearly outweighed the desirable 
consequences.179 
d) Weak evidence against the intervention means that the undesirable consequences of 
implementing the recommendation probably outweighed the desirable consequences.179 
Quality of evidence was assigned as high, moderate, low or very low. In line with 
theGRADE working group’s recommendation, the following definitions were adopted to 
indicate the quality of evidence: 
High quality evidence: Further research is unlikely to change our effect estimate.175. 
Moderate quality evidence: Further research is likely to have an important impact on our 
confidence in the estimate of effect and may change the estimate.175 
Low quality: Further research is very likely to have an important impact on our confidence 
in the estimate of effect and is likely to change the estimate.175 
Very low quality: Any estimate of effect is very uncertain.175 
We worded the recommendations considering the quality and the strength of evidence 
associated with the recommendations. We worded recommendations having strong evidence 
for the associated intervention as “must”, “should”, “need to” and other strong words.176 On 
the other hand, we worded recommendations with weak evidence supporting the associated 
interventions with weak terms such as “may,” “might,” and similar words.176 
We excluded most recommendations for further researchto reduce the bulk of the guideline 
as the purpose of this guideline was mainly to improve practice rather than identifying a 
research gap. However, if the panel believed that further research had a potential for reducing 
uncertainty about the effects of the intervention; and further research was deemed good value 
for the expected costs, we would make a recommendation for further research.176In most 




evidence regarding a useless or a harmful intervention was widely practiced, we considered 
a recommendation against the intervention.176 
We have also included good practice points in the guideline. We made these statements for 
areas where providing a GRADE of evidence was not practical, and the panel believed that 
the statements were necessary. We considered good practice statements in the following 
situations:180 
a) In cases where there was high quality indirect linked evidence supporting the 
recommended action.  
b) In case where the panel was confident that the net benefit of the recommended action 
outweighed the risks, and the recommended action was feasible. 
c) If without the message practitioners failed to execute the action and the practice issue 
needed to be consistent and failure to adhere to the practice is considered as the 
violation of human rights. 
d) If the panel considered that the collection of further evidence was a wise use of time 
or impractical. 
To date, whether these statements (good practice points) should be presented separately or 
along with GRADEd recommendations is a matter of contest.181 Therefore, in the current 
guideline document, we indicated the good practice statements as ‘unGRADEd’  and 
labeledwith a ‘good practice point’ sub-heading. 
Building a condensed list of recommendations 
After extracting recommendations from all included documents, I created a tentative list of 
recommendations. From the tentative list of the recommendations, I re-analysed the contents 
of all recommendations using constant comparison and merged similar recommendations or 
categorized them to provide a means of describing and understanding of the 
recommendations.98I then grouped subcategories together to create categories and main 
categories. I made this categorization based on the target population for the interventions, 
the providers of the interventions, the settings in which the interventions were conducted, 
and the nature and duration of the interventions. If similar recommendations/interventions 
reported in two or more documents were assigned a different quality of evidence, I would 
report the higher quality of evidence.  
Then, I substanciated each recommendation with detailed descriptions by referring to the 
original documents and the primary studies. For guidelines and best practice documents 




understanding about the effectiveness of the interventions and the procedures for putting the 
recommendations into practice. Then, I presented the consolidated list of the 
recommendations under themes that emerged from the data and literature. I used thefindings 
of two qualitative syntheses to support the meaningfulness of the interventions for PLHIV. 
Using these lists of recommendations and their respective descriptions, I finally drafted the 
guideline. 
5.6. RESULTS 
5.6.1. Guideline panel 
I establsihed a multidisciplinary guideline panel comprising researchers, health managers 
and health professionals. The list of panel members is shown in Appendix 16. All the panel 
members signed and returned the declarations of conflict of interest. None of the members 
declared a significant conflict of interest to bias the development of the guideline. All the 
panel members had at present or in the past worked as clinicians and had research 
experience. Two of the panel members work as coordinators of HIV Prevention and Control 
Office (HAPCO). Six of the panel members currently work as clinicians,one of whom 
worked as a HIV treatment coordinator. Four experts were previously involved in HIV-
related and stigma research, but they did not have any financial conflicts that affected the 
outcomes of the current guideline (Appendix 17).All panel members who held managerial 
positions potentially influenced or were influenced by the decision made during the 
guideline development. The expertise of the panel members is summarized as follows: 
1. A health manager from JUHAPCO with experience in teaching, research and 
coordination of HIV programs. 
2. An internist and HIV treatment coordinator from the HIV and Tuberculosis Clinic at 
Jimma University Medical Center(JUMC) with experience in teaching, research and 
treatment provision and coordination of treatment programs for PLHIV. 
3. Two experts of Integrated Clinical and Community Mental Health (ICCM) from Jimma 
University withclinical service, teaching,research and service experience specifically 
on HIV in JUMC. 
4. A specialist in clinical psychiatry with experience in stigma-related research, clinical 
service provision and teaching in JUMC. 
5. A psychologist from Jimma University with research experience relevant to HIV and 




6. An expert nurse from the Infection Prevention and Patient Safety committee 
ofJUMCwith experiencesin developing guideline and clinical service provision. 
7. AHealth Education and Health Promotion expert from Jimma Zonal HAPACO with 
experiences in organizing HIV programs. 
8. An expert of health service management from Jimma University with research, clinical 
service and teaching experience and on systematic reviews training experience. 
9. A health manager from JBI collaborating entity at Jimma University with experiencesin 
HIV-related research, teaching, management, guideline development, systematic 
reviews and best practice implementation. 
10. A sociologist from Jimma University with experience of working on HIV programs  
11. A health manager from the Strategic Plan and Policy Analysis Department in JUMC 
with experiences of both management and clinical service provision. 
12. An expert nurse having HIV-related research, clinical service and training experience 
in JUMC 
5.6.2. Determining the scope of the guideline 
Through an informal consultation of health managers, health professionals and researchers, 
I conducted the initial systematic review (the review reported in chapter three).  I aked the 
experts to indicate any guideline they were aware of that addressed stigma and 
discrimination related to HIV. Through this request, some provided training manuals 
prepared to reduce SAD at the community level. However, no local guidelines had addressed 
the reduction of stigma and discrimination in healthcare settings.Then, experts were 
consulted through their phone contacts, through e-mails,and through Jimma University HIV 
prevention and control office (JUHAPCO). Experts who were willing to be part of the panel 
were invited to a half-day meeting.  
Ata meeting held on July 17, 2016, I formally established a guideline development panel. At 
the meeting, I briefly presented preliminary findings of reviews, introduced the guideline 
development process, including the Delphi technique, and the impact of SAD. After that, the 
I gave The the time to reflect and discuss further on the importance of the guideline to reduce 
HIV-related SAD, current policies and contexts of SAD related to HIV. Furthermore, I asked 
health managers, health professionals and researchers to comment on the importance of such 
a guideline. The experts informed about the necessity of such guidelines. Some of them 
mentioned that some external evaluators had considered such guidelines as one of their 




the meeting, even though the panel stressed the importance of a guideline addressing HIV-
related SAD in contexts such as faith-based organizations, schools, media and healthcare 
settings, when considering the available time for the conduct of the current project, the scope 
of the guideline was limited to healthcare settings. Based on the consultation process, I 
developed the following guideline questions. 
Guideline questions 
Which interventions are effective in reducing stigma and discrimination among healthcare 
workers directed towards PLHIV, people affected by the virus and people associated with 
the virus?  
To address theseguideline questionsI considered the following inclusion criteria. 
a. Population: HCWs working in healthcare facilities 
b. Intervention: Interventions designed to reduce SAD in the healthcare facilities were 
considered. These included training, workshops, and institutional policies and 
infrastructures 
c. Comparators: Comparators included usual care or alternative interventions 
d. Outcomes: The outcomes that were considered when searching and assessing 
evidencewere fear-based stigma, value-based stigma (shame and blame), discrimination 
(isolation, labeling, gossiping and use of extra precautions), and internalized stigma 
e. Settings  
Organizational level: Interventions that were conducted at the level of the healthcare 
facility 
Individual level: Interventions targeting healthcare workers were considered. 
The panel called for detailed analysis of existing documents (guidelines and systematic 
reviews) and their linked primary research evidence to develop recommendations addressing 
the identified guideline questions.  
5.6.3. Development of recommendations 
Documents included in the analysis 
In this analysis, I included six guideline-related documents and six systematic reviews 
previously identified in the initial systematic search as reported in chapter three and the 
systematic review conducted as part of this PhD study and reported in chapter four. 
Recommendations extracted 
The result of the initial review in chapter three clearly indicated that current guidelines, best 




information on the quality of the recommendations and conclusions. This posed a challenge 
in directly adapting the recommendations from existing guideline-related documents. In 
addition, it was challenging to extract recommendations directly from the systematic 
reviews. 
Therefore, we decided to conduct a detailed content analysis of the documents and linked 
primary research evidence. This was aimed to facilitate the evaluationof the quality and 
strength of each recommendation and conclusions found in the systematic reviews and 
guideline-related documents. Based on the detailed content analyses, I sought to develop a 
tentative list of recommendations that could be put into practice to reduce HIV-related 
stigma and discrimination in healthcare settings. In addition, I extracted recommendations 
from the systematic review reported in chapter four.Based on the detailed content analyses 
of the content of the guidelines, best practice documents, systematic reviews and the 
linked/cited research evidence, I initially developed 31 recommendations.  
The recommendations were framed under the following themes:  
a) Structural interventions  
b) Information-based approaches 
c) Skillsbuilding approaches  
d) Contact and empowerment approaches  
e) Biomedical approaches 
f) Measurement of stigma and discrimination  
g) Steps to integrate stigmareduction into healthcare settings 
As some of these recommendations were later modified, merged or dropped based on 
consideration and judgment of the guideline panel, the full list is not presented here. 
5.7. Discussions 
This project attempted to develop an evidence-informed guideline to reduce HIV-related 
stigma and discrimination through a systematic search and analysis of global evidence. This 
chapter described procedures involved in the development of guideline recommendations. 
When planning and developing a guideline, health managers are always confronted with the 
challenges of addressing broad research questions with limited resources and time frames. 
As a remedy to address this challenge, scholars have developed different options for utilizing 
a pre-processed research evidence.120 
The initial purpose of the current project was to utilize existing a pre-processed evidence 




guideline development processes.182Although there were systematic reviews, guidelines 
andbest practice documents in the field of stigma and discrimination related to HIV, those 
guidelines, best practice documents and systematic reviews were not presented in a way that 
they could help in theevaluation of the quality and strength of recommendations. Such 
information would have been helpful for prioritizing alternative recommendations and in 
convincing stakeholders about the preferred interventions. 
In public health and clinical practice that involves behavioral interventions and behavioral 
outcomes; it is not always easy to get pooled evidence, such as meta-analyses.139 The current 
project is proof of this. This might have been because measures for stigma and discrimination 
have been under development in the past three decades and standard measures do not exist. 
Hence, I could not get a clear picture from existing systematic reviews and guidelines, tools 
and best practices regarding the quality and strength of evidence supporting 
recommendations/interventions. I, therefore, analyzed the linked primary research evidence 
to evaluate the quality of the recommendations and findings included in the systematic 
reviews and guidelines. In addition, I conducted an additional systematic review as reported 
in chapter four. 
The detailed analysis of the primary studies included in the guideline-related documents and 
systematic reviews and the conduct of an additional systematic review has given us clarity 
on the quality of the recommendations drawn. After the detailed analysis of the contents, 
with a focus on the target audience, settings, nature of the interventions (their duration and 
intensity) and providers of the interventions, I outlined a tentative list of recommendations.  
Nevertheless, this by itself was not enough for developing the guideline. As I extracted 
recommendations from multiple documents, we came across redundant and similar 
recommendations in the list. To avoid such redundancies and to get a complete picture and 
meaning, I further analyzed the contents using constant comparisons, which enabled meto 
merge some similar components and describe the interventions with the highest quality of 
evidence available.Through this approach, I generated a condensed list of recommendations. 
The incorporation of measures of the quality and strength of evidence with the development 
of the recommendations based on the available research evidence can be regarded as a 
strength of this project.  
Through these procedures, I drafted initial recommendations that were framed under the 




empowerment, biomedical interventions, measurement of stigma and discrimination, and 
steps to integrate stigmareduction activities into healthcare settings. 
Although SAD in healthcare settings are affected by factors beyond healthcare 
facilities,137the current project focused on SADreduction in healthcare settings, particularly 
targeting HCWs. I specially focused on activities that can be performed by and are the 
responsibilities of HCWs. In addition, the recommendations included interventions related 
to infrastructure and supplies to healthcare facilities. These recommendations, I think, will 
help to integrate stigma and discrimination programs into the routines of healthcare facilities. 
However, the appropriateness of these recommendations depends on local factors related to 
healthcare facilities.183Therefore, whether these interventions are feasible for integrating into 
the current health systems needed further assessment. 
While assessing the strength of the recommendations, the guideline panelhas taken local 
circumstances and policy environment into account. This makes the current guideline 
relatively more practical as compared to previous guidelines and best practices in that it will 
enable policy makers to prioritize the recommendations. In general, among the steps to 
develop guidelines described by Shekelle et al.,94I addressed the following four components: 
identifying and refining the subject area, organizing and running guideline development 
groups, assessing evidence identified by a systematic literature searches and translating the 
evidence into recommendations. The last step (evaluation of the evidence after 
implementation) will be addressed in the next chapter (chapter six). 
Since the recommendations were drawn from global literature and not from local studies, 
their appropriateness to the local context and their acceptability by local implementers is not 
known. Evidence utilization is successful only if it considers local factors.178Hence, this 
guideline needs to be evaluated by local experts. In the following chapter (chapter six), I will 
describe how Ifacilitated the evaluation of the draft guideline through a local guideline panel 
with both rigor and feasibility considerations.  
5.8. Conclusion 
I established a multidisciplinary group and determined the scope of the guideline. The panel 
decided to develop a guideline to reduce HIV-related stigma and discrimination among 
HCWs in healthcare settings. I drafted tentative guideline recommendations based on the 
best available global evidence.I framed the recommendations under the following themes: 
structural, information-based and skillsbuilding, contact and empowerment, biomedical 




stigmareduction activities into healthcare settings. The appropriateness of these 







EVALUATION OF A GUIDELINE DEVELOPED TO REDUCE HIV-RELATED 
STIGMA AND DISCRIMINATION IN HEALTHCARE SETTINGS AND 
ESTABLISHING CONSENSUS 
6.1. Abstract 
Concise introduction  
Developing appropriate guidelines, policies, system changes and appropriate orientation of 
the rights and responsibilities of healthcare workers and patients is critical to address HIV-
related stigma and discrimination (SAD) in healthcare settings. To this end, a 
multidisciplinary panel developed a guideline to be implemented in healthcare settings.  
Objective 
The objective of this project was to evaluate the appropriateness of the guideline developed 
to reduce HIV-related SAD to be implemented in the Ethiopian context. 
Methods  
A consensus of the expert panel was established through a Delphi technique. Experts were 
selected based on history of relevant publications, their relationship with the topic, and 
institutional positions they hold. After obtaining consent from participants, initial tentative 
recommendations were distributed to experts through e-mails to be evaluated using the 
modified guideline implementability appraisal (GLIA) v.2.0 checklist. Percentage 
agreements were analyzed by creating scores. Based on the comments of the experts, 
modifications to the recommendations were made and a modified document was sent for 
further evaluation. Following tworounds of the Delphi survey, a panel meeting was 
convened. Finally, the guideline was evaluated by external experts. 
Results  
Firstround survey 
In the firstround of the Delphi survey, all (13) panel members evaluated the guideline. The 
overall score for the general domain of the modified GLIA checklist was 96.56%. The scores 
for individual recommendations ranged from 68.33% to 92.76%. Five recommendations 
received an endorsement of less than 75%.The maximum score was indicated for 
measurability domain (97.71%) and the minimum score was recorded for flexibility domain 
(59.77%). A percentage mean score lower than 75% was obtained for two GLIA V.2.0 




additional tools and training, and suggestions for improving the clarity of the 
recommendations were made.  
Secondround survey 
In the secondround of the Delphi survey, only few comments were raised by the expert panel. 
All the recommendations received endorsement with scores above 75%. A maximum score 
was attained for the measurability domain (100%). A minimum score was recorded for the 
flexibility domain (86.88%). During the second panel meeting, detailed discussions were 
held on the issue of responsibility for implementing the guideline and how some terms 
should be used. 
Evaluation by external experts 
Out of 13 experts invited to participate in the evaluation, six agreed to evaluate the guideline 
using the same checklist that internal evaluators used. The external experts gave an overall 
score of 94.44% to the general domain of GLIA v.2.0. Each recommendation received an 
endorsement over 75%. 
Conclusion  
The current project evaluated implementability of a guideline developed to reduce HIV-
related stigma and discrimination in healthcare settings. The project employed both internal 
and external evaluation. The Delphi survey was followed by a face-to-face meeting that 
helped in further clarifications of points.  
6.2. Concise introduction 
People living with the human immunodeficiency virus (HIV) are confronted with the 
physical, psychological and social impacts of the disease.34, 166-169 Stigma and discrimination 
(SAD),also called the “third phase of HIV/AIDS epidemics”, have been among the 
obstacleschallenging actors working on the prevention and control of HIV.170SAD related to 
HIV are manifested in various forms such as: differential care or refusal to treat, testing and 
disclosure of the sero-status of clients without consent, verbal abuses or gossip, marking the 
files of patients, isolating them and excess use of precautions.57, 58 
The limited awareness of SAD, how they manifest and their consequences, prejudicial and 
stereotypical attitudes related to gender identity and sexual activity, and fear of HIV 
transmission are among factors contributing SAD in healthcare facilities.6 Hence, 
developing appropriate guidelines, policies, and redress systems and appropriate orientation 
of the rights and responsibilities of HCWs and patients are critical.6Cognizant of this, as 




recommendations to reduce SAD in healthcare facilities. Systematically developed 
guidelines are the source of summarized information.4Nevertheless, the development of 
guideline recommendations by itself is not enough. Other factors such as environmental and 
contextual factors need to be considered before making final decisions on the 
implementation of the guideline.184, 185 
Some researchers argue that using a theoretical framework will help to systematically 
identify and address factors that hinder guideline implementation.186, 187Factors such as 
reviewing, reporting and publishing guidelineshave been found to enhance the 
implementation of the guidelines.94On the other hand, Jordan et al.4 argue that dissemination 
should involve an active process apart from the mere publication of guidelines.Moreover, 
before officially publishing or disseminating a guideline, internal and external evaluation is 
required to promote the uptake the guideline.23, 96In addition to the development of tools to 
assess the rigor of the guideline development process,115researchers have developed tools 
that help to assess both the rigor and implementability of guidelines.116Guideline developers 
and experts recommend assessing recommendations included in practice guidelines using 
guideline implementability checklists to make sure that the recommendations are clear and 
easy to implement.23, 96 
As described in chapter five, we have developed guideline recommendations based on an 
analysis of global evidence retrieved through literature searching. Therefore, this project 
aimed to assess the clarity, acceptability, implementability and relevance of the current 
guideline using Guideline Implementability Appraisal (GLIA version 2.0) checklist.174 
6.3. Objectives 
The objective of this project was to evaluate the appropriateness of the guideline developed 
to reduce HIV-related SAD to be implemented in the Ethiopian context. Specifically, the 
project aimed: 
• To evaluate the appropriateness of the guideline to the Ethiopian context through a 
multi-round of Delphi surveys among the guideline panel. 
• To evaluate the appropriateness of the guideline through a survey of external experts.  
• To make amendments to each recommendation included in the guideline based on 





This project assessed the drafted recommendations for feasibility and appropriateness to the 
Ethiopian context. Consensus of the experts engaged in the evaluation was established 
through a modified Delphi technique.106 
6.4.1. Rationale for the use of the Delphi technique in this project 
The Delphi technique involvesa series of questionnaires that are used to test opinion 
consensus amongst a group of experts.102, 105,105The technique can be conducted by email, 
online surveys or by  post.102It is a preferable method of choice when there is little evidence 
regarding the topic, when participant anonymity is required, and when the cost and 
practicalities of bringing the participants together is prohibitive.104 By assuring anonymity, 
it reduces the effect of dominant individuals and unwillingness to abandon publicly 
expressed opinions.107The Delphi technique also reduces reluctance to mention opinions that 
are unpopular, disagree with one's associates, modify previously stated positions.108 
The choice for the specific type of consensus method is determined by the purpose of the 
study, the availability of scientific evidence in the field, the model of participant interaction, 
time and costs.104 The aim of the current project was to translate research evidence into 
practice through the development of an evidence-informed guideline based on the consensus 
of experts. The development of a guideline needs a rigorous process to achieve consensus of 
experts. The Delphi technique is supposed to be more suitable compared to other consensus 
building methods.188 This project sought the opinion of experts by keeping their responses 
anonymous and allowing them to freely express their opinions through e-mail surveys. In 
addition, the technique gave adequate time to the experts to exhaust options before making 
decisions. Hence, a modified Delphi technique was selected as a method of establishing 
consensus.  
The Delphi technique is a hybrid of qualitative and quantitative methods.189The technique 
has been used in health disciplines since the 1970s.105It has been used by researchers to 
translate scientific knowledge and professional experience into informed judgment, in order 
to support effective decision-making.190The Delphi technique has been reported to be the 
most widely used consensus method for developing clinical guidelines.191-193Delphi 
techniques have been used to develop guidelines, to establish consensus on the use of the 
guidelines and to establish and evaluate how well a clinical practice is conforming to 




on the use of the each of the recommendations that constituted a guideline to reduce HIV-
related stigma and discrimination in Ethiopian healthcare settings. 
6.4.2. Delphi process 
The Delphi procedure starts with the selection of experts and is executed in a series of 
rounds.104, 107 In a Delphi survey, appropriate selection of experts is essential for ensuring 
the quality of the data and increasing response rates. There is no standard definition of 
expert188 and the definition depends on the specific objective of the research,188 but in general 
an expert is someone who has some knowledge of a specific subject.188, 195In the current 
project, experts were people who were knowledgeable of the subject matter by virtue of their 
role as clinicians with HIV patients, managers for HIV programs or researching on 
HIV.Experts may be selected based on record of relevant publications, their relationship 
with the topic and institutional positions they hold.109In the current project, the judgment of 
expertise was made based on their contribution in the field. Hence, researchers with relevant 
research projects and publications; health service managers and health professionals working 
on clinical or programmatic areas of HIV were selected as members of the guideline working 
group and experts for the current Delphi study. Apart from their expertise, the availability 
and commitments of the experts in the field were considered in selecting the panel 
members.The snow balling method was used to identifythe experts. Finally, experts who 
were willing to participate were included in the multi-round survey. 
6.4.3. Panel size 
There is no consensus on the panel size required for Delphi studies.190, 196 Different Delphi 
studies have used different sample sizes ranging from as small as five to as large as 2865.190 
In theDelphi technique, sample size does not depend on statistical calculations; rather it 
depends on the dynamics of arriving at consensus.197 Some experts in Delphi techniques 
recommend careful selection of the panel for the specific topic of interest instead of 
increasing sample size or making the sampling process random.198 In this project, 13 experts 
accepted my invitation and participated in the survey.  
As a facilitator of the Delphi technique, I set deadlines for each round of the Delphi and I 
used e-mail reminders for non-responders as an additional mechanism for increasing the 
response rate. I sent the e-mail reminders three days after the deadline.109 Respondents were 
given a three-week period for each round of Delphi.109As in other Delphi techniques, the 
opinion of every group member was reflected in the final group response.108The statistical 




6.4.4. Data collection 
After obtaining the list of experts, I made initial contacts to all experts giving them the 
purpose and procedures involved in the project and requesting them to participate in the 
development of the guideline. After receiving consent, I sent the expertsinitial tentative 
recommendationsby e-mail. Experts were asked to comment on each recommendation. I 
analyzed and summarized both qualitative and quantitative responses.104, 107 
There are three options to startDelphi roundone. The first option is where Delphi roundone 
is conducted as a qualitative study using open-ended questions to develop quantitative tools 
for the successive rounds.199 In this approach, the firstround is used to identify issues to be 
addressed in later rounds. The second option is where qualitative data can be collected 
through focus groups or interviews before the Delphi study and used to inform a quantitative 
firstround of the Delphi.188 The third option is where the quantitative firstround is informed 
through a literature review or clinical practice.188, 200The first approach is often used in a 
classical (original) Delphi.201 The second and third approaches are usually used in a modified 
Delphi technique.201 
In the current project, the tentative recommendations were informed by systematic literature 
searches and content analysis of the evidence. In this project, the modified Delphi, 
sometimes called ‘e-delphi,’201 was used. The purpose of the modified Delphi technique in 
this project was to get a consensus among the guideline panel on the tentative 
recommendations, and to modify the recommendations based on the responses of the 
experts. Therefore, the third approach was employed. Hence, experts were asked to rate each 
tentative recommendation using the Guideline Implementability Appraisal (GLIA V.2.0) 
checklist.174The GLIA checklist has options for both close-ended responses and open-ended 
responses. Hence, in addition to rating the recommendations, the panelists were asked to 
provide their suggestions on how to improve the implementations, feasibility and/or 
wordings of the specific recommendations. Participants were also encouraged to comment 
on the main guideline using track changes and highlights.The GLIA v.2.0 checklist was 
modified and used to assess the implementability of the guideline.174 The GLIA 
v.2.174instrument contains 30 items in ninedomains: global quality, executability, 
decidability, validity, flexibility, effect on process of care, measurability, novelty and 
computability.174 Out of these, the last domain (computability) is used when there is a plan 
for electronic implementation.174 Since this will not be part of the current work, the four 




In this project, a modified GLIA v.2.0 checklist (Appendix 18) was used to assess the 
implementability of the guideline. The comments provided by the experts were incorporated 
into the successive round of the Delphi. In the subsequent round of the Delphi, I asked 
participants whether they would agree with the modified recommendations.104, 107I sent 
additional ideas in each round of the Delphi to the experts in the respective subsequent 
rounds.104, 107 
There is no template indicating the exact number of rounds needed for a Delphi study. Such 
decisions are pragmatically made by the researcher. Hence, the procedure is reiterated until 
the stability of responses is achieved.107 Stability of responses is defined as “the consistency 
of responses between successive rounds of a study.”202(pp.84) Dajani et al.202recommends 
measuring the level of agreement only if a stable answer is reached. Therefore, they 
recommend a hierarchical process as depicted in Figure 5.202 For each recommendation, once 
stability of the responses is achieved, consensus will be established.202 
For this project, recommendations having a general agreement of 75% and above were 
incorporated into the guideline. Recommendations with a rating lower than 75% were 
considered for modification to be incorporated into the subsequent rounds based on the 
comments of the respondents. In addition, specific comments given for each 
recommendation were considered for making modifications, adding or dropping a 
recommendation.The Delphi series stopped after stability was achieved (a 75% level of 
agreement) for each recommendation and if no newer comments emerged. The Delphi 
process is normally expected to achieve both consensus and non-consensus.203 Therefore, in 
the current project, recommendations for which experts consistently disagreed were 






Figure 5.Hierarchical stopping criteria for Delphi studies 
(Source: Dajani JS, Sincoff MZ, Talley WK. Stability and agreement criteria for the termination of 
Delphi studies. Technological forecasting and social change. 1979;13(1):83-90).202Re-used with 
permission from Elsevier (order number: 4216991240242). 
 
6.3.3.4. Data quality control 
In Delphi techniques, the opinion of every group member is reflected in the final group 
response.108 Since decisions are made based on opinions of groups in the real world, Delphi 
techniques are believed to provide evidence of face validity.204 In addition, Delphi is 
conducted in successive rounds, contributing to concurrent validity of the 
findings.205Researchers also believe that a Delphi technique provides reliable findings, 
because it achieves interaction among experts and at the same time avoids individual 
influences.Delphi overlaps both interpretive/qualitative and positivist/quantitative 
paradigms.Hence, researchers recommend the use of the term ‘trustworthiness’ to establish 
rigor in a Delphi study.206Theconcept ‘trustworthiness’ encompasses credibility, 




In Delphi studies, credibility is established by ongoing iteration and feedback given to the 
experts.208 Therefore, the very beginning of the Delphi process makes it credible. In this 
project, dependability was enhanced by including relevant experts in the field.209 
Confirmability is achieved through the collection of thick descriptive data, negative case 
analysis and arranging for a confirmability audit and establishing referential adequacy.207 In 
this project, I kept accurate records of participants’ comments and responses in each round. 
I sent the comments of experts to the panelists in subsequent rounds. In addition, there was 
a face-to-face meeting prepared for further clarification.The transferability of an evidence is 
based on the similarity of contextual factors in the settings.210 Therefore, other researchers 
and guideline implementers or developerswere advised to take the consideration of the 
similarities of their respective contexts with the current situation and the current context of 
JUMC when considering the potential transfer of the evidence into other settings. Contextual 
factors related to the current guideline are described in detail in chapter seven. 
6.3.3.5. Data analyses 
I conducted qualitative content analysis of the comments and I used the result of the analysis 
to modify the recommendations. In addition, I conducted the following quantitative 
analyses: 
1. Percentage response rates, 
2. Percentage scores for each domain of GLIA V.2.0:the total score for each GLIA domain 
was calculated by summing up total scores for all panel members. Then, the percentage score 
was obtained by dividing the total score by the maximum possible score.  
3. Percentage agreement for each recommendation was calculated for each round of the 
Delphi. This information was used to modify recommendations, especially those with 
endorsement of less than 75%. In the cases where experts did not describe reasons for non-
endorsement and for controversial issues, discussions on the recommendations were made 
through face-to-face meetings amongst the panel.  
In this project, I wanted to take into consideration the input of each member of the panel. 
Instead of taking individual responses as outliers and rejecting them, a mechanism was in 
place in which they would clarify their opinions, which opens up for further comment by 
other members of the panel.Moreover, the panel consensus data were complemented with 
external panel review. For the sake of making final decisions on the guideline 
recommendations, I conducted key informant interviews with managers and service 




6.4.5. Ethical considerations 
The project has ethical approval both from the Institutional Review Board (IRB) of Jimma 
Institute of Health (JIH) at Jimma University (RPGC/389/2016) and the University of 
Adelaide Office of Research Ethics, Compliance and Integrity (ORECI) (approval number 
H-2016-140). Prior to the data collection, the objective of the research, potential harms and 
benefits of participating in the project were described to participants. Participants were 
provided with complaints procedure (Appendix 19)and information sheets (Appendix 20), 
based on which informed consent was obtained (Appendix 21). Anonymity of responses was 
assured by not disclosing the identity of participants. 
6.5. Results 
A formal consensus was sought from all the panel members using two rounds of panel 
surveys and an external panel review. This section describes results of these surveys. 
6.5.1. Firstround Delphi survey 
In the firstround of the Delphi survey, all (13) panel members evaluated the guideline. The 
overall score for the general domain of the GLIA version 2.0 score was 112 (% of maximum 
possible score=95.73%). Maximum score was achieved for the measurability domain 
(96.65%) and the minimum score was recorded for the flexibility domain (59.97%). A 
percentage mean score lower than 75% was obtained only for two domains: flexibility and 
validity domains (Table 9).The experts provided comments on how to improve or why 
modifications were needed for individual recommendations included in the guideline.  The 
comments given were categorized into: 
a. General comments:Comments that were provided for the entire guideline. These 
comments were suggestions for additional tools and training that should be part of 
the guideline  
b. Comments on specific recommendations: Comments questioning the clarity and 
feasibility of implementing the recommendations.  
Table 9. Guideline implementability (GLIA V.2.0)domain scores 
GLIA Domain  Internal evaluation External evaluation  
Round 1 Round 2 
Mean SD %age score Mean SD %age score Mean SD %age score 
Executability  21.81 3.35 83.88 15.38 0.77 96.13 10.50 1.51 87.50 
Decidability  33.1 3.36 84.89 23.85 0.38 99.38 17.25 1.54 95.83 
Validity  17.48 4.77 67.23 15.85 0.554 99.06 10.50 1.93 87.5 
Flexibility  23.39 4.23 59.97 20.85 0.38 86.88 9.66 1.37 53.70 
Effect on process of care 24.71 1.04 95.04 15.77 0.44 98.56 11.33 0.89 94.44 
Measurability  25.13 0.96 96.65 16.00 0.00 100 10.17 0.39 84.72 
Novelty  33.44 2.14 85.74 23.08 0.49 96.08 17.00 1.41 94.44 




The scores for individual recommendations ranged from 151 (68.33%) to 205(92.76). Six 
recommendations received an endorsement of lower than 75%. The recommendations with 
endorsement lowerthan 75% were: 
1. Counselling and behaviour change programs to address self-stigma (endorsement 
score=71.04%) 
The most important reasons for the low score for this recommendation was described as lack 
of detailed description of the recommendations and failure to specify the type of behavioural 
change programs.  
2. Group intervention through telephone support for people living with HIV 
(endorsement score=68.33%) 
The feasibility of this intervention was questioned by the panel. Therefore, this 
recommendation was brought for panel discussion during the secondround panel meeting.  
3. Micro-finance and livelihood programs to create economic opportunities 
(endorsement score=70.14%) 
Concern was raised because participants claimed that it was not the mandate of healthcare 
institutions to provide microfinance interventions and resource-wise, this recommendation 
was reported to be not feasible. Therefore, this recommendation was brought for panel 
discussion during the secondround panel meeting.  
4. Training programs to gain facilitation skills, processes to collect and analyse data 
for advocacy (endorsement score = 70.14%) 
This recommendation was rated a low score because of limited description linked with it. 
The feasibility of the recommendation was also questioned. 
5. Developing stigma and discriminationreduction policies with employees 
(endorsement score = 73.76%) 
The panel requested description of this recommendation, specifically by linking with 
previous research findings.  
6. Programs, offices and institutions need to advocate temporary special measures 
such as affirmative action for women and special forums for participation 
(endorsement score=71.04%) 
The feasibility of this recommendation was questioned as it was perceived by some panel 
members to be beyond the scope of health institutions.  In addition to the above comments 
targeting individual recommendations, as mentioned in table 10, the panel suggested that 




the firstround survey are summarized in Table 10.Based on the firstroundcomments, 
modifications were made. The secondround survey was then conducted after incorporating 





Table 10. Summary of comments provided during firstround survey 
S/n Comments  Actions/resolution  
General comments  
1.  The sequence of applying these recommendations is not clearly 
documented 
This has been indicated at the end of the 
recommendations incorporating steps in 
implementation 
2.  In the introduction part, the intended audience should also 
include non-health disciplines such as psychology and sociology 
who work to improve the psychosocial well-being of PLHIV 
Accepted  
3.  For most of the recommendations: patient characteristics (co-
morbidities) were not mentioned 
Most recommendations work for all types of HIV 
patients regardless of their co-morbidities 
4.  Settings such as faith-based organizations may be included as 
part of the guideline 
This is beyond the scope of the current guideline, 
which is limited to healthcare settings 
5.  The guideline should be broad, and the scope should be beyond 
the health sector 
This cannot be addressed within the time frame. 
After this project is over, we may consider 
developing guidelines for other settings 
6.  Additional tools should be part of the guideline  Accepted and added tools to be posted and tools for 
monitoring and evaluation 
7.  Key population should be defined Accepted 
8.  People associated with the virus should be defined  Accepted  
9.  Stigma occurs when those health care workers who are not aware 
of HIV-related stigma provide services to HIV patients. 
Therefore, the type and role of service providers needs to be 
specified. 
Brought for discussion by the panel during the 
second meeting and further explored during key 
informant interviews  
Comments on specific recommendations  
10.  
 
RN1.4, RN2.4 and RN3.4 are fragmented and can be better 
strengthened if they are merged together. 
Accepted and merged the recommendations  
So, RN1.4, RN2.4 and RN3.4 were merged 
11.  RN2.1 should be supported with evidence  Accepted, reference and quality of evidence 
included 
12.  RN2.1 and RN2.2 can be merged Accepted  
13.  RN 2.2. is not detailed  Accepted  
14.  RN2.3 is not detailed. Group support through telephone is not 
clear enough. Are you going to call them or text them through 
SMS?  It is not feasible, and the quality of evidence is also very 
low. Also, it is better to use references 
Brought for discussion by the panel during the 
second meeting 
15.  One of the recommendations, micro-finance interventions is not 
feasible  
Brought for discussion by the panel during the 
second meeting 
16.  RN2.4 needs resources  Suggestions will be sought from panel members on 
whether the allocation of such resources is feasible 
will be discussed 
17.  RN2.6 is not specific  The recommendation was dropped  
18.  RN2.6 is difficult to measure unless we put measurement 
parameters 
Accepted  
19.  RN3.1 is not detailed  Accepted  
20.  RN4.2 is not detailed  Accepted  
21.  RN6.2 Needs details Accepted  
22.  RN6.3 needs details  Accepted  
23.  RN1.4 is not feasible  Accepted  
24.  RN4.1. is not feasible  Accepted  
25.  Co-morbid mental illness among HIV clients plays critical role 
in worsening the stigma towards HIV patient. So, consider 
mental illness  
This will broaden our scope. We may consider 
another guideline for this. 
26.  All recommendation need at least orientation and training   The guideline will be introduced through different 
methods including orientation and training. And 
additional methods will be further sought from the 
panel 
27.  RN1.2, RN 6.3 and 6.11 need to be merged or be described using 
a single recommendation. 
Accepted 
NB: HIV: Human immunodeficiency virus, PLHIV: People Living with HIV, RN: Recommendation number  
6.5.2. Secondround Delphi survey 
Eight of the 13 (61.5%) panel members responded to the secondround survey using the GLIA 
V.2.0 checklist. Five panel members did not provide ratings during the secondround Delphi 
survey. Of these, four of them participated in the secondround panel meeting.In the 




summarized and discussed. Hence, those members who missed the secondround survey got 
the opportunity to reflect on their ideas in the meeting. In the secondround, the general 
domain received an endorsement score of 64/72 (88.89%). Maximum score was attained for 
the measurability domain (100%). A minimum score was recorded for the flexibility domain 
(86.88%)(Table9).In the secondround of the Delphi survey, each recommendation received 
an endorsement of over 75%. Only a few comments were raised by the panel. The summary 
of the comments and the respective resolutions made following the comments is shown in 
Table 11. 
Table 11. Summary of comments made during secondround and the respective 
resolutions 
S/n Comments  Actions/resolution  
1.  Details of peereducation intervention is not presented Accepted  




For RN2.0, include the term expert patients to describe patients involved as service 
providers. This will match with the context 
Accepted 
NB: RN: Recommendation number, HAPCO: HIV Prevention and Control Office 
The highest percentage mean score was attained for the measurability domain (100%) and 
the lowest mean score percentage was attained for the flexibility domain (88.88%) (Table 
9).All individual recommendations receivedendorsements with scores over75%. Since there 
were fewcomments given in the secondroundsurvey and the ratings for the recommendations 
were also high, the panel decided not to haveadditional surveys. Instead, a secondround 
panel meeting was called to discuss in person the comments made thus far and the 
modifications made. Further comments were sought from the panel. Major points raised 
during the meeting are briefly presented below. 
Major points of discussion during the secondround guideline panel meeting  
1. The responsible body for implementation of the interventions should be clearly 
specified: 
Based on detailed discussions, the panel resolved that all health professionals, healthcare 
facility administration and HIV prevention and control offices are responsible for the 
interventions in the recommendations be included in the guidelines. The panel recommended 
that training should be provided for those PLHIV who provide psychosocial support, 
adherence support and peer support for PLHIV.  
2. Whether microfinance intervention can still be part of the guideline: 
The panel decided that HAPCO and healthcare facilities can routinely link patients to support 
organizations. Nevertheless, they agreed that it is very difficult for them to provide financial 




3. Whether telephone support interventions are still feasible for the context:  
The panel resolved with the consensus that in the Ethiopian context, there is no adequate 
evidence indicating that such interventions are feasible. However, they all agreed that these 
interventions (phone calls and reminder texts) can be included as alternative methods for the 
provision of psychosocial support.  
4. Who is responsible for informing the rights and responsibilities to patients?  
The panel resolved with the consensus that all health professionalsshould routinely inform 
patients about the details of procedures, their rights and responsibilities. In addition, 
healthcare facility administration and HIV Prevention and Control Office (HAPCO) are 
responsible to make sure that information is provided to patients on their rights and 
responsibilities. This information should include the rights that each patient has regardless 
of his or her sex, disease status, age and other characteristics.  
5. Whether translating the guideline into local language is needed: 
The panel decided that for healthcare professionals, there is no need to translate the guideline 
into local languages. Nevertheless, the training manual that may be prepared in the future 
for peer supporters and expert patients (non-professionals)should be translated into local 
languages. 
6. Arrangement of recommendations  
The panel suggested that the recommendations should be arranged, not under guiding 
principles, but under major thematic areas as conceptualized in the systematic reviews 
presented in previous chapters.  
6.5.3. Evaluation by external experts 
Of the 13 experts invited to participate in the evaluation, six agreed to evaluate the guideline 
using the same checklist that internal evaluators used. The external experts gave an overall 
score of 51 (94.44%) to the general domain of GLIA. Each recommendation received an 
endorsement over 75%. The maximum score was recorded for the decidability domain 
(95.83%) and minimum score was attained for the flexibility domain (53.70%). The external 
panels did not provide many comments. Major comments made were categorized under 
general comments, comments specific to individual recommendations and comments related 







Table 12.Summarised comments from the external panel 
S/N Comments  Resolution/actions 
General comments  
1.  Recommendations should be action-oriented rather than descriptive. Some recommendations are 
not identifiable because of long descriptions  
Accepted  
2.  Settings in which the guideline is to be implemented is not clearly described  Accepted 
3.  The guideline mainly focuses on the provider or user of the guideline and simply highlights the 
target. The targets must be described in detail in a separate section.   
Accepted  
4.  Target organizations for the guideline are not mentioned except on the cover page. Accepted 
5.  The required service modifications are not mentioned  Accepted  
Comments related to the format of the guideline 
6.  Boxes for strategies and recommendations need to be separate Accepted  
7.  Indicators need to be presented clearly for recommendations  Accepted  
8.  It is better to put boxes and tables at the end of description rather than putting them in the middle 
of text descriptions 
Accepted 
Comments on specific recommendations  
9.  RN3.3 does not show how opinion leaders execute their jobs Accepted  
10.  RN43 does not detail how to empower PLHIV Accepted  
11.  For RN61, RN62, RN63 AND RN64, strategies for implementation was not addressed well Accepted  
12.  RN33 does not show logical sequences Accepted  
13.  RN 51 is not detailed  Accepted  
14.  No evidence presented for RN61, RN62  Accepted  
NB: PLHIV: People Living with HIV, RN: Recommendation number 
6.6. Discussions 
This project attempted to evaluate a guidelineto reduce HIV-related stigma and 
discrimination developed in chapter five, using guideline implementability appraisal (GLIA) 
version 2.0checklist. The internal evaluation was conducted usingtworounds of the Delphi 
survey that was followed by a face-to-face meeting of the guideline panel. The Delphi 
surveyswere complemented by an additional evaluation by external experts. 
In the firstround Delphi survey, a percentage mean score lower than 75% was obtained for 
two domains: flexibility and validity domains of GLIA V2.0 checklist. This indicated that 
more work was needed withincluding detailed descriptions on areas such as strength and 
quality of recommendations and detailed justifications of recommendations. Therefore, 
modifications were made before sending the guideline for the secondround evaluation. The 
modifications made were: incorporating strength and quality of recommendations for those 
recommendations for which such data were available. 
As the experts involved in the Delphi survey were also members of the guideline working 
group, it was my expectation that the risk of dropping out from the study would be minimal. 




my expectation. This is, however, an expected limitation of Delphi techniques.105 In 
addition, it is a common obstacle that guideline developers face when using the GLIA 
checklists as it is a long instrument and may result in low response rates.211However, the 
instrument provides an opportunity for a comprehensive evaluation of guideline 
recommendations. It helps to assess both implementability and rigor of recommendations.211 
The other potential reason for delayed responses and low response rates in the current project 
might be because the experts were occupied with other tasks and that the current project was 
conducted within a tight schedule. I had made efforts to reduce delays and drop outs by 
setting deadlines, e-mail and telephone reminders. Such mechanisms have also been used by 
previous researchers employing Delphi techniques.109On the other hand, the same experts 
who failed to provide responses for the secondround survey participated in a panel meeting 
where they got an opportunity to reflect on their opinions. In the panel meeting, a summary 
of the comments and modifications made in all rounds were presented and reflections were 
made by all participants. Hence, the attrition bias related to drop outs was minimal. 
During the external panel survey, the lowest score was recorded for the flexibility domain 
(53.70%). This was an indication that notifiedme to make the emphasison the quality and 
strength of recommendations. This was a partially expected response as some 
recommendations still lacked quality and strength of evidence supporting them. Hence, for 
such recommendations, I indicatedthem as ‘no quality of evidence assigned’. Later, some of 
such recommendations were assigned as good practice points. 
In addition, there was a concern by external reviewers regarding feasibility issues. Some 
enquired about the commitment of Jimma University Medical Center (JUMC) for availing 
continuous supply of materials for standard precautions. Therefore, this was later explored 
in detail during the key informant interviews (this is reported in chapter seven as part of 
contextualizing the guideline). On the other hand, the response ‘not applicable (NA)’ for 
question 18 might have contributed to the low score in the flexibility domain. The question 
enquires whether the recommendations were made with the consideration of co-morbidities 
among clients, which was not practical for the current guideline.  
In general, except assigninga low endorsement score for the flexibility domain, the external 
panel endorsed all individual recommendations with scores above 75%.For the current 
Delphi survey, since some comments were merged, and additional new recommendations 
were added and dropped iteratively, it was not practical to employstatistical techniques such 




Nevertheless, additional comments were not forthcoming during the secondround and during 
external expert evaluations. In addition, during the second panel meeting, a detailed 
discussion was held both on the comments and the modifications made to address the 
comments. 
The current project employed a modified Delphi technique to establish consensus on 
recommendations based on the best available evidence from systematic reviews. Such 
techniques have been used by previous researchers to develop guidelines.101, 215 One of the 
potential limitations of a modified Delphi approach is the absence of face-to-face 
engagement with panel members.101In the current project, this limitation was minimized by 
incorporating two panel meeting sessions, one before the start of the Delphi survey and one 
after the secondround Delphi survey. This has helped to clarify and discuss vague points. 
However, before implementing the guideline, it is critical to identify contextual and 
environmental factors to tailor the implementation of the guideline to local context. In the 
next chapter (chapter seven) I have indicated how I explored details of contextual factors 
that potentially influence the implementation of the guideline. 
6.7. Conclusion 
The current project evaluated the implementability of a guideline developed to reduce HIV-
related stigma and discrimination in healthcare settings. The project employed both internal 
and external evaluation. The Delphi survey was followed by a half-day meeting that helped 
in further clarification of points and addressing some of the limitations of the series of the 














CONTEXTUALIZING THE EVIDENCE: EXPLORATION OF FACILITATORS 
AND BARRIERS TO THE IMPLEMENTATION OF A GUIDELINE TO REDUCE 
HIV-RELATED STIGMA AND DISCRIMINATION IN ETHIOPIAN 
HEALTHCARE SETTINGS 
7.1. Abstract 
Concise introduction  
Averting stigma and discrimination related to the human immunodeficiency virus (HIV) is 
one of the priority targets of the Federal Ministry of Health (FMOH) of Ethiopia and HIV 
prevention and control offices at different levels. Indepth exploration of local factors is 
needed to integrate a guideline developed to reduce HIV-related stigma and discrimination 
in healthcare settings.  
Objective 
The objective of this project was to assess expected barriers and facilitators to the 
implementation of the guideline and identify tailored recommended activities to maximize 
the uptake of the guideline.  
Methods  
This project employed a descriptive qualitative research. Seven key informant interviews 
were conducted using a semi-structured guide that was developed based on the framework 
suggested by the Registered Nurses Association of Ontario (RNAO). The key informant 
interviews were transcribed and translated into English. After that, the transcriptions were 
coded and analyzed using Atlas ti version 7.5 software package. 
Results  
Guideline attributes, provider-related factors and the presence of other health-related goals 
that complement stigma and discrimination (SAD) reduction programs were identified as 
factors that potentially affect the implementation of the guideline. Guideline attributes 
mentioned as potential facilitators of implementation were being a new guideline, addressing 
gaps in practice and evidence, clarifying the scope of the guideline, comprehensiveness and 
clarity of recommendations, addressing ethical principles and mentioning the rights and 
responsibilities of clients. The absence of previous guidelines on HIV-related SAD and the 
lack of HIV service integration and the widely practiced stigmatizing actions increased the 




providers. Expert patients, regular health education programs, quality movement, 
compassionate, respectful, and caring (CRC) and Clean and Safe Health Facility (CASH) 
initiatives were identified as currently existing opportunities that may be used as agents and 
platforms for the implementation of the current guideline. Study participants recommended 
that the guideline should be disseminated through multidisciplinary team (MDT) meetings, 
gate keepers such as opinion leaders and unit heads, one-to-five networks and mentorship 
programs, training and workshops and posters. As suggested by study participants, the 
success of the implementation of the current guideline can be maximized by encouraging 
internal and external partnership, strengthening teamwork, clarifying steps in 
implementation, using position holders and opinion leaders as role models, advocacy, and 
establishing an implementation structure. 
Conclusion  
The current project identified factors related to the nature of the guideline, the policy and 
practice environment, the health professionals and the commitment of stakeholders that 
affect the uptake of the guideline. Policy makers should disseminate the guideline through 
existing opportunities such asMDT meetings, CRC, one-to-five networks, training and 
workshops. The guideline indicators should be integrated into mentorship, MDT meetings 
and monitoring and evaluation programs of the hospital. Teamwork and partnership with 
stakeholders within and outside the hospital should be strengthened to tackle barriers related 
to the implementation of the guideline. In addition, it is essential to establish implementation 
structure. 
7.2. Concise introduction 
Ethiopia is one of the 20 countries contributing to 80% of the global burden of the human 
immunodeficiency virus (HIV). In 2014, there were an estimated 600 thousand people living 
with HIV (PLHIV) in Ethiopia.216Stigma and discrimination (SAD) related to HIV have 
deterred HIV prevention and control activities in the country.217 Different international and 
faith-based organizations have been working to avert stigma and discrimination for 
decades.218Reduction of HIV-related SAD is one of the priority targets of the Federal 
Ministry of Health (FMOH) of Ethiopia, regional health bureaus and HIV prevention and 
control offices at different levels.218 
Despite all these efforts, the country’s progress report of 2014 on HIV response shows that 
stigma still remains a significant issue and an obstacle towards the effectiveness of HIV 




attitudes towards PLHIV.218 Different studies indicate the persistence of HIV-related stigma 
among the community,219, 220 key population groups,221 and health care providers.57 Stigma 
is still a major barrier to linkage to, and retention in care.222 Stigma and discrimination 
deteriorate the social and living conditions of PLHIV.53 As a result of expansion of 
antiretroviral therapy (ART), the need for psychosocial support among PLHIV in the 
Ethiopian context is increasing.223 Furthermore, as part of the comprehensive needs of 
PLHIV, home-based care activities and adherence support programs are run by volunteers 
and expert patients in Ethiopia.70In the presence of SAD, such activities and programs are 
less likely to be successful. Therefore, averting SADmust be a priority. 
Currently, there are different manuals and guidelines on prevention, care and support related 
to HIV that are in use in Ethiopia.224Although there were no guidelines specifically 
addressing SAD in healthcare settings, all the manuals acknowledge the impact of 
SAD.224As described in the previous chapters, we have systematically developed a list of 
working recommendations to reduce HIV-related stigma and discrimination in healthcare 
settings.  
The JBI model of evidence-based healthcare encourages the consideration of local context 
in the implementation of evidence-based practices. Hence, the transfer, communication, 
education, dissemination, system integration and implementation components of the model 
need to be considered.4 The existence of a synthesized or summarized evidence in the form 
of systematic reviews and guidelines by itself is not enough for the improvement of policy 
and practice.4 
There are various factors that impede the implementation of guidelines.185 Some guidelines 
fail because of factors related to the characteristics of the guideline, including the way the 
guidelines have been written such as the wordings of the recommendations225and the ease of 
understanding, and resource implications.225 Guidelines may fail if they are not user-friendly 
or if they are not relevant to the organization.225 The lack of awareness of the existence of 
the guidelines or limited familiarity with the content of the guideline among healthcare 
workers (HCWs) may also negatively affect the implementation of a guideline.225 In some 
cases the lack of management support and work overload may impede the successful 
implementation of guidelines.225 In addition, organizational factors such as resource 
limitations may also impede the uptake of guidelines.225 
This fact underscores the importance of going beyound the mere synthesis of evidence to 




that affect the implementability of the guideline need to be considered.In the preceding 
chapter, we assessed the clarity, acceptability, implementability and relevance of the current 
guideline using the Guideline Implementability Appraisal (GLIA) checklist.174In addition to 
the factors assessed using the GLIA checklist, indepth exploration of local factors is needed 
in order to integrate the guideline into local policy and practice. Therefore, this project aimed 
to assess expected barriers and facilitators to the implementation of the guideline using key 
informant interviews and identify tailored recommended activities to maximize the uptake 
of the guideline. 
7.3. Objectives 
The objective of this project was to assess expected barriers and facilitators towards the 
implementation of the guideline and identify tailored recommended activities to maximize 
the uptake of the guideline.  
Specifically the project aimed: 
1. To identify the potential barriersto the implementation of SADreduction guideline. 
2. To determine tailored solutions for the expected barriers to the implementation of the 
SADreduction guideline. 
3. To identify the potential facilitators for the implementation of the SAD reduction 
guideline. 
4. To identify strategies for the implementation of the guideline for better uptake and 
adherence. 
7.4. Methods 
7.4.1. Research design 
This project employed adescriptive qualitative research to facilitate an indepth 
understanding of stakeholders’ perceptions of the potential barriers and facilitators to the 
implementation of a guideline developed to reduce HIV-related stigma and discrimination. 
Researcher’s position 
I conducted this project through thecollaboration with key informants (managers and service 
providers) to obtain adequate information that helped me to modify and tailor the guideline 
based on the data obtained from the project.  In this project,I acted as research designer, 
principal investigator, data collector, data analyzer and interpreter. Before conducting the 
research, I had adequate knowledge of the study participants, study setting and study subject 
(HIV-related stigma and discrimination). I assured the study participants about the 




participants through institutional affiliation and collaboration. These factors potentially 
enabled me to get detailed information from the participants through creating rapport. While 
exploringinformation from the perspective of the end users of the guideline, I acted as a 
facilitator to get the detailed report of the guideline’s end users about the factors that would 
positively or negatively impact the implementation of the guideline. Hence, there was 
limited possibility of biasing the findings.  
7.4.2. Study setting 
This project was conducted to explore factors that help to contextualize the guideline in 
Jimma University Medical Centre (JUMC), which is part of Jimma University. Jimma 
University is located in Jimma, a  town located 352 km southwest of Addis Ababa, the capital 
of Ethiopia. The university provides HIV-related services through the HIV and Tuberculosis 
Clinic and the Jimma University HIV Prevention and Control Office (JUHAPCO). The HIV 
and Tuberculosis Clinic is situated in Jimma University Medical Center 
(JUMC),separatefrom other units of the hospital.226 
Jimma University Medical Centre provides inpatient and outpatient health services for more 
than 10 million people living in Southwest Ethiopia. The hospital provides inpatient services 
in six clinical departments (internal medicine, surgery, gynecology and obstetrics, pediatrics, 
psychiatry and ophthalmology) and outpatient services in the chronic illness follow-up 
clinics (diabetes, cardiovascular, asthma, epilepsy, tuberculosis, HIV and psychiatry), 
dermatology, dentistry and other outpatient services.226 
The JUHAPCO is situated in Jimma University and was originally founded in 2002. 
JUHAPCO is supported by the Ethiopian Federal HIV Prevention and Control Office 
(FHAPCO), Ministry of Education (MOE), Global Fund, Ministry of Health (MOH), Joint 
program of United Nations Fund for Children and United Nations Fund for Population 
Agency (UNICEF- UNFPA), Joint Program of Center for Disease Control (CDC) and 
President’s Emergency Plan for AIDS Relief (CDC-PEPFAR) Ethiopia.JUHAPCO provides 
comprehensive HIV prevention activities like educational programs, outreach activities, 
training and care and support for HIV/AIDS affected and infected sub groups, including out-
of-school youth, in school youth, orphan, vulnerable groups in Jimma University and the 
surrounding community.In addition, it provides technical support, training and mentorship 
for the HIV and Tuberculosis Care Clinic and other healthcare facilities in Jimma Zone. The 




7.4.3. Study population 
The key informants who participated in the interviews came from Jimma University, Jimma 
University Medical Center (JUMC), Jimma University HIV prevention and Control Offices 
(JUHAPCO), and Jimma Zone HIV Prevention and Control Offices (JZHAPCO).  
7.4.4. Sample size and sampling procedure 
A purposive sample of seven health professionals and health managers participated in the 
key informant interviews. The participants were selected based on their current roles as 
clinicians, mentors, trainers and managers related to HIV prevention and control. 
7.4.5. Data collection 
Using semi-structured interviews, participants’ perceptions of the potential barriers and 
facilitators to the implementation of the guideline recommendations were sought. The 
qualitative research assessed contextual factors related to JUMC. The qualitative data were 
collected using a semi-structured interview guide that was developed based on the 
framework suggested by the Registered Nurses Association of Ontario (RNAO).117Based on 
this framework, the expected barriers and facilitators to the implementation of best practice 
guidelines are generally categorized into: evidence related factors, target audience related 
factors, resources needed for the implementation, and organizational context in which the 
guideline is to be implemented.117 The semi-structured interview addressed these expected 
areas of barriers and facilitators (Appendix23). The interview guide was translated into local 
languages (Afan Oromo and Amharic) by the researcher and translated back into English by 
another person fluent in the languages to check semantic equivalence. 
I conducted seven key informant interviews. Participants were provided written information 
sheets in English, Amharic or Afan Oromo based on their preferences.  Then, they signed 
consent forms to participate in the study. The interviews were conducted at a place and time 
that was suitable for the participants.Theinitialfindings of the interviews werefurther 
explored,and the opinions of the key informants were cross-compared.  
7.4.6. Data processing and analyses 
The key informant interviews were recorded, transcribed and translated into English. The 
data were analyzed using Atlas.ti 7.5 software package for qualitative data analyses. The 
data were analyzed thematically drawing on the framework suggested by Braun and 
Clark.26The transcriptions were repeatedly read to achieve immersion and obtain the sense 
of a whole data. Then, outstanding features of the data were systematically coded. The codes 




thematically based on replication (confirming what other key informants have said), 
extension (providing additional contextual information that extends findings) and refutation 
(providing a contrary view to what other key informants said).Finally, the themes were 
reviewed and defined to generate the final report. 
7.4.7. Data quality control 
While conducting qualitative research, it is recommended to use the term trustworthiness to 
describe the rigor of the studies.206 The concept ‘trustworthiness’ encompasses credibility, 
transferability, dependability and confirmability.207 
Credibility, in these key informant interviews, was established by getting indetailed 
information from experts with relevant expertise and experience. I adopted a well-
established semi-structured interview guide to clearly incorporate the concepts under 
study.228Besides that, Iwas already familiar to the culture of the local organization under 
study and in the current research I assumed a neutral role.228 Moreover, I attempted to verify 
the viewpoints of different experts against those of others through constantly reviewing the 
list of questions and further probing to get details of variations (negative case analyses) and 
including the opinions of all the participants.4,210 In this project, dependability was enhanced 
by including relevant experts in the field.209 
Confirmability is achieved by the collection of thick descriptive data, negative case analyses 
and arranging for a confirmability audit and establishing referential adequacy.207 In this 
project, accurate records of the responses of the participants were made during the 
interviews. In addition, unique opinions were further explored to understand how and why 
they disagreed with the more popular opinions. This was done through preliminary analysis 
of the data and through revising note books and modifying a list of questions based on the 
emerging themes. 
The transferability of qualitative evidence is based on the similarity ofcontextual factors in 
the settings.210Since most of them are contextually similar to JUMC, the healthcare facilities, 
especially teaching and referral hospitals in Ethiopia may utilize the information generated 
in this qualitative research. In addition, the potential transferability of the evidence to other 
settings should be considered in view of the procedures, settings and context described in 
this project. Moreover, the data generated in this chapter by itself is predominantly the 





7.4.8. Ethical considerations 
The project received ethical approval from the Human Research Ethics Committee (HREC) 
of the University of Adelaide(approval number H-2016-140) and from the Institutional 
Review Board (IRB) of Jimma University Institute of Health (JIH)(RPGC/389/2016). 
Participants were provided with written information sheets(Appendix 24). Written consent 
forms (Appendix 25) were obtained before commencing the interviews with the key 
informants. During the write-up and report writing, participants were not identified by their 
names, positions or roles; only codes were used. 
7.5. Results 
A total of seven key informants participated in the interviews. The key informants came 
from Jimma University, JUHAPCO, JUMC and JZHAPCO. The disciplinary backgrounds 
of the key informants weremedical doctors, nurses, midwives, medical officers and health 
promotion experts with further specialty training in clinical and public health disciplines. 
Using open-coding technique, 119 codes emerged. The codes were then categorized under 
97 categories that were grouped under 32subthemes. The subthemes were finally grouped 
under eight broader themes. Results are presented and described based on the following 
broader themes.  
1. Barriers and facilitators to the implementation of the guideline 
2. Dissemination issues 
3. Training, supervision and mentoring  
4. Implementation issues  
5. Monitoring and evaluation issues 
6. Integration of the guideline into the hospital routine 
7. Sustainability and scaling-up 
8. Resource implications 
7.5.1. Barriers and facilitators to the implementation of the guideline 
This project explored factors whose presences facilitate or deter the implementation of the 
current guideline. Factors are considered as facilitators if their presence promotes the 
implementation of, or adherence to the guideline. Factors are considered as barriers if they 
impede implementation of, or adherence to the guideline. The same factor can be both a 
barrier and a facilitator. If the presence of a factor is a facilitator, its absence is considered 
as a barrier.Hence, barriers and facilitators are presented together here. The barriers and 




a. Characteristics of the guideline 
b. Existing opportunities and platforms in the policy and practice environment 
c. Provider-related factors  
7.5.1.2. Characteristics of the guideline  
The following factors inherent to the guideline were identified as facilitators for the 
implementation of the current guideline. 
a) Addressinga gap in evidence and practice  
b) Comprehensiveness, clarity and consistency of recommendations  
c) Addressing ethical principles and issues related to patient charter 
d) Clarifying the scope of the guideline  
e) Indication of the steps required for the implementation 
f) The presence of implementation tools  
g) Making the guideline appealing and attractive  
The following is an elaboration of each facilitator, followed by relevant quotations from the 
stakeholders. The first facilitator inherent to the guideline was that the guideline addressed 
gaps in evidence and practice. As reported by the key informants, the fact that the current 
guideline addressed gaps in evidence and practice is an opportunity to increase the uptake 
of the guideline. Addressing stigma and discrimination, as one of the priority problems, was 
mentioned as a facilitating factor for the implementation of the current guideline. Key 
informants specifically mentionedthe national goals of getting zero new HIV infectionsin 
the context of persistently prevailing HIV-related stigma.  
“The stigma attached to HIV has increased. Our current plan is to get zero new 
infections.  For that purpose, we have not provided necessary awareness creation 
activities for stakeholders. Therefore, this is an opportunity, because it is one of the 
most priority area of intervention. Stigma is a widespread and a priority problem. 
So, this by itself is a facilitating condition” KI P6 
The study participants stressed that HIV-related goals cannot be realized without curbing 
stigma and discrimination related to HIV. Key informants also reported that SAD related to 
HIV have been overlooked relative to the focus given to the medical therapy of HIV and 
there is no up-to-date guideline that addresses SAD related to HIV in healthcare settings. In 





 “Many organizations did not work on stigma and discrimination in healthcare 
settings. They were focusing their attention on treatment issues alone. Therefore, the 
current guideline is very important initiative to fill this gap. We cannot end HIV by 
drug therapy alone. We need behavioral change. We are still behind from the 
perspective of tackling stigma and discrimination. Earlier, tuberculosis patients 
were being stigmatized but now, that has reduced. But stigma and discrimination 
related to HIV is still a problem. So, we must achieve the same result for HIV-related 
stigma and discrimination.” KI P6 
Mentioning that stigma and discrimination related to HIV and their impacts are widely 
observed among clients and providers, participants also indicated that the current prevailing 
gaps in handling clients is attributed to the lack of guidelines. They also indicated that there 
is a gap in adhering to standard practice in relation to service provision for PLHIV. The 
absence of previous guidelines on HIV-related SAD, weak HIV service integration, the 
separate location of the HIV and Tuberculosis Clinic and the widely practiced stigmatizing 
actions were among the practice gaps reported by study participants. The presence of these 
gaps places an increased demand for the new guideline to reduce HIV-related stigma and 
discrimination and this will potentially increase the uptake of the current guideline.  
“As a guideline addressing our current gaps, there are opportunities that increase 
the uptake of the guideline. People in this locality go somewhere else to get HIV-
related services. This is because, the clinic [TB and HIV Clinic] is already separated 
from other units of the hospital and clients are afraid of going there. Because, if they 
go there, by default, it will beclear that they are HIV positive. The clinic should have 
been part of the hospital adjacent to our units. This did not happen because there 
was no guideline and there was no one concerned about the rights of the clients. If 
the guideline is implemented, managers will understand the problem. And this may 
result in full integration of HIV services into other hospital services.” KI P5 
The absence of any guideline on HIV-related SAD and the lack of HIV service integration 
and the widely practiced stigmatizing actions places increased demand for a new guideline 
on HIV-related stigma and discrimination among healthcare providers. The current 
guideline, as one of new guidelines, is likely to be accepted and implemented by 
stakeholders. 
 “The other factor that we may take as a facilitating condition is the fact that there 




facility that addressed stigma and discrimination. So far, we have something on HIV 
policy, but we do not have any guideline on stigma and discrimination. Since this 
guideline is new and unique, it will attract the attention of stakeholders and 
implementers.” KI P5 
Secondly, study participants mentioned that the recommendations in the guideline were 
developed based on currently available global evidence and indicated this as one of the 
facilitators for effective implementation of the current guideline: 
“…Moreover, the current guideline was based on global up-to-date evidence. This 
will potentially increase the uptake of the guideline, because it addresses a gap that 
has never been attempted before. Therefore, I think we are already on the right 
track.” KI P5 
The third potential facilitator mentioned was the clarity, comprehensiveness and consistency 
of the recommendations included in the current guideline. Study participantsreported that 
the guideline was clear and at the same time,it had detailed information related to 
methodological issues in the guideline development. Participants also said that keeping the 
balance between the clarity and details of the guideline is critical for facilitating the 
implementation of the guideline. 
“The recommendations are very clear. There is a need to keep the balance between 
the burden in reading details and the clarity and completeness of the 
recommendations. If descriptions do not exist, sometimes it is difficult to understand. 
So, keeping the balance is the key. This was addressed in this guideline. The guideline 
recommendations are clear and short.” KI P7 
The fourth attribute inherent to the guideline reported as a facilitator was addressing ethical 
principles. Addressing ethical principles was mentioned as one of the factors that enhance 
the implementation of the guideline because such an action is associated with the 
improvement of hospital service quality. Participants also reported that current agendas such 
as patient charter and patient rights are potential opportunities that facilitate the 
implementation of the current guideline. In addition, mentioning the rights and roles of 
patients and providers, as participants described, facilitates the entire service provision and 
therefore, is one of the facilitating factors for the implementation of the current guideline. 
The other strength of the guideline described by the participants was the indication of 





“What I would like to focus is always professionals forget ethical principles. These 
principles include: autonomy, maleficence, beneficence and justice. When we take 
justice, it means that a client irrespective of his or her clinical status should receive 
appropriate care and services. When we mean beneficence, it means that what the 
health professional works should benefit the patient. When we say maleficence, it 
means that the health professional should not harm the patient. When we come to 
autonomy, it means that the patient has the right to request information, the right to 
refuse or accept the services. All these principles should guide our attitudes and 
practices as health professionals. Our health professionals should be guided by these 
principles.Our current stigma and discriminationreduction guideline has addressed 
these things. This has a significant role in improving the quality of care we provide. 
Our knowledge should be in congruent with our professional ethics. Therefore, I 
think professionals are more likely to accept and implement the guideline as part of 
their professional ethics.” KI P4 
Participants statedthat as one of the guidelines addressing the rights and responsibilities of 
patients, there is an opportunity for better uptake of the current guideline.  
“The issue of governance and patient’s rights are always neglected by healthcare 
workers. In the future, however, this negligence cannot be tolerated anymore. So, we 
must work on it. Patients are asking for their rights. The government is also giving 
priority for these areas. Therefore, this guideline came at the right time and there 
are many opportunities for the implementation.” KI P4 
The fifth guideline attribute potentially affecting the uptake of the guideline was clarification 
of the scope of the guideline. The need to clarify the scope of the guideline was raised as a 
precondition for the successful implementation of the guideline. This includes specifying the 
target users of the guideline and the roles of other stakeholders. The key informants 
recommended that the scope of the guideline and the roles and responsibilities of 
stakeholders should be described in detail.  
While the guideline was prepared for all disciplines of health, medical and allied health 
professionals, some participants suggested choosing either of two approaches for the format 
of the guideline. The first approach suggested was using the same guideline format for all 
health professionals and determining the roles of each health professional category such as 
responsibilities of nurses, midwives, laboratory technicians, physicians, etc., and potential 




On the other hand, the preparation of a separate guideline for each health professional 
category was suggested as another possible alternative though it was also recognised as being 
time consuming and all participants who presented this option believed that the preferred 
option was to include all recommendations in the same guideline for all health professionals. 
The particpants however, recommended the roles of each professional category should be 
described during the training. 
Participants further substantiated the alternative for using the same guideline for all health 
professional categories, mentioning that most recommendations in the guideline work for all 
categories of health professionals. In addition, they suggested that a uniform format of the 
guideline should be used for all health professionals, stating that any guideline related to 
stigma and discrimination should be the same for all health professionals.  
On the other hand, participants suggested that the existence of many new initiatives may be 
perceived as a burden by the healthcare workers and therefore the guidelines should be 
integrated. Hence, they recommended that one guideline could be linked with others. Such 
a linkage can be provided in the guidelines mentioning how the recommendations in one 
guideline complement those of the other guideline.  
“Even if the guidelines are prepared separately, they all can be part of their 
professional practice. We may not need to prepare all guidelines in one hard copy. 
What we can do is linking one guideline with the other. It would be nice if we mention 
other related guidelines so that healthcare professionals refer to the other guideline 
to get comprehensive information. We can revise all other guidelines in this manner 
so that one supports the other.”KI P4 
Study participants also recommended that the guideline should enable HCWs to identify the 
roles and responsibilities and evaluate their actions.  
“The guideline should help us evaluate ourselves with stigma lens. Just after reading 
the guideline, we should be able to examine our roles and responsibilities and think 
of our individual practices. We should identify and characterize stigmatizing 
activities that are currently present in our hospital. I hope the current guideline will 
help us to achieve these objectives” KI P3 
Other factors inherent to the guideline that are expected to facilitate the implementation of 
the guideline were indicating steps to launch the guideline, the presence of implementation 
tools and the attractiveness of the guideline. While the presence of implementation tools 




were raised as facilitators for the implementation of the current guideline, participants 
suggested preparing guidelines in an attractive way, such as in the form of posters. 
“The guideline containsclear steps and checklists that give us clear direction 
about the implementation. I think these steps are practical for our hospital. For 
instance, it indicates the importance of establishing a committee, assessing the 
setup and other essential steps. Therefore, these steps and checklists included in 
the guideline are very essential. They indicate clear direction. In our facility, we 
have limited guidelines and checklists like this guideline. This has created 
confusion and lack of consistency in practice. So, whether people come and go, 
works will be done based on checklists and steps provided in the guideline.” KI 
P5 
7.5.1.3. Existing opportunities, platforms and barriers in the policy and practice environment 
Key informants identifiedexisting opportunities that could facilitate the implementation of 
the current guideline. These are the commitment of stakeholders, existing platforms and the 
complementarities of institutional and programmatic goals with the guideline goals. On the 
other hand, high patient load is expected to impede the implementation of the current 
guideline. 
7.5.1.3.1. The commitment of stakeholders  
Participants reported that the commitment of stakeholders at multiple levels is required for 
the implementation of a guideline.They also stated that the commitment of the hospital and 
stakeholders at national level is evidenced in their programmatic and institutional goals. 
These targets will be realized only if stigma and discrimination attached to the disease is 
reduced. Reducing stigma and discrimination is also one of the priorities of JUMC and the 
government of Ethiopia.  
“Even at national level, there are programs such as health sector transformation 
plan (HSTP) that support such [stigmareduction] initiatives. For instance, one of the 
targets at national level is to reduce new HIV infections by 90%.  Focus was given 
for HIV prevention and control. So, they are committed to reduce stigma and 
discrimination. The current guideline addresses stigma and discrimination, one of 
the areas of HIV prevention and control activities where significant gaps exist. 




In addition, key informants reported that the presence of different stakeholders that support 
HIV-related services are opportunities that could potentially increase the attention given to 
SADreduction programs.  
“For instance, there are stakeholders that provide support on HIV-related palliative 
care and sexually transmitted infections (STIs). Furthermore, stigma mitigation is 
part of a comprehensive care. In addition, there are different training programs on 
HIV, such as on ART, PMTCT and so on. Therefore, there is an opportunity for these 
stakeholders to host stigmareduction programs and guidelines. Hence, there is a 
suitable environment to integrate the guideline into the existing system.” KI P4 
From their experience of implementing previous guidelines and standards, participants 
concluded that JUMC is potentially a favorable environment for the implementation of the 
current guideline. Stigma and discriminationreduction was identified as one of the main 
priorities of the hospital. In addition, the current guideline, as stated by the participants, 
supports the improvement of hospital service quality.  
“Both the hospital and our partners have aimed to have an HIV-free generation. In 
addition, the hospital needs to have quality service in each unit. The current 
guideline can help us as a tool for the improvement of quality of hospital services. 
The hospital management is also committed. Our managers know that clients are at 
the center of their hospital. They always have quality of care as their motto.” 
7.5.1. 3.2. Existing platforms  
Opportunities that key informants identified as platforms for the implementation of the 
current guideline were: the existence of expert patients and associations of PLHIV, the 
existence of regular health education programs, the existence of mentorship programs and 
MDTmeetings.  
Participants reported that currently expert patients (HIV positive lay health workers) are 
involved in the care and support of PLHIV with the intention to reduce unnecessary negative 
interactions from healthcare providers. The expert patients teach the clients about treatment, 
how to take medications, medication side effects and so on. They also share their life 
experiences with the clients, so the clients understand that it is possible to live with HIV.  
“There are a lot of opportunities around us. For instance, there are expert patients. 
They [expert patients] are needed because clients face stigma. Expert patients are 
acting as service providers. on the other hand, they are also acting as role models 




unnecessary negative interactions from healthcare providers. So, as they [clients] 
are diagnosed with HIV, clients are immediately referred to expert patients. So, the 
expert patients teach the clients about HIV, about treatment, about how to take 
medications, about medication side effects and so on. They also share their life 
experiences to the clients. So, the clients understand that it is possible to live with 
HIV.”KI P1 
The existence of expert patients was cited as an opportunity for the introduction of the 
current guideline. The involvement of expert patients in stigma and discriminationreduction 
was identified as one of the critical and practical recommendations. This is because, 
asmentioned by the study participants, expert patients are better informed and have 
witnessed or experienced stigma and discrimination. It was also recommended that expert 
patients needed to be involved in decision-making and being members of committees and 
boards.  
“The expert patients can help us as agents to promote the implementation of the 
guideline by informing health professionals and other clients of their rights and 
responsibilities. In addition, as an issue of governance, expert patients should 
constitute hospital committee and boards. This is the issue of governance and 
accountability. So, we must strengthen this.” KI P7 
The involvement of the associations of PLHIV was raised by the key informants as one of 
the potential opportunities for the introduction of the guideline and tracking its 
implementation. The first strategy suggested to involve the association of PLHIV, was by 
providing the members of the associationstraining, informing them of their rights and 
responsibilities so that they will ask for their rights.  
“From our experience, we have involved the associations of PLHIV in different 
initiatives. There are already established networks of PLHIV. We can also create 
new networks. We may inform them of this new guideline so that they will track its 
implementation. Therefore, the main thing is to empower them.”KI P4 
Key informants also reported that currently, there is regular health education program in the 
hospital (JUMC) and that this program may be used as a platform to introduce the current 
guideline. 
“For instance, currently health education is being provided to address positive living 
and to enable PLHIV cope with the virus. These include how the patient should take 




keep themselves from other diseases. We can also use such platforms to introduce 
the guideline.” KI P3 
7.5.1.3.3. Complementarities with institutional and programmatic goals  
Study participants reported that there are institutional and programmatic goals that need the 
reduction of SAD as a focus. These are already existing programs such as, programs to 
increase treatment utilization and antiretroviral therapy (ART) adherence, and prevention of 
mother to child transmission (PMTCT) service utilization. The achievement of the goals of 
these programs needs stigmareduction as an input.  
“We have significant loss to follow up among HIV clients. This may be due to the 
fear of stigma and discrimination. Therefore, this guideline helps to improve 
adherence to ART.” KI P3 
Additionally, key informants reported that most of the current priority areas such as Clean 
and Safe Health Facility (CASH), quality movement, and Compassionate, Respectful, and 
Caring (CRC) initiatives by the MOH may be successful if stigma is reduced and couldbe 
facilitators for the implementation of the guideline. 
Compassionate, respectful, and caring (CRC) initiative as an opportunity to introduce the guideline 
Study participants reported that in JUMC, there are various new initiatives. One of these 
initiatives is the CRC initiative. The study participants reported the commonalities of CRC 
initiative and stigma reduction guideline. The main agenda of the CRC initiative, as 
participants stated, is to make health professionals develop compassion and respect towards 
his/her client. Participants also reported that the CRC initiative has common objectives with 
those of the current guideline on SADreduction. It facilitates the empowerment of clients 
and addresses the rights of the clients. The reduction of stigmatizing attitudes and actions 
towards clients regardless of their disease status,could help HCWs develop compassionate, 
respectful and caring attitude towards their clients. Therefore, the guideline is expected to 
complement the achievement of the goals of the CRC initiative by changing the attitudes of 
health professionals. On the other hand, the achievement of the goals of the CRC initiative 
could contribute to the success of SADreduction programs. Therefore, the CRC initiative 
could be taken as an opportunity for the implementation of the current guideline. 
“The CRC initiative itself describes what is there in the current stigmareduction 
guideline. It describes how a health professional should approach clients. So, I think 




can be taken as an opportunity for the implementation of the current guideline.” KI 
P2 
Quality movement and good governance as opportunities for the introduction of the guideline  
The other area of complementarity reported by key informants was ‘quality service 
movement’ and good governance. As stated by study participants, good governance 
improves the engagement of clients living with HIV and the associations of PLHIV in 
decision-making issues related to care. This is again an opportunity as client engagement is 
part of the recommendations included in the current stigma guideline.Furthermore, the 
current stigma and discriminationreduction guideline is expected to contribute towards the 
improvement of service quality in the hospital.  
“There is a quality service movement nowadays. This quality service movement 
encourages the delivery of patient-centered care. Therefore, our current stigma and 
discriminationreduction guideline complements this quality service movement. In 
addition, there is an initiative for good governance. This initiative encourages the 
engagement of clients and their association in decision-making issues related to 
care. This is again an opportunity, because client engagement is part of the 
recommendations included in the current stigma and discriminationreduction 
guideline.” KI P6 
Clean and Safe Health facility (CASH) 
Study participants reported that JUMC is working to increase adherence to standard 
precautions as part of CASH program. Infection Prevention and Patient Safety (IPPS) was 
raised as one of the priority problems of JUMC. One reason for this is, as informed by 
participants, is because there is little opportunity for staff to receive up-to-date information 
related to patient care. The current guideline is expected to reduce extra precautions and 
encourage standard precautions among HCWs. If the guideline is implemented, it will reduce 
unnecessary over utilization of protective equipment and materials and thereby saves 
resources. These resources will then be utilized at the right time only when they are needed. 
As mentioned by the participants, HCWs are currently utilizing extra precaution because of 
irrational fear of transmission and the absence of a guideline related to stigma and 
discrimination. 
“By chance, if staff is assigned to work at the clinic [HIV and TB clinic], they 
proceed to work without sufficient orientation. Except the recent progress being 




they [healthcare workers] improve their practice. So, they [healthcare workers] 
think as if the virus jumps from the client to the provider. Sometimes, there is a time 
where they [HCWs] are afraid of greeting them [PLHIV]. If HCWs see something, 
even patient’s saliva, on their shoes, they always bleach their shoes. Others 
unnecessarily wear masks or wear gloves, sometimes double gloves. This is because 
they think that HIV positive clients are thought to transmit tuberculosis and HIV all 
the time. The toilets are separately locked for the staff and clients cannot use them. 
We observe significant extra precaution in our hospital.” KI P2 
Appreciating the recommendations about the standard precautions in the current guideline, 
participants also stated that standard precautionsare important not only for HIV, but also for 
each activity of the hospital. Adherence to standard precautions helps to reduce unnecessary 
wastage of resources and substandard practices by encouraging health professionals undergo 
uniform practices for all types of clients.  
“Adherence to standard precautions is currently low, because professionals do not 
use protective materials for HIV negative clients. And for HIV positive clients, they 
use excessive precautions. This is where the discrimination happens. Therefore, 
professionals should practice standard precaution for all clients regardless of their 
status. For instance, clients who were not tested may be positive, but they are still 
perceived as being HIV negative.” KI P3 
Participants also reported that universal precautionsare provider-oriented and resource-
intensive method of precautions as they advocate the utilization of precautions for every 
patient every time to protect healthcare workers from blood-born microorganisms.Standard 
precautions, as mentioned by study participants, encourage the use of resources only 
whenever it is necessary to do so. It is aimed to protect both clients and providers from 
exposure to body fluids. Participants emphasized that standard precautions should be used 
in the current guideline instead of using universal precautions, claiming that universal 
precautionsare inclined towards the protection of HCWs compared to protecting the rights 
and dignity of clients.   
“Universal precautionsare provider-oriented precautions. This is aimed to protect 
providers_ not clients. Body-substance isolation precautions should also address clients. 
Currently we are using ‘one guideline that operates at two’. It is a single guideline that 
addresses both the needs of clients and providers. It is a transmission-based precaution. 




have the potential to transmit infections. Therefore, we advocate standard precaution. 
So, I suggest that we use the term ‘standard precautions’ in the guideline. So, ‘universal 
precautions’ should be replaced by ‘standard precautions’.”KI P2 
PMTCT utilization, ART adherence, loss to follow up and help seeking among PLHIV 
Study participants reported that the reduction of perceived or actual stigma among clients 
can increase HIV testing rates, ART adherence rates, PMTCT service utilization rates and 
general healthcare service utilization.In addition, as mentioned by the key informants, the 
reduction of SADwould help clients to disclose their sero-status, and their hidden behaviors 
including their feelings. Therefore, tackling SAD is the center of any HIV prevention and 
control programs and could contribute to the achievement of HIV prevention and control 
goals. 
The participants also reported that currently clients are expected to be on ART earlier than 
before. However, most clients are delaying seeking treatment because of the fear of stigma. 
Therefore, addressing of SAD is needed to increase HIV testing and help-seeking behaviors 
of clients. As participants reported, these factors would create the need for the current 
guideline and therefore provide a favorable situation for the implementation of the current 
guideline.  
“The fear of stigma reduces help seeking behavior and disclosure of one’s sero-
status. These people continue disseminating the infection. Currently, we have 
significant loss to follow up among HIV positive clients. This may be due to the fear 
of stigma and discrimination. Therefore, this guideline, in the long run, helps to 
improve adherence to ART, and in general reduces patients’ loss to follow up from 
care. Therefore, tackling stigma and discrimination is the center of HIV curative and 
preventive activities.” KI P3 
7.5.1.3.4. Patient load  
As reported by study participants, the implementation of the guideline implies that HCWs 
should pay attention to the needs of clients. Therefore, the implementation of the guideline 
has the potential to increase the effect on patient load. Similarly, the presence of high patient 
load may reduce the time spent by the HCWs with each patient and hence impede the 
implementation of the guideline. On the other hand, the implementation of this guideline is 
expected to reduce patient load as clients will be getting treatment from their right locality 
if stigma is reduced. This is because, if this guideline is implemented, stigma would be 




healthcare facilities in cities and big towns would not be overburdened by clients. Therefore, 
in the long run, patient load would be reduced. 
“Because of the fear of stigma and discrimination, clients from Jimma go and seek 
treatment from other healthcare facilities. And clients from other areas come and 
receive treatment from Jimma. Even, some clients either avoid getting tested or 
seeking treatment. Therefore, if we could reduce stigma and discrimination, we can 
also reduce unnecessary patient loads, because clients will be able to get services at 
their local facilities.” KI P5 
7.5.1.4. Provider-related factors  
Healthcare worker-related factors that affect the implementation of the guideline are related 
to the knowledge, awareness and attitude, being occupied by other competing interests, 
HCWs’ motivation and the sense of ownership of the guideline.Unrealistic expectations and 
limited awareness of the guideline among healthcare workers were amongthe potential 
barriers reported by the key informants. The key informants emphasized that if HCWs are 
not aware of these guidelines, they will not be able to implement it. In addition, it is expected 
that HCWs do not recognize and acknowledge their stigmatizing behaviors. This was raised 
as a potential barrier to the implementation of the current stigma and discriminationreduction 
guideline.  
“There are some professionals who stigmatize HIV. Some of them still do not attend 
the delivery of a mother who is HIV positive. But, they deny their stigmatizing 
behaviors. So, it is essential to give them the orientation and the training. If HCWs 
do not know how to perform what they are expected to do so, they will carry out 
substandard activities. HCWs may perceive that they are not stigmatizing HIV 
positive clients and they do not need the guideline. But, we may convince them that 
the guideline is for every HCW not just for those HCW’s who stigmatize PLHIV. So, 
we must raisethe awareness of HCWs” KI P6 
As elaborated by study participants, unrealistic expectation of HCWs is another potential 
barrier faced during the implementation. Some healthcare workers expect incentives during 
training and at times, during implementation. Other potential barriers identified by key 
informants were that some professionals perceive that the guideline is imposed on them as a 
commandment. As reported by study participants, this may result because of inadequate 




“On the other hand, the challenges that we may face include the difficulty of 
changing the attitudes of some staff. While we were trying to introduce new 
initiatives, we have tried onsite training without payment. But health professionals 
do not want to attend such a training. Especially, if there is no incentive, 
professionals are not willing to attend it. If they do not have the interest, to what 
extent can they implement the guideline?” KI P1 
On the other hand, the presence of staff that is available and committed to provide training 
was raised as a facilitating factor for the implementation of the guideline.  In addition, the 
commitment of HCWs was mentioned as a facilitating factor for the guideline 
implementation. Specifically, the presence of motivated staffs working in HIV-related 
services was identified as a factor facilitating the uptake of the guideline.  
“Some HCWs are committed to do the necessary tasks. We conduct mentoring for 
different units. In some units, where there are committed staffs, tasks are 
accomplished easily. In other units where there is weak or no commitment of 
healthcare workers, whatever mentoring you provide them, we observe that the 
implementation is always weak. When we come to our healthcare facility [JUMC], 
especially those health professionals who work on HIV treatment and care, they have 
good motivation and commitment towards their job. Therefore, the commitment of 
professionals can be one of the facilitating factors in our hospital” KI P5 
Though the impact was claimed to be minimal for the current guideline, participants reported 
that the implementation of a new guideline may require HCWs to give more time and 
attention to clients than before. Therefore, it is expected that some professionals may be 
resistant to the changes needed. Nevertheless, these expected challenges are minimal and 
HCWs can be convinced of the potential benefit of the guideline. 
The other provider-related factor identified by the key informants was the sense of 
ownership. The sense of ownership for the guideline is one of the key factors that influence 
the implementation of the guideline. Study participants mentioned that guidelines and 
initiatives usually fail because of the lack of sense of ownership and they stressed the 
necessity of working to increase the sense of ownership among HCWs. In addition, they 
reported that the sense of ownership developed because of the involvement of professionals 
from the local institution is one of the facilitators for the successful implementation of the 




“Always, when guidelines reach health professionals not all of them 
implement it correctly. Some of these problems occur because of the lack of 
sense of ownership for the guideline among healthcare workers. From the 
very beginning, a multidisciplinary group of health professionals has been 
involved in the development of the current guideline. In my opinion, this has, 
to some extent induced a feeling of ownership for the current guideline.” KI 
P2 
In addition, key informants reported that the consideration of local factors during the 
development would potentially increase its implementability.  
“What makes this guideline unique is that it was developed at healthcare facility 
level. Other guidelines are usually developed at regional, zonal and national levels. 
The current guideline was prepared by Jimma University in collaboration with the 
University of Adelaide. Previous guidelines were developed just at national or 
international level without taking local circumstances into account. The current 
guideline is unique in that it has assessed local practical situations. It has also sought 
the experiences of health managers and health professionals.” IDI P5 
The key informants also stated that the implementation of previous guidelines failed because 
the implementation of the guidelines was perceived as the responsibility of only those 
individuals who received the initial training on the guideline. Thekey informants stressed 
that the sense of ownership should be built even during the implementation of the guideline. 
“From our experiences, what we have learnt was that there was a perception that 
the initiative is only the concern of those individuals who have been trained on the 
topic of interest. For instance, regarding clean and safe health facility (CASH) 
initiative, we trained two to three professionals from each unit. The objective was 
that these trained people will orient the remaining staff in their units. Nevertheless, 
in our case, many staff members perceived that such new practices or initiatives are 
only the business and concerns of those trained individuals.” KI P1 
In general, many of the codes were either barriers or facilitators to the guideline. The barriers 






Table 13. Barriers and facilitators to the implementation of HIV-related stigma and 
discriminationreduction guideline 
Sub-themes Categories  Subcategories  Codes  
Characteristics of 
the guideline 
Addressing gap in evidence 
and practice  
The persistence of stigma  Stigma historically overlooked  
Stigma common among clients  
Stigma widely observed among HCWs 
Addressing stigma as a priority 
problem 
Absence of guideline 
Gaps in handling clients 
Deviation from standard practice 
Supporting recommendations by 
global evidence 
Recommendations developed based on a 
systematic literature search and panel 
consensus 
Clarifying the scope of the 
guideline  
Specifying the target users Relating the guideline to specific jobs of 
HCWs 
Suggested format for different 
disciplines 
Same format versus different format  
Integration of guidelines  
Enable HCWs to identify their roles and 
responsibilities 




and consistency of the 
recommendations  
 
Description of methods used to 
develop recommendations 
 
Clarity of recommendations   
Comprehensiveness of the 
guideline 
 
Balance between clarity and 
comprehensiveness 
 
Addressing ethical principles 
and issues related to patient 
charter 
Having common goals with 
good governance 
 
Addressing issues related to 
patient charter  
 
Mentioning the rights and roles 
of patients 
Services that clients should receive 
Service environment  
Making the guideline 
appealing and attractive  
Preparing the guideline in the 
form of posters  
 
Indication of steps required for 
the implementation 
  
The presence of 
implementation tools 
Mentorship tools  





Commitment of stakeholders 
 
Commitment of hospital 
management 
 
Presence of stakeholders that 
support HIV programs 
 
Stigmareduction as priority of 
stakeholders 
 
HIV as a focus area of policy 
makers 
 
JUMC is a favourable 
environment 
 




Existing platforms Expert patients  
Associations of PLHIV  
Regular health education 
programs 
 
Mentorship programs  
MDT meeting  
One-to-five networks   
Complementarities with 
existing programs 
Addressing stigma as a roadway 
to achieve priority goals 
Adherence to ART 
PMTCT utilization 
Zero new HIV infections 
Complementarities with new 




The CRC initiative  
Quality movement  




Patient load Potential long-term effect on 
patient load 
Stigma reduction leading to the 




Potential short-term effect on 
patient load 
Implementation as potential time 
consumer 





Knowledge and attitude of 
HCWs  
Limited awareness of the 
guideline 
If HCWs are not aware of the guideline, 
they will not be able to implement it.  
The perception that the 
guideline is imposed on them 
 
Unrealistic expectations Expecting incentives to attend training 
and to implement the guideline 
Failure of HCW’s to recognize 
and acknowledge their 
stigmatizing behaviours 
The perception that they do not 
stigmatize and do not need a guideline 
HCWs being occupied by 
other competing interests 
  
Motivation and commitment Motivation of staff working in 
HIV and TB clinic 
 
Presence of motivated staff to 
provide training 
 
Sense of ownership of the 
guideline  
Sense of ownership because of 
involvement during 
development  
Involvement of professionals from local 
institution 
Sense of ownership during 
implementation 
Perception that the implementation of 
the guideline is the responsibility of 
those individuals who received the 
initial training 
NB: HCWs: Healthcare workers, HIV: Human immunodeficiency virus, PLHIV: People Living with HIV, JUMC: Jimma University 
Medical Centre, MDT: Multidisciplinary team, ART: Antiretroviral therapy, PMTCT: Prevention of Mother to Child 
Transmission,CASH: Clean and safe health facility, CRC: Compasionate, respectful and caring, TB: Tuberculosis,  
7.5.2. Dissemination approaches 
As part of effective guideline implementation, the need for effective dissemination was 
emphasized by the key informants.  
“If we could not get the guideline accessed by healthcare workers, we cannot get it 
implemented.Therefore, the guideline should be accessible to all health 
professionals.” KIP5 
Generally, the dissemination strategies identified were categorized into passive and active 
dissemination strategies. Traditional dissemination strategies such as official letters, 
publishing the guideline, distributing hard copies and availing the guideline in libraries and 
websites were identified as passive methods of dissemination. On the other hand, training, 
short term workshops, peer education, using unit heads as gate keepers, posters and media 
were identified as active strategies for dissemination. Moreover, study participants reported 
that the current mentorship program, multidisciplinary team (MDT) meetings and one-to-
five networks that exist in the Ethiopian healthcare system may be utilized as active 
dissemination platforms. 
“There were times when we introduced guidelines passively through official letters 
and distributing hard copies. But this was not effective. However, there was a time 
when we were effective in introducing the guidelines through active methods such as 




The first platform suggested for the dissemination of the current guideline was the MDT 
meeting program. As reported by key informants, currently, health professionals working on 
different areas related to HIV have aMDT meeting program, where they share different 
issues related to their practices in the care and support for PLHIV. In these meetings, the 
healthcare providers discuss all issues related to their practices, their strengths, weaknesses 
and the challenges faced at work. Key informants suggested that this may be a platform for 
the dissemination and implementation of the current guideline.  
“We have different regular meetings such as multidisciplinary team (MDT) 
meetings. We have also a monthly mentorship program. Therefore, in these 
programs, we can give emphasis to the implementation of the guideline.”KI P4 
The second potential platform for the dissemination of the guideline is mentorship. 
Mentorship is an onsite training where experienced health professionals teach other junior 
and less experienced professionals. As reported by the key informants, these programs have 
brought a radical change in the improvement of the quality of ART services. They also 
reported that mentorship is an excellent platform for sharing experiences. The mentorship 
program includes all units in the hospital such as pharmacy and dispensary units, HIV and 
TB clinic, inpatient and outpatient departments, and so on. Mentors provide technical 
support to health professionals of different disciplines including nurses, midwives, pharmacy 
professionals, laboratory technologists, medical doctors and other health professionals. All 
health professionals have access to this program.It was also reported that mentors can act as 
role models for the implementation of the current guideline. 
 “Our mentors are all role models in their practice. If you are not a role model in 
educational status and in your skill, it will be difficult to teach others at worksite. In 
our hospital, all the mentor nurses, mentor physicians and other health professional 
mentors are role models. Their training experience, their educational status and 
other attributes are better than others. Some of them hold managerial positions and 
some are professionally influential. Therefore, I hope that they will also be role 
models in implementing the current guideline.” KI P4 
Key informantsreported that currently, mentoring is being provided every month using 
mentoring tools that show whether the HCW has performed all the necessary tasks. Key 
informants also reported that if SAD areincluded as part of the mentoring system, it can 




The third potential platform suggested by study participants was healthcare team structures. 
Health professionals have formal and informal teams. Among the current functional team 
structures are teams such as one-to-five networks. Key informants reported that it is possible 
to introduce the guideline through this network.  
“In each unit, there is anetwork called one-to-five network. This is an arrangement 
where workers are grouped to discuss on different issues at work. So, this platform 
may be utilized for the introduction of the current guideline.” KI P6 
The fourth suggested platform was peer education. As recommended by key informants, 
peer education may be utilized as a mechanism of dissemination and implementation for the 
current guideline. 
“The other potential method for the dissemination of the guideline is peer education. 
If healthcare professionals found that the topic is attractive and interesting, they 
often discuss in peers. We can make the guideline appealing and encourage regular 
discussion of stigma and discrimination. So, the main thing that we require is, to win 
their attentions.” KI P6 
The fifth strategy suggested for guideline dissemination was to use unit heads as gate keepers 
so that the unit heads can disseminate the guideline to their subordinates. In addition, it was 
reported that focal persons and health professionals who work on HIV could act as role 
models to influence other HCWs for the implementation of the guideline as they have 
adequate knowledge and experience in services related to HIV.  
“The other strategy is to use unit heads as gate keepers. Then, the unit heads can 
disseminate the guideline to their subordinates. What we require is, involving them 
in the training so that they will act as change agents. This may not be necessarily 
those who are in positions. People who are opinion leaders, who are respected by 
their colleagues and who have appealing personality can act as role models.” KI P7 
As reported by key informants, existing training programs may also be utilized as an 
opportunity to introduce the current guideline. The provision of orientation and training were 
identified as main strategies for the dissemination and implementation of the current 
guideline.  A key informant cited previous experiences of JUMC in which it used training to 
introduce new guidelines effectively. 
“There was a time when we introduced the updated version of PMTCT guideline, 




guidelines through refresher trainings, and through mentorship programs. We can 
use the same approach to introduce the current guideline.” KI P4 
Strategies such as e-mails, and other online methods were also suggested as additional 
alternative methods for the dissemination of the current guideline. Currently, some health 
professionals can get access to computers and the internets at their work sites. Therefore, 
soft copies of the guidelines can be availed toHCWs as an additional alternative strategy. 
The guideline may be disseminated using e-mails and other online platforms. However, this 
method works only for those professionals who have access to the internet. Participants of 
the key informant interviews stated that introducing guidelines through passive 
dissemination methods such as official letters, publishing the guideline and distributing hard 
copies are not as effective as active methods such as MDT meetings,mentorship and team 
approaches to introduce and disseminate guidelines.  
In addition, it was reported that other activities and systems in the hospitals can act as 
dissemination avenues. Specifically, key informants suggested that the regular health 
education program that is being conducted in JUMC should be utilized as a platform to 
introduce the guideline.  






Table 14. Suggested dissemination strategies 
Subthemes  Categories  
Active dissemination  Short-term training  
Peer education 
Workshops  
Posters at service delivery points  
Mentorship  
Regular health education programs  
One-to-five networks 
Using opinion leaders and unit heads as gateways 
Multidisciplinary team meetings  
Media  
Passive dissemination  Distributing hard copies 
Publication  
Availing the guideline in libraries  
Availing the guideline through websites  
Introducing the guideline through official letters 
 
7.5.3. Training, supervision and mentoring 
Mentioning that stigmatizing practices are widely observed in the hospital, study participants 
recommended that training, mentoring and supervision should be conducted for the 
successful implementation of the guideline.  
“There are some professionals who stigmatize HIV and clients living with it. Some 
of them still do not attend delivery of a mother who is HIV positive. We can improve 
this by training them. There is a mentorship program. For instance, healthcare 
workers in the health center support health extension workers. Healthcare workers 
in Jimma University support healthcare workers in the surrounding hospitals and 
health centers. So, if they work together in collaboration in filling these knowledge 
and skills gaps, stigmareduction will be successful.” KI P6 
7.4.3.1. Current training system 
Key informants reported that currently, the Ministry of Health (MOH) of Ethiopia is 
cascading guidelines through the provision of training of trainers (TOT) to health 
professionals. The health professionals who have received the training of trainers will go to 
different places and provide the training for other health professionals. In addition, key 
informants mentioned that health managers are introduced to the guidelines through 
workshops.  
“The trend that is being used by the Ministry of Health so far is as follows. One 
option is providing training of trainers to health professionals. These professionals 
who received the training of trainers will go to different places and provide the 
training of other health professionals. In addition, a one or a two-day workshop is 




As elaborated by key informants, there are regular training programs provided by HIV 
Prevention and Control Office (HAPCO). These training programs include orientation of 
health professionals on new and updated guidelines. Similar arrangements for the current 
guideline can be made. Moreover, training programs can be coordinated though JUMC. 
7.4.3.2. Opportunities for training 
Currently, there are opportunities for the provision of training. These include, the availability 
of suitable training venues in the hospital, the commitment of the hospital administration, 
the presence of committed stakeholders interested to support works related to HIV and the 
presence of adequate and committed staff to provide the training. 
“From my experience, I remember the time when we implemented a nursing 
standard. The hospital administration recognized that the hospital should focus on 
quality of care and decided to implement the standard. The standard was prepared 
by a pool of experts from nursing, public health and medical disciplines. After that, 
we provided the training for around 400 staffs without any payment. This implies 
that if there is a devoted person and if there are patients in need of that service, the 
hospital is always open for that. It is not an easy thing to provide training for 400 
nurses within a short period of time, but it happened because of the commitment of 
the hospital, healthcare workers and committed trainers.” KI P1 
Participants also reported that the presence of motivated staff has influenced previous 
programs positively. Participants reported that the commitment of health professionals in 
JUMCcan be taken as a facilitating factor.  
“When we come to our health facility, especially those health professionals who 
work on HIV treatment and care, they have good motivation and commitment 
towards their job. This can be taken as one of the conducive factors in our hospital. 
There are many committed staffs. They accomplish their tasks appropriately; 
especially those health professionals working on HIV care and treatment programs 
have excellent commitment towards their job.” KI P5 
7.5.3.3. Suggested training strategy and training format 
Different options were suggested to cascade the training on the current guideline. One 
method was to train the heads of units so that they will disseminate it to their subordinates 
through different platforms such as mentorship and one-to-five networks. The other 




“The previous trend was to train department heads so that they will train their staffs. 
In addition, rigorous training may be provided for each staff based on need turn by 
turn. Therefore, few staff members can attend the initial training and provide it to 
the remaining staff.” KI P6 
Two options were suggested for the provision of training on the guideline. This is either to 
prepare a new training program or to integrate the training on the guideline into the current 
programs such as ART training programs. Further exploration indicated that the provision 
of a separate training program for the current guideline could potentially increase the 
attention given towards its implementation compared to integrating it with other training 
programs.Regarding the timing of the training, participants indicated that previous training 
programs are being conducted in shifts (rounds) and the same method should be utilized for 
the current guideline. Key informants proposed training both for those professionals who do 
not directly work with PLHIV and those who closely work with PLHIV.  
“I can mention two types of healthcare providers here. The first group is a group of 
those healthcare providers who directly work with HIV positive clients. It is possible 
to give them a short-term training. This is important because even if they are working 
on the area, they may not recognize their own stigmatizing actions and attitudes. The 
second group is a group of healthcare providers who are not directly involved in the 
direct provision of care and support for HIV positive clients. Still, they have a chance 
to provide the service for the clients in one way or the other. It is also essential to 
orient these professionals through short term training on the impact of stigma. In 
addition, it essential that other non-health professionals are also trained.” KI P1 
Some participants suggested that preparation of the training program in different formats for 
professionals providing care and support to PLHIV and for other health professionals is cost 
effective.However, all key informants agreed that the guideline and the training format for 
all disciplines of health, medical and allied health professionals should be uniform provided 
that there are no budget constrainints for such an arrangement. Participants additionally 
emphasized the importance of describing the roles of each professional during the training. 
Participants also stressed the importance of mixing professionals of different disciplines and 
professionals working in different units to facilitate experience sharing. Regarding whether 
there is a need to tailor the guideline to the educational level of health professionals, it was 
suggested that the educational status of health professionals cannot be an obstacle for the 




“Our health professionals are accredited and can provide minimum services such as 
counseling and testing. I do not think that the educational status of health 
professionals is an obstacle for the implementation of the guideline. Most of them 
can deliver minimum counseling and testing. Some of them have been exposed to 
different types of training related to HIV.” KI P5 
7.5.4. Implementation issues 
The major implementation issues raised were the importance of encouraging partnership, 
advocacy and teamwork, and clarifying the steps in the launch of the guideline, determining 
and clarifying the unit in which the guideline is implemented, and implementing the 
guideline in an innovative way in each unit. 
7.5.4.1. Encouraging internal and external partnership 
Partnership between stakeholders was identified as one of the centralaspectsin the 
implementation of the guideline. Study participants reported that partnership resulted in the 
success of other programs.JUMC, as an organization partnering with different stakeholders 
working on HIV, is a favorable environment for the implementation of the current guideline.  
The existence of different partners interested to work and working on HIV is an opportunity 
that facilitates the implementation of the guideline.  
Stakeholders working on HIV can play a crucial role. In addition, in JUMC and the 
surrounding environment, priority was given towards making partnership with different 
stakeholders. The current system encourages departments to form partnership and work 
together. All these factors can be taken as opportunities to implement the guideline. 
Partnership was also suggested as one of the strategies through which barriers such as 
resource constraints can be addressed. 
7.4.4.2. Strengthening teamwork 
Strengthening teamwork was mentioned as a facilitating factor for guideline 
implementation. Both barriers and facilitators for teamwork were also identified. The 
negative attitudes of some professionals and communication barriers were mentioned as 
major barriers towards teamwork.  
Key informants also reported that the communication issues between healthcare workers 
result in limited awareness of their roles and responsibilities which ultimately 
causesconflicts. And this will negatively affect teamwork.Encouraging effective 
communications and delineating the rights and responsibilities of different categories of 




“We must think of the barriers to this team communication. One of these barriers 
is failure to know one’s roles and responsibilities. If people do not know their 
rights and responsibilities, conflicts may arise. And this will negatively affect 
teamwork. The main thing is to identify the roles of individuals in a team. For 
instance, to identify the roles of physicians, nurses, pharmacy technicians and 
others.” KI P4 
Key informants also identified opportunities that encourage teamwork in JUMC. These 
were: the existence of teamwork guideline, one-to-five network, peer education, MDT 
meetings and a conducive environment for teamwork.InMDT meetings, health professionals 
share the challenges they face in their routine activities. In addition, there is a session at 
which professionals discuss cases and learn from one another. These opportunities may be 
utilized to increase teamwork and group learning among health professionals. In addition, 
key informants suggested that MDT meetings may be used to inform the health professionals 
about the importance of providing client-oriented respectful care.  
“The first thing is that we have one-to-five network. Secondly, we have MDT 
meetings. So, we can use these opportunities to increase teamwork and group 
learning among health professionals.In MDT meeting, for instance, they [health 
professionals] discuss on HIV. So, on these meetings we may emphasize the 
importance of providing client-oriented respectful care.” KI P5 
“The current system encourages teamwork. Healthcare is always a teamwork. We 
have a teamwork as a guidance by our institution [JUMC].” KI P2 
Study participants also emphasized the potential roles of unit heads and opinion leaders in 
building and maintaining team spirit and in strengthening the implementation of the 
guideline.  
“Unit heads and opinion leaders play substantial role in strengthening team 
spirit. These may not be necessarily those who are in managerial positions. 
People who are opinion leaders, who are respected by their colleagues and who 
have appealing personalities can act as role models. Several times the reason for 
problems in team spirit comes when heads of units and senior staff are not 




Moreover, key informants reported that currently, the teamwork of professionals who work 
in the HIV and Tuberculosis Clinic is strong. In addition, the regular activities by the 
teamwork were identified as potential factors to strengthen timely delivery of supplies.  
“Inventories of pharmacy and laboratory materials and kits are being done regularly 
by a team of HCWs who work in HIV and TB Clinic so that PLHIV do not face drug 
or material shortages. They also take actions before drugs run out of stocks. They do 
not want to put their clients at risk. Such a strong teamwork should be sustained.” 
KI P1 
Participants also reported that JUMC is a favorable environmentthat encourages both formal 
and informal ways of learning.  
“As you know our hospital is a teaching hospital. So, it is a nice environment to learn 
from each other and to work in teams. There are both formal and informal ways of 
learning from one another.” KI P5 
7.5.4.3. Clarifying the steps in the launch of the guideline 
Key informants recommendedidentifying a unit in which the implementation should start. 
With the consideration that stigma occurs everywhere in the hospital, participants 
recommended that the guideline should be implemented in each unit of the hospital. This is 
because clients living with the virus get services from different units of the hospital. 
Nevertheless, key informants suggested that the implementation of the guideline should start 
at the HIV and TB Clinic. 
“I suggest that if we start at our HIV and TB Clinic, it will be easier for us for 
implementation. Those professionals working in this clinic have better experience 
and knowledge. So, we can use them as role models to influence health professionals 
in other units.” KI P1 
The steps in the implementation presented in the guideline were also mentioned as 
facilitating factors for implementation.  
 “I think these steps are practical for our hospital. For instance, it indicates the 
importance of establishing a committee, assessing the institution and other essential 
steps. These steps and checklists included in the guideline are very essential. They 
indicate clear direction. In our healthcare facility, we have limited guidelines and 
checklists like this guideline. This has created confusion and lack of consistency in 
practice. But if we have a guideline with clear steps and checklists, whether people come 




7.5.4.4. Position holders and opinion leaders as role models  
Study participants reported that position holders such as unit heads and senior professionals 
may be used as role models for the implementation of the current guideline. 
“It is critical to use unit heads as gate keepers. Then, the unit heads can influence 
their subordinates through both enforcement and by acting as role models. Not only 
unit heads, other position holders, including the top management, can also act as 
role models and promote the implementation of the guideline” KI P6 
7.5.4.5. Advocacy  
Key informants reported that previous initiatives that tried to introduce new guidelines that 
have got support from stakeholders faced few challenges. Partners that try to implement 
activities that did not involve other stakeholders have failed. Therefore, collaboration with 
different stakeholders is critical. Participants also reported that advocacy helps to get 
attention of decision and policy makers at different levels including zonal, regional and 
federal levels. The dissemination of the guideline may also be enhanced through advocacy. 
Key informants also mentioned that the guideline itself is self-advocacy, because it is a 
priority area. Nevertheless, the importance of advocacy was emphasized as there is still 
limited awareness among some stakeholders, especially regarding current gaps.  
“The first factor may be the lack of awareness of different stakeholders from top to 
bottom. Therefore, all stakeholders need to be aware of stigma, we may need an 
advocacy. In this advocacy, we must indicate the existing gaps and convince 
managers. Simple provision of the guideline to healthcare workers, without the 
management support may not take us where we want to go.” KI P6 
Key informants also reported that advocacy is needed for making decisions in resource 
allocation. Alwaysresources are limited and there are activities that need priority. Therefore, 
if stigma and discriminationreduction is not a priority by the zone or the region, resources 
will be shifted to other problems that were given a priority.Specifically, key informants 
stressed the necessity ofconvincingstakeholders early so that they will includeSAD reduction 
in their annual plans. 
7.5.4.6. The need for implementation structure 
Study participants suggested that an implementation structure comprising an implementation 
committee and a focal person who can oversee the implementation is needed. As suggested 
by study participants, the implementation committee should link the HIV Prevention and 




responsibilities of everyone in the team should be defined. In addition, they suggested that 
each unit of the hospital should implement the guideline in an innovative way.  
“As I mentioned earlier, first we must build a structure for the guideline 
implementation. We need a focal person who can oversee the implementation. We 
should have an implementation committee. This committee should link HIV 
Prevention and Control Office to the hospital. And then, roles and responsibilities of 
everyone should be demarcated.” KI P3 
7.5.4.7. Posting reminders and posters  
The other method suggested by key informants for increasing adherence to the guideline was 
using posters for stigma mitigation in each room of the healthcare facilities and posting 
reminders in each of the rooms. One key informant mentioned an experience of using posters 
to remind healthcare workers to adhere to guidelines.  
“For example, as part of increasing adherence to HIV and nutrition guideline, we 
have used posts that indicate body mass index (BMI) levels cut off points. They 
identify the BMI levels as green, red and yellow. We can use the same strategy for 
stigmareduction guideline.” KI P5 
7.5.5. Monitoring and evaluation 
7.5.5.1. Current hospital performance evaluation system 
Key informants reported that there is routine and regular monitoring and evaluation in JUMC 
though it was reported to be weak. Study participants also identified problems related to the 
current monitoring and evaluation such as the lack of organized data and limited utilization 
of the data to improve practice. The frequency of evaluation of JUMC varies from activity 
to activity. Some activities are evaluated quarterly; some are evaluated monthly and some 
are evaluated annually. However, internal monitoring is done even daily. For instance, the 
quality office conducts an internal daily evaluation of the number of patients seen on the 
same day of hospital visit.Currently, each hospital in Ethiopia is being evaluated quarterly 
on areas such as CASH, EHRIG (Ethiopian Hospital Reform Implementation Guideline) 
standards and Maternal and Child Health (MCH) services. Key informants also reported that 
performances are indicated using colors.  
“Yesterday and the day before yesterday entire service evaluation of our hospital was 
conducted. There are checklists by which we evaluate our activities. These are indicated 
in different colors, such as green, amber, yellow and red. For those activities indicated 




highlighted in red, we will design strategy by which we fill the gaps. During this 
evaluation, feedback has been given to the institution as the whole, for each unit and to 
each individual health professional separately.” KI P5 
Key informants reported that there is a performance monitoring team in JUMC. This team 
oversees the appropriate delivery of services. Participants reported that, currently, the 
performance monitoring team is not as strong as expected because of the differences in the 
structures within their respective units.  
“In our hospital, performance monitoring team is weak. This team is composed of 
different professionals such as pharmacists, laboratory technologists, internists, 
gynecologists, and other types of clinicians. So far, they were not strong because of 
the differences in the structure within their respective units. This year, we hope that 
we will solve this problem.” KI P3 
7.5.5.2. HIV-specific monitoring and evaluation 
Study participants reported that HIV has relatively better organized monitoring and 
evaluation system compared to other areas. Different stakeholders are interested in HIV. Key 
informants reported that there are checklists by which both the health professionals and the 
facility are evaluated. They also reported that thereareMonitoring and Evaluation (M&E) 
focal persons andother staff responsible for these activities. Therefore, most of the services 
related to HIV are being reported as part of the Health Monitoring Information System 
(HMIS) data. 
“HIV has got huge attention from different stakeholders. Hence, data on HIV that 
are included in the mentoring check list are being collected. The number of patients 
on treatment, PMTCT and other related issues are being collected and reported. 
There is a format by which both the health professional and the facility are evaluated 
Recently, viral load has been included in the reports.” KI P4 
Nevertheless, participants admitted that the followup forguideline implementation is weak. 
The success of monitoring and evaluation of the implementation of the current guideline 
depends not only on the data collected but also on the availability of data for monitoring and 
evaluation. This will be possible only if the data related to stigma and 
discriminationreduction is linked to institutional HMIS data. Such data is handled by a focal 
person assigned for this specific purpose. 
“There is a focal person for this data. So, if someone comes from outside, he or she 




it is endorsed and we orient stakeholders about the guideline, we can include it in 
our auditing and monitoring system. But we must determine whether this data is 
collected quarterly, monthly or annually.” KI P2 
On the other hand, participants reported that there is a weakness both in data generation and 
utilization. Specially, they mentioned that the current HIV data is not being used for 
decision-making.  
“Last time, I had an opportunity to attend the presentation on HIV service-related report. 
My perception was that HIV data is complete. But, what I discovered from the 
presentation was that it is not being used for decision-making. The data is not well 
organized. There is no one who analyzes and presents the data for decision makers. 
There are also some areas that are not being recorded. So, there is weakness both in 
data generation and utilization. Maybe it has been diluted by HMIS.” KI P7 
Training, implementation, monitoring, evaluation, integration and sustainability related to 




Table 15. Training, implementation, monitoring and evaluation 
NB: ToT: Training of trainers, HCWs: Healthcare workers, PLHIV: People Living with HIV, MDT: multidisciplinary team, HIV: 
Human immunodeficieicny virus, M&E: Monitoring and Evaluation. 
 
7.5.6. Resource implications 
Key informants reported that financial resources are needed to conduct training on the 
guideline, to disseminate the guideline, to implement the guideline and to conduct 
monitoring and evaluation related to guideline implementation.As reported by the 
participants, the resource expenditure is mainly needed to conduct training.  
Broader themes Subthemes  Categories  
Training, mentorship 
and supervision 
Current training Workshops to create awareness among managers 
Cascading programs through ToT 
Opportunities for training  Suitable training venues in the hospital 
Committed stakeholders 
The presence of committed staff 
Suggested training strategy  Cascading through unit heads 
Cascading through ToT 
Suggested training format Integrate into existing training program 
Prepare a new training program 
Training approaches for HCWs based on their level of contact with 
PLHIV 
Mixing professionals of different disciplines  
Describing the roles of each professional 
Implementation Encouraging internal and 
external partnership  
Role of partners in success of guideline implementation 
Attention given to partnership 
Partnership aids to tackle barriers 
Strengthening teamwork Barriers to teamwork (the negative attitude of HCWs and 
communication barriers) 
Remedies to tackle barriers to teamwork (encouraging effective 
communication and delineating the rights and responsibilities of 
different categories of HCWs) 
Utilizing facilitators of teamwork (one-to-five network, peer 
education, MDT meetings) 
The role of unit heads and opinion leaders in building team spirit 
Clarifying steps in 
implementation  
Where to start  
How to start  
Using position holders and 
opinion leaders as role models 
Unit heads as potential role models  
Senior professionals as potential role models  
Opinion leaders as potential role models  
Advocacy  Advocacy for influencing resource allocation  
Advocacy as a means of dissemination  
The need for implementation 
structure  
The need for implementation committee 
Delineating the roles and responsibilities of implementation 
committee 
The need for implementation focal person  
Posting reminders and posters  
Monitoring and 
evaluation 
Current hospital performance 
evaluation system 
 
Frequency of evaluation  
Type of service being evaluated  
Responsible body for monitoring and evaluation 
Type of data being generated 
Problems related to monitoring and evaluation 
Limited data available in a usable format 
HIV-specific monitoring and 
evaluation 
Staff responsible for M&E 
Type of data being collected 
Availability of data 
Current responsible body for 
evaluation 
External evaluation 




“Yes, we need resources. First, from the start, we should disseminate the guideline. 
So, we need to print it.  When we think of printing it also includes, printing and 
posting of posters. The other issue that needs resource expenditure is related to 
training, such as refreshments and per diem. We also need resources to develop the 
training curriculum. The monitoring of the guideline implementation also requires 
resources.” KI P5 
“We need easy and user-friendly materials such as hand books for the guideline. 
This handbook is a short form of the same guideline. This may be a leaf let or another 
material that has information contained in the guideline. All these things require 
resource expenditure” KI P2 
Mentioning that health professionals are at different levels of understanding and 
competence, key informants stressed that there should be a training manual that is 
understandable to all types of health professionals.As part of dissemination, resources are 
needed to makethe guidelineavailable online or to avail the guideline and checklists in 
different formats and in different units. Resources are also needed to use media to advertise 
the guideline and to conduct dissemination workshops.Participants also stressed that the 
implementation process by itself requires resources.Though theyreported that there is no 
need for additional human resources, they emphasized the need for additional material 
resources.  
“We need audiovisual materials to promote the implementation of the guideline. This 
may include videos, leaf lets, brochures or posters. It is essential to use these 
materials. We need these materials for the entire hospital community. For instance, 
we may present life history of stigma victims and the impact of stigma on clients. “KI 
P2 
Key informants also stressed that materials for standard precautions should be supplied 
regularly. The shortages of supplies for personal protection equipments may impede the 
implementation of the guideline.  
“The thing is, if there is shortage of supplies such as gloves, the health professional 
should not perform invasive procedures for all patients not just for PLHIV. If there 
is a shortage of supply, the healthcare worker adhering to standard practice may 
refuse treating patients and he may be misinterpreted as being negligent. So, finally, 




guideline. This may lead HCWs to convey wrong messages and may lead him or her 
to use differential precautions, which is one component of discrimination.” KI P7 
Additionally, the commitment of the hospital to ensure continuous supply of materials for 
standard precautions was reported as one of the opportunities for successful implementation 
of the guideline. Although resources may be adequate, stock out of materials and supplies 
may be obstacles to the implementation of the guideline. 
In addition, key informants reported that the monitoring and evaluation of the 
implementation of the guideline needs resources in the form of per diem for mentors and 
supervisors. However, they also reported that this mentorship, monitoring and evaluation 
may be conducted along with existing programs and hence may not require additional 
resources. 
7.5.7. Integration of the current guideline into the hospital monitoring and evaluation 
system 
Participants reported that the current guideline is compatible with the existing system. They 
also emphasized that the guideline indicators should be integrated into the hospital indicators 
to assist towards the sustainable implementation of the guideline. As reported by key 
informants, currently, most hospital indicators are developed nationally. Key informants 
alsopointed out that it may be difficult to add additional indicators into the current list of 
indicators developed at national level. They recommended that until the guideline is scaled 
up nationwide, indicators related to the current stigma and discriminationreduction guideline 
can be integrated with institution-level ones.  
“The problem is that these indicators are developed nationally. We have around 197 
indicators currently. It may be difficult to add indicators for the current guideline 
into this list. On the other hand, we have also indicators at our own hospital level. 
So, until we scale up the guideline nationwide, we can include the indicators into 
institution-level indicators.” KI P3 
Participants identified preconditions for the integration of the guideline into the current 
monitoring and evaluation system. These preconditions are: deciding the responsible body 
that owns the evaluation program and indicating the responsibilities of different stakeholders 
and the frequency of evaluation.As reported by study participants, it is the responsibility of 
the quality office of the hospital to carry out internal evaluation.Participants also suggested 
that JUHAPCO should take the role as an external evaluator and the HIV and Tuberculosis 




HIV and TB Clinic should provide reports on activities done related to stigma and 
discrimination to the planning office of JUMC. As such, the guideline will be integrated into 
the hospital system.For such integration to be realized, participants suggested that the 
indicators of the current guideline should be included in institution-level indicators.   
“As an external evaluator, HAPCO may take the responsibility. And as a unit to 
provide routine reports related to the implementation of the guideline, I suggest that 
the HIV and TB Clinic should take the responsibility. So, they can provide similar 
reports on activities done related to stigma and discrimination. Then they will submit 
the report to the planning office. And then, the guideline will be integrated into the 
hospital system.” KI P2 
Key informants stressed that there should be mentoring and supervisory visits to monitor 
and evaluate the implementation of the guideline. They also reported that mentoring can be 
used as a platform for introducing, implementing and evaluating the guideline. Participants 
suggested that the person who conducts the supervion and evaluation should have adequate 
exposure and training. In addition, participants stressed that there should be an outside 
evaluator. Study participants also suggested that there should be a focal person from the HIV 
and Tuberculosis Clinic itself who oversees the work and who closely supervises them. It 
was emphasized that all supervisors need to be trained on the guideline. 
““Any professional can conduct the evaluation. But this person should be one who 
provides feedback and who has exposure and training on the guideline.  For instance, 
currently, professionals from the Nursing School are conducting supervision and 
mentoring for professionals in JUMC and other surrounding healthcare facilities. 
We can do the same thing for the evaluation and mentorship related to the current 
guideline.”KI P1 
“I also suggest that there should be a focal person from the ART unit itself that 
oversees the work. This is important because he /she closely supervises them. In 
addition, from the Nursing School, there should be close follow up, otherwise they 
[health workers] may overlook the work. All those involved in the supervisions and 
mentorship should first receive training on the guideline” KI P1 
Key informants further stressed that health professionals should have clear tools such as 
mentoring tools and evaluation checklists to guide them what to do and what to measure. In 
addition, the need for training manuals, training curriculum and visual aids, such as posters 




levels of understanding and competence, the manual should be understandable to all types 
of health professionals.  
7.5.7.1. Integrating the guideline into the mentorship system and supervisory visits  
Study participants also reported that currently there are focal persons that monitor the 
implementation of different activities using mentoring and evaluation tools.Mentioning that 
other guidelines were introduced through mentoring and supervisory visits, key informants 
emphasized that a responsible body for monitoring and evaluation should be determined in 
advance. 
“Other guidelines were introduced effectively through mentoring and supervisory 
visits. There should be a partner to monitor the implementation. That partner may 
be from the hospital itself or it may be an external supervisor. We must determine 
the responsible body first. For instance, Jimma University conducts mentoring 
program for this hospital.” KI P5 
Participants also suggested that the guideline indicators should be integrated into mentoring 
checklists, key performance indicators (KPI) of the hospital and ultimately into the HMIS 
of the hospital.Participants reported that there is a uniform reporting system enabled through 
indicators developed for reporting to regional state health bureau and the ministry of health. 
They also reported that JUMC can modify indicators developed for institutional level 
reporting. 
“Currently, the data being collected from this hospital includes areas such as key 
performance indicators (KPI). In HMIS, we have one plan, one budget and one 
report. The idea is that any report provided from and to any organ should be uniform. 
We have a report that we send to the regional health bureau and the Federal Ministry 
of Health. We cannot add or reduce indicators developed atregionaland national 
levels. However, we can add or remove these indicators at the hospital level. We are 
ready to integrate the indicators related to the current guideline into the indicators 
of the hospital.” KI P3 
In addition, two options were proposed regarding the integration of the guideline indicators. 
One option was to keep the indicators separately to seek attention and give more focus for 
it. The other option was to integrate them into ART service evaluation or HIV services 




7.5.7.2. Data generation for monitoring and evaluation 
Study participants reported that there is Site Improvement through Monitoring (SIM) system 
in JUMC.Site Improvement though Monitoring system is a system in which performance is 
evaluated and graded. The evaluators indicate the result of the performance evaluation in 
colors. These colors include red, yellow, amber and green.  
“In SIM [Site Improvement through Monitoring], performances are indicated in 
colors, such as red, yellow, amber and green. For example, our performance is 
usually green, but our waste management system is still red. This is because our 
hospital was previously old, and it is currently under construction. These evaluators 
may use guideline standards as indicators. They evaluate care and treatment, TB and 
HIV, laboratory and pharmacy and other services.” KI P5 
Study participants emphasized that data generation on guideline implementation should not 
be for the sake of simple external evaluation, but for service improvement. The data 
generated should be utilized by unit managers and service providers to improve 
performance.Nevertheless, they admitted that currently there are weaknesses related to the 
utilization of data for service improvement.  
“There are problems in making the data ready for service improvement. It needs 
further work. To tackle this problem, we have hired M&E focal person. Now, 
information and data management are one of our priority areas. The MOH has also 
given strong attention for this issue.” KI P1 
Key informants suggested that the management should make a request for data and should 
enforce the focal person to improve data handling process by the HMIS personnel. 
“Managers should enforce personnel working on HMIS so that they generate 
appropriate data for decision-making. If they need training, appropriate training 
must be provided to them. In addition, the management should request for the data. 
If there is no one in need of the data, the HMIS persons will not handle or report the 
data appropriately.” KI P7 
7.5.8. Scaling up and sustainability 
Key informants reported that currently, gaps exist in successful implementation and scaling 
up of guidelines.Describing the challenge associated with the provision of the training for 
all staff at the same time, they recommended that the training should be provided in rounds. 
They suggested that the guideline should be scaled up through the provision of training of 




“In JUMC, there are more than 1500 staffs. Therefore, it is difficult to provide this 
training and orientation to all these staff at the same time. The previous trend was to 
train department heads so that they will train their staffs. On the other hand, a 
rigorous training may be provided for each staff based on need turn by turn. For 
instance, in Clean and Safe Health facility (CASH) and Kaizen continuous quality 
improvement initiative, orientationswere provided for unit heads and then the unit 
heads provided the training for each staff turn by turn.” KI P5 
In addition, study participants recommended that the guideline should be implemented first 
in JUMC and scaled up to other healthcare facilities as an exemplar practice so that JUMC 
can share experiences to others. Key informants recommended that the university (Jimma 
University) should take the initiative to introduce the guideline as an exemplary new 
practice. Specifically, participants recommended that after piloting in JUMC and collecting 
data on all the challenges related to the implementation, the guideline can be scaled up 
nationwide incorporating any gaps and challenges. To aid the dissemination, a workshop 
should be prepared to introduce the guideline to stakeholders at regional and national levels. 
In addition, professional conferences such as Ethiopian Public Health Association (EPHA), 
Ethiopian Medical Association (EMA)and others can be used to disseminate the guideline 
to other places. This option is particularly an opportunity to catch the attention of different 
partners. Moreover, the university may arrange a workshop and introduce the guideline to 
different stakeholders. They also suggested asking different Non-Governmental 
Organizations (NGOs) to prepare a workshop and thereby support the implementation of the 
guideline.  
Moreover, key informants suggested that the guideline should be integrated into a pre-
service teaching curriculum for allied health, medical and health science students. The 
themes generated under resource implications, integration, scaling up and sustainability 





Table 16. Resource implementation, integration, sustainability and scale up 
NB: HMIS: Health Manangement Infromation Sytem, JUMC: Jimma University Medical Centre. 
7.6. Discussions 
In their theoretical framework for theoryinformed behavior change interventions to 
implement evidence, French et al.187 emphasize the need for the identification of barriers,and 
facilitators and specifically modifiable barriers and specific roles of stakeholders to address 
the barriers. In the current project, I identified barriers and facilitators tothe implementation 
of SADreduction guideline, and dissemination, training, implementation, monitoring and 
evaluation issues related to the guideline.  
7.6.1. Facilitators and barriers 
In line with previous studies,183there were factors that were identified both as barriers and 
facilitators for the implementation of the current guideline. Some scholars argue that using 
a theoretical framework will help to systematically identify and address factors that impede 
guideline implementation.186,187,229Davidet al.230categorized factors affecting 
implementation of innovations and guidelines into six domains, namely a) characteristics of 
the guideline, b) characteristics of the health professionals, c) the practice setting, d) 
Broader themes  Subthemes    Categories   
Resource implications Resources for training  Per diem for trainers and trainee 
Preparation of modules and manuals  
Printing posters, guidelines and handbooks 
Resources for dissemination  Printing the guideline 
Publishing  
Arranging media  
Resources for implementation   Facilities for standard precaution 
Resource for monitoring, supervising and mentoring  
Integration Data collection for monitoring and evaluation The need to create a culture of utilizing data to 
improve performance  
Site improvement though monitoring system (SIM) 
Tools and checklists   Mentoring checklists  
Monitoring and evaluation checklists  
Integrating the guideline with mentorship and 
supervisory visits  
Mentorship as dissemination strategy 
Mentorship to provide an onsite technical support 
during implementation 
Mentorship for the evaluation of adherence to the 
guideline. 
Integrating checklists related with stigma into 
mentoring checklists  
Suggested responsible body for supervision and 
evaluation  
Experienced professionals  
A professional who has been trained on the guideline 
The need for internal focal person for evaluation 
Need for an outside evaluator 
The need to enforce and train personnel working on 
HMIS 
Scaling up and 
sustainability 
Platform for sharing best practice 
implementation experience  
Professional conferences 
Workshop for policy makers 




incentives, e) regulations and f) patient-related factors.I will describe the six barriers and 
facilitators identified in the current project as follows: 
a) Characteristics of the guideline 
In the current research, I identified the following factors inherent to the guideline that 
potentially impact the uptake of the guideline prepared to reduce HIV-related stigma and 
discrimination: clarity, comprehensiveness, compatibility with existing practice, initiatives 
and system, all of which were facilitating factors in the context of the study area. Previous 
research has indicated that the lack of trialability, the lack of compatibility, the lack of 
observability and complexity of innovations and guidelines may deter the implementation 
of guidelines.230,231On the other hand, for the current guideline, trialability was identified as 
a facilitating factor if training is provided for healthcare workers. In addition, the existence 
of up-to-date recommendations in the guideline was identified as one of the good qualities 
of the current guideline facilitating its uptake. 
The potential positive impact of a guidelineon the clinical process facilitates the uptake of 
theguideline.12,183 On the other hand, the lack of expectation of the desirable outcomes of 
adherence to a guideline may hinder the implementation of the guideline.12, 225For the current 
guideline, key informants indicated that the reduction of stigma and discrimination 
contributes not only to the success of HIV-related goals, but also other initiatives, such as 
service quality, CASH and CRC initiatives.  
b) Attributes of health professionals  
The awareness and motivation of HCWsfacilitates the uptake of a guideline.12, 183 In line 
with this, the motivation of the staff in the facility (JUMC)was raised as a facilitator for the 
implementation of the current guideline. The motivation of health professionals, especially 
those working in the HIV and TuberculosisClinic, was identified as a facilitating factor for 
the dissemination and implementation of the current guideline. 
On the other hand, key informants reported that provider-related factors such as provider 
attitudes and awareness of the guideline negatively impact the implementability of the 
guideline. Unrealistic expectations or limited awareness of the guideline among healthcare 
workers potentially hinder the uptake of the current guideline. In agreement with this, 
previous research indicated that the lack of awareness of the existence of the guideline and 
limited familiarity of the content of the guidelines or disagreement with the 
recommendations may negatively affect the implementation of guidelines.183As a remedy 




bedisseminated through existing opportunities and platforms such as MDT meetings, one-
to-five networks, and existing training and mentorship programs.  
Evidence should be tailored to local context.4,67In the current guideline, I tried to build the 
sense of ownership among local stakeholders and tailor the guideline to local context. In line 
with this, previous researchers indicated that guidelines developed by end-users or by 
consensus methods increased clinicians’ ownership of the guideline and were associated 
with increased compliance.232 In addition, the involvement of health professionals from local 
institutions in designing implementation and dissemination strategies facilitates the uptake 
of a guideline.232 
c) The practice setting 
In this project, I identified factors in the policy and practice environment (practice settings) 
that affect the implementation of the guideline. The implementation of a guideline depends 
on the ability of multiple stakeholders to plan and execute the various steps needed to 
implement the guideline.9Global evidence indicates that the lack of management support 
hampers guideline implementability.12, 225For the current guideline, as reported by key 
informants, the management of Jimma University and the JUMCis committed to support and 
facilitate the implementation of the guideline as it contributes to priority goals of the hospital.  
In addition, the existence of training programs and venues and committed stakeholders were 
identified as facilitators. In line with this, previous stigma and discriminationreduction 
guidelines emphasized the necessity of convincing stakeholders during the implementation 
of SADreduction programs.130 
Organizational factors such as resource limitations may hamper the implementation of 
guidelines.8 For the current stigma and discriminationreduction guideline, the continuous 
supply of materials for standard precaution consumes resources. The current study revealed 
that the hospital is committed to providing these materials continuously. In addition, in the 
long run, stigma and discriminationreduction will also contribute to the reduction of extra-
precaution which will in turn reduce unnecessary wastage of resources.  
Work overload is one of the factors that commonly impedesadherence to guidelines.12, 225 
The same concern was raised in the current project. On the other hand, stigmareduction, as 
study participants raised, in the long run can contribute to the reduction of unnecessary work 
load that result from clients overloading facilities in large towns and cities. Such patient load 




surroundings to hide their sero-status from the residents of their locality, this is specifically 
caused because of higher levels of SAD. 
d) Incentives  
Limited structural support such as financial disincentives may negatively affect the 
implementation of a guideline.12, 225Among the provider-related factors potentially expected 
to hinder the implementation of the current guideline identified were unrealistic expectations 
of incentives during training and implementation of the guideline. On the other hand, the 
management of the university and the hospital is committed to support and facilitate the 
implementation of the guideline as it contributes to priority goals of the hospital. In addition, 
HCWsworking on HIV are relatively more compensated when compared to other healthcare 
workers.  
e) Regulations  
The regulation of guideline implementation by accreditation or licensing bodies facilitates 
the implementation of a guideline.230 Currently, there arementoring, monitoring and 
evaluation systems in the Ethiopian context that are relatively stronger in HIV-related 
practices. The fact that stigma is a human rights issue was raised as a facilitator for the 
implementation of the current guideline.41The current study also indicated, as one of the 
guidelines addressing ethical and governance issues, there is an opportunity for better uptake 
of the current guideline. Therefore, it is possible to integrate stigma and 
discriminationreduction guideline into the regulation, monitoring and evaluation systems of 
healthcare facilities. Moreover, key informants reported that the guideline is can potentially 
be utilized as a teaching material for allied health, medical and health science students, in 
which case it will also be incorporated as part of the professional accreditation system. 
f) Patient-related factors 
The presence of empowered and educated patients that ask for the right information and 
demand for standard practice facilitates the uptake of a guideline.230 The existence of expert 
HIV positive clients was presented as one facilitating condition for the empowerment of 
other patients. In addition, the guideline informs the rights and responsibilities of clients 
empowering them with adequate information.  
Similar to what has been elaborated above, according to the framework suggested by 
RNAO,117 the expected barriers and facilitators for the implementation of best practice 
guidelines can generally be categorized into: evidence (guideline) related factors, target 




the guideline is to be implemented and resources needed for the implementation.117 Most of 
these components overlap with the framework suggested by David et al,230but regulation and 
incentive components were not emphasized by RNAO.117As described above, the factors 
identified as barriers and facilitators can be conceptualized using the conceptual framework 
developed by Dave et al.230 and RNAO.117 
7.6.2. Dissemination 
When implementing new guidelines or improving adherence to guidelines, one of the 
practical challenges is bringing about changes in health professional behavior. Drawing on 
the diffusion of innovation theory, trans-theoretical model of behavior changes, health 
education theory, social influence theory, and social ecology, and evidence from systematic 
literature reviews on the effectiveness of behavior change strategies, Moulding et al.233 
developed a dissemination and implementation framework for guidelines. Their framework 
underscored that there is a need to assess the readiness of practitioners for the 
implementation of guidelines, of barriers to change and the levels at which the interventions 
should be targeted.The current project sought the readiness and commitment of relevant 
stakeholders, including health professionals to implement the newly developed guideline.  
In their review reported in 2013, McCormack et al.234 found that multi-component 
dissemination strategies are more effective at improving guideline adherence compared to 
single dissemination strategies. However, there is no sufficient evidence to recommend one 
method over the other. Though different dissemination mechanisms have been used by 
policy makers and guideline developers, preferable methods depend on local 
circumstances.234 
In the current project, though different alternatives were suggested, no specific combinations 
were suggested for dissemination. However, study participants categorized the 
dissemination strategies into active and passive methods.Orientation workshops, training, 
one-to-five networks, MDT meetings of health professionals workingon care and support of 
PLHIV and mentorship programs were suggested as preferable and active mechanisms of 
dissemination. 
On the other hand, distribution of hard copies, publishing and availing the guideline in 
libraries and websites were identified as passive mechanisms of dissemination, but as 
potential strategies to substantiate other mechanisms.In agreement with these findings, 
Grimshaw et al.235 reported that there is moderate quality of evidence indicating that the 




In agreement with our findings, Prior et al.232reported that multifaceted interventions, 
interactive education and clinical reminder systems are effective guideline implementation 
strategies. On the other hand, they reported that passive education and information 
dissemination methods such as conferences, websites and didactic lectures were not effective 
in guideline implementation. Additionally, other researchers have identified factors that 
enhance the implementation of guidelines such as reviewing, reporting and publishing 
guidelines.94 In the current study, key informants recommended that distribution of guideline 
both in hard copies and soft copies can be taken as alternative strategies for dissemination.  
The dissemination mechanisms that are effective in one setting may not work in other 
settings.Although health professionals in the current study context have access to computers, 
not all of them do. In addition, Internet availability is limited.Therefore, preference of active 
dissemination strategies over passive ones is logical.  
7.6.3. Implementation 
Apart from dissemination, guideline development organizations utilize different 
mechanisms to promote intervention of guidelines.These include: online reminders, 
educational outreach, interactive educational techniques and multifaceted interventions.179In 
the current study, the suggested mechanisms for effective implementation were provision of 
short-term training and workshops, using posters at service delivery points, using expert 
patients and integrating the guideline into mentorship and MDT programs. 
In the current project, posting reminders was suggested as a mechanism for increasing the 
adherence to the guideline. In agreement with this, Grimshaw et al. found a moderate quality 
of evidence indicating that reminders lead to improvement in patient care.235 
Participatory educational interventions increase the uptake of guidelines by end users.233  
Similarly, in the current project, key informants reported the uptake of the guideline can be 
potentially improved through training and mentorship programs.Practice facilitation is 
among the mechanisms for enhancing the implementation of practice guidelines. 
Doughertyet al. define outreach or practice facilitation as “…a multifaceted approach that 
involves skilled individuals who enable others, through a range of intervention components 
and approaches, to address the challenges in implementing evidence-based care guidelines 
within the primary care.”236(pp.63)Baskerville et al.237 found that primary care facilitators were 
more likely to adopt evidence-based guidelines through practice facilitation.In line with this 
evidence, key informants of the current project suggested mentorship as a mechanism for 




field of HIV, mentorship programs have been successful in facilitating the dissemination of 
new and evidence-based practices.238 
Determining leaders is critical for the implementation of a guideline.179 The current study 
also found determining the implementation structure and afocal person as critical points for 
effective guideline implementation.The accuracy, and timeliness of organizational and inter-
organizational information systems affect the implementation of a guideline.9In the current 
project, key informants suggested that guideline indicatorsshould be integrated into the 
monitoring and evaluation system of the hospital (JUMC). In addition, key informants 
identified delineating roles and responsibilities and strengthening teamwork among the 
necessary factors for the implementation of the guideline.As suggested by the key 
informants of the current project, partnership within and outside the organization can also 
be utilized to tackle barriers during the implementation of the current guideline.  
The current MDT meetings of expertsand one-to-five networks of health professionals were 
suggested as a platform for dissemination, implementation and evaluation of the current 
guideline. In line with this, Grimshaw et al. reported that there is low-quality evidence 
indicating that educational meetings improve patient care. 235 
The existence of expert HIV patients in JUMCwas suggested as a potential platform to 
enhance adherence to the current guideline. Similarly, Grimshaw et al.235 found moderate 
quality evidence  supporting patient-mediated interventions to improve professional 
performance. 
The integration of a guideline into routine records increases the uptake of, or the adoption 
of the guideline.233In the current project, we found that continuous monitoring, evaluation 
and mentorship programs are critical in the integration of the guideline into the system of 
the hospital. Key informants recommended that checklists and monitoring and evaluation 
tools should be integrated into mentorship, Health Management Information Systems 
(HMIS) and Key Performance Indicators (KPI) of the hospital. In line with these findings, 
Grimshaw et al.235 found a moderate quality of evidence indicating that audit and feedback 
improves patient care. 
7.7. Conclusion 
For the current guideline, I sought experts’ perceptions both on the facilitators and barriers 
to the implementation of the current guideline on the reduction of stigma and discrimination 
related to HIV. Therefore, it is critical to consider all potential barriers, facilitators and 




project identified factors related to the nature of the guideline, the policy and practice 
environment, the health professionals and the commitment of stakeholders that potentially 
impact the uptake of the guideline.Policy makers should disseminate the guideline through 
existing opportunities such as MDT meetings, one-to-five networks, and training and 
workshops. Multidisciplinary team meetings, mentorship programs, and one-to-five 
networks can be used both as a mechanism of dissemination and implementation for the 
current guideline. Teamwork and partnership with stakeholders in and outside the hospital 
should be strengthened to tackle barriers related to the implementation of the guideline. In 
addition, it is essential to establish an implementation structure comprising an  
implementation committee and implementation focal person. 
The current guideline indicators should be integrated into mentorship, MDT meetings and 
evaluation programs of the hospital. Facility managers and unit heads should make sure that 
the data collected for monitoring and evaluation is being utilized to improve performance. 
Moreover, as the guideline is being implemented in JUMC, data on implementation 







REDUCING HIV-RELATED STIGMA AND DISCRIMINATION IN 
HEALTHCARE SETTINGS: AGUIDELINE TO INFORM POLICY AND 
PRACTICE 
Unit one: Introduction 
8.1.1. Overview 
This guideline was prepared to aid stigma and discriminationreduction activities in Ethiopian 
healthcare settings. The document is presented in four units. Unit one introduces the 
significance of developing the current guideline, by describing the background, context, 
nature of stigma and discrimination, how stigma affects clients and health professionals, and 
purpose and scope of the guideline. Unit two describes the process through which the 
guideline recommendations were developed. Unit three presents the guideline 
recommendations. Unit four describes implementation, monitoring and evaluation issues 
related to the guideline. 
8.1.2. Background 
Infection  by the human Immunodeficiency virus (HIV) often results in stigma and fear for 
those living with the infection, as well as those caring for them, and may affect the entire 
family.239, 240Stigma attached to HIV often results in loss of socio-economic status, 
employment, income, housing, health care and mobility.240, 241As a result of their health 
service utilization, people living with HIV (PLHIV) may face discrimination, rejection and 
insults.239Therefore, stigma related to HIV negatively impacts adherence to, and uptake of 
services.45, 52, 68, 239, 242 If not addressed, stigma contributes to continued transmission of the 
virus. 
8.1.3. Context of the guideline 
There is a global commitment to end the epidemics of the universal precautions, HIV/AIDS 
human immunodeficiency virus and acquired immunodeficiencysyndrome (HIV/AIDS) by 
the year 2030.39However, this commitment cannot be realized without curbing stigma and 
discrimination (SAD) related to HIV and AIDS.41For centuries, SAD have resulted in lower 
uptake of preventive services, testing and counseling services, delayed seeking or avoidance 
of care, treatment and support services.129To this end, the World Health Organization 
(WHO) and the Joint United Nations Program on HIV/AIDS (UNAIDS) have set a ‘zero 




In Ethiopia, like in many other countries, SAD have deterred HIV prevention and control 
activities.217, 218Stigma related to HIV has been documented among the community,219, 220 
key population groups,221 and health care providers.57, 124 Stigma acts as a barrier to linkage 
to, and retention in care.222Research has also indicated that stigma deteriorates the social and 
living conditions of PLHIV.53The government of Ethiopia is committed to achieving 
universal health coverage for all its citizens and zero discrimination to healthcare in 
healthcare facilities. Among the efforts in improving access to quality healthcare services, 
few are setting the national healthcare quality strategy and Compassionate, Respectful, and 
Caring (CRC) initiatives.244 
In addition, Ethiopia has a law that protects PLHIV against stigma and discrimination.245The 
Federal ministry of Health (FMOH), the Federal HIV Prevention and Control Office 
(FHAPCO) and other partners working on HIV have put stigma and discriminationreduction 
among their priority target areas.218Previous Ethiopian-based research hasindicated that the 
absence of, or the lack of awareness of policies, guidelines and protocols that protect PLHIV 
from SADis associated with higher levels of SAD among HCWs and hence researchers have 
recommended the development of policies, guidelines and protocols that protect PLHIV 
from SAD.57, 124, 125However, there is no guideline developed based on research evidence to 
help to reduce SAD in healthcare settings. This guideline document, therefore, aims to fill 
this gap. 
8.1.4. Stigmarelated to HIV in healthcare settings 
HIV-related stigma is defined as ‘prejudice, discounting, discrediting and discrimination 
directed at people perceived to have HIV or AIDS and individuals, groups and communities 
with which they are associated’.16(pp.1107)Stigma related to HIV can be disaggregated into 
domains such as drivers, facilitators, manifestations, and intersectional stigma.2 
Drivers or individual-level factors that are associated with stigma and discrimination are lack 
of awareness of SAD, how they manifest and their consequences, prejudicial and 
stereotypical attitudes related to gender identity, sexual activity and fear of HIV transmission 
stemming from limited knowledge.2The fear of HIV infection among healthcare workers is 
related to incomplete knowledge on the modes of transmission, limited availability of 
materials for standard precaution or over-estimation of the risk of acquiring the virus through 
occupational exposure.24Socially-driven stigma results from the values held by people 
linking PLHIV as participating in socially stigmatizedbehaviours such as promiscuity. 




Facilitators are institutional or societal factors that affect the occurrence of stigma and 
discrimination. Institutional factors that contribute to stigma and discrimination include 
shortage of supplies and lack of training programs and lack of appropriate policies, standards 
and regress system to address stigma and discrimination.2 
Manifestations are the immediate consequences of stigma such as discrimination or expected 
stigma. In healthcare facilities, stigma related to HIV is manifested as: 
• Denial of care58, 125, 172 
• Provision of substandard care125, 172 
• Making a health service conditional (e.g. registering as an  antiretroviral (ART) 
customer in the facility,57 bringing along the sexual partner57, 172 
• Premature discharge172 
• Poor follow-up125 
• HIV testing without consent172 
• Breaches of confidentiality (e.g. disclosure without consent and marking files)57, 125, 
154, 172 
• Using excessive protective barriers to prevent infection57, 125, 172 
• Compulsory or forced treatment172 
• Segregation of clients or marking the files of clients who are HIV positive13 
• Unnecessarily referring the client to other institutions172 
• Stigmatizing words (gossip and labelling) and actions57, 172 and blaming those 
infected by HIV.58 
Layered or intersecting stigma is a double stigma faced as a result of HIV status, gender, 
profession, poverty or sexual orientation.2 
8.1.5. Impact of stigma and discrimination in healthcare settings 
Stigma and discrimination affect clients living with the virus in different ways. Those who 
are stigmatized, or fear being stigmatized may behave as follows:  
• Fear taking an HIV test and delay getting tested until they are desperately ill, well 
beyond the optimal stage for ART.7, 54 
• Avoid going to healthcare facilities for HIV and other health-related services 7 
• Avoid going to a healthcare facility for delivery or drop out of a prevention of 
mother-to-child transmission (MTCT) program for fear of disrespectful care from healthcare 




• Do not disclose important information to healthcare facility staff for a proper 
diagnosis or course of treatment53 
• The complication related to not being treated has an impact of increased transmission 
of the disease that negatively affects the country’s development at large.7, 54 
• Travel outside of their communities to access antiretroviral therapy (ART) in secret 
or hide their use of ART and, thus, take inconsistent doses of the medication.246 
• Avoid disclosing their sero-status to sexual partners or avoid insisting on safer sex7 
• May not access information and services needed to help them prevent getting HIV.7 
In addition, HCWsdelay, deny or avoid care, or provide substandard care for 
PLHIV.125Stigma and discrimination also affects HCWs. Healthcare facility staff living with 
HIV may also face gossip or exclusion by other healthcare facility staff, discrimination at 
work if there are no policies in place to protect their rights, and hostility from clients. They 
often hide their HIV status, avoid discussing their situation with others, and suffer in silence. 
Because of the fear of being stigmatized, or even losing their jobs, healthcare facility staff 
may avoid testing for HIV and access treatment either late or not at all. They may become 
seriously ill or die, causing further strain on an overburdened healthcare system. In addition, 
healthcare providers may even avoid getting tested or getting post exposure prophylaxis after 
sudden occupational exposure because of the fear of stigma and discrimination. Moreover, 
in some circumstances, healthcare workers face secondary stigma simply as a result of their 
association with PLHIV.161, 162 
8.1.6. The purpose of the current guideline 
The purpose of this guideline is to help HIV prevention and control office coordinators, 
health professionals, counselors (social and psychological aspect) and health managers 
(including facility administrators) to plan SADreduction interventions.The implementation 
of the guideline may contribute to the following goals:   
1. To reduce stigmatizing attitudes and actions of HCWs towards PLHIV, their 
families, care givers and key population groups. 
2. To reduce stigmatizing policies and procedures towards people living or affected by 
HIV in healthcare facilities. 





The fulfillment of the above objectives will, in the long run, help to ensure that all people 
living with, and affected by the virus have access to comprehensive care and support 
services. It may also contribute to the promotion of the psychological wellbeing of people 
affected by HIV. In addition, it may enhance the capacity of HCWs to act as role models in 
reducing SAD. 
8.1.7. Scope of the guideline 
Target audience of the guideline 
This guideline includes evidence-informed recommendations to reduce SAD related to HIV 
among HCWs, PLHIV and their families. It includes the summary and grading of the 
evidence and discussion of implementation issues.The guideline is mainly intended for 
facility administrators and other personnel who play a role in ensuring that policies, 
procedures and available supplies to promote a safe workplace for staff, and the delivery of 
highquality services. This guideline may be utilized by HIV prevention and control offices, 
hospitals, health centers and other governmental and non-governmental organizations. 
The guideline is intended for health professionals from different disciplines including, 
Nurses, Medical Doctors, Laboratory Technicians, Medical Anthropologists, Medical 
Sociologists, Psychologists and Psychiatrists, Health Promotion experts, Midwives, 
Pharmacists, Health Extension Workers and community volunteers. Professionals and non-
professionals other than those in health disciplines working in healthcare facilities or 
working on psycho social aspects of HIV can also utilize the guideline recommendations. In 
addition, social support groups /home-based care volunteers may utilize the guideline. 
Furthermore, patient advocates, faith-based organizations and non-governmental 
organizations (NGOs) involved in providing supportto facilitate healthcare services for 
PLHIV may use the guideline.Others interested to respond to stigma and discrimination 
within healthcare settings may also find the recommendations and tools in this guideline 
useful. Alhough the guideline was mainly developed to improve services delivered to 
PLHIV in healthcare settings, it may also be utilized for teaching purposes.  
What are the contents of the guideline? 
The guideline addresses interventions to reduce HIV-related SAD among HCWs. It contains 
draft recommendations and information about implementing the guideline. This guideline 
does not replace, but complements and supports HIV-related guidelines that already exist. 
This guideline may complement HIV disclosure guidelines, greater involvement of people 




health and rights of women living with HIV, guidelines on intimate partner violence, ART 
guidelines, Voluntary Counseling and Testing (VCT) guidelines, Provider Initiated 
Counseling and Testing (PIHCT) guidelines, guidelines for improving entry into and 
retention in care for PLHIV, prevention of mother to child transmission (PMTCT) guidelines 
andInfection Prevention and Patient Safety (IPPS)guidelines. 
Areas not covered in this guideline 
1. Interventions related to law enforcement in the community. 
2. Treatment of mental illnesses among PLHIV. 
3. Drug therapy of any minor or major psychological or psychiatric disorders. 
Unit two: Process of developing the guideline 
8.2.1. Summary of the guideline development process: 
Activities involved in the guideline development are summarized as follows. 
1. Establishment of the guideline panel and declaration of conflicts of interest. The 
members of the panel and the summarized declaration of conflict of interest is 
appended (Appendices 16 and 17). 
2. A systematic literature search that identified interventions to reduce SAD towards 
PLHIV by HCWs. The result of the review clearly indicated that current guidelines 
and systematic reviews were less informative and contained limited information on 
the quality of the recommendations and conclusions. Therefore, a decision was made 
to re-trace the linked primary research evidence. Details of the search strategy and 
search results are shown in Appendices 1 and 2. In addition, an additional systematic 
review of quantitative evidence was conducted. Search strategies and search results 
of the systematic review of quantitative evidence are shown inAppendices 6 and 7.  
3. A guideline panel meeting was convened to determine research questions. On July 
17, 2016, a guideline panel convened a meeting and discussed the results of the initial 
search and determined research questions and scope of the guideline. The research 
questions considered during the development of the guideline are indicated in section 
8.2.2 of this chapter. 
4. An iterative activity including data extraction, appraisal of linked evidence and 
drafting tentative recommendations was carried out. The recommendations in this 
guideline were mainly derived from six guidelines and best practice documents and 
six systematic reviews2, 133, 134, 140, 163(including the systematic review reported in 




documents were published by the Department for International Development 
(DFID),247Physicians for Human Rights (PHR),128United States Aid for International 
Development (USAID)6, 7 and Tanzanian Commission of AIDS (TCA).130A detailed 
content analysis of the documents and linked primary research evidence was carried 
out.Using the GRADE profile software package,86 summaries of findings tables were 
generated along with the quality of evidence (Appendix 28). 
5. Recommendations were drafted with the considerations for the nature of the 
interventions, target audience and quality of evidence. The strengths of 
recommendations were included in the recommendations through considerations of 
the balances between the potential costs and the benefits of the interventions. In 
addition to consideration of locally visible policy and practice and consultation of 
local experts, patient values and preferences reported in previous local 125 and 
international studies135, 137 were considered.For practice areas where providing a 
GRADE of evidence was not practical, good practice points were provided.180 
6. Internal evaluation of the guideline was conducted using tworounds of the Delphi 
survey.106 During this evaluation, the tentative lists of recommendations were tested 
for feasibility and appropriateness to the Ethiopian context. Followingtwo rounds of 
the Delphi survey, the panel convened its second meeting to discuss the comments 
from the first and second round and modifications made based on the comments. In 
the meeting, the panel discussed the feasibility of tailoring some recommendations 
to the local context. 
7. External evaluation and key informant interviews to further identify and describe the 
barriers and facilitators to implement the guideline were conducted. Experts were 
invited to comment on the guideline. Based on the result of the external evaluation 
and key informant interviews, the guideline was revised.  
8. Revision of the guideline and write-up of the final draft were undertaken. 
8.2.2. Key issues and questions considered 
While drafting this guideline, we considered the following research questions. 
Which interventions are effective in reducing SAD among HCWs directed towards PLHIV, 
people affected by the virus and people associated with the virus? To address this research 
question, the following inclusion criteria were considered: 
a. Population: Healthcare workers including health professionals and administrative staff 




b. Intervention: Interventions designed to reduce SAD in the healthcare facilities. These 
included training, workshops, and institutional policies and infrastructures. 
c. Comparators: Usual care or no interventions and alternative interventions. 
d. Outcomes: Fear-based stigma, value-based stigma (shame, blame) and discrimination 
(isolation, labeling, gossiping and use of extra precautions). 
e. Settings  
Organizational level: Interventions conducted at the level of healthcare facilities. 
Individual level: Interventions targeting HCWs. 
The guideline panel considered the content, duration, intensity, mode of delivery and the 
provider of the interventions.  
Unit three: Recommendations 
 The recommendations in this guideline are presented under four themes: 
A. Structural interventions  
B. Information-based and skillsbuilding approaches  
C. Contact and empowerment approaches 
D. Recommendations for research 
A. Structural interventions 
This theme encompasses interventions related to organizational programs and policies. 
1. Organizational policy revision and development  
Stigma and discrimination related to HIV are fueled by organizational factors termed as 
facilitators. Among common facilitators of stigma are the absence of policies and guidelines 
that support PLHIV or the presence of discriminatory policies in healthcare facilities that 
affects the rights of PLHIV.2 This indicates that healthcare facility practices, standards, 
policies and guidelines should be examined and revised with the consideration of the rights 
of PLHIV.7Healthcare facility managers should create a safe environment both for their 
workers and for their clients. Creating a safe environment includes ensuring that the 
following activities are undertaken. 
1. Healthcare facilities should have institutional anti-stigma and discrimination policies. 
It is recommended that facility administrators develop SADreduction policies with their 
employees so that they have the ownership of the policies. This is an effective way to 
support the desired behavior change.155 
2. Having standard operating procedures (SOPs) and redress-and-reward systems to ensure 




3. Making the facility accessible and safe for all patients, providing private spaces for 
patient consultations, examinations, and counselling.132 
4. Ensuring appropriate infrastructure and supplies are in place to protect staff, as 
necessary. Healthcare facilities should ensure the availability of sufficient stocks of 
necessary materials such as drugs, gloves, syringes, needle disposal bins, and hand 
washing stations to enable HCWs to provide quality care and practice effective infection 
prevention and control.132 
5. Providing appropriate training on universal precautions, HIV/AIDS, SAD and 
addressing the three actionable drivers of SAD.7 
6. Using appropriate words to identify HIV and PLHIV.Therefore, programs and 
institutions should use non-stereotypical images and concepts of PLHIV. There should 
be a system to review all the written or visual communication materials and approaches 
with a stigma lens.7 
To realize the above practices in healthcare facilities, there should be supportive policy and 
guideline. 
Recommendation1: Healthcare institutions or programs should review and/or develop 
institutional policies and practices with their employees.7, 154, 155 [Very low quality, strong 
evidence] 
Facility managers can utilize internationally tested tools, such as “PLHIV-friendly” 
checklist6, 7, 155, 247 (Appendix 27) to review facility-specific information related to SAD. 
This helps facility administrators to identify gaps in institutional policies and guidelines.6The 
details of the measurements and indicators are provided in the monitoring and evaluation 
section (section 8.4 of this chapter). 
2. Dissemination of policies and procedures related to stigma and discrimination 
Ethiopian studies have indicated that health professionals describe the absence or the lack of 
awareness of policies and guidelines that protect PLHIV in healthcare facilities and the 
absence of, or the lack of guidelines and protocols are associated with higher levels of SAD 
among HCWs.57, 124This underscores the necessity of increasing awareness of, and 
dissemination of the existing policies, procedures, and guidelines. 
Recommendation 2: Information about and/or enforcement of policies and procedures 
that protect PLHIV should be disseminated to HCWs and their clients 133, 138, 154, 155, 




Such information may be provided through training, workshops and the distribution of hard 
copy documents for each health professional and at each service delivery point. In addition, 
simplified patient versions of the policies and procedures should be provided to clients. 
3. Putting in place a mechanism to address complaints 
Recommendation 3: Healthcare facilities should put in place standard operating 
procedures (SOP’s) and a code of conduct related to stigma in healthcare institutions. 
Healthcare institutions should create a system of lodging and dealing with complaints in 
healthcare facilities.6, 7, 154, 155[Very low quality, strong evidence] 
The rights of patients, mentioned in guideline for the management of Ethiopian federal 
hospitals, should be executed.249 Healthcare workers must comply with the legal norms and 
standards enshrined in human rights instruments and the national law245 and HIV AIDS 
policy.250 Healthcare workers should use non-stereotypical terms and concepts of PLHIV. 
There should be a system to review all communication materials and approaches with a 
stigma lens.7Where healthcare providers fail to comply with rules and standard operating 
procedures, the facility managers should act in accordance with the rules and procedures 
provided by the healthcare facility and possibly the law. In order to ensure that health 
services are being provided in accordance with the law, standards and the rights of clients, 
there should be a standard procedure that creates a system of lodging of grievances by 
patients.7The development of code of a conduct will facilitate such an accountability among 
healthcare workers.6, 154 Therefore, healthcare workers should be provided with an 
opportunity to develop a code of conduct as indicated in the implementation section of this 
guideline document (section 8.4). 
4. Involvement of PLHIV in developing standards 
The development of standard operating procedures is expected to reduce SAD. These 
standards and procedures should not be biased and should include the perspectives of 
PLHIV. Clients living with HIV should be involved in the procedure to note bias in SOPs 
and unintentional negative attitudes of HCWs to reduce institutional SAD.248 
Good practice point 1: There should be a partnership between HCWs and HIV infected 
patients during developing SOPs.  
5. Adequate supplies and infrastructures must be available in healthcare 
institutions: 
Healthcareworkers should practice standard precautions at all times regardless of the sero-




to PLHIV, and the utilization of PLHIV-specific extra precautions have been raised as a 
concern by PLHIV in previous qualitative research.125, 137 There is a negative correlation 
between avoidance intent and adherence to universal precautions.146The shortage of 
materials for standard precaution encourages differential use of these scarce supplies 
specifically for PLHIV.132 Therefore, having the proper tools to care for patients regardless 
of their disease status decreases HCWs’ fear of contracting the disease and being stigmatized 
for being associated with PLHIV.2, 7, 132, 155, 247 Appropriate and timely follow up is critical 
so that these supplies and stocks do not run not.  
Recommendation 4: Healthcare facilities must provide adequate stocks of gloves, drugs, 
syringes, needle disposal bins, and hand washing stations that enable HCWs to provide 
quality care and practice universal precautions. [Low quality, strong evidence]  
6. Accountability for confidentiality, informed consent and non-discrimination 
In previous researches, PLHIV raised concerns about breaches of confidentiality, denial of 
care and the provision of substandard care by HCWs.125 Patients should not be denied of 
care or be provided substandard care based on their disease status. Clients should not be 
tested for HIV without their knowledge or after refusal of the test. Patient’s sero-status 
should not be disclosed to the third body without the knowledge and consent of the patient. 
Segregating patients within the healthcare facility and using distinguishing marks such as 
writing “HIV+” on patient’s chart should be prohibited.132, 155 
Good practice point 2: Procedures and policies in healthcare facilities should ensure the 
rights of patients to confidentiality, informed consent and non-discrimination.155 
All clients should have access to treatment, regardless of their sero-status.155 Ensuring 
accountability for the rights of patients to confidentiality, informed consent and non-
discrimination involves establishing institutional reporting mechanisms that allow clients to 
report and seek redress if SAD occur (i.ewhen HCWs intentionally or unintentionally 
discriminate clients). In addition, HCWs should be transparent, open to scrutiny, and 
accountable to the clients they serve, for example, by providing information to them on the 
details of the procedures being performed.7In addition, healthcare facilities should support 
PLHIV and key affected populations to secure and claim their rights and support from the 
healthcare facility administration. 
How:  
The rights of clients to confidentiality, informed consent and non-discrimination should be 




▪ Developing effective systems of lodging and dealing with complaints. 
▪ Providing adequate information to clients on their rights. 
▪ Building capacities related to knowledge of rights, gender, documenting violations and 
presenting and defending complaints through training. 
▪ Advocating for policy change (especially around human rights, compulsory testing and 
breaches of confidentiality). 
▪ Provision of training or orientations to healthcare staff on issues of confidentiality, 
informed consent, and sensitivity toward PLHIV and key affected populations to ensure 
that mechanisms to redress human rights violations will be non-stigmatizing and non-
discriminatory so that they do not discriminate and breachthe confidentiality of clients.7 
Good practice point 3: Policies and programmes to reduce stigma and discrimination must 
be directed at all HCWs.132, 155, 247 
Healthcare workers from each department, regardless of whether they have close contact 
with clients living with HIV should be educated and trained to have accurate knowledge of 
HIV, patient’s rights, and how to approach clients. This is because the HIV and Tuberculosis 
Clinic is not expected to provide comprehensive care, such as delivery services, surgical 
services, ophthalmic and dental care and other services for PLHIV.155, 247 Therefore, clients 
living with HIV access theseservices from other units of the hospital. In order to avoid or 
reduce stigma and discrimination in all units and provide non-discriminatory services to 
PLHIV in all units of the hospital, SADreduction activities should target all HCWs.132 
Structural interventions 
1. Healthcare institutions should review and/or develop institutional policies 
and practices with employees. [Very lowquality, strong evidence] 
2. Information about and/or enforcement of policies and procedures that 
protect PLHIV should be disseminated to HCWs and their clients [Very 
lowquality, strong evidence] 
3. Healthcare facilities should put in place SOP and code of conduct related to 
SAD in the healthcare institutions. [Very lowquality, strong evidence] 
4. There should be a partnership between HCWs and PLHIV in developing 
SOPs. [Ungraded] 
5. Healthcare facilities must provide adequate materials for standard 




6. Procedures and policies in healthcare facilities should ensure the rights of 
patients to confidentiality, informed consent and non-discrimination. 
[Ungraded] 
7. Policies and programmes to reduce SAD must be directed at all HCWs. 
[Ungraded] 
B. Information and skillsbuilding approaches 
1. Participatory educational programs that encourage 
dialogue  
The lack of knowledge of what contributes to SAD and prejudicial attitudes towards PLHIV 
are major drivers of SAD.58 There is a need to provide participatory programs that affect 
both the cognitive and affective domains of HCWs’ attitudes.137 Participatory training 
programs create an opportunity to reflect on sensitive and taboo topics and can contribute to 
the reduction of prejudices.7, 137Such open discussions help in the identification of SAD 
through the encouragement of discussions of the values and personal feelings of the HCWs.7, 
130, 152Healthcare providers should be provided with adequate time and space to reflecton 
their values, prejudices and attitudes.130 
Recommendation 5: Multifaceted educational programs that encourage discussion of 
values and personal feelings about PLHIV should be provided to HCWs to improve their 
attitudes towards PLHIV. [Very low-quality, strong evidence] 
For instance, a Chinese study used a multifaceted educational program comprisingdidactic 
lectureson HIV epidemiology, natural history, transmission routes and clinical care, 
combined with activities that encourage discussion of participants’ values and personal 
feelings about HIV. The intervention was effective in improving empathy and general 
attitudes towards PLHIV, and  reducing avoidance attitude among HCWs.152 
2. Combination of participatory educational programs 
with contact strategies  
Recommendation 6: Stigmareduction interventions for HCWs should include a 
combination of participatory approaches that encourage discussions, intersection and 
critical thinking and contact strategies to reduce value-based stigma.7, 154[Very low-quality, 
strong evidence] 
Healthcare workers should be provided with adequate training on standard precautions, HIV, 
SAD so that the actionable drivers of SAD canbe addressed. Participatory educations of 




discussions preferably facilitated or co-facilitated by PLHIV.2, 154, 155, 251Such an intervention 
may be arranged in a modular form and should be complemented by contact strategy 
(interaction with PLHIV).156 For instance, an Egyptian study used an interactive training and 
discussion that focused on HIV-related stigma, infection control and medical ethics using 
five modules. The intervention was complemented by interaction with PLHIV. The study 
reported a significantly lower levels value-based stigma and fear-based stigma among 
HCWs assigned to the intervention when compared to that ofHCWs in control healthcare 
facilities.156 
3. Combination of participatory education with 
supportive work environment 
The practice of standard precaution will only be realized if there is an enabling environment 
(adequate supplies, and adequate knowledge and skills of HCWs).154, 155Appropriate 
education combined with an infrastructure for standard precaution reduces irrational fear of 
acquiring infection through casual contact.154, 155 For instance, in Vietnam and in India, 
training, participatory hospital policy development and provision of material supplies used 
in combination, was found to be effective in reducing fear-based stigma and extraprecautions 
when handling PLHIV in healthcare facilities.2, 13, 155 
Recommendation 7: Healthcare institutions and stigmareduction programs should 
provide the necessary skills (training) and supportive work environments in healthcare 
facilities.7, 155[Very low-quality, strong evidence]  
The training program should encompass topics such as care provision for PLHIV, SAD 
related to HIV and human rights. The training should be complemented with supplies for 
standard precautions to prevent transmission of infection. This will enable HCWs to provide 
services or conduct their work in a non-stigmatizing and non-discriminatory manner. 
How: 
This can be achieved through involving all staff in stigmareduction exercises, and in training 
and policy development to create a stigma-free environment at all levels. Healthcare facility 
managers should ensure that the healthcare environment encourages respect for patients’ 
rights among both HCWs and patients. In addition, structural barriers should be addressed. 
All the necessary supplies including hand washing facilities, gloves and other materials 
should be continuously supplied. Therefore, along with the provision of participatory 
educational interventions, health care facilities need to ensure that their staff are provided 




4. Peer education of HCWs 
Recommendation 8: Professionallyassisted peergroup education of HCWs should be 
undertaken to reduce client contact stigma in healthcare facilities.2, 160, 253 [Very lowquality, 
strong evidence] 
Professionallyassisted peer education programs should be conducted as a mechanism for 
stigmareduction in healthcare facilities. Peer education sessions should address topics such 
as HIV transmission, the importance of counseling and education of families, patients’ 
dignity, confidentiality and standard precaution. The peer education sessions should be 
conducted in small groups of 10 to 12 HCWs using participatory activities such as role-
play.160 
For example, an eight-sessions peer education intervention was conducted among HCWs in 
Chile. The sessions covered a) the importance of community HIV prevention, b) standard 
precautions, c) HIV testing d) providing care that respects dignity and confidentiality, e) 
human sexuality, transmission of sexually transmitted infections (STIs); (f) partner 
communication and HIV prevention; (g) counselling about HIV infection; and (h) teaching 
HIV prevention to clients and families. The sessions encompassed participatory learning 
activities such as role-play. The intervention resulted in a significant decrement in client 
contact stigma among HCWs.160 
5. Identifying and training popular opinion leaders 
Recommendation 9: Stigmareduction programs should identify and train popular opinion 
leaders2, 254 [Moderate-quality, strong evidence] 
Programs working to reduce prejudicial attitude and avoidance intent among HCWs should 
identify and train popular opinion leaders. The popular opinion leaders should be trained 
standard precaution and occupational safety and SAD using participatory learning activities 
such as group discussion, games, and roleplays.2, 254 Such an intervention will facilitate the 
transfer of knowledge and skills among HCWs. 
How: 
Opinion leaders need to be strengthened to lead a stigmareduction, beginning with support 
to increase their own understanding of SAD and the benefits of reducing SAD, to improve 
knowledge and overcome irrational fear of HIV transmission, and to deal with their own 
socially driven stigma toward PLHIV. Once equipped with knowledge and understanding, 
opinion leaders are more likely to welcome partnerships with PLHIV to tackle SAD and to 




identified and trained so that they can influence others by becoming role models. Efforts to 
address these objectives can be accomplished in the following two ways.7 
a) Technically supporting the opinion leaders to become role models in their practice 
towards the reduction of SAD. 
b) Supporting the opinion leaders in the process of planning to reduce SAD. 
For instance, a stigmareduction program in Chinese healthcare facilities identified and 
trained popular opinion leaders on compliance to universal precaution procedures and 
ensuring occupational safety, (2) reducing stigma and improving the provider-patient 
relationship, (3) making efforts to care for patients, and (4) overcoming difficulties and 
building up a better healthcare facility environment. The popular opinion leaders were 
engaged in informal communications with their co-workers. The popular opinion leaders 
had a three-sessions re-union activity where they revised their informal communication 
activities, problem-solving skills, group solidarity and skillsbuilding activities through 
interactive games. The study reported a significantly higher reductions in prejudicial 
attitudes and avoidance intent among hospitals assigned to intervention groups when 
compared to that of control hospitals.254 
Information-based approaches 
1. Multifaceted educational programs that encourage discussions of values and 
personal feelings about PLHIV should be provided to HCWs to improve 
their attitudes towards PLHIV. [Very lowquality, strong evidence] 
2. Stigmareduction interventions for HCWs should include a combination of 
participatory approaches that encourage discussions, intersection and 
critical thinking and contact strategy to reduce value-based stigma. [Very 
lowquality, strong evidence] 
3. Healthcare institutions should provide the necessary skills (training) and 
supportive work environments in healthcare facilities. [Very lowquality, 
strong evidence] 
4. Professionally assisted peergroup education of HCWs should be used to 
reduce client contact stigma in healthcare facilities. [Very low-quality, 
strong evidence] 
5. Stigmareduction programs should identify and train popular opinion 




C. Empowerment of PLHIV and contact strategies 
Healthcare facilities and stigmareduction programs can empower PLHIV through involving 
them in planning stigmareduction activities and through the provision of training on the 
reduction of SAD. Clients living with HIV should be provided comprehensive information 
about their rights and the available treatment options. Clients living with HIV should be 
provided comprehensive services and when necessary they should be linked to existing 
community services outside healthcare facilities.132Healthcare facilities should empower 
PLHIV through the following methods: 
1. Active and full involvement of PLHIV: Ensuring that mechanisms exist to support the 
full, active, meaningful participation of PLHIV and key affected populations in all 
phases. The process for their involvement should address barriers that could affect 
participation such as attitudes, methods, resources, logistics and language barriers. The 
Greater involvement of People Living with or affected by HIV/AIDS (GIPA) principle 
is one example of how this can be done. 255, 256 
2. Informing patients of their rights: Patients may not be aware of their health-
relatedrights, or what to do if their rights have been violated. Healthcare workers should 
ensure that information on the rights and complaint processes are prominently located in 
the healthcare facilities in which they work, that they themselves can talk to patients 
about their rights, and participate and lead in community efforts to educate people about 
their rights. 
3. Providing comprehensive information: For patients to be empowered to make 
healthcare decisions, HCWs should providethem with comprehensive information about 
their health and available treatment options in a manner that is easily understood and 
empathetic.132 
1. Empowerment through active and full involvement of PLHIV 
Active involvement of PLHIV can be used as a contact strategy to reduce HIV-related SAD. 
Contact strategies are among effective mechanisms to reduce HIV-related SAD.257 Specific 
approaches that have been used as contact strategies include: 
1. Using PLHIV and key population members in SADreduction programs, as 
workshop facilitators or as patient advocates.7 
2. Bringing HCWs and PLHIV or key population groups to work together.158 





4. Strengthening existing networks and supporting development of new ones, where 
appropriate. 
a) Empowering PLHIV through involving them in training 
and workshops 
Recommendation 10: A testimony of PLHIV or PLHIV advocates should be combined 
with participatory educational interventions for HCWs to reduce both value-based and 
fear-based stigma among HCWs. [Very lowquality, strong evidence]  
Participatory educational programs combined with the testimony of HIV positive clients 
act as contact strategies in reducing SAD towards PLHIV. Previous projects utilizing the 
combination of participatory education and testimony of PLHIV have improved the attitudes 
of HCWs towards keeping the sero-status of clients confidential and to respect the patient’s 
right to HIV testing and to correctly practice universal precautions in China, India and 
Vietnam.2, 133, 154, 155, 251 
b) Contact strategy and empowerment through involvement 
in joint planning with HCWs 
Recommendation 11: People Living with HIV need to be actively involved in developing 
and implementing SAD reduction efforts by empowering them with adequate 
information.2, 158, 248 [Very low-quality, strong evidence] 
Negative self-perceptions and perceived workplace stigma prevents PLHIV from seeking 
and adhering to treatments at healthcare facilities. Negative self-perceptions and internalized 
stigma among PLHIV are also associated with higher rates of depression.259 
Programs that combined contact strategy (bringing HCWs and PLHIV together) and 
comprehensive information provision for PLHIV have been effective in reducing the 
perception of stigma among clients living with HIV and its negative impact. For instance, a 
multi-country program reduced perceived stigma and negative self-perception, and 
improved self-esteem among PLHIV through a joint workshop of PLHIV and HCWs that 
enabled sharing information, and contact between PLHIV and healthcare 
workers.158Therefore, programs intended to reduce SAD should use a combination of contact 
strategy (bringing HCWs and PLHIV together) and information provision to reduce stigma 
and improve self-perception and self-esteem among PLHIV.2, 158 
Expert patients can potentially mobilize other clients towards stigmareduction and 
healthcare utilization.130 Currently expert patients work in Ethiopian healthcare facilities as 




planning with HCWs to address PLHIV-related concerns.10 These expert patients can also 
be members of different committees in the hospital to address the voices of PLHIV during 
the development of policies and programs. 
c) People living with HIV as service providers 
Recommendation 12: People living with HIV should be provided training to act as 
service providers and peer mentors for other PLHIV. [Moderate quality, strong 
evidence] 
People living with HIV should be provided training to act as service providers and peer 
mentors for other PLHIV to encourage them to seek and adhere to treatment.258 Currently, 
they are working as adherence supporters, case managers and expert patients.10 
Training PLHIV to provide psycho social interventions was effective in reducing 
internalized stigma and avoidance coping. For instance, in India, women living with HIV 
were trained to become accredited social health activists (ASHA) for assisting PLHIV to 
cope with difficulties and challenges they face in seeking healthcare services. The training 
sessions delivered to ASHAs included:a) HIV and dealing with the illness; b) learning about 
ART and ways to overcome barriers; c) parenting and maintaining a healthy home 
environment; d) how to improve coping, reduce stigma and care for family members; e) 
basics of good nutrition and easy cooking tips; and f) benefits of engagement in a life skills 
class. The ASHA intervention reduced internalized stigma and avoidance coping.140, 260 
d) Strengthening existing networks and supporting 
development of new ones where appropriate. 
Networks provide a critical support system and strengthen PLHIV to challenge SAD as it 
happens, and supports them in demanding the right to live free of SAD. Networks also offer 
the organizational structure for empowerment and capacity strengthening, addressing self-
stigma, building self-worth, and nurturing resiliency. Therefore, strengthening self-support 
groups such as women support groups and PLHIV support groups is very essential.7 
Empowering PLHIV to identify problems, implement and evaluate actions taken to address 
these problems is critical.132 For instance, an empowerment program in which Thai women 
living with HIV met together and worked with facilitators to identify their needs, design 
action plans, implement and evaluate their actions was effective in improving their coping 
ability and quality of life.140, 261, 262Although healthcare facilities may not have the capacity 




training and linking them to other external organizations that provide social support for 
PLHIV. 
Empowerment of PLHIV and contact strategies 
1. A testimony of PLHIV or PLHIV advocates should be combined with 
participatory educational interventions for HCWs to reduce both value-
based and fear-based stigma among HCWs [Very lowquality, strong 
evidence] 
2. PLHIV should be actively involved in developing and implementing 
SADreduction efforts by empowering them with adequate information. 
[Very lowquality, strong evidence] 
3. PLHIV should be provided training to act as service providers and peer 
mentors for other PLHIV. [Moderate quality, strong evidence] 
All of the above recommendations are conceptualized and described using a framework 








Figure 6. Framework for addressing stigma and discrimination in healthcare facilities 
(adapted from Jain, 20123) 
D. Recommendations for further research 
The current evidence of effectiveness of stigma-reduction interventions is limited in quality. 




should use validated scales of measurement for stigma to determine the effectiveness of the 
interventions.Future researche should also compare one type of intervention with another 
type of interventions.  
Unit four: Implementation, monitoring and evaluation 
This section describes how the guideline should be put into practice and how stigma and 
discrimination reduction activities should be evaluated and monitored. 
8.4.1. Putting this guideline into practice 
The recommended interventions may be arranged in healthcare institutions and 
organizations working on HIV prevention and control and care and support for PLHIV. The 
recommendations may be organized and planned at healthcare facility, district, zonal, and 
regional coordination offices and national coordination offices. There are resources that 
facilitate the implementation of this guideline.These resources have been tested in different 
countries and found to be effective. These include: tool kits and training manuals,24, 263and 
tools for assessment, monitoring and evaluation.6, 264The following implementation tools 
may be utilized to implement SADreduction programs. 
Tool 1: Checklist for a stigma-free facility environment and policies264(Appendix 27) 
Tool 2: Checklist for discrimination-free healthcare facilities (for posting on service delivery 
points) adopted fromUNAIDS/WHOagenda for discrimination-free healthcare facilities243 
(Appendix 28). 
Tool 3: Checkpoint for service providers (Appendix 29): This tool was developed by the 
current guideline developers with the considerations of the manifestations of stigma to alert 
HCWs and let them examine the appropriateness of their practices.  
Tool kits: There are training guides for stigma-free facilities for different types of audiences 
with different options. These tools are found in the stigma package of the Health Policy 
Program (HPP).6 
The following steps are suggested for promoting a stigma-free healthcare facilities.6,154 The 
steps were adapted from the Health Policy Program (HPP).6 
1. Set up or identify stigma action group 
2. Assess the healthcare facility for the levels of SAD 
3. Review current policies and practices  
4. Get ideas from the community and local organizations  
5. Develop and launch a code of conduct  




7. Monitor progress  
1. Set up or identify a stigma action group 
An implementation structure comprising an implementation committee and an 
implementation focal person should be established. Senior managers, opinion leaders, unit 
heads, clinical staff, nonclinical staff, and service users should be involved in the 
implementation committee. The group will be responsible for developing and implementing 
stigma-related activities in the healthcare facility and monitoring the progress. Unit heads, 
clinical mentors, senior staffs and opinion leaders may be used as role models for 
stigmareduction activities.  
2. Assess the healthcare facility 
Assess the levels of SAD within the healthcare facility using healthcare workers’ 
questionnaire to get the most complete and up-to-dated information about knowledge, 
attitudes, and practices in the healthcare facility.6The implementers and organizers of 
stigmareduction or the stigmareduction action group should use the checklist for a stigma-
free facility environment and policies to get adequate and up-to-date information about the 
extent to which the healthcare facility supports and delivers stigma-free services (Appendix 
27).6 The results of this assessment should be shared with staff. 
3. Review current policies and practices 
In meetings or other regular activities, adequate time should be allocated to discuss policies 
and practices related to HIV-related SAD. Each department or unit could develop its own 
ideas on new policies or guidelines to counteract SAD. Regular multidisciplinary team 
(MDT) meetings of HCWs working on care and support services should also raise SAD as 
part of their meeting agenda. In addition, discussion of stigma and client’s rights should be 
included in one-to-five networks of HCWs. 
4. Get ideas from the community and local organizations 
The ideas of the community and local organizations, including associations of PLHIV, 
NGOs working on care and support of PLHIV should also be gathered. These stakeholders 
should be encouraged to contribute their perspectives on SAD. Meetings with these 
stakeholders should be held to discuss the efforts to create a stigma-free healthcare facility. 
In addition, partnership with relevant stakeholders should be strengthened to get their 
support for stigmareduction programs.  




A code of conduct should be developed in a participatory manner with healthcare facility 
staff. The code of conduct or practice is a set of agreed principles and behaviors in areas 
such as patient confidentiality, patient rights and respect, and quality of care. Clients 
(specifically expert patients) should also be involved in the development of the code of 
conduct or should provide feedback on the code of conduct.The staff’s, client’s and 
community’s awareness of the code of conduct should be increased through meetings and 
by posting the code of conduct at service delivery points. Once launched, the code of conduct 
should be peer-influenced and displayed in service areas and staff rooms, and  be promoted 
to let staff members know what it means for their work.6 
6. Mainstream stigma-free norms and practices 
An action plan should be developed to implement the code of conduct and any other SAD 
reduction activities needed for a stigma-free healthcare facility. In developing the action 
plan, it is imperative to emphasize the sustainability of the stigmareduction activities. 
Therefore, SAD reduction should be included in regular MDT meetings, and in mentorship 
programs related to HIV care and support services.6 Stigmareduction programs can be 
complemented and can complement initiatives such as CRC initiatives, clean and safe health 
facility (CASH) and Citizen’s Charter. In addition, one-to-five networks in the healthcare 
facility may be used to disseminate and monitor the implementation of stigmareduction 
activities. 
7. Monitor progress 
The code of conduct should be assessed, reviewed regularly and modified if necessary. 
Success stories and challenges should be documented.6 The monitoring and evaluation may 
be integrated into the hospital performance monitoring and evaluation and into MDT 
meetings and mentorship programs.Healthcare facility policies, regulations and practice and 
HCW behaviors for change should be monitored and assessed the using indicators shown in 
section 4.2. 
8.4.2. Monitoring and Evaluation 
The effects of SADreduction efforts should be monitored and evaluated both at individual 
healthcare provider level and at organizational level. The HCW survey questionnaire may 
be utilized to monitor changes at individual healthcare provider level. This tool is found in 
the stigmareduction package of HPP.6 There is a manual showing how to utilize this 
questionnaire.18 This questionnaire has been field-tested in many countries. Additionally, 




Furthermore, facility-based policy indicators can be used to monitor and evaluate the 
institution’s stigmareduction efforts. These indicators have been extracted from SAD 
indicator registries.265Details of how to use each indicator are provided as follows: 
Indicators 
Indicator 1: Healthcarefacility staff: Institutional policies  
The first indicator (ID:1079) measures the percentage of healthcare facility staff who report 
that their facility has written guidelines to protect PLHIV from discrimination.It measures 
the awareness of healthcare facility staff about written guidelines in their facility to protect 
PLHIV from discrimination. 
Numerator: Number of healthcare facility staff who reportyes 
Denominator: Number of all healthcare facility staff who answer the statement 
Calculation: Numerator/ denominator 
This indicator is constructed from the response to the following question: 
My healthcare facility has written guidelines to protect PLHIV from discrimination (yes, no, 
don’t know). 
Indicator 2: Healthcare facility staff: Enforcement of institutional policies   
This indicator (ID:1080) measures the percentage of healthcare facility staff who report that 
they will get into trouble at work if they discriminate against PLHIV.It measures whether 
healthcare facility staff perceives that there are negative consequences for staff that 
discriminate against PLHIV in their healthcare setting. 
Numerator: Number of healthcare facility staff who report yes 
Denominator: All healthcare facility staff who answer the statement 
Calculation: Numerator / denominator 
This indicator is constructed from the response to the following question: 
I will get into trouble at work if I discriminate against PLHIV (yes, no, don’t know). 
Indicator 3: Healthcare facility staff: Fear of HIV infection  
This indicator (ID:1081) measures the percentage of healthcare facility staff who worry 
about getting HIV when providing care or services to PLHIV. Itmeasures HIV infection 
worry among healthcare facility staff when performing certain work-related activities – both 





Numerator:  Number of healthcare facility staff who report worry to any of the three 
statements. 
Denominator:  Number of all healthcare facility staff who answer at least one of the three 
statements. If a respondent responds non-applicable or was missing to all three statements, 
they should be excluded from the denominator.  
Calculation: Numerator / denominator 
This indicator is constructed from the responses to the following set of prompted questions: 
How worried would you be of getting HIV if you did the following? Would you be 1. very 
worried, 2. worried, 3. a little worried, 4. not worried? (If any of the following is not one of 
your job responsibilities, please select “Not applicable”). 
1. Touched the clothing of a patient living with HIV 
2. Dressed the wounds of a patient living with HIV 
3. Drew blood from a patient living with HIV 
Indicator 4: Healthcarefacility staff: Attitudes and opinions  
Percent of healthcare facility staff that hold stigmatizing views about PLHIV. This indicator 
(ID:1082) measures value-driven stigma (stereotyping and prejudices) that healthcare 
facility staff have towards PLHIV. 
Numerator: Number of healthcare facility staff who agree with any of the first three 
statements or disagree with the fourth statement. 
Denominator: Number of all healthcare facility staff who answer at least one statement 
Calculation: Numerator / denominator 
This indicator is constructed from the responses to the following set of prompted questions: 
Do you strongly agree, agree, disagree or strongly disagree with the following statements? 
1. Most people living with HIV do not care if they infect other people. 
2. People get infected with HIV because they engage in irresponsible behaviors. 
3. People living with HIV should feel ashamed of themselves. 
4. Women living with HIV should be allowed to have babies if they wish. 
Indicator 5: Healthcare facility staff: Observed enacted stigma  
Percent of healthcare facility staff who have observed unjust treatment of PLHIV in their 
facility.This indicator (ID:1083) measures healthcare facility staff’s observation of enacted 




Numerator:Among healthcare facility who report observing a patient living in their facility 
within the past 12 months, number of healthcare facility staff who reported ‘yes’to either 
question. 
Denominator:Number of all healthcare facility staff who report observing a patient living 
in their facility within the past 12 months. 
Calculation: Numerator / denominator 
This indicator is constructed from the responses to the following set of prompted questions: 
In the past 12 months, have you observed the following actovities in your healthcare facility? 
1. Healthcare workers unwilling to care for a patient living with or thought to be living with 
HIV 
2. Healthcare workers providing poorer quality of care to a patient living with or thought to 
be living with HIV. 
Indicator 6: Healthcare facility staff: Unnecessary precautions and measures 
Percent of healthcare facility staff who use unnecessary precautions when providing care or 
services to a patient living with HIV.This indicator (ID:1084) measures healthcare facility 
staffs’ use of unnecessary precautions or measures when providing care or services to a 
patient living with HIV. It measures personally enacted stigma. 
Numerator: Number of healthcare facility staff who report ‘yes’to eitherquestion 
Denominator: Number of all healthcare facility staff who respond to at least one of the two 
statements 
Calculation: Numerator / Denominator 
This indicator is constructed from the responses to the following set of prompted questions: 
Do you typically use any of the following measures when providing care or services for a 
patient living with HIV? 
1. Avoid physical contact 
2. Wear double gloves 
Indicator 7: Healthcare facility staff needs and support 
Percent of healthcare facility staff who report an unsupportive working environment to 
protect staff from work related HIV exposure.From the perspective of healthcare facility 
staff, the indicator (ID:1085) measures institutional drivers of HIV-relatedSAD. It measures 
if healthcare facility staff perceives that there are adequate supplies (e.g. gloves), and 




Numerator: Number of healthcare facility staff interviewed who disagree with at least one 
statement 
Denominator:Number of all healthcare facility staff who answer at least one statement 
Calculation: Numerator / denominator 
Items: 
Do you strongly agree, agree, disagree or strongly disagree with the following statements? 
1. There are adequate supplies in my facility that reduce my risk of becoming infected with 
HIV. 
2. There are standardized procedures/protocols in my healthcare facility that reduce my risk 
ofbecoming infected with HIV. 
All the above indicators are facility-level policy indicators. The assessment for these 
indicators may be conducted through facility–based surveys of healthcare facility staff such 
as service provision assessments and quality assurance assessments. All the above indicators 











DISCUSSION, CONCLUSION AND RECOMMENDATIONS 
9.1. Chapter overview 
This chapter presents the discussionrelated to the overall PhD project. It also highlights 
challenges that I encountered, actions I took and justifications for the alternative resolutions. 
The chapter finally draws conclusions and recommendations from the process involved and 
the results of the project.  
9.2. Discussion 
The translation of research evidence into practice requires the appraisal of available research 
and generation of evidence-based recommendations that are often presented in the form of 
guidelines.266 These guidelines should be systematically developed and adapted to the local 
context.266 
The overall aim of the current project was to develop an evidence-informed guideline to 
reduce HIV-related SAD in the Ethiopian healthcare settings. The guideline development 
process included the consideration of both globally available research evidence and 
contextual factors. I attempted to get an understanding of the recommended mechanisms for 
the implementation of the guideline from the perspective of stakeholders. The stakeholders 
gave invaluable information from their past experiences in implementing guidelines, their 
day-to-day experiences and the considerations of the current local policy environment.  
The rigor of the body of evidence from which recommendations were adapted and/or 
extracted,was appraised. We used the Appraisal of Guideline Research and Evaluation 
(AGREE) checklist115to assess the methodological quality of previous guidelines, and the 
JBI critical appraisal checklist to appraise the methodological quality of systematic reviews. 
Alhough, the project initially aimed to adapt and/or extract recommendations from existing 
guidelines and systematic reviews, this was not practical because of the limited transparency 
in the existing documents. In addition to detailed analyses of the primary research evidence 
linked to the systematic reviews, guidelines and best practice documents, an additional 
systematic review was conducted. Hence, the quality of primary studies was assessed using 
checklists from JBI. During the development of the guideline recommendations,we also 
rated the quality and strength of evidence supporting recommendations using the 
GRADEapproach.86 
Although the above activities helped to ensure that there was a transparent reporting of the 




across settings and contexts. Therefore, assessing barriers to, and facilitators of guideline 
implementation has been indicated as one of the critical components aiding the adaptation 
and implementation of guidelines.183I therefore conducted both an internal and external 
evaluation of the guideline using the Guideline Implementability Appraisal (GLIA) 
checklist116 to identify potential barriers and tailored interventions to tackle these barriers. 
Nevertheless, the GLIA checklist does not allow a researcher to create a dialogue and to get 
rich data on end users’ perceptions of the guideline.211In addition, the GLIA checklist is too 
long, and it was challenging to get responses using this checklist. However, I was able to get 
adequate insights in order to iteratively work on the guideline using the checklist. 
To tackle the limitation of this tool, Iconducted key informant interviews with health 
professionals and health managers to identify local factors that affect the implementation of 
the guideline.This key informant interview data enabled me to determine important 
contextual factors that may impact the implementation of the guideline. Some of the factors 
explored in the current project may also be extrapolated to other guidelines. These factors 
include provider-related factors such as motivation, teamwork, knowledge and attitude, and 
local platforms such as one-to-five networks and mentorship programs that may also 
improve the uptake of other guidelines. 
Michie et al.267 have produced 12 domains that explain behavior change necessary for 
guideline implementation.Among the domains identified by Michie et al.,267I identified 
knowledge, skills, anticipated outcomes, environmental and contextual factors that are 
potentially expected to affect the implementation of the cuurent guideline. 
As a limitation, most of the recommendations included in the current guideline were drawn 
from low and very lowquality evidence. The only option available in such circumstances 
was either to withdraw the guideline topic or develop recommendations using an explicit 
methodology.101The guideline panel, chose the latter, because guidelines are most needed in 
areas where there are only limited or no evidence avaliable. This is because uncertainties are 
expected to be more common in areas where there is limited or no evidence avaliable.101 
Clinicians and policy makers usually do not have time to thoroughly appraise evidence and 
produce appropriate recommendations or decisions.268They need evidence in the form of a 
summary such as guidelines and evidence summaries.119The GRADE recommends that 
guideline panels make recommendations although their confidence estimates are low and/or 
there is a balance between desirable and undesirable consequences.269In addition, addressing 




panel believed that the guideline addresses equity and improves quality of care and 
adherence to the implementation of the required practice.Therefore, we developed the 
guideline recommendations based on evidence from systematic reviews using a modified 
Delphi technique. This is in line with the definition of a guideline given by Institute of 
Medicine (IOM) which emphasizes the importance of systematic reviews to develop 
guidelines.14 
While putting the current guideline into practice, it is imperative to consider the quality of 
the recommendations. The quality of evidence available to date is limited. This was the main 
reason that most findings from the reviews from which guideline recommendations were 
drawn were assigned low or very lowquality evidence. Nevertheless, the panel thoroughly 
considered the problem as well as feasibility and preference issues. Hence, the panel was 
urged to make recommendations inspite of the very low-quality available.  
Therefore, in this project I attempted to integrate research-based and consensus-based 
recommendations using a formal consensus method (a modified Delphi approach). Previous 
researches such as Zhang et al.215 and Rayner et al.270 used a similar procedure to develop 
evidence-basedand expertconsensus guidelines.Rycroft also employed a similar method, but 
utilized a nominal group technique in place of Delphi technique.271The involvement of 
stakeholders and local end users of the guideline has created a sense of ownership for the 
current guideline. On the other hand, the dearth of high quality research evidence that guides 
decision on choice of alternative interventions implies that further research with better 
quality designs such as RCTs is required. Particularly, future research should use validated 
instruments to measure SAD related to HIV. 
The recommendations in the current guideline were mainly developed based on the principle 
of Eisenberg’s summary called ‘globalize evidence, localize decisions’.178For the current 
project, this was realized through the consideration of the best available effective 
interventions, and analysis of contextual and environmental factors specific to JUMC. 
Therefore, it is recommended that policy makers who want to adapt the guideline to other 
contexts need to assess their specific local and environmental factors in order to adapt such 
recommendations to their own settings. The factors that need to be considered may include: 
prevalence of HIV, HIV-related SAD, the ease of implementing the recommendations in 
their specific localities, values and preferences of local stakeholders, and considerations of 
equity and costs to their institutions and the society. These factors may lead to differences 




While it is essential to consider the limitations of the body of evidence from which the 
recommendations were drawn, it is equally important to note the scope of the current 
guideline. The current guideline does not address interventions related to national 
legislation,which in most intances, is beyond the scope of healthcare facilities. The current 
guideline is limited in focus in developingspecific recommendations and ensuring 
accountability in healthcare settings. It was the panel’s belief that limiting the scope and 
adapting the guideline to the specific context and addressing the roles and responsibilities in 
the specific settings is far more important than compromising the strength of the 
interventions by intermingling them with recommendations of various settings in a single 
document.  
Nevertheless, HIV-related SADare also affected by social, cultural and political factors 
beyond the healthcare facility.137Hence, national stakeholders and program managers 
working on such areas need to refer to other sources. Although the body of knowledge is 
limited and most of the factors are determined by the political commitment of the countries, 
it is still valid to include such components in national planning. 
The utilization of knowledge to action cycle (KTA) published by Graham et al.67 has been 
suggested by researchers to improve guideline implementability.211In general, the current 
guideline development project addressed few components of the KTA cycle.67 These 
wereidentification of the problem, adapting knowledge to local context, assessing barriers to 
knowledge use and tailoring and implementing interventions to the identified barriers.67The 
other component of the KTA cycle (knowledge monitoring, knowledge evaluation and 
sustaining knowledge), that is also part of the phase 3 of the CAN implement guideline 
adaptation framework,23 can be realized through the utilization of the monitoring and 
evaluation tools linked with the current guideline and detailed information collected on 
monitoring and evaluation aspects of the guideline during the key informant interviews. 
Hence, the next step is embedding this guideline into healthcare and professional education 
systems. As recommended in the previous chapter, integration of the indicators into hospital 
key performance indicators (KPI), Health Management Information Systems (HMIS) and 
mentorship system is vital. 
In addition to the validity, reliability, clinical appropriateness, clinical flexibility, clarity and 
development through a multidisciplinary team engagement process, documenting the 
process involved in the development of the guideline have been reported as important 




development project was conducted through the involvement of a multidisciplinary team of 
experts. As indicated in the earlier chapters, procedures involved in the development of the 
guideline were transparently reported. 
In general, this project attempted to develop an evidence-informed guideline. The guideline 
is the first of its type in the specified locality in that it has considered the best available 
evidence and local factors simultaneously. The guideline should be implemented in JUMC 
based on contextual information obtained from the key informant interviews. Werecommend 
that the guideline be implemented based on the procedure shown in Figure 7.  
 
Figure 7. Suggested implementation procedure for the guideline 
While it is not always easy to implement guidelines in low resource settings, practice 
guidelines may not only help to improve client outcomes, but be used as a roadmap to define 
health service goals.275In the context of difficult gaps in guideline development, adaptation 
and implementation, the current guideline may generate interest from other researchers, 
policy makers, and professional associations to initiate such a system of systematic 
development of guidelines nationally and locally.  
9.3. Conclusion 
The current guideline development project integrated research-based and consensus-based 
recommendations using a formal consensus method. Although the guideline 
recommendations were developed based on low/very lowquality evidence, the project 




guideline. The involvement of endusers and local stakeholders willpotentially raise the sense 
of ownership for the current guideline. Further highquality researches such as RCTs utilizing 
validated instruments may fill the current dearth of high quality research in HIV-related 
SAD. The utilization of both the GLIA checklist and key informant interviews provided 
detailed information for contextualizing the guideline. While there are tools to evaluate 
guidelines, guideline developers and policy makers should consider the limitations of 
currently available checklists to evaluate and test the appropriateness of guidelines. The 
current project provided practical mechanisms to disseminate, implement, monitor and 
evaluate the guideline based on information collected both using the GLIA checklist and key 
informant interviews. 
9.4. Recommendations 
This PhD project sought to develop a guideline to reduce HIV-related stigma and 
discrimination in healthcare settings through the iterative consultation of local 
multidisciplinary experts. Potential barriers and facilitators to implement the guideline were 
identified. In addition, issues related to training, dissemination, monitoring, evaluation and 
sustainability were described. I recommend that policy makers and practitioners employ the 
tips suggested by the experts for the implementation of the guideline.Policy makers in other 
countries and settings should assess their facilities and the transferability of the evidence 
before adapting the current guideline to their own contexts. Given that the evidence 
addressing SAD to date is limited, it is imperative data related to SADreduction activities is 
collected not only to improve services but also to provide an evidence base. Moreover, 
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Appendix 1: Search strategy 
CINAHL 
Last search date =23/07/2016 
1. (MH "HIV-Infected Patients+") OR (MH "HIV-AIDS Nursing") OR (MH "HIV Infections+") OR (MH 
"HIV Education") OR (MH "HIV-1") OR "HIV" OR (MH "AIDS Serodiagnosis") =68090 
2. (MH "AIDS Serodiagnosis") OR (MH "AIDS Patients") OR (MH "Attitude to AIDS") OR (MH "HIV-
AIDS Nursing”) =8,427 
3.  (MH "Acquired Immunodeficiency Syndrome") OR (MH "Human Immunodeficiency Virus+”) =15633 
4. (MH "Discrimination") OR (MH "Prejudice") OR (MH "Stigma") OR (MH "Stereotyping") OR (MH 
"Homophobia") OR "prejudices" OR "Stigma" OR “prejudice” =21890 
5. MM "Psychological Well-Being" OR (MH "Adaptation, Psychological")  
6. (MH "Systematic Review") OR (MH "Scoping Review") OR (MH "Cochrane Library") =32980 
7. (MH "Meta Analysis") OR (MH "Meta Synthesis")=18924 
8. TI (review OR meta-analysis OR Syntheses OR overview) =92538 
9. (MH "Social Work Practice") OR (MH "Policy Making") OR (MH "Public Policy") OR "guideline" OR 
(MH "Guideline Adherence") =35733 
10. TI (guideline OR guidance OR consensus) =12193 
11. 1 OR 2 OR 3 =68812 
12. 4 OR 5 =41074 
13. 6 OR 7 OR 8 OR 9 OR 10 =153325 
14. 11 AND 12 AND 13 =178 
15. Limit 20 by [English Language] AND Exclude MEDLINE AND limit to humans=32 
Cochrane  
Last search date: 31/10/2016 
ID Search Hits 
#1 MeSH descriptor: [HIV] explode all trees 2934 
#2 MeSH descriptor: [Acquired Immunodeficiency Syndrome] explode all trees 1266 
#3 MeSH descriptor: [Social Stigma] explode all trees 101 
#4 MeSH descriptor: [Adaptation, Psychological] explode all trees 4684 
#5 MeSH descriptor: [Resilience, Psychological] explode all trees 109 
#6 MeSH descriptor: [Self Concept] explode all trees 5644 
#7 MeSH descriptor: [Stereotyping] explode all trees 329 
#8 MeSH descriptor: [Quality of Life] explode all trees 19272 
#9 #1 or #2  3925 
#10 #3 or #4 or #5 or #6 or #7 or #8 or #9  (Word variations have been searched) 31865 
#11 #9 and #10 in Other Reviews 145 





Last search date: 18/06/2016 
1. ‘human immunodeficiency syndrome virus’/exp OR ‘acquired immune deficiency syndrome’/exp OR 
‘human immune deficiency syndrome’:ab,ti =134,876 
2. ‘acquired immunodeficiency syndrome’:ab,ti OR ‘human immunodeficiency virus’:ab,ti OR ‘human 
immune deficiency virus’ OR ‘acquired immune-deficiency syndrome’:ab,ti OR ‘acquired immune-
deficiency syndrome’:ab,ti OR ‘human immune-deficiency virus’:ab,ti =85561 
3. ‘social stigma’/exp OR ‘social discrimination’/exp OR ‘stereotype’/exp  =27930 
4. 'coping behavior'/exp OR 'psychological wellbeing'/exp =56879 
5. 1 OR 2=202,289 
6. 3 OR 4=84,052 
7. 5 AND 6 =1457 
8. Guideline OR (Practice AND guideline) OR Guidance OR ‘consensus’/exp OR ‘practice guideline’:ab,ti 
OR guidance:ab,ti OR consensus:ab,ti=576722 
9. 7 AND 8=265 
10. 7 AND [Cochrane review]/lim OR [Systematic review]/lim OR [meta-analysis]/lim=34 
11. 8 OR 9=76 
12. 5 AND[humans]/lim AND[English]/lim AND [embase]/lim=62 
PSYCINFO  
Last search date: 20/07/2016 
1. Exp HIV/ =37587 
2. (Human immune deficiency syndrome OR acquired immune deficiency syndrome).sh,ti,ab = 2873 
3. exp "AIDS (ATTITUDES TOWARD)"/ OR exp AIDS/ =15188 
4. exp Social Stigma/ or exp Stereotyping/ or exp Prejudice/ or exp discrimination/ or exp Violence/ or 
exp Domestic Violence/ or exp Workplace Violence/ =132135 
5.   exp Social Discrimination/ or exp Stigma/ or exp "AIDS (Attitudes Toward)"/ or exp "Physical 
Illness (Attitudes Toward)"/ =21519 
6. (Stigma* OR discrimination OR prejudice* OR labeling OR stereotyp* OR disclosure).sh,ti,ab 
=149852 
7. Exp Quality of Life/ OR exp Social Support/ OR exp Coping Behavior/ OR exp Emotional 
Adjustment/ =120046 
8. (coping OR cope OR self-management OR bereave* OR (quality of life)).ti,ab.=141846 
9. judgment/ OR Stereotyped Attitudes/ OR Blame/ OR exp guilt/ OR shame/ or embarrassment/=39895 
10. 1 OR 2 OR 3 =38247 
11. 4 OR 5 OR 6 OR 7 OR 8 9 = 439223 
12. 10 AND 11=8911 
13. (Systematic review OR Meta analyses OR Research syntheses).sh,ti,ab =21218 
14. (Guideline or practice guideline OR consensus).sh,ti,ab =27669 
15. exp TREATMENT GUIDELINES/ or exp Evidence Based Practice/ =19286 
16. 14 OR 15 OR 16=64818 
17. 16 AND 17=135 
18. Limit 18 to (human and English language) =132 
 
PubMed 




1 "Acquired Immunodeficiency Syndrome"[Mesh] OR "HIV"[Mesh] OR "HIV Infections"[Mesh] 
=280056 
2 “acquired immune deficiency syndrome”[tw] OR “acquired immunodeficiency syndrome” [tw] OR 
“Human immunodeficiency virus” [tw] OR “Human immune deficiency virus” [tw] OR “acquired 
immuno-deficiency syndrome” [tw] OR “acquired immune-deficiency syndrome” [tw] OR “human 
immune-deficiency virus” [tw] OR “human immune-deficiency virus” [tw] OR HIV[tw] OR hiv-
1*[tw] OR hiv-2*[tw] OR hiv1[tw] OR hiv2[tw] OR HIV infect*[tw] OR HIV/AIDS[tw]=356252 
3 (("Social Stigma"[Mesh]) OR ("Discrimination (Psychology)"[Mesh] OR “Social 
Discrimination"[Mesh] )) OR "Prejudice"[Mesh] =496805 
4 Stigma* [tiab] OR discrimination [tiab] OR prejudice [tiab] =118630 
5 Disclosure [MESH] OR Truth Disclosure [Mesh] OR Self Disclosure [Mesh] =35010 
6 "Resilience, Psychological"[Mesh] OR "Adaptation, Psychological"[Mesh] OR "Emotional 
Adjustment"[Mesh] OR "Stress, Psychological"[Mesh] OR "Self-efficacy"[Mesh] OR "Self-
concept"[Mesh] OR "Self-psychology"[Mesh] OR "Self-Care"[Mesh] =322879 
7 1 OR 2=360985 
8 3 OR 4 OR 5 OR 6 = 488093 
9 8 AND 9=15727 
10 10 AND ((Practice Guideline[ptyp] OR Meta-Analysis[ptyp] OR Review[ptyp] OR Guideline[ptyp] 
OR Scientific Integrity Review[ptyp] OR systematic[sb] OR Consensus Development 






Appendix 2: Search results 
Database/websites  Search strategy Last date checked Number of 
records 




EMBASE Comprehensive search 18/06/2016 62 
PsycINFO  Comprehensive search 20/06/2016 132 




Cochrane (DARE=7, CDSR=6) 
 




British HIV Association (BHVIVA) 
website 
 
Checking for guidelines, standards and position 
statements 
26/06/2016 3 
HIV and AIDS clearinghouse Check for toolkits and guidelines under subject stigma 
and discrimination 
26/06/2016 42 
NGC (National Guideline 
Clearinghouse) 
Checked guidelines 25/06/2016 4 
AIDSINFO Checked guidelines 26/06/2016 0 
HIV insite Checked for guidelines 26/06/2016 0 
USAID development experience 
clearinghouse 
“Stigma” in USAID Policy Document OR 
Handbook/Manual under HIV/AIDS 
26/06/2016 8 
UNAIDS Website check 25/06/2016 3 
WHO guidelines Website check 25/06/2016 5 
CDC Guidelines and 
recommendations 
Website check 26/06/2016 0 
international guideline library (GIN 
library 
(evidence report OR guideline OR guideline clearing 
report OR implementation tool OR guideline 
methodology) HIV, excluding WHO guidelines and 
HIVinsite 
26/06/2016 3 
Health policy project website  Publications   23/06/206 1 
Physicians for human rights  Search “stigma” “discrimination” 23/06/2016 1 
ICRW HIV/AIDS stigma and discrimination publications  23/06/2016 12 
Others (FHAPCO website, request 
from officials, references of 
references, google scholar) 
  5 
Total    1666 
Duplicates    62 






Appendix 3: JBI critical appraisal checklist for systematic reviews and research 
syntheses 
Reviewer      Date     
Author     Year   Record Number   
 Yes No Unclear Not applicable 
1. Is the review question clearly and explicitly stated? □ □ □ □ 
2. Were the inclusion criteria appropriate for the review question? □ □ □ □ 
3. Was the search strategy appropriate? □ □ □ □ 
4. Were the sources and resources used to search for studies adequate? □ □ □ □ 
5. Were the criteria for appraising studies appropriate? □ □ □ □ 
6. Was critical appraisal conducted by two or more reviewers independently? □ □ □ □ 
7. Were there methods to minimize errors in data extraction? □ □ □ □ 
8. Were the methods used to combine studies appropriate? □ □ □ □ 
9. Was the likelihood of publication bias assessed? □ □ □ □ 
10. Were recommendations for policy and/or practice supported by the reported data? □ □ □ □ 
11. Were the specific directives for new research appropriate? □ □ □ □ 
 Overall appraisal:  Include □ Exclude □ Seek further info □ 
Comments (Including reason for exclusion) 
             
             










Appendix 4: Results of AGREE II reporting criteria checklist 
S/n Item USAID,20127 Carr, 
20156 
PHR,2011 UNAIDS,2007129 Carr, 
2007127 
TCA,2009130 
1.  The overall objective(s) 
of the guideline is (are) 
specifically described. 
The specific benefit from 
the guidelines are 
specific to the health 
topic 
Yes Yes Yes Yes Yes Yes 
2.  The health question(s) 
covered by the guideline 
is (are) specifically 
described. 
No No No No No No 
3.  The population (patients, 
public, etc.) to whom the 
guideline is meant to 
apply is specifically 
described. 
Yes Yes Yes Yes Yes Yes 
4.  The guideline 
development group 
(their discipline, roles 
and institutions) was 
clearly described 
NC NC Yes NC Yes Yes 
5.  The views and 
preferences of the target 
population (patients, 
public, etc.) have been 
sought 
NC NC NC NC NC NC 
6.  The target users of the 
guideline are clearly 
defined. 
No Yes Yes No No No 
7.  Search methods used to 
locate evidence were 
clearly reported. 
No No No No No No 
8.  The criteria for selecting 
the evidence are clearly 
described. 
No No No No No No 
9.  The strengths and 
limitations of the body 
of evidence are clearly 
described. 
No No No No No No 




No No No No No No 
11.  The health benefits, side 
effects, and risks have 
been reported 
No No No No No No 
12.  The links between the 
recommendations and 
the supporting evidence 
were clearly described. 
No No No No No No 
13.  The methodology to 
conduct external review 
was reported 
No No No No No No 
14.  A procedure for updating 
the guideline is 
provided. 
No No No No No No 
15.  The recommendations 
are specific and 
unambiguous. 
No Yes Yes No No No 
16.  The different options for 
management of the 
condition or health issue 
are clearly presented 
NA NA NA NA NA NA 
17.  Key recommendations 
are easily identifiable. 
No Yes Yes Yes Yes Yes 
18.  The guideline describes 
facilitators and barriers 
to its application. 




19.  The guideline provides 
advice and/or tools on 
how the 
recommendations can be 
put into practice. 
Yes Yes Yes Yes Yes Yes 
20.  The potential resource 
implications of applying 
the recommendations 
have been described. 
No No Yes No No No 
21.  The guideline presents 
monitoring and/or 
auditing criteria. 
Yes Yes Yes Yes Yes Yes 
22.  The influence of the 
funding body on the 
guideline was described. 
No No No No No No 
23.  Competing interests of 
guideline development 
group members have 
been recorded and 
addressed. 
NC NC NC NC NC NC 
24.  Total yes scores 4 7 10 5 6 6 
NB: NA: Not applicable, NC: Not clear, PHR: Physicians for Human Rights, TCA: Tanzanian Commission of AIDS, USAID: United 




















1 Were review 
questions clearly 
stated? 
Yes Yes Yes Yes Yes Yes 




Yes Yes Yes Yes Yes Yes 
3 Was search 
strategy 
appropriate? 
Yes  Yes Yes Yes UC Yes 
4 Were the sources 
and resources 
used to search 
for studies 
adequate? 
Yes  Yes Yes Yes No Yes 




Yes Yes Yes Yes UC UC 
6 Was critical 
appraisal 
conducted by 
two or more 
reviewers 
independently? 
Yes Yes Yes Yes UC UC 





Yes Yes Yes Yes UC Yes 
8 Were the 
methods used to 
combine studies 
appropriate? 
NA NA NA NA NA NA 




UC UC UC UC UC UC 
10 Were 
recommendation
s for policy 
and/or practice 
supported by the 
reported data? 
Yes  Yes Yes Yes Yes Yes 





Yes Yes Yes Yes Yes Yes 
 Total Yes 9 9 9 9 4 7 






Appendix 6: Search strategy to locate primary studies 
CINAHL 
1. Last search date =23/07/2016 
2. (MH "HIV-Infected Patients+") OR (MH "HIV-AIDS Nursing") OR (MH "HIV Infections+") OR 
(MH "HIV Education") OR (MH "HIV-1") OR "HIV" OR (MH "AIDS Serodiagnosis") =70307 
3. (MH "AIDS Serodiagnosis") OR (MH "AIDS Patients") OR (MH "Attitude to AIDS") OR (MH 
"HIV-AIDS Nursing”) =8597 
4. (MH "Acquired Immunodeficiency Syndrome") OR (MH "Human Immunodeficiency Virus+”) 
=15866 
5. (MH "Discrimination") OR (MH "Prejudice") OR (MH "Stigma") OR (MH "Stereotyping") OR 
(MH "Homophobia") OR "prejudices" OR "Stigma" OR “prejudice” =23174 
6. MM "Psychological Well-Being" OR (MH "Adaptation, Psychological") =20672 
7. 1 OR 2 OR 3 =71029 
8. 4 OR 5 =43308 
9. 6 AND 7=4363 
10. Limit 8 by [English Language] AND [Exclude MEDLINE AND limit to humans=777 
Cochrane  
Last search date: 20/05/17  
ID Search Hits 
#1 MeSH descriptor: [HIV] explode all trees 2943 
#2 MeSH descriptor: [Acquired Immunodeficiency Syndrome] explode all trees 1267 
#3 MeSH descriptor: [Social Stigma] explode all trees 113 
#4 MeSH descriptor: [Adaptation, Psychological] explode all trees 4750 
#5 MeSH descriptor: [Resilience, Psychological] explode all trees 123 
#6 MeSH descriptor: [Stereotyping] explode all trees 335 
#7 MeSH descriptor: [Self Concept] explode all trees 5760 
#8 MeSH descriptor: [Quality of Life] explode all trees 19694 
#9 #1 or #2  3935 
#10 #3 or #4 or #5 or #6 or #7 or #8  28673 
#11 #9 and #10 in Trials 142 
 
EMBASE 
Last search date: 18/06/2017 
13. ‘human immunodeficiency syndrome virus’/exp OR ‘acquired immune deficiency syndrome’/exp OR 
‘human immune deficiency syndrome’: ab,ti =135, 583 
14. ‘acquired immunodeficiency syndrome’: ab,ti OR ‘human immunodeficiency virus’:ab,ti OR ‘human 
immune deficiency virus’ OR ‘acquired immune-deficiency syndrome’:ab,ti OR ‘acquired immune-
deficiency syndrome’:ab,ti OR ‘human immune-deficiency virus’:ab,ti =95,815 
15. ‘social stigma’/exp OR ‘social discrimination’/exp OR ‘stereotype’/exp =29,168 
16. ‘prejudice’/exp OR ‘prejudice’:ab,ti=5032 
17. 1 OR 2=205,768 
18. 3 OR 4=33,762 
19. 5 AND 6 =1004 
20. #7 AND [EMBASE]/lim NOT [Medline]/lim=301 
21. #8 AND ('clinical article'/de OR 'clinical trial'/de OR 'comparative study'/de OR 
'controlled study'/de OR 'evidence based medicine'/de OR 'evidence based practice'/de 
OR 'human'/de OR 'pilot study'/de OR 'randomized controlled trial'/de) =274 
22. #9 AND ('clinical article'/de OR 'clinical trial'/de OR 'comparative study'/de 
OR 'controlled study'/de OR 'evidence based medicine'/de OR 'evidence based 
practice'/de OR 'human'/de OR 'pilot study'/de OR 'randomized controlled trial'/de) 
AND [humans]/lim AND [English]/lim=266 
 
PsycINFO  
Last search date: 20/05/2017 
1. Exp HIV/ =38093 




3. exp "AIDS (ATTITUDES TOWARD)"/ OR exp AIDS/ =15258 
4. exp Social Stigma/ or exp Stereotyping/ or exp Prejudice/ or exp discrimination/ or exp Violence/ or 
exp Domestic Violence/ or exp Workplace Violence/ =133991 
5. exp Social Discrimination/ or exp Stigma/ or exp "AIDS (Attitudes Toward)"/ or exp "Physical 
Illness (Attitudes Toward)"/ =21977 
6. (Stigma* OR discrimination OR prejudice* OR labeling OR stereotyp* OR disclosure).sh,ti,ab 
=152385 
7. Exp Quality of Life/ OR exp Social Support/ OR exp Coping Behavior/ OR exp Emotional 
Adjustment/ =121878 
8. (coping OR cope OR self-management OR bereave* OR (quality of life)).ti,ab.=144748 
9. judgment/ OR Stereotyped Attitudes/ OR Blame/ OR exp guilt/ OR shame/ or 
embarrassment/=40426 
10. 1 OR 2 OR 3 =38756 
11. 4 OR 5 OR 6 OR 7 OR 8 9 = 448676 
12. 10 AND 11=10101 
13. Limit 12 to (human and english language) =9737 
14. Limit 13 to (“0300 clinical trial” OR “0410 experimental replication” OR “1900 scientific 
simulation” OR “2100 treatment outcome”)=216 
ProQuest Dissertations and Theses 
1. ti(hiv 1) OR ti(hiv 2) OR ti(hiv) OR ti(acquired immunodeficiency syndrome) OR ti(human 
immunodeficiency virus)=9776 
2. su(hiv 1) OR su(hiv 2) OR su(hiv) OR su(acquired immunodeficiency syndrome) OR su(human 
immunodeficiency virus)=7383 
3. su(stigma hiv) OR diskw(Stigma) OR ti(stigma) OR su(hiv stigma) OR ti(discrimination) OR 
su(prejudice) OR ti(prejudice) OR su(aids attitude)=8626 
4. 1 OR 2=11,326 
5. 3 AND 4=283 
6. 5 AND ENGLISH=279 
PubMed 
Last search date: 20/05/2017 
1. "Acquired Immunodeficiency Syndrome"[Mesh] OR "HIV"[Mesh] OR "HIV 
Infections"[Mesh]=281060 
2. “acquired immune deficiency syndrome”[tw] OR “acquired immunodeficiency syndrome” [tw] OR 
“Human immunodeficiency virus” [tw] OR “Human immune deficiency virus” [tw] OR “acquired 
immuno-deficiency syndrome” [tw] OR “acquired immune-deficiency syndrome” [tw] OR “human 
immune-deficiency virus” [tw] OR “human immune-deficiency virus” [tw] OR HIV[tw] OR hiv-
1*[tw] OR hiv-2*[tw] OR hiv1[tw] OR hiv2[tw] OR HIV infect*[tw] OR HIV/AIDS[tw=358968 
3. ((“Social Stigma”[Mesh]) OR (“Discrimination (Psychology)”[Mesh] OR “Social Discrimination” 
[Mesh])) OR “Prejudice”[Mesh]=50181 
4. Stigma* [tiab] OR discrimination [tiab] OR prejudice [tiab] =120425 
5. Disclosure [MESH] OR Truth Disclosure [Mesh] OR Self Disclosure [Mesh] =35243 
6. "Resilience, Psychological"[Mesh] OR "Adaptation, Psychological"[Mesh] OR "Emotional 
Adjustment"[Mesh] OR "Stress, Psychological"[Mesh] OR "Self-efficacy"[Mesh] OR "Self-
concept"[Mesh] OR "Self-psychology"[Mesh] OR "Self-Care"[Mesh] =325427 
7. 1 OR 2=363703 
8. 3 OR 4 OR 5 OR 6=492714 
9. 7 AND 8=15878 
10. 9 AND (Comparative Study[ptyp] OR Evaluation Studies[ptyp] OR Pragmatic Clinical Trial[ptyp] 
OR Randomized Controlled Trial[ptyp] OR Clinical Trial[ptyp])=1253 





Appendix 7: Search results for search conducted to locate primary studies 




PubMed  Comprehensive search 20/05/2017 1215 
EMBASE Comprehensive search 18/06/2017 266 
PsycINFO  Comprehensive search 20/05/2017 216 
CINAHL Comprehensive search 23/04/2017 777 
Cochrane  Comprehensive search 20/04/2017 142 
HIV and AIDS clearinghouse Check for toolkits and guidelines under subject stigma 
and discrimination 
26/04/2017 5 
USAID development experience 
clearinghouse 
“Stigma” in USAID evaluation under HIV/AIDS 26/04/2017 1 
ICRW HIV/AIDS stigma and discrimination publications  23/04/2017 3 
ProQuest Dissertation and Theses comprehensive search 21/06/2017 279 
Other sources (reference of references)   18 
Total    2,927 
Duplicates    71 












Appendix 8: JBI critical appraisal checklist for randomized controlled trials 
Reviewer      Date    
Author     Year   Record Number   
 Yes No Unclear NA 
1. Was true randomization used for assignment of participants to treatment groups? □ □ □ □ 
2. Was allocation to treatment groups concealed? □ □ □ □ 
3. Were treatment groups similar at the baseline? □ □ □ □ 
4. Were participants blind to treatment assignment? □ □ □ □ 
5. Were those delivering treatment blind to treatment assignment?  □ □ □ □ 
6. Were outcomes assessors blind to treatment assignment? □ □ □ □ 
7. Were treatments groups treated identically other than the intervention of interest? □ □ □ □ 
8. Was follow-up complete, and if not, were strategies to address incomplete follow-up utilized? □ □ □ □ 
9. Were participants analyzed in the groups to which they were randomized? □ □ □ □ 
10. Were outcomes measured in the same way for treatment groups? □ □ □ □ 
11. Were outcomes measured in a reliable way? □ □ □ □ 
12. Was appropriate statistical analysis used? □ □ □ □ 
13. Was the trial design appropriate, and any deviations from the standard RCT design (individual 
randomization, parallel groups) accounted for in the conduct and analysis of the trial? 
□ □ □ □ 
Overall appraisal:  Include □ Exclude □ Seek further info □ 
Comments (Including reason for exclusion) 
             
             





Appendix 9: JBI critical appraisal checklist for quasi-experimental studies  
(non-randomized experimental studies) 
Reviewer      Date     
Author       Year   Record Number 
 Yes No Unclear Not 
applicable 
1. Is it clear in the study what is the ‘cause’ and what is the ‘effect’ (i.e. there 
is no confusion about which variable comes first)? 
□ □ □ □ 
2. Were the participants included in any comparisons similar?  □ □ □ □ 
3. Were the participants included in any comparisons receiving similar 
treatment/care, other than the exposure or intervention of interest? 
□ □ □ □ 
4. Was there a control group? □ □ □ □ 
5. Were there multiple measurements of the outcome both pre-and post the 
intervention/exposure? 
□ □ □ □ 
6. Was follow up complete and if not, were differences between groups in 
terms of their follow up adequately described and analysed? 
□ □ □ □ 
7. Were the outcomes of participants included in any comparisons measured 
in the same way?  
□ □ □ □ 
8. Were outcomes measured in a reliable way? □ □ □ □ 
9. Was appropriate statistical analysis used? □ □ □ □ 
Overall appraisal:  Include □ Exclude □ Seek further info □ 
Comments (Including reason for exclusion) 
             
             





Appendix 10: JBI critical appraisal checklist for analytical cross-sectional Studies 
Reviewer      Date      
 
Author       Year  Record Number___ 
 
 Yes No Unclear Not applicable 
1. Were the criteria for inclusion in the sample clearly defined? □ □ □ □ 
2. Were the study subjects and the setting described in detail? □ □ □ □ 
3. Was the exposure measured in a valid and reliable way? □ □ □ □ 
4. Were objective, standard criteria used for measurement of the condition? □ □ □ □ 
5. Were confounding factors identified? □ □ □ □ 
6. Were strategies to deal with confounding factors stated? □ □ □ □ 
7. Were the outcomes measured in a valid and reliable way? □ □ □ □ 
8. Was appropriate statistical analysis used? □ □ □ □ 
Overall appraisal:  Include □ Exclude □ Seek further info □ 
Comments (Including reason for exclusion) 
             
             






Appendix 11: JBI critical appraisal checklist for case Series 
Reviewer      Date      
Author      Year  Record Number  
 Yes No Unclear Not 
applicable 
1. Were there clear criteria for inclusion in the case series?  □ □ □ □ 
2. Was the condition measured in a standard, reliable way for all 
participants included in the case series? 
□ □ □ □ 
3. Were valid methods used for identification of the condition for all 
participants included in the case series? 
□ □ □ □ 
4. Did the case series have consecutive inclusion of participants?  □ □ □ □ 
5. Did the case series have complete inclusion of participants? □ □ □ □ 
6. Was there clear reporting of the demographics of the participants 
in the study? 
□ □ □ □ 
7. Was there clear reporting of clinical information of the 
participants? 
□ □ □ □ 
8. Were the outcomes or follow up results of cases clearly reported?  □ □ □ □ 
9. Was there clear reporting of the presenting site(s)/clinic(s) 
demographic information? 
□ □ □ □ 
10. Was statistical analysis appropriate?  □ □ □ □ 
Overall appraisal:  Include □ Exclude □ Seek further info  □ 
Comments (Including reason for exclusion) 
             
             


























Appendix 13: Studies excluded and reasons for their exclusion 
S/n Study  Reason for exclusion  
1.  Baskan,2014
276 
Attitude of nurses toward PLWHAs was not assessed at the pre-test as the AIDS Attitude Scale was 
introduced only at 12 months follow-up 
2.  Church 
2013277 
Client outcome, instead of HCW outcome, was measured, and the measured outcomes had 
measurement bias 
3.  Bennet 
1997278 
Measurement bias (composite scores not created; scale mean scores were not reported), poor fidelity of 
the intervention and small sample size 
4.  Ezedinachi 
2002279 
No measurement scale was created to measure stigma. Single items were used to assess the impact of 
the intervention. Clear comparison data is not available in the form of mean score and SD. 
5.  Giebel 
2017280 
Did not create composite score or scale to measure stigma 
6.  Kaponda253 Differences in HCW characteristics in the baseline and post-intervention, measurement bias (several 
attitudes measured with only two items, affecting reliability of those measures) stigma items were not 
developed specifically for health professionals 
7.  Neema 
201262 
Measurement bias, individual separate items (instead of composite scales) were used to measure 
attitude. Participants of the pre-test are different from those of post-test. 
8.  McKanzie, 
2017281 
Measurement bias (items were reported separately, no composite score or scale was reported). 
9.  Pisal 2007282 Measurement bias (items were reported separately, no composite score or scale was reported). 
10.  Pratt 2001283 Did not report outcomes quantitatively.  
11.  Robiner 
1994284 
More intervention groups reported having attended training and more contact with PLHIV than control 
groups. This poses difficulty in assessing the effect of the intervention (one-day training). The study 
was planned and implemented only after the intervention (continuing education conference) had 
already occurred. Pre-test measures were not taken. The intervention’s fidelity was not assured. The 
size and characteristics (geographically heterogenous) of the sample had limitations. Adequate 
description was not given on how anxiety was measured 
12.  Santana 
1992285 
Lacks details of measurement scales for attitude 
13.  Stewart 
1999286 
The hypotheses were not aimed to compare attitude, but comfort and intent to perform preventive 
measures (in performing assessment) the treatment arms. Incomplete data (n1 and n2, SD were not 
reported) 
14.  Wang 
2009287 
Measurement bias (Physician stigma knowledge was reported) not actual stigma. No scale was 
described to measure patient stigma 
15.  Wu 2008288 Measurement bias (stigma measured and reported separately by three separate items) 






Appendix 14: Invitation for panel membership 
Dear colleague,  
Through the assistance of the university of Adelaide and Joanna Briggs Institute, we are 
developing an evidence-informed guideline to reduce HIV-related stigma and discrimination 
in healthcare settings. This project will constitute part of the requirements for the Doctor of 
Philosophy of Garumma Tolu Feyissa.  
Therefore; we would like to involve experts in the field. Hence, we are planning to establish 
a guideline panel composed of experts (researchers, health professionals and health 
managers). Therefore, we are planning to include you, because you have research experience 
and/or experience in managing HIV related programs or working with HIV clients.  Your 
role as a guideline working group may include: 
1. Appraisal of documents: some, but not all of you, may be involved in this process based 
on your availability. 
2. Selection of body of evidence: You will be provided with a summary of documents and 
be asked to select them to be included in developing guidelines. 
3. Responding to the iterative round of Delphi surveys: This will involve multiple round 
surveys that ask you whether you accept recommendations to be included in a guideline. 
In each round, you will be presented with the summary of responses from previous rounds. 
To respond to each round of the survey, which will be sent through e-mail, you will be given 
a maximum of two weeks. The success of the Delphi survey depends on the timely responses 
provided by the panel selected from the range of backgrounds. Therefore, all the members 
of the guideline panel are recommended to respond to these surveys. 
At the end of the project, based on your consent, your names may be published with the 
guideline.Each panel member is expected to declare any potential conflict of interest. The 
form for this declaration will be sent you through an e-mail once you agree to participate. 
 We, therefore, warmly invite you to be part of the panel. 
 
Kind regards 






Annex 15: Declaration of conflict of interest 
The following questions are designed to allow participants to declare real or apparent 
conflicts of interest. Conflicts of interest include the panel member’s participation in the 
development or the endorsement of guidelines that are to be reviewed for this project. 
Conflicts of interest may include relationships with pharmaceutical companies or other 
companies whose services are related to the current guideline. Financial interests that require 
declaration may include honoraria, consultancies, employment, and stock ownership. The 
purpose of the disclosure is to have participants declare any potential conflict of interests to 
any of the guidelines that are under consideration. 
 
1. Participation in guideline development 
 
Have you ever been involved in developing the guidelines (as a member of the 
committee)? 
If yes, identify the guideline 
Yes No 
If yes, identify the guideline and describe your involvement 
Title of the guideline  
Describe your involvement  
2. Guideline endorsement 
Have you participated in the process of endorsing guideline? If yes, identify 
the guideline 
Yes No 
If yes, identify the guideline and describe your involvement 
Title of the guideline  
Describe your involvement  
3. Employment 
Are you or have you been employed by a guideline developer or an entity with 
commercial interest? 
Yes No 
If yes, please describe. 
4. Ownership interests 
Do you have ownership interests, which are not publicly traded, which has 
commercial interest in any of the guidelines under consideration? 
Yes No 
If yes, please describe 
5. Partnership interests 
Do you have any partnership interests in any of the entity that has commercial 
interest with the guidelines under consideration? 
Yes No 
If yes, please describe. 
6. Research funding 
Are you currently receiving or have received funding from an entity that has 
commercial interest in any of the guidelines under consideration? 
Yes No 
If yes, please describe. 
7. Honoraria 
Have you been paid honoraria or received gifts from a guideline developer or 
an entity having commercial interests in any of the guideline under 









If yes, please describe. 
8. Consultancy 
Have you ever served as a consultant for any entity engaged in developing a 
guideline or had a commercial interest in any of the guidelines under 
consideration? 
  
If yes, please describe. 
9. Other potential conflicts of interests   




Appendix 16: Panel members 
The guideline was developed by a panel composed of multidisciplinary team including 
public health experts, internists, mental health professionals, psychiatrists, nurses, health 
promotion experts, sociologists, health service management experts, methodologists and 
practitioners, health managers and researchers. 
1. Mr. Garumma Feyissa (MPH, HE/HEP, and PhD candidate in Evidence-based 
healthcare) facilitator 
2. Professor Mirkuzie Woldie (MD, MPH, HSM, V/president of JU institute of Health 
sciences) professor of health policy and health services management 
3. Mr. Fikru Tafesse (HAPCO coordinator (MPH, HSM)  
4. Dr. Daniel Yilma (Internist, JUMC treatment coordinator and CDC focal person) 
5. Mr. Sena Belina (MSc, Maternity Nursing) 
6. Mr. Matiwos Soboka (MSc, ICCM), Assistant professor 
7. Dr. Elias Tesfaye (MD, Consultant psychiatrist) 
8. Mr. Gebeyehu Tsega (MPH, HSM) 
9. Mr. Mulugeta Misgana (MSc, Maternity Nursing, Clean and safe health 
facility(CASH) focal person) 
10. Mr. Shemeles Legesse (Nurse Midwife, MPH HSM) the then director for Strategic 
Plan and policy analysis of JUMC and current chief administrative and development 
director of JUMC 
11. Mr. Berhanu Nigussie (Psychologist, PhD candidate) 
12. Mr. Habtamu Kerebih (MSc, ICCM) 
13. Mr. Dereje Wonde (MA Sociology) 






Appendix 17: Summary of declaration of conflict of interest 
Two of the panel members (FT and TS) worked as HIV prevention and control coordinators. 
One of the panel members worked as HIV treatment coordinator. Three of the panel 
members (GF, MW and BN) have previously been involved in guideline development, but 
for unrelated topics.Two of the panel members (DY and MM) have been involved in the 
development of an infection prevention and hospital safety guideline for the same hospital. 
Five (FT, DY, TS, GF and SB) of the panel members have been providing short-term training 
on PMTCT, ART PIHCT, STI and other HIV-related topics. Three of the panel members 
had publications on HIV topics, including HIV-related stigma (MW, GF and MS). One panel 
member (ET) had a research experience on mental health stigma. None of the members 






Appendix 18: Modified GLIA checklist 
The University of Adelaide, 
Faculty of Health Sciences 
School of Public Health, Joanna Briggs Institute  
Introduction  
Through the technical assistance of researchers at Joanna Briggs Institute, the University of 
Adelaide, a guideline working group based in Jimma University has drafted 
recommendations that will be part of an evidence-informed guideline for reducing HIV-
related stigma and promoting positive coping among people living with HIV and their 
families.  
The purpose of the current phase of the project is to investigate the implementability of the 
recommendations. Therefore, we are seeking the opinions of experts. For each of the 
questions we have outlined questions for which you have the following alternatives: yes (1), 
no (N), not applicable (NA) or not sure (NS). If your responses are either no, not applicable 
or not sure, please provide your reasons. The description for each recommendation indicated 
by codes (RN1.1, RN1.2…) is found in the main document. 
I. Global considerations (entire guideline) 
 
S/n Question  Y N NA NS comments 
1.  Does the guideline clearly define the target patient population?      
2.  Does the guideline clearly define its intended audience (i.e., types of 
providers)? 
     
3.  Are the settings in which the guideline is to be used clearly described?      
4.  Do the organization(s) and author(s) who developed the guideline have 
credibility with the intended audience of the guideline? 
     
5.  Does the guideline suggest strategies for implementation or tools for 
application e.g., a summary document, a quick reference guide, educational 
tools, patients' leaflets, online resources or computer software? 
     
6.  Is it clear in what sequence the recommendations should be applied?       
7.  Is the guideline internally consistent, i.e., without contradictions between 
recommendations or between text recommendations and flowcharts, 
summaries, patient education materials, etc.?  
     
8.  Are all recommendations easily identifiable, e.g., summarized in a box, bold 
text, underlined, etc.?  
     
9.  Are all recommendations (and their discussions) concise? (Longwinded 
explanations impair implementability.) 






Questions  Recommendation 
identification 
Y N NA NS Comments  
10. Is the recommended action (what to 
do) stated specifically and 
unambiguously? That is, would 
members of the intended audience 
execute the action in a consistent way? 
In situations where two or more 
options are offered, the executability 
criterion is met if the user would select 
an action only from the choices 
offered. 
RN1.1      
RN1.2      
RN1.3      
RN1.4      
RN2.1      
RN2.2      
RN2.3      
RN2.4      
RN2.5      
RN2.6      
RN3.1      
RN3.2      
RN3.3      
RN3.4      
RN4.1      
RN4.2      
RN4.3      
RN4.4      
RN4.5      
RN5.1      
RN6.1      
RN6.2      
RN6.3      
RN6.4      
RN6.5      
RN6.6      
RN6.7      
RN6.8      
RN6.9      
RN6.10      
RN6.11      
11. Is sufficient detail provided or 
referenced (about how to do it) to 
allow the intended audience to perform 
the recommended action, given their 
likely baseline knowledge and skills? 
 
RN1.1      
RN1.2      
RN1.3      
RN1.4      
RN2.1      
RN2.2      
RN2.3      
RN2.4      
RN2.5      
RN2.6      
RN3.1      
RN3.2      
RN3.3      
RN3.4      
 RN4.1      
RN4.2      
RN4.3      
RN4.4      
RN4.5      
RN5.1      
RN6.1      
RN6.2      




RN6.4      
RN6.5      
RN6.7      
RN6.8      
RN6.9      
RN6.10      
RN6.11      
Additional comments: 
Decidability 
Questions  Recommendation 
identification 
Y N NA NS Comments  
12. Would the guideline's intended 
audience consistently determine 
whether each condition in the 
recommendation has been satisfied? 
That is, is each and every condition 
described clearly enough so that 
reasonable practitioners would agree 
when the recommendation should be 
applied? 
RN1.1      
RN1.2      
RN1.3      
RN1.4      
RN2.1      
RN2.2      
RN2.3      
RN2.4      
RN2.5      
RN2.6      
RN3.1      
RN3.2      
RN3.3      
RN3.4      
RN4.1      
RN4.2      
RN4.3      
RN4.4      
RN4.5      
RN5.1      
RN6.1      
RN6.2      
RN6.3      
RN6.4      
RN6.5      
RN6.6      
RN6.7      
RN6.8      
RN6.9      
RN6.10      
RN6.11      
13. Are all reasonable combinations of 
conditions accounted for, i.e., is the 
recommendation comprehensive? 
 
RN1.1      
RN1.2      
RN1.3      
RN1.4      
RN2.1      
RN2.2      
RN2.3      
RN2.4      
RN2.5      
RN2.6      
RN3.1      
RN3.2      
RN3.3      
RN3.4      
RN4.1      
RN4.2      
RN4.3      
RN4.4      
RN4.5      
RN5.1      
RN6.1      
RN6.2      
RN6.3      
RN6.4      




RN6.6      
RN6.7      
RN6.8      
RN6.9      
RN6.10      
RN6.11      
14. If this recommendation contains 
more than one condition, is the 
logical relationship (ANDs and 
ORs) between conditions clear? 
 
RN1.1      
RN1.2      
RN1.3      
RN1.4      
RN2.1      
RN2.2      
RN2.3      
RN2.4      
RN2.5      
RN2.6      
RN3.1      
RN3.2      
RN3.3      
RN3.4      
RN4.1      
RN4.2      
RN4.3      
RN4.4      
RN4.5      
RN5.1      
RN6.1      
RN6.2      
RN6.3      
RN6.4      
RN6.5      
RN6.6      
RN6.7      
RN6.8      
 RN6.9      
RN6.10      
RN6.11      





Question  Recommendation 
identification 
Y N NA NS Comments 




RN1.1      
RN1.2      
RN1.3      
RN1.4      
RN2.1      
RN2.2      
RN2.3      
RN2.5      
RN2.6      
RN3.1      
RN3.2      
RN3.3      
RN3.4      
RN4.1      
RN4.2      
RN4.3      
RN4.4      
RN4.5      
RN5.1      
RN6.1      
RN6.2      
RN6.3      
RN6.4      
RN6.5      
RN6.6      
RN6.7      
RN6.8      
RN6.9      
RN6.10      
RN6.11      
16. Is the quality of evidence 




RN1.1      
RN1.2      
RN1.3      
RN1.4      
RN2.1      
RN2.3      
RN2.4      
RN2.5      
RN2.6      
RN3.1      
RN3.2      
RN3.3      
RN3.4      
RN4.1      
RN4.2      
RN4.3      
RN4.4      
RN4.5      
RN5.1      
RN6.1      
RN6.2      
RN6.3      
RN6.4      
RN6.5      
RN6.7      
RN6.8      
RN6.9      
RN6.10      









 Y N NA NS Comments  
17. Is the strength of each recommendation stated 
explicitly? Note: Strength of recommendation 
reflects anticipated level of adherence and is 
different from quality of evidence (Q16). 
Potential statements to satisfy this criterion 
might include “Strong recommendation”, 
“Standard”, Clinical option”, etc. 
RN1.1       
RN1.2       
RN1.3       
RN1.4       
RN2.1       
RN2.2       
RN2.3       
RN2.4       
RN2.5       
RN2.6       
RN3.1       
RN3.2       
RN3.4       
RN4.1       
RN4.2       
RN4.3       
RN4.4       
RN4.5       
RN5.1       
RN6.1       
RN6.2       
RN6.3       
RN6.4       
RN6.5       
RN6.6       
RN6.7       
RN6.8       
RN6.9       
RN6.10       
RN6.11       
18. Does the recommendation specify patient 
characteristics (such as coincident drug therapy 
and common co-morbid conditions) that require 
or permit individualization? 
RN1.1       
RN1.2       
RN1.3       
RN1.4       
RN2.1       
RN2.2       
RN2.3       
RN2.4       
RN2.5       
RN2.6       
RN3.1       
RN3.2       
RN3.4       
RN4.1       
RN4.2       
RN4.3       
RN4.4       
RN4.5       
RN5.1       
RN6.1       
RN6.2       
RN6.3       
RN6.4       
RN6.5       
RN6.6       
RN6.7       
RN6.8       
RN6.9       
RN6.10       
RN6.11       
19. Does the recommendation specify practice 
characteristics (such as location and availability 
of support services) that require or permit 
modification? 
 
RN1.1       
RN1.2       
RN1.3       
RN1.4       




RN2.2       
RN2.3       
RN2.4       
RN2.5       
RN2.6       
RN3.1       
RN3.2       
RN3.3       
RN3.4       
RN2.1       
RN2.2       
RN2.3       
RN2.4       
RN2.5       
RN2.6       
RN3.1       
RN3.2       
RN3.3       
RN3.4       
RN4.1       
RN4.2       
RN4.3       
RN4.4       
RN4.5       
RN5.1       
RN6.1       
RN6.2       
RN6.3       
RN6.4       
RN6.5       
RN6.6       
RN6.7       
RN6.8       
RN6.9       
RN6.10       







IV. Effect on process of care  
Questions  Recommendation 
identification 
Y N NA NS Comments  
20. Can the recommendation be carried out without 
substantial disruption in current workflow? 
RN1.1      
RN1.2      
RN1.3      
RN1.4      
RN2.1      
RN2.2      
RN2.3      
RN2.4      
RN2.5      
RN2.6      
RN3.1      
RN3.2      
RN3.3      
RN3.4      
RN4.1      
RN4.2      
RN4.3      
RN4.4      
RN4.5      
RN5.1      
RN6.1      
RN6.2      
RN6.3      
RN6.4      
RN6.5      
RN6.6      
RN6.7      
RN6.8      
RN6.9      
RN6.10      
RN6.11      
21. Can the recommendation be pilot tested without 
substantial resource commitment? For example, 
buying and installing expensive equipment to 
comply with a recommendation is not easily 
reversible. 
 
RN1.1      
RN1.2      
RN1.3      
RN1.4      
RN2.1      
RN2.2      
RN2.3      
RN2.4      
RN2.5      
RN2.6      
RN3.1      
RN3.2      
RN3.3      
RN3.4      
RN4.1      
RN4.2      
RN4.3      
RN4.4      
RN5.1      
RN6.1      
RN6.2      
RN6.3      
RN6.4      
RN6.5      
RN6.6      
RN6.7      
RN6.8      
RN6.9      
RN6.10      






Questions  Recommendation identification Y N NA NS Comment 
s 
22. Can adherence to this recommendation be 
measured?  Measurement of adherence requires 
attention to both the actions performed and the 
circumstances under which the actions are 
performed. 
RN1.1      
RN1.2      
RN1.3      
RN1.4      
RN2.1      
RN2.2      
RN2.3      
RN2.4      
RN2.5      
RN2.6      
RN3.1      
RN3.2      
RN3.3      
RN3.4      
RN4.1      
RN4.2      
RN4.3      
RB4.4      
RN4.5      
RN5.1      
RN6.1      
RN6.2      
RN6.3      
RN6.4      
RN6.5      
RN6.6      
RN6.7      
RN6.8      
RN6.9      
RN6.10      
RN6.11      
23. Can outcomes of this recommendation be 
measured?  Outcomes include such things as 
changes in health status, mortality, costs, and 
satisfaction. 
 
RN1.1      
RN1.2      
RN1.3      
RN1.4      
RN2.1      
RN2.2      
RN2.3      
RN2.4      
RN2.5      
RN2.6      
RN3.1      
RN3.2      
RN3.3      
RN3.4      
RN4.1      
RN4.2      
RN4.3      
RN4.4      
RN5.1      
RN6.1      
RN6.2      
RN6.3      
RN6.4      
RN6.5      
RN6.6      






RN6.8      
RN6.9      
RN6.10      




VI. Novelty / innovation  
Questions  Recommendation 
identification 
Y N NA NS Comments 
24. Can the recommendation be performed by the guideline’s 




















RN1.1      
RN1.2      
RN1.3      
RN1.4      
RN2.1      
RN2.2      
RN2.3      
RN2.4      
RN2.5      
RN2.6      
RN3.1      
RN3.2      
RN3.4      
RN4.1      
RN4.2      
RN4.3      
RN5.1      
RN6.1      
RN6.2      
RN6.3      
RN6.4      
RN6.5      
RN6.6      
RN6.7      
RN6.8      
RN6.9      
RN6.10      
RN6.11      
25. Is the recommendation compatible with existing attitudes 
and beliefs of the guideline’s intended users? 
 
RN1.1      
RN1.2      
RN1.3      
RN1.4      
RN2.1      
RN2.2      
RN2.3      
RN2.4      
RN2.5      
RN2.6      
RN3.1      
RN3.2      
RN3.3      
RN3.4      
RN4.1      
RN4.2      
RN4.3      
RN4.4      
RN4.5      
RN5.1      
RN6.1      
RN6.2      
RN6.3      
RN6.4      
RN6.5      
RN6.6      
RN6.7      
RN6.8      
RN6.9      
RN6.10      
RN6.11      




26. Is the recommendation consistent with patient expectations? 
In general, patients expect their concerns to be taken 
seriously, benefits of interventions to exceed risks, and 
adverse outcomes to fall within an acceptable range. 
 
RN1.2      
RN1.3      
RN1.4      
RN2.1      
RN2.2      
RN2.3      
RN2.4      
RN2.5      
RN2.6      
RN3.1      
RN3.2      
RN3.3      
RN3.4      
RN4.1      
RN4.2      
RN4.3      
RN4.4      
RN5.1      
RN6.1      
RN6.2      
RN6.3      
RN6.4      
RN6.5      
RN6.6      
RN6.7      
RN6.8      
RN6.9      
RN6.10      
RN6.11      
Additional comments: 
Further comments 
Barrier  Specific Suggested remedy Resolution  
    
    
    
    
    







Appendix 19: Contact information (Delphi survey) 
This document is for people who are participants in a research project. 
Contacts for Information on Project and Independent Complaints Procedure 
The following study has been reviewed and approved by the University of Adelaide 
Human Research Ethics Committee: 
Project Title: 
Reducing HIV related stigma and discrimination in healthcare settings: 






The Human Research Ethics Committee monitors all the research projects, which it has 
approved. The committee considers it important that people participating in approved 
projects have an independent and confidential reporting mechanism, which they can use if 
they have any worries or complaints about that research. 
This research project will be conducted according to the NHMRC National Statement on 
Ethical Conduct in Human Research (see 
http://www.nhmrc.gov.au/publications/synopses/e72syn.htm) 
1. If you have questions or problems associated with the practical aspects of your 
participation in the project, or wish to raise a concern or complaint about the project, 
then you should consult the principal supervisor: 
Name: Associate professor Craig Lockwood 
e-mail: craig.lockwood@adelaide.edu.au 
2. If you wish to discuss with an independent person matters related to:  
  making a complaint, or  
  raising concerns on the conduct of the project, or  
  the University policy on research involving human participants, or  
  your rights as a participant, 
 contact the Human Research Ethics Committee’s Secretariat on phone (08) 8313 6028 




Appendix 20: Participant Information Sheet (Participants of Delphi) 
Project Title: Developing/adapting and implementing an evidence-informed guideline to 
reduce HIV-related stigma and discrimination in healthcare settings 
Human Research Ethics Committee Approval Number: H-2016-140 
Principal Supervisor: Craig Lockwood 
Student Researcher: Garumma Tolu Feyissa 
Student’s Degree: PhD 
Dear Participant, 
You are invited to participate in the research project described below. 
What is the project about? 
The purpose of this project is to develop a guideline to reduce HIV-related stigma and 
discrimination in healthcare settings. Based on systematic literature searches, we have 
outlined some recommendations that may be included in the guideline. Before disseminating 
the guideline, testing the practical appropriateness and clarity of the recommendations is 
imperative. In this project, therefore, we will collect the input from experts. The expert panel 
consists of health managers, health professionals and researchers.  
As one member of the panel, we seek your input. We will be collecting opinions from 
experts on the draft recommendations through a series of e-mail surveys. 
Who is undertaking the project? 
This research will form the basis for the degree of Doctor of Philosophy for Mr. Garumma 
Tolu Feyissa at the University of Adelaide under the supervision of Associate professor 
Craig Lockwood and Associate Professor Zachary Munn, both from the University of 
Adelaide in Australia. The researchers involved in this project are all affiliated to Joanna 
Briggs Institute. The institute has been providing global support for evidence-based 
healthcare through training and developing methodologies for knowledge syntheses, transfer 
and utilization. 
Why am I being invited to participate? 
This project seeks to develop an evidence-informed guideline to reduce HIV-related stigma 
and discrimination in healthcare settings. The input from experts is essential to develop 
practical and feasible recommendations. Health managers, health professionals, and 
researchers are supposed to be knowledgeable of how health services should be designed to 
reduce HIV-related stigma and discrimination in healthcare settings. Being one of the 




selected to participate in the project. Before disseminating the guideline, the researchers 
would like to tailor the interventions taking local circumstances into consideration. 
Therefore, this project will seek opinions of experts on the draft recommendations outlined. 
Based on the consensus of the panel, we will develop practical recommendations that will 
be included in the guideline.  
What will I be asked to do? 
As a participant in this project, you will be asked to comment on the list of recommendations 
provided to you through e-mail on recommendations to be included in a guideline to reduce 
HIV-related stigma and discrimination in healthcare settings. The project involves asking 
participants for their opinions through a series of e-mail surveys. Participants are expected 
to respond to e-mails within a deadline of two weeks. 
How much time will the project take? 
The time needed to read through and comment on the recommendations may vary depending 
on individual circumstances. We guess that it will take one to two hours to respond to the 
questionnaires in each round. There will be multiple rounds of e-mail surveys. We expect 
two to three rounds of these survey. 
Are there any risks associated with participating in this project? 
Participating in this project does not pose any risks to the participants. However, it may 
consume your time and may remind you of old memories. 
What are the benefits of the research project? 
This project may not have immediate benefit as an individual for you. Nevertheless, it may 
help to develop and implement a guideline to reduce HIV-related stigma and discrimination 
in healthcare settings. This may reduce stigma related to HIV and thereby the services 
provided to HIV patients and their health service utilization in the long run. The guideline 
developed in this project may be used by health professionals and health managers (HIV 
prevention and control offices or health departments at different levels) and 
nongovernmental organizations.  
Can I withdraw from the project? 
Your participation is important for the success of this project. However, participation in this 
project is completely voluntary. If you agree to participate, you can withdraw from the panel 
at any time. Your non-participation or interrupting the interview will not affect your 
employment or your treatment. 




The information you provide will be kept confidential. However, the information provided 
by you will be provided as a summary to all the members of the panel. In that summary, the 
specific information that each person has provided will not be identified individually, but as 
a group input. Only the research team will access the specific information that you provide 
us. The final version of the report will be communicated to relevant stakeholders, the 
university of Adelaide (as a PhD dissertation), in conferences and peer-reviewed journals. 
The results of the study will be used to prepare the final version of a guideline used to reduce 
HIV-related stigma and discrimination in healthcare settings. Based on your consent, your 
name may be published in the final guideline. 
Who do I contact if I have questions about the project?  
If you have questions or problems associated with the practical aspects of your participation 
in the project, or wish to raise a concern or complaint about the project, then you should 
consult the project coordinator (Mr. Garumma Tolu Feyissa) through an e-mail address 
garumma.feyissa@adelaide.edu.au or phone call +251 931523749 or skype 
garumma.tolu.feyissa.  
What if I have a complaint or any concerns? 
The study has been approved by the Human Research Ethics Committee at the University of 
Adelaide (approval number H-2016-140) and by the Ethical review board of Jimma 
University College of Health Sciences. If you have questions or problems associated with 
the practical aspects of your participation in the project or wish to raise a concern or 
complaint about the project, then you should consult the Principal Investigator. Contact the 
chair of the Ethical review board of Jimma University College of Health Sciences (professor 
Mirkuzie Woldie) on phone +251 91780 4051 or by e-mail mirkuzie@yahoo.com.You can 
also contact the Human Research Ethics Committee’s Secretariat of the University of 
Adelaide on phone +61 8 8313 6028 or by email to hrec@adelaide.edu.au. If you wish to 
speak with an independent person regarding concerns or a complaint, the University’s policy 
on research involving human participants, or your rights as a participant. Any complaint or 
concern will be treated in confidence and fully investigated. You will be informed of the 
outcome. 
If I want to participate, what do I do? 
If you want to participate in the project, please return the signed consent form to the 





Garumma Tolu Feyissa (Assistant Professor) 
Craig Lockwood (Associate Professor) 
Zachary Munn (Associate Professor) 





Appendix 21: Consent form for Delphi panel and external panel 
1. I have read the attached Information Sheet and agree to take part in 
the following research project: 
Title: 
Reducing HIV related stigma and discrimination 
in healthcare settings: towards the development 





2. I have had the project, so far as it affects me, fully explained to my satisfaction by the 
research worker. My consent is given freely. 
3. Although I understand the purpose of the research project it has also been explained 
that involvement may not be of any benefit to me. 
4. I have been informed that, while information gained during the study may be published, 
I will not be identified, and my personal results will not be divulged. 
5. I understand that I am free to withdraw from the project at any time. 
6. I am aware that I should keep a copy of this Consent Form, when completed, and the 
attached Information Sheet. 
Participant to complete: 
Name:  _____________________ Signature: ________________________ Date:







Appendix 22: Participant Information Sheet (External Experts) 
 
 
PROJECT TITLE: Developing/adapting and implementing an evidence-informed 
guideline to reduce HIV-related stigma and discrimination in healthcare settings 
Human Research Ethics Committee Approval Number: H-2016-140 
Principal Supervisor: Craig Lockwood 
Student Researcher: Garumma Tolu Feyissa 
Student’s Degree: PhD 
Dear Participant, 
You are invited to participate in the research project described below. 
What is the project about? 
Through the assistance of researchers at Joanna Briggs Institute (the University of Adelaide), 
a guideline working group has drafted recommendations that will be part of an evidence-
informed guideline for reducing HIV-related stigma and promoting positive coping among 
people living with HIV and their families. The recommendations were drafted through 
multiple phases including systematic literature searches and expert consultation.  
In this phase of the project, we will gather opinions of external experts through e-mails to 
test the implementability of the guideline recommendations.  
Who is undertaking the project? 
This research will form the basis for the degree of Doctor of Philosophy for Mr. Garumma 
Tolu Feyissa at the University of Adelaide under the supervision of Associate Professor 
Craig Lockwood and Associate Professor Zachary Munn, both from the University of 
Adelaide. The researchers involved in this project are all affiliated to Joanna Briggs Institute. 
The institute has been providing global support for evidence-based healthcare through 
training and developing methodologies for knowledge syntheses, transfer and utilization. 
Why am I being invited to participate? 
This project seeks to develop an evidence-informed guideline to reduce HIV-related stigma 
and discrimination in healthcare settings. The input from experts is essential in order to 
develop practical and feasible recommendations. Being one of the potential stakeholders to 




project. The input we receive from stakeholders having adequate knowledge and experience 
of local context will help us to draft recommendations tailored to the local context. 
What will I be asked to do? 
As a participant in this project, you will be asked to comment on the list of recommendations 
to be included in a guideline to reduce HIV-related stigma and discrimination in healthcare 
settings. The project involves asking participants for their opinions through e-mails.  
How much time will the project take? 
The time needed to read through and comment on the recommendations may vary depending 
on individual circumstances. We estimate that it will take you one to two hours to respond 
to the questionnaire. 
Are there any risks associated with participating in this project? 
Participating in this project does not pose any risks to the participants. However, it may 
consume your time and may be reminded of old memories. 
What are the benefits of the research project? 
This project may not have immediate benefit as an individual for you. Nevertheless, it may 
help us to develop and implement a guideline to reduce HIV-related stigma and 
discrimination in healthcare settings. This may reduce stigma related to HIV and thereby the 
services provided to HIV patients and their health service utilization in the long run.  
Can I withdraw from the project? 
Your participation is highly important for the success of this project. However, participation 
in this project is completely voluntary. If you agree to participate, you can withdraw from 
the panel at any time. Your non-participation or interrupting the interview will not affect 
your employment or your treatment. 
What will happen to my information? 
The information you provide will be kept confidential. However, the information provided 
by you will be included in reports that may be published or presented in conferences as a 
summary. In that summary, the specific information that each person has provided will not 
be identified individually. Only the research team will access the information that you 
provide us. The information you provide us will be kept privately. The final version of the 
report will be communicated to relevant stakeholders, the University of Adelaide (as a PhD 
dissertation), in conferences and peer-reviewed journals. The results of the study will be 
used to prepare the final version of a guideline used to reduce HIV-related stigma.  




If you have questions or problems associated with the practical aspects of your participation 
in the project, or wish to raise a concern or complaint about the project, then you should 
consult the principal supervisor (Associate Professor Craig Lockwood) through an e-mail 
address craig.lockwood@adelaide.edu.au 
What if I have a complaint or any concerns? 
The study has been approved by the Human Research Ethics Committee at the University of 
Adelaide (approval number H-2015-xxx). If you have questions or problems associated with 
the practical aspects of your participation in the project, or wish to raise a concern or 
complaint about the project, then you should consult the Principal Investigator. Contact the 
Human Research Ethics Committee’s Secretariat on phone +61 8 8313 6028 or by email to 
hrec@adelaide.edu.au. If you wish to speak with an independent person regarding concerns 
or a complaint, the University’s policy on research involving human participants, or your 
rights as a participant. Any complaint or concern will be treated in confidence and fully 
investigated. You will be informed of the outcome. 
If I want to participate, what do I do? 
If you want to participate in the project, please return the signed consent form to the student 
researcher (Mr. Garumma Tolu Feyissa). 
Yours sincerely, 
Garumma Tolu Feyissa (Assistant professor) 
Craig Lockwood (Associate Professor) 
Zachary Munn (Associate Professor) 





Appendix 23: Semi-structured interview guide for health professionals and health 
managers 
The University of Adelaide, 
Faculty of Health Sciences 
 School of Public Health, Joanna Briggs Institute 
Semi-structured interview guide  
Introduction 
A guideline working group has developed an evidence-informed guideline for reducing 
HIV-related stigma and discrimination in healthcare settings. This guideline represents an 
appropriate means to reduce HIV-related stigma and improve quality of services delivered 
to people living with, and affected by HIV.  
Before disseminating the guideline in the form of publications and conference presentations, 
we would like to assess facilitators and barriers for the implementation of the guideline 
recommendations in Ethiopian healthcare settings. As a health professional or a health 
manger working with HIV patients, we believe that you will provide us detailed information 
on barriers and facilitators towards the implementation of the guideline recommendations. 
Our interview may take 30 min to one hour. Is the environment where you are sitting right 
now suitable? Do you need to make more adjustments so that there will be no disturbance 
during our discussion? If you are comfortable, we can continue our discussion now. 
A. Questions related to the nature of the evidence  
1. Have you read the document (guideline)?  
2. Are the recommendations included in this guideline clear and easy to understand? If 
not, how might you make them so? 
3. How might the guideline be made accessible to health professionals and health 
managers (facility heads, department heads, zonal and district health department 
heads)? Can it be built into current documentations? 
4. How can the recommendations included in this guideline be implemented? 
5. What might prompt the implementation of the guideline recommendations? What are 
the obstacles and facilitating factors for the implementation? 
6. Are additional tools needed? Are the tools suggested clear and easy?  
B. Questions related to potential adopters 
1. Are the schedules of health professionals flexible to allow them attendance at 




2. Have health professionals in your facility ever been exposed to evidence-based 
practice? If so, what has their previous experiences been? What went well? What 
did not go well? What can we learn from previous experiences? How can we 
modify the implementation approach? 
3. Do health professionals in your department work together as a team? How might 
that team work be improved? 
4. Do department heads or senior health professionals play role model in 
implementing the new recommendations? 
5. How is staff education on new protocols and guidelines delivered currently? How 
well does it work? If it works could the education needed to implement the 
current guideline recommendations be provided in this format? If not, is there 
another approach to education that might work with health professionals in your 
unit? 
6. Is there any specific format that you recommend for the category of health 
professionals? (Nurses, health officers, medical doctors, clinical psychologists, 
psychiatrists, laboratory technicians, etc.) 
C. Resources 
1. What resource constraints do you expect? (Probe: time, human, material, 
financial)? How can these resource constraints be tackled for the implementation 
of the guideline recommendations? 
D. Environmental factors 
1. What other competing interests of the organization impede the implementation 
of the recommendations? 
2. What are the corporate priorities? Does the implementation of these guideline 
recommendations complement the strategic goals for HIV control and 
prevention? What impact does it have on infection preventions and patient 
safety? 
3. What is the patient load of the facility? Does this impede the implementation of 
the recommendations? 
4. Are there adequate facilities for meetings and educational sessions (rooms, time, 
and motivated staff)? 




1. What types of data are already being monitored in the organization (hospital and JU 
and Jimma zone HAPCO)? Can you obtain access to that data? 
2. Is there any regular audit for practice in this health facility? 
3. Has ever current practice been evaluated? If yes, when? By whom? 







Appendix 24 Participant information sheet (in depth interview) 
Project Title: Developing/adapting and implementing an evidence-informed guideline to 
reduce HIV-related stigma and discrimination in healthcare settings  
Human Research Ethics Committee Approval Number: H-2016-140 
Principal Investigator: Craig Lockwood 
Student Researcher: Garumma Tolu Feyissa 
Student’s Degree: PhD 
Dear Participant, 
You are invited to participate in the research project described below. 
What is the project about? 
Through the assistance of researchers at Joanna Briggs Institute, the University of Adelaide, 
a guideline working group has drafted recommendations that will be part of an evidence-
informed guideline for reducing HIV-related stigma and discrimination in healthcare 
settings.  
In previous phases of this research, we have consulted an expert panel to comment on 
recommendations drafted through systematic literature searches and have made changes to 
the recommendations. In this phase, we are seeking indetailed information from health 
professionals on barriers and facilitators to the implementation of these recommendations. 
Therefore, we will collect the opinions of health professionals about the feasibility of 
application of the recommendations through indepth interviews. 
Who is undertaking the project? 
This research will form the basis for the degree of Doctor of PhilosophyforMr. Garumma 
Tolu Feyissa at the University of Adelaide under the supervision of Associate professor 
Craig Lockwood andAssociate Professor Zachary Munnfrom the University of Adelaide and 
professor Mirkuzie Woldie from Jimma University. The researchers involved in this project 
are all affiliated to Joanna Briggs Institute (JBI) and JBI collaborating center (JBC) at Jimma 
University. The JBI has been providing global support for evidence-based healthcare 
through training and developing methodologies for knowledge syntheses, transfer and 
utilization. 
Why am I being invited to participate? 
This project investigates the feasibility of application of the recommendations to reduce 




stakeholders to provide us information on the feasibility of implementation of the guidelines, 
you are now invited to participate in this final phase. 
What will I be asked to do? 
As a participant in this project, you will be asked about the barriers and facilitators towards 
implementing a guideline to reduce HIV-related stigma and promote positive coping among 
people living with and affected by HIV. The project involves asking participants indepth 
questions that may take 30 minutes to one hour about the guideline recommendations. In 
order not to miss the information you provide us the researcher will use an audio-recording. 
However, if you do not want your voice to be recorded, the interview may continue without 
recording your voice, and the information you provide us will be written down in a note 
book. After the interview, the interviewer may contact you for further clarifications. The 
interview will be conducted in a time that is comfortable for you.  
How much time will the project take? 
The interview may take from 30 minutes to one hour. 
Are there any risks associated with participating in this project? 
Participating in this project does not pose any risks to the participants. However, it may 
consume your time and may remind you of old memories. 
What are the benefits of the research project? 
This project may not have immediate benefit as an individual for you. Nevertheless, it may 
help to develop practical recommendations to reduce HIV-related stigma and discrimination 
in healthcare settings. This may reduce stigma related to HIV and thereby the services 
provided to HIV patients and their health service utilization in the long run. 
Recommendations tailored to the local context based on inputs from experts are expected to 
be feasible and practical for implementation. Developing these evidence-informed 
recommendations will play imperative role in improving the quality of health services 
delivered for HIV positive patients.  
Can I withdraw from the project? 
Your participation is highly important for the success of this research. However, 
participation in this research is completely voluntary. If you agree to participate, you can 
withdraw from the study at any time. Your non-participation or interrupting the interview 
will not affect your employment or your treatment. 




The information you provide will be kept confidential. After the interview is over, the audio-
records will be changed into a written form, in which you are only identified by codes, not 
names. The voice records will then be deleted after the transcription is over. Only the 
research team will access the voice records and written forms of the voice records. The 
records and transcripts will be kept privately. Your name will not be identified in the final 
report. Any clues that identify you personally will be removed from the final report. The 
final version of the report will be communicated to relevant stakeholders, the university of 
Adelaide (as a PhD dissertation), in conferences and peer-reviewed journals. The results of 
the study will be used to prepare the final version of a guideline used to reduce HIV-stigma.  
Who do I contact if I have questions about the project?  
If you have questions or problems associated with the practical aspects of your participation 
in the project, or wish to raise a concern or complaint about the project, then you should 
consult the principal supervisor (Associate Professor Craig Lockwood) through an e-mail 
address craig.lockwood@adelaide.edu.au.  
What if I have a complaint or any concerns? 
The study has been approved by the Human Research Ethics Committee at the University of 
Adelaide (approval number: H-2016-140). If you have questions or problems associated with 
the practical aspects of your participation in the project or wish to raise a concern or 
complaint about the project, then you should consult the Principal Investigator. Contact the 
Human Research Ethics Committee’s Secretariat on phone +61 8 8313 6028 or by email to 
hrec@adelaide.edu.au. If you wish to speak with an independent person regarding concerns 
or a complaint, the University’s policy on research involving human participants, or your 
rights as a participant. Any complaint or concern will be treated in confidence and fully 
investigated. You will be informed of the outcome. 
If I want to participate, what do I do? 
If you want to participate in the project, please return the signed consent form to the 
researcher (Mr. Garumma Tolu Feyissa) and arrange a place and time for interview. 
Yours sincerely, 
Garumma Tolu Feyissa (Assistant professor) 
Craig Lockwood (Associate professor) 
Zachary Munn (Associate professor) 




Appendix 25: Consent form for participants of in depth interview 
 
 
1. I have had the project, so far as it affects me, fully explained to my satisfaction by the 
research worker. My consent is given freely. 
2. Although I understand the purpose of the research project it has also been explained 
that involvement may not be of any benefit to me. 
3. I have been informed that, while information gained during the study may be published, 
I will not be identified, and my personal results will not be divulged. 
4. I understand that I am free to withdraw from the project at any time. 
5. I agree to the interview being audio/video recorded.  Yes  No  
6. I am aware that I should keep a copy of this Consent Form, when completed, and the 
attached Information Sheet. 
Participant to complete: 
Name:  _____________________ Signature: ________________________ Date:
 ___________________________  
Researcher/Witness to complete: 
I have described the nature of the research to
 ________________________________________________________________________  
  (print name of participant) 
and in my opinion, she/he understood the explanation. 
Signature: ________Position: ________Date: ________ 
  
Title: 
Reducing HIV related stigma and discrimination in healthcare settings: 
towards the development of an evidence-informed guideline 






Appendix 26: Quality and strength of evidence 
1. Interventions to reduce stigmatizing attitudes and actions of healthcare workers 
1.1.Peer education of healthcare workers 
Peer education of HCWs for stigma 
Question: Should Peer education of HCWs be used in stigma? 
Settings: healthcare setting 
Bibliography:  
1. Norr KF, Ferrer L, Cianelli R, Crittenden KS, Irarrázabal L, Cabieses B, et al.Peer group intervention for HIV prevention among 
health workers in Chile. Journal of the Association of Nurses in AIDS Care. 2012;23(1):73-86.  
Settings: healthcare setting 
Intervention: Peer education of HCWs 










Assumed risk Corresponding risk 
 Control Peer education of HCWs     
Public contact 
stigma 
Scale from: 1 to 
3. 
The mean public contact 
stigma in the control 
groups was 
1.11  
The mean public contact stigma 
in the intervention groups was 
0.07 lower 













The mean client contact 
stigma in the control 
groups was 
1.81  
The mean client contact stigma 
in the intervention groups was 
0.28 lower 







*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk 
(and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and 
its 95% CI). 
CI: Confidence interval;  
GRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of effect.  
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change 
the estimate. 
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to 
change the estimate. 
Very low quality: We are very uncertain about the estimate. 
1 No control group and the sample sizes at the baseline and post intervention survey are different, hence downgraded two levels for risk 
of bias 
2 Wide and statistically non-significant confidence interval 
Statement of evidence 
Norr et al. 2012153used professionally assisted peer education intervention and found a 
significantly lower scores of public contact stigma (MD=-0.0795% CI-0.12 to -0.02) among 
HCWs who received professionally assisted peer education intervention compared to that of 
HCWs in the control group [Low-quality evidence]. In addition, professionally assisted peer 
education intervention resulted in a significantly lower client contact stigma (MD=-
0.28(95% CI-0.37 to -0.19). 
Considerations 
A recent synthesis of qualitative studies reported that emotional reactions and fear 
management activities that health professionals take, had negative impact on PLHIV.137 The 
current team work structures in Ethiopian health facilities including one-to-five structures, 




in Ethiopian healthcare facilities such as compassionate, respectful and caring initiatives, are 
conducive opportunities to establish and reinforce peer education system. This creates more 
feasible structural environment to implement the intervention. The quality of evidence in the 
study was graded as low-quality evidence. Taking these factors into consideration, the 
evidence was taken as low- quality, strong evidence. 
1.2.Participatory education programs  
1.2.1. Multi-faceted educational program 
Question: Should A 5-day workshop comprising didactic lecture be used for Stigma? 
Settings: Healthcare setting 
Bibliography: Williams AB, Wang H, Burgess J, Wu C, Gong Y, Li Y. Effectiveness of an HIV/AIDS educational program for Chinese 
nurses. Journal of advanced nursing. 2006;53(6):710-720. 
A 5-day workshop comprising didactic lecture for Stigma 
Patient or population: patients with Stigma 
Settings: Healthcare setting 
Intervention: A 5-day workshop comprising didactic lecture 










Assumed risk Corresponding risk 
 Control A 5-day workshop comprising 
didactic lecture 
    
Empathy 
Scale from: 1 to 6. 
Follow-up: mean 
5 days 
The mean empathy in the 
control groups was 
4.1  
The mean empathy in the 
intervention groups was0.2 









Scale from: 1 to 6. 
Follow-up: mean 
5 days 
The mean avoidance 
attitude in the control 
groups was 
3.5  
The mean avoidance attitude in the 














The mean general attitude 
towards PLHIV in the 
control groups was 
3.5  
The mean general attitude towards 
PLHIV in the intervention groups 









care for PLHIV 




The mean nurses’ 
willingness to care for 
PLHIV in the control 
groups was 
97  
The mean nurses’ willingness to care 
for PLHIV in theintervention groups 







*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk 
(and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and 
its 95% CI). 
CI: Confidence interval;  
GRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of effect.  
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change 
the estimate. 
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to 
change the estimate. 
Very low quality: We are very uncertain about the estimate. 
1 No enough information on how lost participants were handled was given. 9% did not provide responses to all questions 
2 No control group 
 




One study  conducted in China (Williams et al.2006152) used a 5-day multifaceted 
educational program comprising didactic lectures on HIV/AIDS epidemiology, natural 
history, transmission routes and clinical care combined with activities that provoke 
discussion of participants’ values and personal feelings about HIV/AIDS. The intervention 
resulted in significant improvement in empathy (mean difference (MD) 0.2 higher); 
reduction in avoidance attitude (MD 0.4 lower) and improvement in general attitude towards 
PLHIV (MD 0.6 higher) and willingness to care for PLHIV (MD 13 higher). [Very low 
quality of evidence]The findings from the study was assigned a very low-quality evidence. 
Considerations  
The intention of health professionals to avoid providing services to PLHIV and the 
utilization of PLHIV-specific extra precautions has been raised as a concern by PLHIV in 
previous qualitative researches.125, 137Moreover, currently, HAPCO has training programs 
and venues and there are adequate motivated staff in Jimma University that are willing to 
provide trainings and workshops. In addition, Jimma University Teaching Hospital has 
motivated staff, and suitable training venues and committed administration that supports in 
service training and workshops.With these considerations, multi-faceted educational 
programs containing didactive lectures, was assigned as very low-quality, strong evidence. 
 
1.2.2. Participatory education programs, provision of supplies and materials and 
Participatory hospital policy development 
Participatory self-guided assessment and intervention for Stigma 
Question: Should Participatory self-guided assessment and intervention be used for Stigma? 
Settings: Healthcare setting  
Bibliography: 
1. Mahendra V, Gilborn L, Bitra G, Samson L, Mudoi R, Jadav S, et al. Reducing stigma and discrimination in hospitals: Positive 
findings from India. Washington, DC: Population Council; 2006  
2. UNAIDS. Reducing HIV stigma and discrimination: A critical part of national AIDS programs: A resource for national stakeholders 
in the HIV response: Joint United nations program on HIV/AIDS (UNAIDS); 2007. 











Assumed risk Corresponding risk 
 Control Participatory self-guided 
assessment and intervention 
    
Stigma index (attitude 
towards PLIV and healthcare 
related practices) 
Scale from: 21 to 63 
Follow-up: mean 6 months 
The mean stigma 
index (attitude 
towards PLIV and 
healthcare related 
practices) in the 
control groups was 
42.79  
The mean stigma index (attitude 
towards PLIV and healthcare 
related practices) in the 
intervention groups was 







Use of glove when drawing 
blood if sero-status is 
unknown 
Follow-up: mean 6 months 








642 per 1000 1000 per 1000 




Sought informed consent 
before HIV test 
Follow-up: mean 6 months 








403 per 1000 862 per 1000 
(471 to 1000) 
Moderate 
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk 
(and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and 
its 95% CI). 
CI: Confidence interval; RR: Risk ratio;  
GRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of effect.  
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change 
the estimate. 
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to 
change the estimate. 
Very low quality: We are very uncertain about the estimate. 
1 No control group 
2 The hospitals were conveniently selected. A cross sectional sample of providers was taken from the selected hospitals.  
 
1.2.3. Addressing ‘fear-based’ stigma (stemming from lack of knowledge) 
compared to addressing both fear-based and social stigma (stemming 
from moral judgments). for Hospital staff 
Patient or population: Hospital staff 
Settings: Hospital 
Intervention: Addressing ‘fear-based’ stigma (stemming from lack of knowledge) 
Comparison: addressing both fear-based and social stigma (stemming from moral judgments). 
Bibliography: 
Pulerwitz J, Oanh KT, Akinwolemiwa D, Ashburn K, Nyblade L. Improving hospital-based quality of care by reducing HIV-related 
stigma: evaluation results from Vietnam. AIDS and behavior. Feb 2015;19(2):246-256. 



















stigma (stemming from lack of 
knowledge)     
Fear-based stigma 
Scale from: 4 to 12. 
Follow-up: mean 6 months 
The mean fear-
based stigma in the 
control groups was 
5.1  
The mean fear-based stigma in 
the intervention groups was0.37 








Scale. Scale from: 5 to 15. 
Follow-up: mean 6 months 
The mean social 
stigma in the 
control groups was 
7.4  
The mean social stigma in the 
intervention groups was0.14 








Overusing any form of 
barrier protection 
scale 
Follow-up: mean 6 months 








168 per 1000 98 per 1000 
(59 to 155) 
Signs on bed indicating HIV 
status 
Follow-up: mean 6 months 








851 per 1000 587 per 1000 
(285 to 832) 
Marked files indicating HIV 
status 
Follow-up: mean 6 months 








98 per 1000 55 per 1000 
(30 to 98) 
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk 
(and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and 
its 95% CI). 




GRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of effect.  
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change 
the estimate. 
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to 
change the estimate. 
Very low quality: We are very uncertain about the estimate. 
1 Cross-sectional nature of data collection, Facility characteristics were not considered 
Statement of evidence 
Two pre-post studies (Pulewitz et al. 201513 and Mahendra et al.2006154) utilized a 
combination of staff training, participatory policy development, and the provision of 
materials and supplies. In both studies, the interventions were combined with the testimony 
of PLHIV or PLHIV advocates. The studies resulted in significant reductions in 
discriminatory actions of healthcare workers (marking files, overuse of barriers when 
handling PLHIV) six months after the intervention. In both studies, there was very low-
quality of evidence in support of the intervention. 
Consideration 
From the synthesis of qualitative studies, it was found that the overuse of any form of barrier 
or segregation of PLHIV files was found a critical stigmatizing action that clients want to be 
tackled.137 Lack of confidentiality was raised as a concern by PLHIV in qualitative 
studies.125, 137 
In addition, in an Ethiopian based qualitative research, PLHIV recommended that healthcare 
providers be provided with training.125Moreover, currently there are training programs on 
HIV related topics supported by various partners. Therefore, training programs for stigma 
reduction can be integrated into such programs. Taking these considerations into action, the 






1.2.4. Participatory education program with the testimony of PLHIV or PLHIV 
advocates 
1.2.4.1. Modular interactive training and discussion 
Interactive training and discussion focusing on HIV-related stigma, infection control and medical ethics and contact with 
PLHIV for Value based stigma and fear based stigma 
Question: Should interactive training and discussion focusing on HIV-related stigma, infection control and medical ethics and contact 
with PLHIV be used for Value based stigma and fear based stigma? 
Bibliography:  
Lohiniva A-L, Benkirane M, Numair T, Mahdy A, Saleh H, Zahran A, et al. HIV stigma intervention in a low-HIV prevalence setting: 
a pilot study in an Egyptian healthcare facility. AIDS care. 2016;28(5):644-652. 
 










Assumed risk Corresponding risk 
 
Control Interactive training and discussion focusing 
on HIV-related stigma, infection control 
and medical ethics and contact with PLHIV 






1 to 10 
The mean fear-based 
stigma in the control 
groups was3.2  
The mean fear-based stigma in the intervention 
groups was2.1 lower 












1 to 10 
The mean value-
based stigma in the 
control groups was 
3.8  
The mean value-based stigma in the 








*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk 
(and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and 
its 95% CI). 
 
CI: Confidence interval;  
GRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of effect.  
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change 
the estimate. 
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to 
change the estimate. 
Very low quality: We are very uncertain about the estimate. 
1 One control hospital and one experimental hospital was used (Conveniently selected) 
2 Groups had different scores in fear-based stigma at baseline 
Evidence statement 
Three studies (two observational studies (Pulewitz et al.201513 Mahendra et al. 2006154 and 
Lohiniva et al.2016290) used the testimonies of PLHIV or PLHIV advocates as a component 
of their participatory educational interventions. The studies demonstrated significant 
reductions in stigma scores and significant improvement in the practice of universal 
precaution and respect for client’s confidentiality six months after the intervention 
(Mahendra et al.2006154). Interventions having contact-based approach components also 
resulted in significant reductions in fear-based and value-based stigma (Lohiniva et al. 
2016290 and Pulewitz et al. 201513) and value-based stigma (Lohiniva et al. 2016290) The 





A recent synthesis of qualitative studies reported that emotional reactions and fear 
management activities that health professionals take had negative impact on PLHIV. The 
use of extra-precaution specifically when handling PLHIV was a concern for PLHIV.137 In 
addition, standard precaution is one of the requirements of hospitals.Moreover, currently, 
HAPCO has training programs and venues and there are adequate motivated staff in Jimma 
University that are willing to provide trainings and workshops. In addition, Jimma 
University Medical Center (JUMC) has motivated staffs, and suitable training venues and 
committed administration that supports in service training and workshops. The existence of 
expert patients is also an opportunity that helps to realize the contact strategy provided along 
with the modular training.With the above considerations, participatory education program 
with the testimony of PLHIV or PLHIV advocates or a contact strategy component, was 
assigned as strong, very low-quality evidence. 
1.3.Identifying and training popular opinion leaders 
Training popular opinion leaders for stigma 
Question: Should Training popular opinion leaders be used for stigma? 
Settings: Healthcare settings 
Bibliography:  
1. Li L, Guan J, Liang L-J, Lin C, Wu Z. Popular opinion leader intervention for HIV stigma-reduction in health care settings. AIDS 
Education and Prevention. 2013;25(4):327-335.  
 










Assumed risk Corresponding risk 
 Control Training popular opinion 
leaders 
    
Avoidance intent 




The mean avoidance intent in 
the control groups was 
18.65  
The mean avoidance intent in 
the intervention groups was 
1.87 lower 











The mean prejudicial attitude 
in the control groups was not 
reported 
 
The mean prejudicial attitude 
in the intervention groups 
was 
3.77lower 













The mean compliance to UP 
in the control groups was 
32.88  
The mean compliance to UP 
in the intervention groups 
was 
1.65 lower 







*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk 
(and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and 
its 95% CI). 
CI: Confidence interval;  
GRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of effect.  
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change 
the estimate. 




change the estimate. 
Very low quality: We are very uncertain about the estimate. 
1 The hospitals were randomized into intervention and control groups. A matched-pair design was applied to optimize the 
randomization. However, method of the selection of the pairs was not clear. 
2 No explanation was given about blinding of allocators 
NB: UP: Universal precaution 
Evidence statement  
One RCT (Li et al.2013254) identified and trained popular opinion leaders to reduce stigma 
and discrimination in healthcare facilities. The trial found significant reduction in avoidance 
intent (MD=-1.87(95% CI -2.05 to -1.69 lower) and prejudicial attitude (MD=-3.78  
(95% CI -5.4 to -2.09) and increment in compliance to universal precaution (MD=-1.65  
(95% CI -.89 to -1.41)) 12 months after the intervention. The evidence from this trail was 
assigned as moderate-quality evidence. 
Considerations  
Prejudicial attitudes have been raised as concerns by PLHIV in a previous qualitative 
reviews137 The intention of healthcare professionals to avoid providing services to PLHIV 
and the utilization of PLHIV-specific extra precautions has been raised as a concern by 
PLHIV in previous qualitative researches.125, 137 
The current teamwork structures in Jimma University Medical Center (JUMC), including 
one-to-five structures, HIV mentorship program and regular Multidisciplinary Team (MDT) 
meetings and new initiatives in healthcare facilities such as compassionate, respectful and 
caring (CRC) initiatives create a conducive environment to establish and reinforce this 
intervention. With these considerations, identifying and training popular opinion leaders was 





2. Interventions to reduce perceived/felt stigma and increase coping among PLHIV 
2.1.Participatory planning (Contact strategy) 
Question: Should Contact strategy with information giving and empowerment be used for HIV-related stigma? 
Settings: Healthcare settings 
Bibliography: 
Uys L, Chirwa M, Kohi T, Greeff M, Naidoo J, Makoae L, et al. Evaluation of a Health Setting-Based Stigma Intervention in Five 
African Countries. AIDS Patient Care and STDs. 2009;23(12):1059-1066. 
Contact strategy with information giving and empowerment for HIV-related stigma 
Patient or population: patients with HIV-related stigma and HCWs (nurses) 
Settings: Healthcare settings 
Intervention: Contact strategy with information giving and empowerment  










Assumed risk Corresponding risk 
 
Control Contact strategy with 
information giving and 
empowerment  
    
PLHIV self-esteem 
Scale from: 10 to 40 
Follow-up: mean 1 
months 
The mean PLHIV self-
esteem in the control 
groups was 
19.46  
The mean PLHIV self-esteem 
in the intervention groups was 
2.12 higher 









Scale: Not described 
Follow-up: mean 1 
months 
The mean PLHIV 
workplace stigma in the 
control groups was 
0.46  
The mean PLHIV workplace 
stigma in the intervention 
groups was 
0.31 lower 







Total stigma score 
Scale: Not described 
Follow-up: mean 1 
months 
The mean total stigma 
score in the control groups 
was 
0.42  
The mean total stigma score in 
the intervention groups was 
0.17 lower 








Scale: Not described 
Follow-up: mean 1 
months 
The mean self-perception 
in the control groups was 
0.82  
The mean self-perception in 
the intervention groups was 
0.46 lower 









Scale: Not described 
Follow-up: mean 1 
months 
The mean nurses' 
stigmatizing behaviour in 
the control groups was 
0.46  
The mean nurses' stigmatizing 
behaviour in the intervention 
groups was 
0.07 higher 







*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk 
(and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and 
its 95% CI). 
CI: Confidence interval;  
GRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of effect.  
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change 
the estimate. 
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to 
change the estimate. 
Very low quality: We are very uncertain about the estimate. 
1 No control group. The intervention sites were conveniently chosen by researchers based on accessibility and willingness to participate. 
2 Five unique case studies were combined, which might have masked differences among the settings 
3 case series 
4 Wider confidence interval 
Evidence statement 
A multi-country observational study (Uys et al.2009158) used a contact strategy which 
included information giving, empowering PLHIV and bringing PLHIV and healthcare 
workers together to plan together.The study found increased self-esteem (MD=2.12  
(95% CI 0.18 to 4.06) and reduced negative self-perception (MD=-0.46  




(95% CI -0.35 lower to 0.01) among PLHIV one month after the intervention. Overall, the 
quality of evidence is very low. 
Considerations 
Currently expert patients work in Ethiopian healthcare facilities as adherence supporters and 
counsellors. Hence, they can bring other clients together to plan with HCWs to address 
PLHIV related concerns. In addition, the self-perception and perceived workplace stigma is 
critical for PLHIV to attend and adhere to treatments at health facilities. Negative self-
perception and internalized stigma is also associated with higher rates of depression.259With 
these considerations, empowering PLHIV to come together to plan with HCWs in reducing 






Appendix 27: Facility assessment checklist (PLHIV Friendly checklist for healthcare 
facilities) 
Name of Hospital: _____________________________________________________________ 
Report Months: _______________________________________________________________ 
No of stigma and discrimination related complaints from the PLHIV: ________________ 
Assessment of quality of care 
PLHIV friendly checklist 
I. Access to care services  
a. Practice  Yes 
/No 
Remarks  
1 Treatment and care for PLHIV (or patients awaiting results of an HIV test) was denied, 
delayed, or referred elsewhere for services available within the hospital 
  
2 Treatment and care for PLHIV was of the same quality as the 
treatment and care provided to other patients 
  
3 PLHIV are not segregated or isolated   
4 The hospital actively links PLHIV to sources of existing Palliative Care social support in 
their own communities such as NGOs, PLHIV networks and other social support services 
  
b. Training   
1.  All staff have received training in “Patients’ right and the right of PLHIV to equal care and 
confidentiality” during the last 6 months 
  
C. Quality Assurance   
1.  An accessible patient grievance cell, which registers and addresses 
patient complaints, is in place and opened daily 
  
2.  The existence of the grievance cell is posted in each ward and in all 
patient waiting areas 
  
3.  Timely action was taken against perpetrators of stigma and 
discrimination of PLHIV 
  
d. Policy   
1 A hospital policy is in place that guarantees all the above   
2.  Hospital policy on access and right to care is posted in all 
departments and patient waiting areas 
  
3.  All hospital staff are aware of the policy   
II. TESTING AND COUNSELLING   
a. Practice   
1.  All HIV tests were voluntary   
2.  All HIV tests were done after pre-test counselling by a trained 
counsellor and taking informed consent 
  
3.  All test results were communicated to the patient during post-test counselling by a trained 
counsellor 
  
b. Training   
1.  HIV test counsellors are trained and have received refresher training during the last one 
year 
  
2.  All hospital staff have been trained in principles and procedures of voluntary testing and 
counselling 
  
c. Quality Assurance   
3.  Criteria for assessing quality of pre-and post-counselling, and follow up counselling has 
been defined and all relevant hospital staff are aware of the criteria 
  
4.  There is a system to ensure that the counselling needs the defined 
criteria of quality 
  
d. Policy   
1.  A hospital policy that guarantees all the above is in place   
2.  Hospital policy on testing and counselling is displayed in all 
departments and patient waiting areas 
  
3.  All hospital staff providing services to PLHIV are aware of this 
Policy 
  
III. CONFIDENTIALITY   
a. Practice   
1.  Information about HIV status was communicated only to the patient and treating doctor   
2.  PLHIV have been encouraged to and supported to disclose status to the spouse and other 
family members 
  
3.  PLHIV beds, wards, and files are not labelled in way to their HIV 
status to other patients or staff 
  
4.  The discharge sheet and other patient documents do not mention 
HIV positive status 
  
b. Training   
1.  All hospital staff have received trained in the principles of and 
patients’ rights to confidentiality during the last 6 months 
  
c. Quality Assurance   
1.  There is a system to monitor the management of information 





d. Policy   
1.  A hospital policy guarantees all the above is in place   
2.  Hospital policy on testing and counselling is displayed in all 
departments and patient waiting areas 
  
3.  All hospital staff are aware of this policy   
IV. INFECTION CONTROL   
a. Practice   
1.  Standard Precautions are practiced by all hospital staff irrespective of the known HIV 
status of the patients 
  
2.  Waste management guidelines are practices always by all the staff   
3.  All needle prick injuries and other exposures to infected body fluids are recorded within an 
hour of exposure 
  
4.  All staff are aware of the procedure of accessing PEP always   
5.  All staff were provided with free hepatitis vaccines and post 
exposure prophylaxis (PEP) as and when necessary 
  
b. Training   
1.  All staff have been trained in infection control (including universal 
precautions), waste management, and PEP during the last 6 months 
  
c. Quality Assurance   
1.  Essential supplies for standard precautions and infection control are available always to all 
staff 
  
2.  PEP drugs are available and accessible to all staff always   
3.  An infection control team is in place and meets every month to 
monitor infection control practices and supplies 
  
4.  Information, education and communication (IEC) materials on 
infection control procedures are posted in all wards, operation 
theatres and staff areas 
  
5.  PEP guidelines have been posted in all wards, operation theatres and staff areas   
d. Policy   
1.  Hospital policy that guarantees all the above and a safe working environment for all 
hospital staff is in place 
  
2.  Hospital policy on infection control and staff safety is placed in all departments and patient 
waiting areas 
  
V. QUALITY OF CARE   
a. Practice   
1.  PLHIV were provided the highest standard of clinical management and care available at 
the hospital 
  
2.  All pregnant women were offered, though not compelled to accept, HIV testing, 
antiretroviral (ARV) treatment to reduce likelihood of mother-to-child transmission of 
HIV during delivery (if possible) and advice on infant feeding 
  
3.  Testing of pregnant women was voluntary and confidential and was accompanied by pre-
and post-test counselling 
  
4.  PLHIV were offered, or referred services that offer advice on 
nutrition and health promoting lifestyles 
  
5.  All HIV positive pregnant women and their babies were referred to the ART centre   
b. Training   
1.  All clinical staff have received training in management of 
opportunistic infections and broad principles of management of 
HIV infection 
  
c. Quality Assurance   
1.  ART and/or essential drugs for reducing mother-to-child 
transmission and treating opportunistic infections) OIs) have been available all the time 
and have been administered whenever needed 
  
2.  The clinicians involved in management of HIV infection have been tracking advances in 
clinical management of HIV and AIDS 
  
3.  Guidelines for management of opportunistic infections and other diseases for PLHIV 
(including those on ART) are available in each department 
  
d. Policy   
1.  A hospital policy that guarantees all the above is in place   





Appendix 28: Discrimination free checklist short version for post on service points 






Appendix 29: Reminders for health professionals 
Checkpoints-a poster at service delivery point 
As a disciplined health professional are you free from the following actions? 
1. Denial of care, 
2. Provision of substandard care 
3. Making a health service conditional (for example, registering as ART customer in 
the facility, bringing sexual partner, 
4. Premature discharge, 
5. Poor follow up 
6. HIV testing without consent, 
7. Breach of confidentiality (example, disclosure without consent, marking files),  
8. Using excessive protective barriers to prevent infection, 
9. Compulsory or forced treatment, 
10. Segregation of clients or marking the files of clients who are HIV positive, 
11. Unnecessarily referring the client to other institutions, 
12. Stigmatizing words (gossip and labelling) and actions and  
13. Blaming those infected by HIV.  
 
 
 
 
 
 
 
 
  
